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Abstract 
 
Staphylococcus aureus is a bacterial pathogen that is believed to be the most common 
agent of human infectious disease, causing conditions ranging from common skin lesions 
to life-threatening illnesses.  S. aureus has also shown a remarkable ability to develop 
resistance to antimicrobial treatment, making infections difficult to treat.  In the post-
genomic era, proteomic studies analyzing the protein complement of a genome in a 
particular organism at any given time, have gained real significance. This result is largely 
due to dynamic changes in protein expression profiles which can lead wide alterations in 
physiology and behavior.  For proteomics, it is necessary to maximize protein 
concentration and to devise a method that can be easily employed and provide 
reproducible results.  Most proteomic studies of S. aureus involve 2D gel electrophoresis 
(2-DE); however, 2-DE has many drawbacks.  Proteins that are too large, hydrophobic, 
acidic, or basic are poorly resolved.  Multi-dimensional protein identification (MudPIT) 
allows complex protein samples to be analyzed in solution.  As yet, there has not been a 
study involving solely 2D liquid chromatography followed by mass spectrometric 
analysis in S. aureus; therefore we sought to catalogue the intracellular proteome and 
secretome of a commonly used and well-studied lab strain, SH1000. This was conducted 
during post-exponential and stationary phases of growth so as to understand its adaptation 
over time by utilizing differential protein synthesis.  We found cytoplasmic proteins 
involved in glycolysis to be highly expressed in post-exponential phase while proteins 
involved in tricarboxylic acid cycle to be prevalent in stationary phase.  We also found 
x 
 
production of agr-regulated secreted toxins and proteases to be upregulated in stationary 
phase. In addition to this we employed proteomic approaches to quantitatively profile the 
secretomes of leading clinical isolates of S. aureus, as such a study is currently lacking. 
These included the two most common hospital-associated S. aureus strains (USA100 and 
USA200), and the two most common community-associated S. aureus strains (USA300 
and USA400). We found agr-regulated proteins are generally upregulated in CA-MRSA 
strains USA300 and USA400 and surface-associated proteins to be upregulated in HA-
MRSA strains USA100 and USA200.  This finding concurs with literature regarding 
transcriptomic studies showing a hyperactive agr in CA-MRSA strains compared to HA-
MRSA strains.   
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Introduction 
 
The Staphylococci.  Staphylococcus is a genus of Gram-positive bacteria that have 
characteristic spherical cells (cocci) in the arrangement of grape-like clusters. Indeed the 
word staphylos is derived from Greek, meaning bunch of grapes.  These bacteria are 
facultative anaerobes and are commonly tolerant to high concentrations of salt that 
normally inhibit the growth of other bacteria [52, 76].  Staphylococci include bacteria 
that are a part of the normal skin flora, such as Staphylococcus epidermidis, and others 
who are medically significant human pathogens, such as Staphylococcus aureus [13]. 
Staphylococcus aureus 
 Staphylococcus aureus is different from other staphylococci due to the rich golden 
pigmentation of its colonies, as denoted by its name aureus, which is Greek for “golden”.  
It can be found anywhere in the environment, from soil, air, water, and sewage; as well as 
inhabiting the skin and mucous membranes of warm-blooded animals. It is innately 
resistant to desiccation, and can live on inanimate objects for extended periods of time 
[105].   S. aureus is an opportunistic pathogen, meaning that it is not obligated to this 
lifestyle, but more commonly causes disease only upon entering the body via wounds or 
indwelling devices [121].  The genome of S. aureus commonly consists of a single, 
circular chromosome of approximately 2.8 million base pairs [85].  Additionally, strains 
of S. aureus may also possess mobile genetic elements such as prophages, plasmids and 
transposons that can be transferred between themselves and other gram-positive bacteria 
[162, 114].     
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The diseases of Staphylococcus aureus   
As a major human pathogen, S. aureus is believed to be the most common cause of 
human disease [51].  It has the ability to cause a wide range of infections that are both 
nosocomially and community acquired.  These diseases vary from common skin lesions, 
such as wound infections and abscesses, to life-threatening illnesses, such as septicemia 
and endocarditis [121].  Moreover, localized skin infections can spread from the initial 
site of colonization to other parts of the body via systemic dissemination.  This can lead 
to metastatic infections at locations such as the heart muscle, joints, brain, lungs, and 
bones; causing endocarditis, septic arthritis, brain abscesses, pneumonia and 
osteomyelitis [121].  Another subset of diseases caused by S. aureus is toxinoses.  These 
are caused by particular toxins, and include scalded skin syndrome (exfoliative toxins), 
toxic shock syndrome (toxic-shock syndrome toxin), and gastroenteritis (enterotoxins) 
caused by food poisoning [5].  Recently, the production of the Panton-Valentine 
leukocidin (PVL) toxin has been associated with fatal necrotizing pneumonia, leading to 
death within 36 hours [70].   
Toxin production by Staphylococcus aureus 
S. aureus is an adaptive and versatile pathogen that possesses a diverse arsenal of 
virulence factors, which it employs to cause disease in a variety of niches within the host.  
These virulence factors are, however, considered accessory elements as they are not 
crucial to survival.  The virulence determinants of S. aureus include cytolytic toxins, 
several extracellular proteins [152, 91, 146], major secreted proteases [188, 117, 178], 
and surface-associated factors [37] that work alone or in concert to facilitate disease.  
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Alpha-hemolysin is perhaps the major secreted toxin, and is cytolytic in action, forming 
pores in the membrane of red blood cells, epithelial cells, endothelial cells, platelets, and 
mononuclear immune cells.  Membrane damaged caused by direct action of this toxin 
often results in apoptosis of the target cell, and necrosis of surrounding tissue [12, 53, 19, 
132]. In addition to alpha-hemolysin, S. aureus also produces at least 3 other such factors, 
including the β-, γ-, and δ-hemolysins. The β-hemolysin is another cytolytic toxin that 
induces hot-cold lysis of red blood cells [61, 65], and is one of the most abundant 
proteins secreted by S. aureus into the extracellular medium [450].  δ-hemolysin is a 
small and heat-stable protein that can be lytic towards several types of membranes, 
including those of red blood cells, organelles and even bacterial protoplasts [61].  The γ-
hemolysin and other toxins produced by S. aureus (such as a number of leukocidins), 
contain two components, commonly termed S and F [75, 98].  In the case of PVL it has 
the ability to lyse only neutrophils and macrophages [158], whilst the gamma-hemolysin 
can also lyse red blood cells by forming a pore in their membrane [98, 182].  In addition 
to toxins that act directly on the membrane of host cells, S. aureus also produces 
pyrogenic toxin superantigens that include staphylococcal enterotoxins A-E and toxic 
shock syndrome toxin-1 (TSST-1) [17].  These superantigens stimulate T cells and 
cytokine activity that adversely affects the host by causing fever, shock, and 
immunosuppression [137].  Exfoliative toxins on the other hand, have a far more specific 
mode of action, causing scalded-skin syndrome via the targeted destruction of human 
desmoglein 1, causing blister formation and sloughing of the skin [130].  Additionally, 
there are a total of seven phenol-soluble modulins (PSMα1-PSMα4, PSMβ1, PSMβ2, and 
delta-toxin), which display leukocidal activity, and facilitate evasion of the host immune 
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system.  The psm genes have been identified in all sequenced strains of S. aureus, 
however, the expression of these genes can differ significantly [194].     
In addition to specific toxins, S. aureus also produces extracellular enzymes that serve as 
virulence factors by degrading host tissue, facilitating dissemination, and helping to 
evade the host immune system.  Coagulase, for example, converts fibrinogen to fibrin 
[102] and is thought to create a clot around localized infections to protect the bacteria 
from host defenses [172].  Conversely, staphylokinase is an activator of plasminogen [32] 
and may serve to release bacteria from these fibrin clots to allow spreading to other sites 
of the body [93].  S. aureus also produces a series of extracellular proteases that are 
commonly produced as a pre-proenzyme which are enzymatically inactive, and require 
activation in the extracellular millieu [178].  Perhaps the most abundant of these is the 
SspA or V8 serine protease, which cleaves immunoglobulins, thereby inhibiting host 
defense mechanisms [157].  It also seems to be important for transition from adhesive to 
non-adhesive phenotypes via degradation of fibronectin-binding proteins, and other 
proteins on the surface of S. aureus cells [100, 126].  In addition to the V8 protease, there 
are many other serine protease-like enzymes (SplA through SplF) that have trypsin-like 
catalytic activity, but are not cleaved by other enzymes for activation.  S. aureus also 
secretes two cysteine proteases, known as staphopain A and staphopain B.  Staphopain A 
has strong activity against elastin, suggesting a role in the pathogenesis of S. aureus 
[154], whilst staphopain B (sspB) cleaves fibronectin, fibrinogen, and kininogen, 
suggesting that it may serve to allow the spread of S. aureus during infection [35, 178].  
The final major proteolytic enzyme is a metalloprotease, known as aureolysin, which has 
activity against plasma protease inhibitors, suggesting a role in the pathogenesis of S. 
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aureus [154, 155].  A further protease-like enzyme, lipase, exists, which is a glycerol 
ester hydrolase that cleaves long-chain triacylglycerols [109], and may have a role in the 
in vivo nutrition of S. aureus [166].   
The regulation of toxin production   
The success of S. aureus as a pathogen is commonly attributed to its vast array of 
virulence determinants, which are tightly controlled by a central global regulator called 
agr (for accessory gene regulator) [4, 91, 144, 145, 152].  agr is a quorum sensing, two-
component regulator that is maximally expressed during post-exponential growth, where 
it represses surface and attachment proteins and induces the transcription of toxins and 
exoproteins [202].  agr is of particular importance to S. aureus, as cells which contain a 
mutated or nonfunctional agr gene are attenuated in virulence in animal models of 
infection [205].  The agr effector molecule is a small regulatory RNA, known as RNAIII, 
which also encodes the delta-hemolysin.  RNAIII acts as a regulator of target genes [91, 
146] by binding to target mRNA molecules and either stabilizing them, or targeting them 
for destruction [135, 113, 186].  The most significant of these interactions is thought to be 
for a repressor of toxin production, known as Rot. RNAIII binds to, and inhibits Rot 
mRNA translation, thereby facilitating the upregulation of extracellular virulence factor 
synthesis [66, 18].  RNAIII also serves to negatively regulate the synthesis of protein A 
and the fibronectin-binding proteins, which are used for adhesion [91, 143, 171].   
In addition to agr there are a number of other important regulators of toxin production in 
S. aureus, with perhaps the next most important being SarA.  SarA (for staphylococcal 
accessory regulator) is a DNA-binding protein that acts as a transcriptional regulator of a 
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variety of different genes that play a role in pathogenesis and metabolic processes [9, 29, 
30, 49].  Specifically, it controls the expression of surface and secreted proteins by 
binding to the promoter regions of target genes and either repressing them, or bringing 
about their upregulation.  Its targets include other regulatory systems, such as agr [30, 
160], and virulence genes, such as protein A (spa), fibronectin-binding protein A (fnbA) 
and the major extracellular proteases [64, 208, 16].  The final major regulator of toxin 
production is the two-component system SaeRS (for S. aureus exoprotein expression). 
SaeRS modulates the production of secreted proteins such as coagulase and alpha-
hemolysin at the level of transcription [721].  The regulation of these exoproteins by 
SaeRS overlaps that of the Agr regulon [72], though it has no direct effect on the 
expression of agr or sarA [71].      
Drug resistance in Staphylococcus aureus   
In the early 1940’s, penicillin was introduced for the treatment of bacterial infections; 
however, shortly after S. aureus strains appeared that were resistant to this antibiotic. 
[104].  Since this time, the same has proven true for almost every other antibiotic, 
including erythromycin, tetracycline, and streptomycin [41, 78].  Methicillin, introduced 
in 1960, was used as an effective treatment for infections caused by antibiotic resistant 
strains of S. aureus.  This antibiotic differs from penicillin as its unique structure blocks 
the β-lactam ring from inactivation by β-lactamases. However, methicillin-resistant S. 
aureus (MRSA) strains were discovered shortly thereafter, in 1961 [83].  Methicillin 
resistance is conferred by the mecA gene, which is harbored on a mobile genomic island 
known as the staphylococcal cassette chromosome mec (SCCmec) [89].  Given the 
widespread distribution of MRSA strains, and limited therapeutic options, glycopeptide 
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antibiotics, such as vancomycin (Van), have been commonly used as a last resort drug 
[84].  It acts by irreversibly binding to D-ala-D-ala residues of N-acetylmuramic acid 
pentapeptide precursors.  Binding of these precursors by Van prevents peptide cross-
linking between growing layers of peptidoglycan, and consequently weakens the cell wall 
of gram-positive bacteria [8].  Expectedly, in 1996, a S. aureus isolate in Japan was found 
to be resistant to increased concentrations of Van [84].  The new strain was termed Van 
intermediate S. aureus (VISA), and cases of VISA soon began making an appearance 
throughout Europe, Asia, and the USA; and are now present worldwide [153].  Since 
2002, nine cases of Van resistant Staphylococcus aureus (VRSA) have appeared in the 
United States [2, 3, 59, 196].  The difference between VISA and VRSA strains can be 
found at the molecular level, with VISA isolates possessing mutations in existing genes, 
while VRSA have acquired exogenous genetic material.  The intermediary resistance of 
VISA strains to Van is speculated to be modulated by synthesis of a thicker cell wall that 
contains an increased number of D-ala-D-ala residues, which trap Van molecules in the 
outer layers of the cell wall, keeping it from accessing cell wall precursor targets in the 
cytoplasm [79].  Van resistance in VRSA isolates on the other hand, is attributed to 
expression of vanA, found on a conjugative plasmid that is likely obtained from Van 
resistant Enterococcus faecalis (VRE) by horizontal gene transfer [196].  The Van 
resistance of VRSA strains is achieved by changing the D-ala-D-ala pentapeptide 
residues attached to N-acetylmuramic acid to D-ala-D-lac.  Van, having a lower affinity 
for D-ala-D-lac, consequently does not inhibit synthesis of the altered cell wall in VRSA 
isolates [122].   
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Trends in S. aureus infections   
S. aureus infections have commonly been confined to health care facilities [43].  
Historically, such infections affect the immunocompromised, the young or the very old.  
These hospital-acquired methicillin resistant S. aureus (HA-MRSA) strains are highly-
resistant to antibiotics, making HA-MRSA infections very difficult to treat.  The two 
most common HA-MRSA strains in the United States are CDC PFGE (pulse-field gel-
electrophoresis) types USA100 and USA200 [127].  Recently, community-acquired 
methicillin resistant S. aureus (CA-MRSA) infections have been reported in individuals 
with no ties to health care facilities [1, 94, 138].  These CA-MRSA strains appear to be 
far more virulent than HA-MRSA, and are especially significant because they cause 
infections in young, healthy individuals with no predisposing factors [24, 54].  There are 
a number of genetic differences between HA-MRSA and CA-MRSA which might 
explain the vast differences in their transmission, spread and pathogenesis.  Specifically, 
CA-MRSA strains usually possess SCCmec types IV, V, or VII [194], whilst HA-MRSA 
strains commonly harbor SCCmec types I-III.  There are currently a total of seven 
SCCmec variations, with the common CA-MRSA types being the smallest, probably 
facilitating the expedient transfer of these elements between S. aureus strains [164].  HA-
MRSA strains usually possess the larger SCCmec types I, II, and III, which are more 
burdensome energetically, and result in the slower growth of encoding strains [147, 162].  
Another distinguishable feature of CA-MRSA is the presence of the bacteriophage-
encoded Panton-Valentine leukocidin toxin (PVL) [193].  PVL is an exotoxin that creates 
pores in the membrane of leukocytes, effectively destroying them, and exposing 
surrounding cells to their damaging contents, commonly leading to tissue necrosis [36, 
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189].  Recent work has suggested that PVL is not the only toxin involved in CA-MRSA 
hypervirulence, as PVL-negative and PVL-positive CA-MRSA strains have been found 
to be equally virulent in sepsis and abscess models of infection using mice [193].  
Supporting this finding, Wardenberg et al. recently demonstrated that hyperexpression of 
α-hemolysin, not PVL, is the essential factor in necrotizing pneumonia infections [20].  
Further to this, a study by Diep et al., showed that CA-MRSA USA300 strains contain 
another mobile genetic element known as the arginine catabolic mobile element (ACME).  
This locus has been suggested to contribute to the rapid growth and survival of USA300, 
giving it a selective advantage in disease causation [116].  Transcriptome studies have 
demonstrated that despite sharing a core genome of approximately 82%, S. aureus strains 
demonstrate huge variations in gene expression profiles and pathogenesis [116, 120].  
Thus the virulence of S. aureus is likely not determined by the presence or absence of 
variable genetic elements, but by alterations in the temporal expression of innate core 
factors.  A key example of this is that the marked hypervirulence of CA-MRSA strains 
appears to be attributable to differential gene expression resulting from elevated activity 
of regulators such as agr.  This regulator mainly controls the expression of secreted 
toxins and surface-associated proteins that help the organism adhere to the host and 
become invasive.  Despite their increased virulence however, CA-MRSA strains 
currently have reduced antibiotic resistance compared to HA-MRSA.  With that said, 
CA-MRSA resistance is on the rise, and these strains have recently been reported to be 
replacing HA-MRSA strain in healthcare facilities [195].     
Proteomics.  Experimentally, genomics is the study of entire genomes, whilst 
transcriptomics is the study of mRNA transcription, giving insights into the gene 
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expression of a particular organism at a given time.  Proteomics, the identification of 
entire protein sets present in biological samples, complements these approaches, and is a 
relatively recent development in the post-genomic era.  Because mRNA levels do not 
always correlate with the synthesis of proteins, proteomics has become an extremely 
useful tool for the study of differential protein expression as a result of varying 
physiological conditions.   This discipline has gained significance because proteomes are 
highly dynamic, and protein expression profiles can change relatively quickly.  
Understanding changes in a given proteome from a particular organism can provide much 
insight into its behavior, physiology and interaction with its environment.  
Mass spectrometry.  A major tool used in proteomic studies is mass spectrometry. This 
technique uses protein samples cleaved by a site-specific enzyme, such as trypsin, for the 
identification of proteins present in a biological sample.  Following digestion, samples 
are washed of salts and detergents, which can interfere with the formation of ions in the 
mass spectrometer, and therefore affect the determination of molecular mass [87].  After 
de-salting, peptides are fractionated by high-performance liquid chromatography (HPLC) 
using a strong cation exchange (SCX) column.  Each resulting fraction is then ionized by 
MALDI (matrix assisted laser desorption ionization) or ESI (electrospray ionization), 
coupled to a mass spectrometer.  A MALDI mass spectrometer utilizes a laser to produce 
ions from a sample that has been mixed with a matrix and crystallized on a sample plate.  
The most common matrices used for MALDI-TOF peptide analysis include 2,5-
dehydroxybenzoic acid (DHB) and α-cyano-4-hydroxycinnamic acid [174, 136].  The 
sample plate is then placed inside the mass spectrometer in a vacuum at high voltage, and 
the matrix absorbs laser radiation and rapidly breaks down.  This causes the matrix to 
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expand into gas phase, bringing analyte molecules with it, and the matrix dissociates, 
leaving a pure and ionized analyte [44].  Mass analysis of the peptides by time-of-flight 
(TOF) entails accelerating ions, resulting in different ion velocities that are inversely 
proportional to the square root of the mass-to-charge ratio.  These ions are separated in 
the flight tube and the time of their arrival to the detector is then converted to the mass of 
the ions [34, 55].  An ESI mass spectrometer involves the spraying of samples from a 
needle at high potential, into a chamber at atmospheric pressure.  Droplets of the sample 
in solution are formed, and the solvent is evaporated, creating a stream of ions from the 
sample to be analyzed by the mass spectrometer [55, 56].  Electrospray ionization was 
introduced in the 1980s as a new method for ionizing and introducing peptides into gas 
phase, and spraying peptides across a potential difference [43] between a capillary and 
the opening of a mass spectrometer [56].  Once in the gas phase, peptide fragments enter 
a collision chamber and are collided with atoms of inert gas, such as argon, producing 
collision-induced dissociation [197].  As a result, peptides are mainly fragmented at 
amide linkages, and the resulting fragments are sent to a mass analyzer to detect the 
fragments according to mass-to-charge ratio.  The resulting mass spectrum is made of 
ions that are characteristic of a sequence of amino acids in a particular peptide.  The mass 
spectral data from these peptides is then compared to protein sequences contained in 
databases specific to the originating organism [43, 174, 204]. 
Proteome analysis techniques.  In order to generate proteome samples for mass 
spectrometric analysis, two major approaches have been used.  The first, and perhaps 
most common of these, is two-dimensional gel electrophoresis (2-DE). Using this 
technique, proteins are first separated by differences in electric charge (isoelectric 
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focusing), and then perpendicularly by SDS-PAGE.  Separated protein spots are then 
visualized by staining, and those protein spots of interest are excised from the gel and 
analyzed by mass spectrometry [74, 106].  Though the data obtained from 2-DE is of 
significant value, it has many drawbacks.  Proteins that are very large, hydrophobic, 
acidic, or basic are poorly resolved [80].  For this reason a newer method, known as 
multi-dimensional protein identification (MudPIT) [39], has become more commonplace.  
MudPIT combines multi-dimensional liquid chromatography with tandem mass 
spectrometry; allowing complex protein samples to be analyzed. Experimentally, 
proteomes are digested with trypsin to generate peptide fragments.  Using HPLC, the 
peptide fragment mixture is then applied to a column packed with a strong cation 
exchange (SCX) resin.  The eluted peptides collected in fractions are then analyzed using 
a mass spectrometer.  After the mass spectral data are obtained, database searches are 
performed which identify the proteins from the original samples.  This technique is very 
efficient because it is a relatively expedient method of analysis, and the two-dimensional 
chromatographic separation of peptides also increases the number of proteins identified 
[80, 148].            
Proteomic research and Staphylococcus aureus.  The first proteomic study of S. aureus 
protein expression was conducted by Ziebandt et al. almost a decade ago [208].  The 
study compared extracellular proteins of two closely related strains, RN6390 (laboratory-
derived) and COL (clinical isolate) using 2D-gel electrophoresis and N-terminal 
sequencing, or MALDI-TOF, for the identification of proteins.  Eighteen secreted 
proteins were identified in COL [208], an early hospital-acquired methicillin resistant S. 
aureus isolate [69], of which nine had not yet been found in the laboratory strain 
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RN6390.  Comparing the cytoplasmic proteins of RN6390 and COL showed only a few 
differences between the two strains, as opposed to the more striking difference in 
expression of secreted proteins [208].  This was a particularly important finding given the 
importance of secreted proteins in the virulence of S. aureus.  This study also compared 
the secretomes of S. aureus mutants lacking the global regulator of virulence, SarA, in an 
RN6390 background.  Five proteins (glycerolester hydrolase, autolysin, β-hemolysin, 
lipase, and immunodominant antigen A) were found to be positively regulated by SarA, 
with a further twelve shown to be negatively controlled by this regulator, including 
secreted proteases such as staphopain, V8 protease, and aureolysin.  In this same study, 
proteomic techniques were employed to understand the role of the major alternative 
sigma factor, SigmaB.  SigmaB is involved in induction of the general stress response of 
other gram-positive bacteria [81] and is thought to have a role in the virulence of S. 
aureus [25, 142].  In a sigB mutant, α-hemolysin, lipase, and thermonuclease were 
produced at significantly higher levels than in the wild-type [28, 111].  Conversely, nine 
other secreted proteins were found to be negatively regulated by SigmaB (including 
enterotoxin B, serine proteases, leukotoxin D, β-hemolysin, and glycerol ester hydrolase) 
[208].   
In 2002, Bernardo et al used different forms of SDS-PAGE, followed by MALDI-TOF 
analysis, to identify the secreted proteins of three strains: methicillin sensitive 
ATC29213, methicillin resistant ATC 43300, and a clinical isolate provided from the 
University Clinic of Cologne in Germany [11].  What was found was that important 
proteins such as the major autolysin, staphylococcal nuclease, and three hypothetical 
proteins could not be resolved by 2D-gel electrophoresis.  These proteins in particular 
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have high pI values; 9.65, 9.21, 9.21, 9.17, 9.28, respectively.  As mentioned before, 2D-
gel electrophoresis is not an effective technique for resolving proteins that are too basic.  
Subsequently, Bernardo et al found that these proteins could be resolved by conventional 
1D-gel electrophoresis (SDS-PAGE) and identified by MALDI-TOF mass spectrometry.  
Compared to 2D-gel electrophoresis, 1D-gel electrophoresis requires less protein, yielded 
more reproducible results, and allowed for the detection of some alkaline proteins.  2D-
gel electrophoresis, however, had the ability to identify proteins in low abundance when 
compared to 1D-gel electrophoresis [11].  In a later study by Kohler et al, cytoplasmic 
proteins of S. aureus COL were analyzed using two methods:  2D-gel electrophoresis and 
multidimensional liquid chromatography followed by mass spectrometry using a matrix-
assisted laser ionization-time of flight (MALDI-TOF) mass spectrometer.  The 
combination of these two methods identified a total of 1123 cytoplasmic proteins.  Four-
hundred and seventy-three proteins were identified by 2D-gel electrophoresis and 
belonged to the transcriptional and translational machinery, aerobic respiration and 
fermentation pathways, and some biosynthetic pathways.  A gel-free method, followed by 
MALDI-TOF mass spectrometry, yielded an additional 650 proteins that mainly 
belonged to metabolic pathways, and included alkaline and hydrophobic proteins that 
were not seen in the 2D gel electrophoresis analysis [107].       
In S. aureus the expression of virulence genes is regulated in a highly coordinated 
manner.  Cell surface-associated proteins are expressed during exponential growth, while 
secreted virulence factors are expressed during post-exponential growth [202].  In another 
study by Ziebandt et al, again using 2-DE, 70 secreted proteins were found to be affected 
by a mutation in another major global regulator of toxin production, agr.  Amongst these 
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affected proteins, many virulence factors such as proteases, toxins, lipases, and 
staphylokinase were found to be upregulated by agr.  Apart from upregulating the 
expression of secreted proteins in late exponential and stationary phases, agr seemingly 
represses the expression of proteins usually present in cells during exponential growth, 
such as immunodominant antigen A, autolysins, and protein A [206].   
In an attempt to quantify the entire S. aureus proteome, Becher et al. analyzed 
cytoplasmic, membrane-bound, surface-associated, and secreted proteins in growing and 
non-growing cells of S. aureus COL by a combination of 2-DE and mass spectrometric 
analysis [10].  Cytoplasmic proteins were metabolically labeled, and, using a combination 
of 2-DE and GeLC-MS/MS (a fusion of 1-DE and LC-MS/MS analysis), a total of 1796 
proteins were identified, representing ~67% proteomic coverage of S. aureus.  In the 
transition from exponential to stationary phase of growth, it was apparent that ribosomal 
proteins, translational factors, and some enzymes involved in amino acid synthesis were 
significantly down-regulated.  Proteins that were found to be upregulated in stationary 
phase include PEP carboxykinase (PckA, a gluconeogenetic enzyme), enzymes involved 
in the TCA cycle, and members of the phosphate regulon.  Membrane proteins were 
analyzed in this study via a combination of GeLC-MS/MS [45] and trypsin shaving 
[200].  The GeLC-MS/MS approach resulted in the contamination of membrane 
proteomes with cytoplasmic proteins, whilst the shaving method, using trypsin, revealed 
only membrane proteins in the isolated fractions.  With the membrane-targeted approach, 
a total of 125 proteins were identified including integral as well as peripheral proteins, 
and accounted for ~56% of all predicted membrane proteome.  Specifically, proteins 
associated with phosphotransferase systems (PTS), the glycerol uptake facilitator (GlpF), 
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and transporters involved in uptake of C3 carbon sources were found at increased levels 
during the stationary phase [10].  Membrane proteins found to be up-regulated in 
stationary phase included ABC transporters involved in the import of amino acids and 
oligopeptides, whilst those found in decreased levels included high affinity iron-
compound ABC transporters.  Interestingly, the highly conserved Sec secretion 
machinery was found to be present at constant levels from the exponential to stationary 
phases of growth [10].  This study also used a biotinylation approach for surface-exposed 
cell wall-associated proteins analysis.  The advantage of this is that such proteomes can 
be purified with minimal contamination by other subproteomic fractions.  A total of 146 
surface-associated proteins were identified, including membrane proteins, proteins that 
are covalently attached to the cell wall, lipoproteins, cell wall-associated proteins 
containing signal peptides, and cell wall-associated proteins that were also found to be 
secreted [10].  Proteins involved in adhesion such as fibronectin-binding proteins (Fnbps) 
[171] and fibrinogen-binding protein (ClfB) [126] were mainly upregulated in the 
exponential phase of growth.  Conversely, levels of ClfA and immunodominant protein 
IsaB were significantly increased in stationary phase [10].  The last fraction, secreted 
proteins, was analyzed using a GeLC-MS/MS approach.  With this technique, a total of 
57 secreted proteins were identified, mainly during stationary growth.  Specifically, there 
was an observable switch from the production of proteins involved in adhesion, biofilm 
formation, and cell invasion during exponential growth, to the production of virulence 
factors such as toxins, enzymes, and superantigens in stationary growth [10].  This study 
represents the most comprehensive quantification of the S. aureus proteome to date.     
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In 2010, a study by Hempel et al. quantitatively profiled the SigmaB-dependent 
expression of surface-associated proteins by metabolic labeling, biotinylation, and GeLC-
MS/MS.  A total of 49 proteins were found to be regulated by SigmaB [82], 21 of which 
were known to be dependent or influenced by SigmaB at the transcriptional level [14, 
149, 206].  The remaining 28 proteins have not been described as being modulated by 
SigmaB activity.  Consistent with the literature, fibrinogen-binding proteins ClfA and 
ClfB were found to be strongly decreased in the sigB mutant, whilst there was an 
accumulation of surface-associated proteins noted, mainly in stationary phase [82].  This 
negative influence of SigmaB must be indirect as sigma factors can only act directly as 
positive regulators [67, 206].   
In a 2010 study by Ziebandt et al., the secretomes of 25 clinical isolates of S. aureus 
revealed an extreme heterogeneity of secreted protein expression due to genomic 
plasticity, and differences in regulation.  Of the 63 identified secreted proteins, only 7 
proteins (IsaA, Lip, LytM, Nuc, SA0620, SA2097, and SA2437) were commonly 
produced by clinical isolates of different clonal lineages [207].  This finding is likely 
explained by the observation that up to 30% of the genomes of different S. aureus isolates 
consist of variable mobile genetic elements, such as pathogenicity islands, lysogenic 
bacteriophages, plasmids, and transposons [198].  Virulence determinants are commonly 
encoded on these mobile genetic elements, thus facilitating proteome variability [207]. 
Finally, recent proteomic analyses in S. aureus have been focused on characterization of 
cell surface proteomes.  Cell surface proteins are directly in contact with the extracellular 
environment and might perhaps serve as the largest group of targets for vaccine or 
antibody development.  These surface-exposed proteins were termed the “surfacome” in a 
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study by Dreisbach et al. in 2010 [45].  The aim of this study was to refine and optimize 
the isolation technique of surface proteins to increase the number of proteins identified 
and reduce the number of contaminating cytoplasmic proteins due to cell lysis.  
Seemingly, the most effective method for identifying surface-exposed proteins is by 
shaving these proteins with trypsin followed by MS analysis [176, 180, 185].  The study 
compared different buffers and trypsin digestion conditions to determine the best method 
for the isolation of surface-exposed proteins.  The trypsin shaving technique was used to 
analyze S. aureus strains from different clonal lineages, including the laboratory strain 
RN6390, early clinical isolates Newman and COL, and the CA-MRSA strain USA300.  
After mass spectrometric analysis, 39 surface-exposed proteins were found in RN6390, 
59 in Newman, 47 in COL, and 24 in USA300.  Taken together, a total of 96 surface-
exposed proteins were detected from all four strains, 5 proteins of which contained an 
LPXTG motif for covalent attachment to the cell wall. A further 17 were predicted to be 
completely secreted into the extracellular environment, and 2 other secreted proteins also 
had motifs for cell wall-binding.  Intriguingly, there were two toxins that were detected 
on the surface of the cell that are not predicted to be secreted. Additionally, 16 ribosomal 
proteins and 17 proteins involved in metabolism or possessing housekeeping functions 
were also found in the surfacome [45].  The fact that only 7 proteins (including GAPDH 
and FBA) were common to all four strains illustrates the heterogeneity of S. aureus 
strains and their associated sub-proteomic fractions.  In a similar study published at the 
same time, Ventura et al. analyzed the surface-exposed proteome (terming it the 
“surfome”) of the CA-MRSA USA300 strain known as LAC (LA County Clone) [190]. 
A total of 113 surface-exposed proteins were identified in LAC during the post-
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exponential phase of growth, the most abundant of which was Protein A.  Surprisingly, a 
novel uncharacterized two-component leukotoxin was also detected in the surfome, 
termed LukGH. This newly identified bipartite toxin was found to have a significant role 
in pathogenesis, specifically via pore formation in human PMNs [190].  
Quantitative proteomic analysis of S. aureus. There are several methods for 
determining relative protein expression within a given organism, the most popular 
method being 2-DE.  Using this technique, proteins are first separated by differences in 
electric charge (isoelectric focusing), and then perpendicularly by SDS-PAGE.  Separated 
protein spots are then visualized by staining, and those protein spots of interest are 
excised from the gel and enzymatically digested with trypsin.  The resulting peptides are 
then analyzed by mass spectrometry.  This technique, however, has many drawbacks.  
Proteins that are very large, hydrophobic, acidic, or basic are poorly resolved.  Another 
popular method for determining relative protein expression is known as iTRAQ [168].  
iTRAQ (isobaric tag for relative and absolute quantitation) is a peptide-labeling 
technique used for identification and relative quantification of proteins from different 
samples in one single experiment.  The iTRAQ 4-plex analyzes four different samples in 
one single experiment after labeling peptides from each sample with an isobaric tag 
reagent, which includes a reporter moiety and a balance moiety.  The mass of the balance 
moiety from each reagent is different in order for the total mass of the balance and 
reporter moieties to equal 145 because mass of each reporter moiety is different [168].  A 
workflow for the iTRAQ-labeling of peptides is outlined in Figure 1. 
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Figure 1.  Workflow for iTRAQ-labeling of peptide samples  
After MS/MS analysis, which includes high collision induced dissociation, the balance 
moieties are lost, leaving only the reporter tags.  Because of the unique isotopic 
distribution of each reporter tag (114, 115, 116, and 117), it is possible to determine 
relative protein expression across the different samples in a single experiment.  An 
example of a mass spectrum resulting from MS/MS analysis of an iTRAQ sample is 
shown in Figure 2.   
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Figure 2.  Example of mass spectrum resulting from MS/MS analysis of iTRAQ sample 
Differential expression of a particular protein across the four samples can be determined 
by the relative abundance of each reporter tag resulting from MS/MS analysis.  Figure 3 
displays an example of the relative intensities of each reporter tag indicating relative 
protein expression. 
Figure 3.  Relative abundance of reporter ion intensity from iTRAQ sample 
A 2005 study by Choe et al., compared 2-DE and shotgun proteomic analysis with 
isobaric-tagged samples (iTRAQ) of Escherichia coli for relative protein expression after 
induction of rhsA [31], believed to be involved in biosynthesis and export of capsular 
polysaccharides [129].  The purpose of this study was to determine the best method for 
biological reproducibility that minimizes technical variability.  It was found that shotgun 
proteomic analysis with iTRAQ samples provided the best reproducibility with minimal 
outlier data [31].  In 2006, Wolff et al. studied the heat shock response of exponentially-
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growing Bacillus subtilis cells by gel-free iTRAQ-labeled samples and by the 2-DE 
approach for quantitation of proteins involved in this response.  It was found that the 
proteomic analysis of gel-free iTRAQ-labeled protein samples resulted in the 
identification of more proteins, and was more reproducible [201].  With regards to S. 
aureus, the first such quantitative proteomic analysis was focused on Van resistance. Van 
has commonly been used as a last resort drug to treat MRSA infections [84].  It acts by 
preventing peptide cross-linking between growing layers of peptidoglycan, consequently 
weakening the cell wall [8].  In 1996, a S. aureus isolate in Japan was found to be 
resistant to intermediate concentrations of Van [84], and are now present throughout 
Europe, Asia, and the USA [153].   Drummelsmith et al. in a 2007 study developed a 
method for the rapid identification of potential biomarkers of VISA strains with the use 
of 2-DE and iTRAQ tagging.  A VISA strain, Mu50, was compared to a Van-sensitive 
MRSA strain, CMRSA-2, for relative protein expression of cytoplasmic proteins.  It was 
found that expression of SAV2095, known as SceD-like protein, is consistently and 
significantly increased in VISA strains.  This protein has a potential association with the 
cell wall which is known to be thickened in such isolates [47].   
Project Aim.  The studies detailed above reveal a concerted effort to develop the most 
efficient and productive methods for discovering proteins that are differentially expressed 
in S. aureus.  Each provides knowledge and insight into the intricate phenotypic 
switching mechanisms employed by S. aureus that make it such a successful human 
pathogen.  Previous studies have been fraught with problems, including the use of 2D gel 
electrophoresis that is not efficient for resolving proteins that are too hydrophobic, large, 
acidic, or basic.  To date, there has not been a proteomic study solely based on 2D liquid 
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chromatography followed by mass spectrometry (2DLC-MS).  Studies that do involve 
some 2DLC-MS analysis use a urea concentration that is too low for solubilization of 
insoluble proteins, do not include filter sterilization of supernatants to remove bacterial 
cells and ensure purity of secreted proteins, and centrifuge secreted proteins during 
precipitation at a speed that is too low to ensure maximal protein recovery [176, 206, 
208].  Appropriate method refinement is therefore important for obtaining reproducible 
data across several biological replicates of a sample.  In this work we seek to, through 
method refinement, catalogue the intracellular proteome and secretome of a commonly 
used and well-studied lab strain of S. aureus SH1000 during post-exponential and 
stationary phases of growth to provide an insight into its physiology; and how it adapts to 
its changing environment over time by utilizing differential protein synthesis.  
Additionally, we aim to profile the secretomes, of clinically significant strains currently 
afflicting individuals in hospitals (USA100 and USA200) and in the community 
(USA300 and USA400) settings.  A proteomic analysis encompassing the entire 
secretomes of these clinically relevant strains is lacking.  With this proteomic approach 
we hope to not only identify but also quantify the production of secreted proteins that 
enable this organism to swiftly infect and cause disease in a patient.  It is possible these 
analyses could lead to the identification of antigens and the development of protective 
vaccines against S. aureus. 
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Materials and Methods 
 
Buffers. 
Phosphate buffered saline 
0.8% sodium chloride 
0.14% disodium phosphate 
0.02% potassium chloride 
0.02% potassium dihydrogen phosphate 
UDS buffer 
6M urea 
5mM DTT 
1% SDS 
50mM Tris-HCl 
Strains, media, and growth conditions. 
For cataloguing of the S. aureus intracellular proteome and secretome, the common lab 
strain SH1000 was used.  For relative toxin expression, the strains USA100 (N315), 
USA200 (MRSA252), USA300 (LAC), and USA400 (MW2) were used.  Overnight 
cultures of the wild-types (SH1000, USA100, USA200, USA300, and USA400) were 
grown in 3% tryptic soy broth (TSB).   
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To obtain a sample from each strain at a specific phase of growth, 1 ml of the overnight 
culture was added to 100 ml of 3% TSB.  The new culture was allowed to grow for 3 
hours and then the optical density of the new culture was standardized to 0.05 in 400 ml 
of TSB.  The new synchronous culture was allowed to grow until the desired phase of 
growth: post-exponential (5 hours) and stationary (15 hours).  When incubating, the 
cultures were grown at 37˚C shaking at 250 rpm with a volume to flask ratio of 1:2.5, 
ensuring adequate aeration of cultures.   
Cataloguing of intracellular proteome and secretome of S. aureus. 
Cytoplasmic protein extraction 
The synchronized cultures of SH1000 were allowed to grow until post-exponential and 
stationary phases of growth.  Cultures were then centrifuged for 10 minutes at a speed of 
4,150 rpm.  The pellets were washed three times with PBS, pH 7.4, and finally 
resuspended in 1 ml of UDS buffer, pH 8, with 0.1 mm disruption glass beads.  Cells 
were then lysed using a BioSpec Mini-BeadBeater for a total of 4 minutes, with 
intermittent cooling phases.  The lysed cells were then centrifuged for 10 minutes at 
13,300 rpm.  The supernatants were collected and centrifuged again, to prevent 
contamination from non-cytoplasmic proteins and ensure purity of the intracellular 
protein fractions, for 10 minutes at the same speed and then transferred to new tubes.  
Protein concentrations were determined using a Pierce 660 nm protein assay kit and then 
standardized to 1 mg/ml.   
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Secreted protein extraction 
Synchronized cultures of SH1000 were allowed to grow until post-exponential and 
stationary time points.  The cultures were then centrifuged for 10 minutes at a speed of 
4,150 rpm.  Supernatants were collected and any contaminating bacterial cells were 
removed by filter sterilization. Clean supernatants were then concentrated using Millipore 
Centricon Plus-70 centrifugal filter units before being precipitated in a final concentration 
of 10% trichloroacetic acid overnight at 4˚C.  The following day, the precipitated proteins 
were centrifuged at 8,500 rpm for 70 minutes at 4˚C.  The resulting pellets of precipitated 
secreted proteins were washed with 100% ice cold ethanol and centrifuged for 70 minutes 
at 8,500 rpm at 4˚C for a total of three times.  After air drying the samples and after 
determination of protein concentrations, samples were standardized to 1 mg/mL.   
Trypsin digestion 
Protein samples were reduced with 50µl of 200mM dithiothreitol for 1 hour at room 
temperature followed by alkylation with 200 µl of 200 mM iodoacetamide for another 
hour in the dark at room temperature.  Any remaining alkylating reagent was consumed 
with 200µl of 200 mM dithiothreitol.  The samples were then diluted up to 5ml with 25 
mM ammonium bicarbonate and then digested with a ratio of 1:30 by weight of trypsin to 
protein (33.33µl) overnight at 37˚C.  The following day, the digested proteins were de-
salted with C-18 Vydac columns.   The C-18 Vydac columns were activated with 1 ml of 
100% acetonitrile and repeated once.  The columns were then equilibrated with 1 ml of 
0.1% formic acid in water and repeated once.  The samples were applied to the columns 
and the peptides were washed twice with 1 ml of 0.1% formic acid in water.  The 
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peptides were eluted from the columns with 300 µl of 0.1% formic acid in acetonitrile 
and repeated for a total of 3 times.  Once de-salted, the peptide samples were dried using 
the SpeedVac centrifuge.  The peptides were resuspended in 100 µl of 0.1% formic acid 
in water and sonicated for 10 minutes.   
Mass spectrometric analysis of peptides 
The peptide samples were then placed in the autosampler of the LTQ XL mass 
spectrometer.  Each sample was fractionated in the gas phase as opposed to fractionation 
utilizing multidimensional HPLC.  For gas phase fractionation, three separate methods 
were created.  The first method scanned ions with a mass-to-charge ratio within a range 
of 350-550.  The second method scanned ions with a mass-to-charge ratio within a range 
of 550-750.  Finally, the third method scanned ions with a mass-to-charge ratio of 750-
1500.  There were a total of 6 full scan events with the top five most intense ions in a 120 
minute HPLC gradient and CID normalized collision energy of 35.0%.     
Identification of proteins 
The resulting files from mass spectrometric analysis of the samples were processed using 
Mascot Daemon software for database searching with a Uniprot database containing 
sequences specific to the S. aureus COL strain.  A maximum of 1 missed cleavage by 
trypsin was allowed.  Peptide tolerance was set to ±2.5 Da and the MS/MS tolerance was 
set to ±0.6 Da.  After alkylation with iodoacetamide, the peptides were quantitatively 
modified at cysteine residues by carbamidomethylation.  Variable modifications include 
acetylation of the protein at the N-terminus, oxidation of methionine, and 
phosphorylation of serine, threonine, and tyrosine.  Proteins were identified and listed 
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using Scaffold 3 software.  A random concatenated database of the S. aureus COL strain 
was created in Scaffold 3 for the detection of false-positive identification of proteins 
using a decoy database search strategy.  A false-positive rate less than 5% was found 
acceptable.     
Relative Toxin Production of S. aureus using iTRAQ.  
Concentration of secreted proteins 
Synchronous cultures of USA100, USA200, USA300, and USA400 were grown to post-
exponential phase (5 hours) or to stationary phase (15 hours).  Once the cultures had 
grown to the desired phase, they were centrifuged at 4,150 rpm for 10 minutes.  After 
centrifugation, the supernatants were filter sterilized and then concentrated using 
Millipore Centricon Plus-70 filter units according to the manufacturer’s instructions.  
Following concentration of the supernatants, the proteins were precipitated with 10% 
trichloroacetic acid overnight at 4˚C.  Following precipitation, the supernatants were 
centrifuged at 8,500 rpm for 70 minutes at 4˚C.  The supernatants were removed, leaving 
the protein pellet to be washed.  The proteins were washed with 100% ice cold ethanol 
and then centrifuged at 8,500 rpm for 70 minutes at 4˚C.  The ethanol washing was 
repeated a total of 3 times.  After the last ethanol wash, the pellets were allowed to air 
dry.   
Trypsin digestion of secreted proteins 
Labeling with the iTRAQ reagents was completed according to the manufacturer’s 
instructions.  The secreted protein pellets were resuspended in dissolution buffer provided 
by the iTRAQ kit.  The Pierce 660 nm Protein Assay was used to determine the 
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concentrations of the protein samples.  The concentrations were standardized to 100 µg in 
a final volume of 20 µl of dissolution buffer.  One µl of denaturant (SDS) was added to 
each sample followed by 2 µl of reducing reagent.  The samples were incubated at 60˚C 
for 1 hour.  After the incubation period, 1 µl of cysteine blocking reagent was added to 
the samples followed by a 10 minute incubation period at room temperature.  Trypsin 
was added to the samples in a ratio of 1:30 (3.33µl) and the samples were digested for 
12-16 hours at 37˚C.   
iTRAQ labeling of  peptides 
The iTRAQ reagents were allowed to reach room temperature and were mixed with 70 µl 
of ethanol.  The peptide samples were individually labeled with the iTRAQ reagents 
(USA100-114, USA200-115, USA300-116, USA400-117) for 1 hour at room 
temperature.  After the incubation period, the 4 labeled samples were combined into a 
new tube.  To rid the sample of ethanol, the samples were dried using the SpeedVac 
centrifuge.  The samples were then resuspended in 1 ml of 0.1% formic acid in water.  
The labeled peptides were then de-salted using C-18 Vydac columns as previously 
described.  After de-salting, the samples were dried using the SpeedVac centrifuge and 
then resuspended and sonicated in 25 µl of 0.1% formic acid in water.    
Mass spectrometric analysis of iTRAQ-labeled peptides 
The peptide samples were placed in the autosampler of the LTQ Orbitrap XL mass 
spectrometer.  There were a total of 7 full scan events which included a full survey scan 
(m/z 350-1500) and subsequent MS/MS of the top 3 most intense ions of a range of 350-
1500 m/z in a 180 minute gradient.  There were 3 scan events with CID of 35.0% 
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normalized collision energy in the linear ion trap followed by 3 scan events with HCD of 
40.0% normalized collision energy at a mass resolving power of 30,000 full scan MS 
with 7,500 high collision induced dissociation scan in the Orbitrap mass analyzer.  
Identification and Quantitation of iTRAQ-labeled peptides 
The resulting files from mass spectrometric analysis of the samples were processed using 
Mascot Daemon software for database searching with the USA100, USA200, USA300, 
and USA400 strains.  A maximum of 1 missed cleavage by trypsin was allowed.  Peptide 
tolerance was set to ±10 ppm and the MS/MS tolerance was set to ±0.6 Da.  A fixed 
modification of the peptides included methyl methanethiosulfonation of the cysteine 
residues of trypsin-digested peptides.  Variable modifications, on the other hand, included 
acetylation of the proteins at the N-terminus and oxidation of methionine.  The resulting 
files from database searching using Mascot were then submitted to the HCD merging tool 
provided by the ExPASy proteomics server (http://www.ex-
pasy.ch/tools/HCD_CID_merger.html) to merge the qualitative peptide sequence-ion m/z 
range of CID with the quantitative reporter-ion m/z range of HCD.  Following merging of 
HCD with CID spectra, the resulting files were re-searched using Mascot Daemon 
software.  Proteins were identified and quantified using Scaffold 3 Q+ software.  A 
random concatenated database of the S. aureus USA100, USA200, USA300, and 
USA400 was created in Scaffold 3 for the detection of false-positive identification of 
proteins. 
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Results 
 
The application of mass spectrometry for proteome analysis in S. aureus.  As a 
medically significant pathogen, S. aureus employs an arsenal of virulence factors to cause 
and maintain infection in humans.  These virulence factors and other proteins central to 
the survival of S. aureus are differentially expressed as the organism progresses through 
the different phases of growth.  When used for the study of different tissues and 
organisms, mass spectrometry can be a useful tool for the identification and quantitation 
of protein variations within cells. Therefore in this project we aimed to catalogue the 
intracellular proteome and secretome of a common lab strain of S. aureus SH1000 during 
post-exponential and stationary phases of growth to provide an insight into its physiology 
and how it adapts to its changing environment over time by utilizing differential protein 
synthesis.  We also aimed to profile the secretomes of clinically significant strains 
currently afflicting individuals in hospitals (USA100 and USA200) and in the community 
(USA300 and USA400) settings as a complete secretomic analysis of these clinically 
relevant strains is currently lacking.   
An improved method for the extraction of intracellular proteomes from S. aureus 
cells.  Traditionally, cytoplasmic protein extraction in S. aureus was performed by 
boiling cells; allowing them to burst and release cytoplasmic proteins into the buffer.  
Initially we followed such a protocol, extracting cytoplasmic proteins from the S. aureus 
laboratory strain SH1000.  After many repetitions of this approach, coupled with reading 
protein concentration using a Nanodrop device, we obtained highly inconsistent results.  
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As such, it was important to determine if this resulted from inefficient extraction methods 
or inaccuracies of the Nanodrop device for determining protein concentration.  To resolve 
this, we used a Pierce 660nm Protein Concentration Assay to calculate protein 
concentration via use of the included protein standards and a BioTek Synergy II plate 
reader.  The subsequent readings obtained revealed far more consistent results from our 
extraction, however protein yields were consistently low, for example 147.7 µg/ml for a 
post-exponential phase culture and 152.2 µg/ml for a stationary phase culture of SH1000. 
To maximize protein concentrations, different methods for cell lysis were tested.  Four 
different lysis methods were used in quintuplicate: boiling of cells; mechanical shearing 
of cells by bead-beating with 0.1mm glass beads; treatment of cells with a dedicated lytic 
agent, lysostaphin; and sonication of cells using a disruptor.  For each of these methods, a 
100 ml overnight culture of SH1000, grown in a 250 ml Erlenmeyer flask, was 
centrifuged at 4,150 rpm for 10 minutes.  The resulting pellets were washed twice with 
phosphate buffered saline (PBS) to eliminate any remaining growth medium, before 
being resuspended in 1 ml of fresh PBS.  Each of the resuspended SH1000 cell samples 
were then subjected to the various cell lysis methods. 
For lysis via boiling, samples were placed in a 100C water bath for 10 minutes.  
Mechanical shearing was achieved with an approximately 0.5 cm depth of 0.1 mm glass 
disruption beads in the sample tube and a BioSpec Mini BeadBeater programmed for 4 
total minutes of lysis, with regular cooling intervals.  To enzymatically lyse the cells, 100 
µg lysostaphin was added to cells resuspended in PBS, before incubation at 37˚C for 1 
hour.  Finally, for sonication, a disrupting probe was inserted in tubes containing 
resuspended cells, which were pulsed at an amplification of 70% for 20 seconds, with 10 
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seconds rest periods between treatments.  Cells were sonicated for a total of 3 minutes. 
Following each different lysis method, samples were centrifuged, and supernatants 
removed to new 1.5 ml tubes.  These tubes were centrifuged further, and the supernatants 
were again removed to clean 1.5 ml tubes. This process was performed to remove all cell 
wall and membrane proteins, and ensure the purity of the cytoplasmic fraction. Using 
each of these methods for extraction we obtained consistent results for each method, 
however they varied by process used (Table 1).        
Boiling Bead-beating Lysostaphin treatment Sonication 
194.6 µg/ml 766.6 µg/ml 853.27 µg/ml 256.6 µg/ml 
Table 1.  Comparison of different cell lysis techniques for extraction of cytoplasmic proteins.  Data 
presented is the average of 5 samples that showed less than 10% variation. 
The protein yields for boiling and sonication were dramatically low when compared to 
that from bead-beating and lysostaphin treatment.  Lysostaphin treatment and bead-
beating of the cells yielded comparable protein concentrations, although lysostaphin 
treatment produced consistently higher yields. For our analyses, bead-beating was 
selected as the preferred method because of its ease and speed of use, and the low cost 
associated with it, compared to lysostaphin treatment. 
Proteomic analysis of S. aureus SH1000 cytoplasmic proteins via 1D SDS-PAGE 
coupled with LC-MS/MS.  For our initial proteomic analysis of cytoplasmic proteins we 
grew an overnight culture of SH1000 and extracted proteins via the bead-beating method 
detailed above. These were then resolved via 1D SDS-PAGE.  After electrophoresis, the 
gel was cut into 7 fragments (Figure 4), which were subjected to in-gel digestion with 
trypsin.     
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Figure 4.  1D SDS-PAGE analysis of cytoplasmic proteins from an overnight culture of S. aureus 
SH1000.  M refers to molecular weight markers in kDa and F1-F7 refer to the excised fragments.   
After trypsinization, the fragments were analyzed by a ThermoFinnigan LTQ mass 
spectrometer.  Database searching of the returned results for all 7 fragments identified a 
total of 380 cytoplasmic proteins (Table 2).  The database used for searching the mass 
spectral data was the general, non-specific Uniprot database (NCBI).  This search found 
many contaminant proteins belonging to organisms other than S. aureus.  The reason for 
this is likely that, after trypsin digestion, the resulting S. aureus peptides have incidental 
homology to peptides from organisms unrelated to S. aureus, as a result of using a non-
specific database.   
Identified Proteins (380) Accession # Spectral Counts 
bifunctional autolysin (atl)  SACOL1062 67 
ATP-dependent Clp protease, putative  SACOL2563 56 
sdrD protein (sdrD) SACOL0609 43 
N-acetylmuramoyl-L-alanine amidase domain protein  SACOL2666 36 
DNA-directed RNA polymerase, beta' subunit (rpoC)  SACOL0589 35 
translation elongation factor G (fusA)  SACOL0593 34 
chaperonin, 60 kDa (groEL)  SACOL2016 32 
ATP synthase F1, beta subunit (atpD)   SACOL2095 32 
dnaK protein (dnaK)   SACOL1637 31 
transketolase (tkt)   SACOL1377 30 
Table 2.  The ten most abundant cytoplasmic proteins identified from overnight cultures of S. aureus 
SH1000, separated by 1D SDS-PAGE 
SH1000 M 
200
0 
116 
97.2 
66.4 
44.3 
29.0 
14.3 
6.5 
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Spectral counts measure relative protein quantification by comparing the number of 
identified MS/MS spectra from the same peptide to the total number of identified MS/MS 
spectra found in a dataset.  The number of spectra matched to peptides from a protein is 
used as a measure of protein abundance in the sample [118]. 
Amongst the most abundant proteins identified were bifunctional autolysin (Atl), 
putative, ATP-dependent Clp protease, SdrD protein, N-acetylmuramoyl-L-alanine 
amidase domain protein, RNA polymerase (β unit), translation elongation factor G 
(FusA), GroEL chaperonin, ATP synthase F1 β subunit (AtpD), DnaK protein, and 
transketolase.  Some of the identified proteins in Table 2, however, were not expected to 
be located in the cytoplasm of S. aureus.  The bifunctional autolysin, SdrD protein, and 
N-acetylmuramoyl-L-alanine amidase domain protein were expected to be surface-
associated proteins; whereas ATP synthase F1 β subunit (atpD) was expected to be 
present in the cell membrane.  The cytoplasmic proteins found in Table 2 are involved in 
important biological processes. For example, the ATP-dependent Clp protease, 
chaperonin GroEL, and DnaK are involved in protein turnover and folding; whilst the 
RNA polymerase β subunit is involved in mRNA transcription.  Additionally, translation 
elongation factor FusA has a role in protein synthesis and the ATP synthase produces 
ATP from ADP in a proton gradient present across the cell membrane.  Finally, 
transketolase has a role in the pentose phosphate pathway.         
Analysis of the effects of solubilization buffer on protein concentration yield.  In 
addition to lysis methods, we also investigated the buffer used to solubilize proteins 
during extraction.  As hydrophobic proteins can be easily lost during sample preparation, 
two different resuspension buffers were compared in an attempt to maximize protein 
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yield in general, and specifically capture the maximum number of hydrophobic proteins.  
In our analysis above, PBS was used to resuspend cells for the extraction of cytoplasmic 
proteins described in Table 1; however PBS is not efficient at dissolving insoluble 
proteins, and may not be able to guarantee maximum proteome coverage.  Due to its 
molecular structure, urea is able to solubilize insoluble proteins by expanding 
hydrophobic cores via hydrogen bonding, encouraging the solvation of hydrophobic 
regions and allowing water to compete with intraprotein interactions.  UDS buffer (6M 
urea, 5mM DTT, 1% SDS, 50mM Tris-HCl, pH 8) has been used in other studies for 
protein extraction [124], and therefore we set out to compare results obtained with this 
solution, with PBS.  Cytoplasmic proteins from overnight cultures of SH1000 were 
extracted in PBS and in UDS by mechanical shearing of the cells.  The concentrations of 
the cytoplasmic proteins from each sample were determined using a Pierce 660 nm 
Protein Assay.  We found that UDS buffer commonly yielded protein concentrations 
from SH1000 cultures in stationary phase of around 1256 µg/ml compared to PBS, which 
was only around 783 µg/ml.  UDS appeared to allow for more coverage of the 
cytoplasmic proteome, including hydrophobic proteins, and was thus chosen as our buffer 
for future analyses.  
The use of complex mixture analysis coupled with HPLC separation to increase the 
number of proteins identified from overnight cultures of S. aureus cells.  Given that 
the S. aureus genome contains approximately 2800 genes, our analysis above (Figure 2, 
Table 2) clearly does not represent the entire intracellular proteome of overnight SH1000 
cells. Therefore, whilst 380 was a promising initial result, we employed alternative 
approaches to maximize the total number of proteins we could identify because proteins 
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that are very large, hydrophobic, acidic, or basic are poorly resolved by gel 
electrophoresis.  For this reason a newer method was used, known as multi-dimensional 
protein identification (MudPIT), which combines multi-dimensional liquid 
chromatography with tandem mass spectrometry; allowing complex protein samples to be 
analyzed.  Experimentally, proteomes are reduced and digested with trypsin to generate 
peptide fragments.  Using HPLC, the peptide fragment mixture is then applied to a 
column packed with a strong cation exchange (SCX) resin.  The eluted peptides collected 
in fractions are then analyzed using a mass spectrometer.  This technique is very efficient 
because it is a relatively expedient method of analysis and the two-dimensional 
chromatographic separation of peptides also increases the number of proteins identified 
[145, 76].  Therefore, our new methodology involved using complex mixture analysis of 
cytoplasmic proteins coupled with HPLC separation, rather than 1D SDS-PAGE gel 
resolution.  Thus proteins were again extracted from an overnight culture of SH1000 as 
described above. These were then reduced, alkylated, and digested overnight with 
trypsin.  The resulting peptide fragments were fractionated via HPLC by applying the 
peptide fragments to a column packed with a strong cation exchange (SCX) resin.  The 
resulting fractions containing peptides were then analyzed using a ThermoFinnigan LTQ 
mass spectrometer.  After obtaining the mass spectral data, we analyzed the returned 
information using a database specific to S. aureus strain COL (a close relative of 
SH1000).  This had the effect of more accurate protein identification and also returned all 
proteins as belonging to S. aureus. This proteomic analysis of overnight S. aureus 
SH1000 cells yielded a total of 747 cytoplasmic proteins identified (Table 3).  
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Identified Proteins (747) Accession # Spectral counts 
alkaline shock protein 23  SACOL2173 1129 
enolase (eno)    SACOL0842 886 
translation elongation factor Tu (tuf)  SACOL0594 873 
glyceraldehyde 3-phosphate dehydrogenase (gapA1)   SACOL0838 873 
formate acetyltransferase (pflB)   SACOL0204 577 
aldehyde dehydrogenase (aldA1)   SACOL0154 372 
ATP-dependent Clp protease, putative  SACOL2563 371 
DNA-binding protein HU (hup)  SACOL1513 356 
pyruvate dehydrogenase complex E3 component, lipoamide dehydrogenase (pdhD)   SACOL1105 341 
dnaK protein (dnaK)  SACOL1637 298 
Table 3.  The ten most abundant cytoplasmic proteins identified from MudPIT analysis of SH1000 
Compared to proteins identified from 1D SDS-PAGE found in Table 2, proteins 
identified by MudPIT analysis in Table 3 were overall more abundant.  For example, in 
Table 1, Clp protease had a total of 56 spectral counts whereas the spectral counts for this 
particular protein in Table 3 were 371.  Also, there was seemingly less contamination by 
non-cytoplasmic proteins.   
Specific cataloging of the S. aureus intracellular proteome using MudPIT analysis.  
Reproducibility using HPLC fractionation proved to be highly inconsistent; therefore a 
new fractionation method was needed for the cataloging of SH1000.  Usually, ions with 
mass-to-charge ratios, used to determine the masses of peptides, between the values of 
350 and 1500 are selected in the mass spectrometer for analysis.  With a new gas phase 
fractionation method, three separate protocols were created in the mass spectrometer.  
The first method scanned ions with a mass-to-charge ratio within a range of 350-550.  
The second method scanned ions with a mass-to-charge ratio within a range of 550-750.  
Finally, the third method scanned ions with a mass-to-charge ratio of 750-1500.  Each 
sample was analyzed using the three methods with three injections each.   
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Having derived methodologies that were effective and consistent for the intracellular 
proteomic analysis of S. aureus, we undertook a cataloging project using the laboratory 
strain SH1000.  For this analysis, we chose to isolate intracellular proteomes from two 
different phases of growth: post-exponential (5 hours), and stationary (15 hours).  Toxin 
production begins in the post-exponential phase with toxins accumulating in the 
stationary phase.  For this reason, these two time points are of particular interest when 
cataloging proteomes of S. aureus.  Thus, 1 milliliter of an overnight culture of SH1000 
was added to a fresh 250 ml flask containing 100 ml of TSB which was incubated for 3 
hours at 37˚C.  After incubation, these cultures were again used to inoculate fresh TSB 
(identical conditions) at an optical density of 0.05.  These test cultures were then allowed 
to grow at 37˚C for the appropriate amount of time for each growth phase.  Cytoplasmic 
proteins were extracted by mechanically shearing the cells with glass beads in UDS 
buffer for a total of 4 minutes.  Protein yields were calculated using a Pierce 660 nm 
Assay and standardized to 1 mg/ml for trypsin digestion.  After trypsin digestion, the 
samples were subsequently analyzed by mass spectrometry for the final identification of 
cytoplasmic proteins present in the original cultures. 
The ten most abundant cytoplasmic proteins identified by MudPIT analysis from SH1000 
during post-exponential phase are included in Table 4.  A total of 346 proteins were 
identified including DNA polymerase III β subunit, DNA polymerase I, DNA 
topoisomerase 4, and DNA ligase.  Each of these is involved in the central cellular 
process of DNA synthesis.  There was also a presence of DNA-directed RNA polymerase 
subunits ω, β, and β’ for mRNA transcription.  Many aminoacyl tRNA synthetases were 
also present in SH1000 during post-exponential phase, as were proteins involved in 
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protein synthesis, including elongation factor Tu, elongation factor G, and numerous 30S 
and 50S ribosomal proteins.  The majority of the proteins identified such as enolase, 
pyruvate kinase, pyruvate dehydrogenase, fructose bisphosphate aldolase, dihydrolipoyl 
dehydrogenase, phosphoglycerate mutase, are involved in central carbon metabolism and 
energy generation.  These proteins would be expected in the post-exponential phase 
because cells in this phase have not yet entered the stationary phase and are metabolically 
active and still growing.  The complete list of proteins identified can be found in the 
Appendix.   
Identified Proteins (346) Accession Number Sample 1 Sample 2 
Elongation factor Tu sp|Q5HIC7|EFTU_STAAC 239 119 
Probable transglycosylase isaA sp|Q5HCY1|ISAA_STAAC 81 111 
Elongation factor G sp|Q5HIC8|EFG_STAAC 89 65 
Enolase sp|Q5HHP1|ENO_STAAC 64 39 
Pyruvate kinase sp|Q5HF76|KPYK_STAAC 54 27 
Dihydrolipoyl dehydrogenase sp|Q5HGY8|DLDH_STAAC 39 36 
Pyruvate dehydrogenase E1 component subunit beta sp|Q5HGZ0|ODPB_STAAC 35 38 
Bifunctional autolysin sp|Q5HH31|ATL_STAAC 45 24 
50S ribosomal protein L30 sp|Q5HDX6|RL30_STAAC 28 25 
50S ribosomal protein L15 sp|Q5HDX7|RL15_STAAC 15 45 
Table 4.  The ten most abundant cytoplasmic proteins identified from MudPIT analysis of SH1000 
during post-exponential phase 
The ten most abundant cytoplasmic proteins identified by MudPIT analysis from SH1000 
during stationary phase are included in Table 5.  A total of 366 proteins were identified, 
including most of the proteins found in post-exponential phase, although in lesser 
quantities.  As will be mentioned later, the method had to be refined yet again due to poor 
and inconsistent results using the HPLC.  The newer gas phase fractionation method that 
will be mentioned bypasses the need for the HPLC but sacrifices proteome coverage.  
Proteins involved in DNA replication, transcription, protein synthesis, and central carbon 
metabolism were present in stationary phase cultures of SH1000.  Though toxins such as 
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phenol soluble modulins and delta hemolysin are expected to be secreted, they are still 
present in high quantities intracellularly during stationary growth, when toxins begin to 
accumulate.   
Identified Proteins (366) Accession Number Sample 1 Sample2 
Elongation factor Tu  sp|Q5HIC7|EFTU_STAAC 246 521 
Antibacterial protein (Phenol soluble modulin) tr|Q5HGQ7|Q5HGQ7_STAAC 115 215 
Probable transglycosylase isaA sp|Q5HCY1|ISAA_STAAC 140 124 
Pyruvate kinase  sp|Q5HF76|KPYK_STAAC 115 58 
Uracil phosphoribosyltransferase  sp|Q5HE88|UPP_STAAC 66 66 
Elongation factor G sp|Q5HIC8|EFG_STAAC 81 67 
Dihydrolipoyl dehydrogenase  sp|Q5HGY8|DLDH_STAAC 78 48 
Bifunctional autolysin  sp|Q5HH31|ATL_STAAC 92 31 
Cell division protein ftsZ sp|Q5HGP5|FTSZ_STAAC 68 43 
Delta-hemolysin  sp|Q5HEG6|HLD_STAAC 98 18 
Table 5.  The ten most abundant cytoplasmic proteins identified from MudPIT analysis of SH1000 
during stationary phase 
Derivation of an improved method for extraction of the S. aureus secretome.  Given 
that S. aureus secretes a variety of exoproteins and toxins throughout growth, we 
determined it of significant importance to globally analyze these proteins at a proteomic 
level.  As such, 100 ml of an overnight culture of SH1000 grown in a 250 ml flask was 
centrifuged for 10 minutes at a speed of 4,150 rpm.  Secreted proteins were precipitated 
from the supernatant by adding 10% trichloroacetic acid and incubating for 1 hour.  After 
the incubation period, the precipitated secreted proteins were washed with room 
temperature acetone and then centrifuged for 10 minutes at a speed of 13,300 rpm.  
Washing with acetone was repeated a total of 3 times and the secreted protein pellet 
resuspended in UDS buffer.  This was then fractionated via HPLC and analyzed using a 
ThermoFinnigan LTQ mass spectrometer.  Our analysis revealed a total of 728 proteins 
identified from the supernatants collected from the overnight cultures of SH1000 which 
unexpectedly contained many cytoplasmic proteins.  Thus it would appear that 
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centrifuging is not sufficient for the removal of bacterial cells that could contaminate the 
supernatant fraction with cytoplasmic proteins.  In order to improve the purity of secreted 
proteins in supernatants we inserted a filter sterilization step after centrifugation to 
remove cell contamination.   
Further to this, TCA based precipitation of secretomes is difficult, time consuming and 
inconsistent, as a result of the large volumes involved (up to 400 ml).  In order to 
maximize efficiency and expedite analysis, we employed Millipore Centricon Plus-70 
Centrifugal Filter Units with a 5 kDa cutoff to concentrate supernatants.  This method 
allowed for reduction in culture volumes; however protein concentrations directly from 
this process were still lower than required for analysis.  Protein precipitation using 
trichloroacetic acid was thus still necessary to be able to resuspend the secreted proteins 
in UDS in an even smaller volume for subsequent mass spectrometric analysis.  
Therefore, we investigated a new method for precipitating secreted proteins so as to 
significantly increase yields and concentrations.  After the addition of 10% TCA to the 
concentrated supernatant, we extended incubation times to overnight at 4˚C.  Samples 
were then centrifuged at 4˚C for 70 minutes at a speed of 8,500 rpm.  Supernatant were 
discarded and protein pellets washed with 100% ice cold ethanol, before centrifugation 
again at 4˚C for 70 minutes at a speed of 8,500 rpm.  The ethanol washing was repeated a 
total of 3 times to ensure complete removal of TCA. Use of this method resulting in 
significantly higher proteins yields compared to the former, more rapid method of TCA 
precipitation.  As an average, a stationary phase culture of SH1000 yielded a 
concentration of 336.6 µg/ml of proteins using the new TCA precipitation method 
compared to the older precipitation method that yielded an average of only 201.8 µg/ml.    
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Specific cataloging of the S. aureus secretome using MudPIT analysis.  As with our 
intracellular investigations, given that we have determined effective methods for analysis, 
we set about cataloging the secretome of S. aureus SH1000.  Because HPLC 
fractionation proved to give inconsistent results, as with the analysis of the intracellular 
proteome of S. aureus, we resorted to the gas phase fractionation method detailed above.     
 We again conducted this study for post-exponential and stationary phase cultures to 
observe the alteration of secreted proteins during growth.  Accordingly, we took the 
supernatants derived from the intracellular cataloging experiments and filter sterilized 
them.  These were then concentrated using Millipore Centricon Plus-70 centrifugal filter 
units with a 5 kDa cutoff, before precipitation using the TCA method derived above.  
After precipitation, the concentrations of secreted proteins were calculated using a Pierce 
660 nm Assay before standardization to 1 mg/ml.  Proteins were then digested with 
trypsin followed by mass spectrometric analysis for the identification of proteins secreted 
by S. aureus during the different growth phases.   
The ten most abundant secreted proteins identified by MudPIT analysis from SH1000 
during post-exponential phase are included in Table 6.  A total of 38 secreted proteins 
were identified; the complete list can be found in the Appendix.  Though some 
cytoplasmic proteins such as enolase, glyceraldehyde-3-phosphate dehydrogenase, and 
pyruvate dehydrogenase can still be identified in the secreted protein fraction of S. 
aureus, filter sterilization of the supernatant excludes whole cells of S. aureus minimizing 
contamination by cytoplasmic proteins.  For the most part, secreted proteins of SH1000 
identified in the post-exponential phase were surface-associated proteins.  These proteins 
included immunodominant antigen A, bifunctional autolysin, staphylococcal secretory 
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antigen SsaA2, putative surface proteins, probable transglycosylase SceD, glycerol 
phosphate lipoteichoic acid synthase, and lipase 1.  Because agr activity increases during 
post-exponential phase, toxin production has just begun and has not yet accumulated in 
the supernatant, accounting for the low number of proteins identified in Table 6.       
Identified Proteins (38) Accession Number Sample 1 Sample 2 
Probable transglycosylase isaA sp|Q5HCY1|ISAA_STAAC 234 186 
Bifunctional autolysin  sp|Q5HH31|ATL_STAAC 42 31 
Staphylococcal secretory antigen ssaA2  sp|Q5HDQ9|SSAA2_STAAC 46 39 
Staphopain A  sp|Q5HEL3|SSPP_STAAC 10 6 
Enolase  sp|Q5HHP1|ENO_STAAC 8 7 
Surface protein, putative  tr|Q5HDZ9|Q5HDZ9_STAAC 8 2 
Probable transglycosylase sceD  sp|Q5HEA4|SCED_STAAC 5 3 
Glycerol phosphate lipoteichoic acid synthase  sp|Q5HHV4|LTAS_STAAC 5 6 
Glyceraldehyde-3-phosphate dehydrogenase 1  sp|Q5HHP5|G3P1_STAAC 7 5 
Lipase 1  sp|Q5HCM7|LIP1_STAAC 5 0 
Table 6.  The ten most abundant secreted proteins identified from MudPIT analysis of SH1000 
during post-exponential phase 
The ten most abundant secreted proteins identified by MudPIT analysis from SH1000 
during stationary phase are included in Table 7, with a total of 346 secreted proteins 
identified.  Overall, the number of secreted proteins identified was higher in the 
stationary phase compared to the post-exponential phase.  Most importantly, the 
production of secreted toxins and exoenzymes increases immensely in stationary phase.  
Those identified in SH1000 during stationary phase include alpha, delta, and gamma 
hemolysins, serine proteases SplB and SplC, phenol soluble modulins, leukotoxin LukD, 
leukocidin-like protein 1, and staphopains A and B.       
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Identified Proteins (346) Accession Number Sample 1 Sample 2 
Lipase 1  sp|Q5HCM7|LIP1_STAAC 608 361 
Bifunctional autolysin  sp|Q5HH31|ATL_STAAC 269 229 
Probable transglycosylase isaA  sp|Q5HCY1|ISAA_STAAC 527 143 
Surface protein, putative  tr|Q5HDZ9|Q5HDZ9_STAAC 148 114 
Putative uncharacterized protein  tr|Q5HI54|Q5HI54_STAAC 174 119 
Enolase  sp|Q5HHP1|ENO_STAAC 70 99 
Alpha-hemolysin  tr|Q5HGS1|Q5HGS1_STAAC 85 82 
Lipase 2  sp|Q5HJ48|LIP2_STAAC 105 85 
Glyceraldehyde-3-phosphate dehydrogenase 1  sp|Q5HHP5|G3P1_STAAC 93 72 
Glycerol phosphate lipoteichoic acid synthase  sp|Q5HHV4|LTAS_STAAC 74 46 
Table 7.  The ten most abundant secreted proteins identified from MudPIT analysis of SH1000 
during stationary phase 
The application of proteomic methodologies for quantitative analysis of secreted 
toxins from a variety of S. aureus clinical isolates.  Having refined effective methods 
for the extraction and mass spectrometric analysis of S. aureus proteomes, we proceeded 
to apply these methods to a relevant biological question.  Clinically significant strains of 
S. aureus currently affecting individuals in healthcare facilities and in the community 
have thus far only been studied at the genomic and transcriptomic levels.  Therefore, we 
decided to study these strains at the proteomic level, as this analysis has to date not been 
completed.  Understanding the differential expression of secreted proteins could give 
insight into phenotypic switching mechanisms of S. aureus and strain dependent 
variations in virulence. 
S. aureus infections have commonly been confined to health care facilities [41] largely 
affecting immunocompromised, young, or old individuals.  These hospital-acquired 
methicillin resistant S. aureus (HA-MRSA) strains are highly-resistant to antibiotics, 
making HA-MRSA infections very difficult to treat.  The leading HA-MRSA strain in the 
United States is USA100 with HA-MRSA strain USA200 a close second [127].  
Recently, community-acquired methicillin resistant S. aureus (CA-MRSA) infections 
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have been reported in individuals with no ties to health care facilities [1, 94, 138].  In the 
United States, the most common CA-MRSA strains are known as USA300 and USA400 
[110, 177].  These CA-MRSA strains appear to be far more virulent than HA-MRSA and 
are especially significant because they cause infections in young, healthy individuals with 
no predisposing factors [24, 54].  Despite their increased virulence, CA-MRSA strains 
currently have reduced antibiotic resistance compared to HA-MRSA; however it has 
recently been reported that CA-MRSA are beginning to replace HA-MRSA strain in 
healthcare facilities [195]. 
Therefore, synchronous cultures of hospital-associated methicillin resistant S. aureus 
(HA-MRSA) strains (USA100 and USA200) and community-associated methicillin 
resistant S. aureus (CA-MRSA) strains (USA300 and USA400) were grown to the post-
exponential (5 hours) and stationary phases of growth (15 hours).  After extraction of 
secreted proteins from the supernatants of these cultures, the concentrations of these 
proteins were standardized to 100 µg before overnight trypsin digestion.  The resulting 
peptides were labeled using iTRAQ reagents, before mass spectrometric analysis by an 
LTQ Orbitrap.  The reagents (having masses of 114, 115, 116, and 117) were used to 
label USA100, USA200, USA300, and USA400 respectively.  Each of these analyses 
was performed separately a total of 3 times for each strain.  After database searching of 
the spectral data using Mascot Daemon, Scaffold 3 was used to determine the secretomes 
of each clinical strain (USA100, USA200, USA300, USA400).  Each strain was analyzed 
using a database derived from the relevant strains genome sequence.  Using Scaffold 3, a 
t-test analysis was performed on the derived data to determine any statistically significant 
changes in production of major secreted toxins between the various strains, and between 
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the two different phases of growth (post-exponential and stationary).  A p-value ≤ 0.05 at 
a 95% level of confidence was considered to be statistically significant.   
Relative standard deviation and standard error for the three biological replicates.  
For statistical analyses, each biological sample was replicated a total of three times.  To 
determine variability from sample preparation, relative standard deviation and standard 
error were calculated for each biological replicate from the comparison of one clinical 
strain to another.  The ten most abundant proteins and one low abundance protein were 
chosen to determine the variability from one biological replicate to another.  The relative 
standard deviation of all the proteins in a given biological replicate was then averaged.  
The relative standard deviation value is in the form of a percent and a percent ≤ 20 
determines sample variability due to sample preparation is low, meaning the technical 
replicates were statistically sound (See Appendix).   
Analysis of variations in secretomes of HA-MRSA and CA-MRSA strains.  Separate 
databases were created for each strain: N315 for USA100, MRSA252 for USA200, 
FPR3757 for USA300, and MW2 for USA400.  When database searching of the spectral 
data from each iTRAQ sample, each clinical strain was analyzed by its own database, 
which can affect the number of proteins identified in Scaffold 3.  In the post-exponential 
phase, 109 proteins were identified using the USA100 database, 89 proteins were 
identified using the USA200 database, 114 proteins were found using the USA300 
database, and 119 proteins were found using the USA400 database.  In stationary phase, 
246 proteins were discovered using the USA100 database, 230 proteins were identified 
for USA200, 224 proteins were found for USA300, and 240 proteins were identified 
using the USA400 database.  There was an overall increase in the number of proteins 
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identified in the transition from post-exponential phase to stationary phase, as one might 
expect, resulting from toxin accumulation and/or cellular lysis. 
Gene Ontology Annotations of HA-MRSA and CA-MRSA clinical strains.  Using the 
complete proteome set for each clinical strain found at Uniprot.org in conjunction with 
JCVI CMR, a website containing complete genome sets of prokaryotic organisms, the 
role of each protein identified from each strain was annotated.  Gene ontology of HA-
MRSA strain USA100 during post-exponential phase is outlined in Figure 5.  Proteins 
abundant during this phase include those involved in protein synthesis, energy 
metabolism such as glycolysis, gluconeogenesis, tricarboxylic acid cycle, pentose 
phosphate pathway, fermentation etc., and proteins involved in the biosynthesis and 
degradation of the cell envelope.   
 
Figure 5.  Gene ontology of HA-MRSA USA100 during post-exponential phase  
Figure 6 displays gene ontology of USA100 during stationary phase growth.  The 
majority of the proteins involved found during stationary phase are involved in energy 
49 
 
metabolism, protein synthesis and metabolism, purine and pyrimidine metabolism, cell 
envelope, as well as proteins of unknown function and those that are conserved 
hypothetical proteins. 
 
Figure 6.  Gene ontology of HA-MRSA USA100 during stationary phase 
The gene ontology of the other HA-MRSA known as USA200 during post-exponential 
phase is demonstrated in Figure 7.  Most of the proteins expressed at this growth phase 
are involved in protein synthesis and energy metabolism.   
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Figure 7.  Gene ontology of HA-MRSA USA200 during post-exponential phase 
The gene ontology of USA200 during stationary phase is demonstrated in Figure 8.  It 
seems USA200 upregulates the production of proteins involved in purine and pyrimidine 
metabolism, toxin production, protein metabolism, and detoxification.  These proteins 
would be expected during stationary phase as nutrients become scarce and S. aureus 
upregulates the production of proteins involved in creating a nutrient source. 
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Figure 8.  Gene ontology of HA-MRSA USA200 during stationary phase 
Figure 9 outlines the gene ontology of the leading CA-MRSA strain known as USA300.  
The proteins identified are from post-exponential phase of growth.  USA300 mainly 
expresses proteins involved in protein synthesis, energy metabolism, cell envelope, 
protein metabolism, protein folding, and other uncharacterized proteins, as well as those 
that are hypothetical conserved proteins.   
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Figure 9.  Gene ontology of CA-MRSA USA300 during post-exponential phase 
During stationary phase, USA300 generally produces more proteins involved in energy 
metabolism and protein synthesis.  Interestingly, USA300 significantly upregulates the 
production of certain conserved hypothetical proteins.  Proteins involved in purine and 
pyrimidine metabolism, toxin production, and pathogenesis are generally upregulated 
during stationary phase (Figure 10). 
 
Figure 10.  Gene ontology of CA-MRSA USA300 during stationary phase 
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The other CA-MRSA strain, USA400 seems to produce proteins involved in protein 
synthesis, energy metabolism, toxin production and resistance, protein metabolism, and 
in the cell envelope.  There also seems to be a significant presence of proteins with 
unknown functions.   
 
Figure 11.  Gene ontology of CA-MRSA USA400 during post-exponential phase 
After transitioning from post-exponential phase to stationary phase, USA400 upregulates 
the expression of even more proteins involved in protein synthesis, energy metabolism, 
and those with unknown functions.  Also, proteins involved in toxin production and 
resistance, fatty acid and phospholipid metabolism, and purine and pyrimidine 
metabolism are also upregulated in the later phase of growth.   
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Figure 12.  Gene ontology of CA-MRSA USA400 during stationary phase 
Changes in the expression of major secreted proteins between two HA-MRSA 
strains during post-exponential growth.  Analysis of the secreted proteins of HA-
MRSA USA200 compared to the leading HA-MRSA USA100 strain at this time point 
revealed there were limited variations in protein levels.  Seemingly, USA200 produces 
6.8-fold more penicillin binding protein 2’ from the mecA gene, at this time point when 
compared to USA100.  Further to this, the foldase protein PrsA, which is involved in 
controlling the rate of protein folding [192], is expressed at levels 3.2-fold higher in 
USA200 when compared to USA100.  The production of putative surface protein 
SA2285, however, is 20.34 times greater in USA100 than in USA200.  This putative 
surface protein SA2285 is large (1370 aa) and contains domains involved in adhesion, 
and for the cleavage of human IgA, suggesting a role in pathogenesis [187].  Because 
toxin production begins during the post-exponential growth, not much variation would be 
expected at this time point.      
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Identified Proteins  Accession Number P-Value USA100 USA200 
Putative surface protein SA2285 P61598|PLS_STAAN 0.0000073 1 0.049164184 
 
Penicillin binding protein 2' 
 
Q7A8C6|Q7A8C6_STAAN 
 
0.000000000074 
 
1 
6.806270155 
Foldase protein prsA  
 
P60748|PRSA_STAAN 
 
0.000035 
 
1 3.236942617 
 
Table 8.  A comparison of the secretomes of USA100 and USA200 during the post-exponential phase 
of growth 
Changes in the expression of major secreted proteins between two CA-MRSA 
strains during post-exponential growth.  Table 9 depicts the significant changes in 
secreted protein production between the two CA-MRSA strains, USA300 and USA400.  
There is a downregulation (0.58-fold) of putative lipoprotein Q2FIT2 in USA300 when 
compared to USA400.  Putative lipoprotein Q2FIT2 contains a potential signal peptide 
sequence and a conserved DM13 domain that possibly functions as a sugar kinase in 
bacterial two component systems [90].  On the other hand, the leading CA-MRSA strain 
USA300 upregulates the production of alpha hemolysin (1.8-fold), phenol soluble 
modulin (PSMα1) (3.4-fold), a putative uncharacterized protein 
SAUSA300_pUSA010004 (10.9-fold) that has no known homologs, and an 
uncharacterized protein Q2FFS8 that is homologous to a beta-lactamase protein (10.8-
fold).  The presence of thermonuclease, a heat stable DNase, did not change significantly 
in either strain.  
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Identified Proteins  Accession Number P-Value USA300 USA400 
Alpha-hemolysin Q2FHS2|Q2FHS2_STAA3 0.00018 1 0.550173608 
Thermonuclease Q2FIK2|Q2FIK2_STAA3 0.0016 1 1.219681925 
Putative uncharacterized protein 
SAUSA300_pUSA010004 
Q2FDE2|Q2FDE2_STAA3 0.025 1 
0.091960838 
Putative uncharacterized protein  Q2FFS8|Q2FFS8_STAA3 0.019 1 0.092562355 
Putative lipoprotein  Q2FIT2|Q2FIT2_STAA3 0.042 1 1.712581503 
Phenol-soluble modulin alpha 1 peptide  P0C7Y0|PSMA1_STAA3 0.046 1 0.306315112 
Table 9.  Secreted proteins of USA400 demonstrating significant changes in expression compared to 
USA300 during post-exponential phase of growth 
Changes in the expression of major secreted proteins between HA-MRSA and CA-
MRSA strains during post-exponential phase.  The secreted proteins of the leading 
CA-MRA strain (USA300) are compared to HA-MRSA USA100 during post-exponential 
phase of growth, in Table 10.  Overall, USA100 produces almost 52 times more putative 
surface protein SA2285 and 1.55 times more foldase.  Immunodominant antigen A and 
SasD are both upregulated about 13-fold more in USA100 compared to USA300.  The 
immunodominant antigen A, a probable transglycosylase (IsaA), contains a potential 
signal peptide for secretion and is likely involved in peptidoglycan turnover [170].  The 
Serine-aspartate repeat-containing protein D, also known as SasD is likely to have a 
signal peptide sequence as well as conserved domains involved in fibrinogen binding.  
Interestingly, the data provided in Table 10 correlates well with the literature concerning 
HA-MRSA and CA-MRSA.  Surface proteins are expected to be downregulated in CA-
MRSA due to hyperactivity of agr that negatively affects production of these proteins as 
it upregulates production of secreted toxins and proteases.  It is unsurprising, therefore, 
that CA-MRSA strains such as USA300 do not produce surface-associated proteins as 
much as HA-MRSA strains such as USA100.       
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Identified Proteins Accession Number P-Value USA100 USA300 
Putative surface protein SA2285  P61598|PLS_STAAN 0.0000019 1 0.019251877 
Probable transglycosylase isaA  P99160|ISAA_STAAN 0.030 1 0.075564941 
Serine-aspartate repeat-containing protein D  Q7A780|SDRD_STAAN 0.0086 1 0.0732664 
Foldase protein prsA  P60748|PRSA_STAAN 0.049 1 0.643330071 
Table 10.  Secreted proteins of USA300 demonstrating significant changes in expression compared to 
USA100 during post-exponential phase of growth 
When compared to USA100 during post-exponential growth, USA400 significantly 
upregulates the expression of staphopain A (4.1-fold).  Interestingly, this correlates with 
the observation that CA-MRSA strains have higher agr activity and therefore produce 
more secreted toxins and proteases than HA-MRSA [195].  USA400 also seems to 
produce more penicillin binding protein 2’ (1.7-fold) when compared to USA100, but 
there is a marked downregulation of putative surface protein SA2285 in USA400 (0.04-
fold). 
Identified Proteins Accession Number P-Value USA100 USA400 
Putative surface protein SA2285  P61598|PLS_STAAN 0.00014 1 0.040001113 
Staphopain A  P65826|SSPP_STAAN 0.0046 1 4.10146935 
Penicillin binding protein 2' Q7A8C6|Q7A8C6_STAAN 0.025 1 1.711120053 
Table 11.  Secreted proteins of USA400 demonstrating significant changes in  expression compared to 
USA100 during post-exponential phase of growth 
Production of penicillin binding protein 2’ seems to be markedly decreased (0.35-fold) in 
the leading CA-MRSA strain USA300, when compared to the HA-MRSA USA200.  This 
observation correlates with the finding that HA-MRSA strains seem to be more resistant 
to antibiotic treatment than CA-MRSA strains. 
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Identified Proteins  Accession Number P-Value USA200 USA300 
Penicillin binding protein 2' Q6GKQ7|Q6GKQ7_STAAR 0.047 1 0.353094018 
Table 12.  Secreted proteins of USA300 demonstrating significant changes in expression compared to 
USA200 during post-exponential phase of growth 
CA-MRSA USA400 may produce more penicillin binding protein 2’ than HA-MRSA 
USA100 (Table 12), but HA-MRSA USA200 produces 2.8-fold more of this protein than 
USA300.  Because HA-MRSA strains are known to be more antibiotic resistant [127], it 
is expected to find a HA-MRSA strain such as USA200 producing significantly more 
penicillin binding protein 2’ than a CA-MRSA strain such as USA300.  The same 
relationship between HA-MRSA and CA-MRSA can be seen in Table 13 as USA200 
produces 2.2-fold more penicillin binding protein 2’ than USA400.      
Identified Proteins Accession Number P-Value USA200 USA400 
Penicillin-binding protein 2' Q6GKQ7|Q6GKQ7_STAAR 0.035 1 0.45315937 
Table 13.  Secreted proteins of USA400 demonstrating significant changes in expression compared to 
USA200 during post-exponential phase of growth 
Changes in expression of major secreted proteins between two HA-MRSA strains 
during stationary phase.  When compared to USA100, USA200 seems to produce 
significantly more zinc metalloprotease (5.52-fold), less lipase 1 (0.2-fold), and foldase 
(0.66-fold).  Compared to the post-exponential phase of growth, there seems to be a 
decreased presence of foldase protein PrsA in USA200 during stationary phase.   
Identified Proteins Accession Number P-Value USA100 USA200 
Zinc metalloproteinase aureolysin Q7A378|Q7A378_STAAN 0.012 1 5.521879552 
Lipase 1  P65289|LIP1_STAAN 0.040 1 4.922412009 
Foldase protein prsA  P60748|PRSA_STAAN 0.045 1 1.512870373 
Table 14.  Secreted proteins of USA200 demonstrating significant changes in expression compared to 
USA100 during stationary phase of growth 
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Changes in expression of major secreted proteins between two CA-MRSA strains 
during stationary phase.  There is a marked upregulation of phenol soluble modulin 
PSMα1 (16.1-fold), PSMα4 (2.5-fold), antibacterial protein SAUSA300_1067 (2.0-fold), 
known as PSMβ2, antibacterial protein SAUSA300_1068 (10.6-fold), known as PSMβ1, 
elastin-binding protein EbpS (4.8-fold), a putative cell wall surface anchor family protein 
(1.4-fold), and a CHAP domain family protein (5.1-fold) in USA400 when compared to 
USA300.  It is predicted to have a signal peptide sequence and it also has a conserved 
domain involved in cell wall degradation.  On the other hand, there is an upregulation of 
alpha hemolysin (4.7-fold), an ABC transporter substrate-binding protein (1.8-fold), and 
putative uncharacterized protein SAUSA300_pUSA010004 (7.8-fold) in USA300.  
Interestingly, PSMα1 is higher in USA300 in the post-exponential phase of growth than 
in USA400, however the reverse is true during post-exponential growth.   
Identified Proteins Accession Number P-Value USA300 USA400 
Alpha-hemolysin  Q2FHS2|Q2FHS2_STAA3 0.0000000026 1 0.210747 
Phenol-soluble modulin alpha 1 peptide  P0C7Y0|PSMA1_STAA3 0.0000018 1 16.10036 
Antibacterial protein SAUSA300_1067 Q2FHR4|Q2FHR4_STAA3 0.0012 1 2.022183 
CHAP domain family Q2FIX4|Q2FIX4_STAA3 0.0016 1 5.090964 
Elastin-binding protein ebpS  Q2FGW1|EBPS_STAA3 0.0033 1 4.839727 
Putative uncharacterized protein 
SAUSA300_pUSA010004 
 |Q2FDE2_STAA3 0.0054 1 
0.12851 
Putative cell wall surface anchor family 
protein 
Q2FE08|Q2FE08_STAA3 0.0074 1 
1.362511 
Antibacterial protein SAUSA300_1068 Q2FHR3|Q2FHR3_STAA3 0.017 1 10.55861 
Phenol-soluble modulin alpha 4 peptide  P0C817|PSMA4_STAA3 0.022 1 2.464562 
ABC transporter, substrate-binding protein Q2FJ07|Q2FJ07_STAA3 0.029 1 0.552823 
Table 15.  Secreted proteins of USA400 demonstrating significant changes in expression compared to 
USA300 during stationary phase of growth 
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Changes in expression of major secreted proteins between HA-MRSA and CA-
MRSA strains during stationary phase.  Table 16 demonstrates changes in secreted 
protein production of CA-MRSA USA300 compared to HA-MRSA USA100.  Parallel to 
transcriptomic studies comparing HA-MRSA and CA-MRSA, there is a significant 
upregulation of gamma (2.3-fold) and alpha hemolysins (12.7-fold) in USA300 compared 
to USA100.  These observations are associated with a hyperactivity of agr in CA-MRSA 
strains compared to HA-MRSA strains.  On the other hand, production of the putative 
surface protein SA2285 is 33.8 times greater in USA100. 
Identified Proteins Accession Number P-Value USA100 USA300 
Putative surface protein SA2285 P61598|PLS_STAAN 0.00069 1 0.02960504 
Gamma-hemolysin component C Q7A3S2|HLGC_STAAN 0.030 1 2.30802049 
Alpha-Hemolysin  Q7A632|Q7A632_STAAN 0.032 1 12.6955356 
Table 16.  Secreted proteins of USA300 demonstrating significant changes in expression compared to 
USA100 during stationary phase of growth 
There is an enormous upregulation of secreted toxins such as lipase 1 (10-fold), lipase 2 
(4.6-fold), enterotoxin C (21.9-fold), the zinc metalloprotease aureolysin (1.8-fold), and 
elastin-binding protein EbpS (18.1-fold) in CA-MRSA USA400 when compared to HA-
MRSA USA100.  There is also a significant upregulation the SA2006 (8-fold) and 
SA0841 (5.1-fold) proteins in USA400.  These two proteins contain conserved MAP 
domains involved in adherence.  
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Identified Proteins Accession Number P-Value USA100 USA400 
Lipase 2  Q7A7P2|LIP2_STAAN 0.0022 1 4.611289 
Enterotoxin type C P0A0L4|ENTC3_STAAN 0.0033 1 21.88768 
Elastin-binding protein ebpS  Q7A5I6|EBPS_STAAN 0.0033 1 18.1368 
Lipase 1  P65289|LIP1_STAAN 0.0047 1 10.02552 
SA2006 protein  Q7A483|Q7A483_STAAN 0.020 1 8.034026 
Zinc metalloproteinase aureolysin  Q7A378|Q7A378_STAAN 0.031 1 1.837579 
SA0841 protein Q7A6G0|Q7A6G0_STAAN 0.040 1 5.091233 
Table 17. Secreted proteins of USA400 demonstrating significant changes in expression compared to 
USA100 during stationary phase of growth 
When comparing the production of secreted proteins between HA-MRSA USA200 and 
CA-MRSA USA300, it is evident USA200 produces significantly more zinc 
metalloprotease (3.6-fold) and a putative exported protein Q6GI28 (2.5-fold) than 
USA300.  Putative exported protein Q6GI28 contains a predicted signal peptide 
sequence, and is homologous to a LytR transcriptional regulator.  It also has a conserved 
domain putatively involved in transcriptional attenuation [77].  Production of gamma 
hemolysin component C, on the other hand, does not significantly change between 
USA200 and USA300. 
Identified Proteins Accession Number P-Value USA200 USA300 
Zinc metalloproteinase aureolysin Q6GDG5|Q6GDG5_STAAR 0.00038 1 0.279331 
Putative exported protein Q6GI28|Q6GI28_STAAR 0.014 1 0.394861 
Gamma-hemolysin component C  Q6GE13|HLGC_STAAR 0.047 1 1.379588 
Table 18. Secreted proteins of USA300 demonstrating significant changes in expression compared to 
USA200 during stationary phase of growth 
Side by side, CA-MRSA USA400 produces significantly more elastin-binding protein 
EbpS (14.8-fold) and an uncharacterized protein SAR1965 (5.2-fold) than USA200.  A 
signal peptide sequence is not been predicted for uncharacterized protein SAR1965, and 
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appears to be homologous to intracellular proteases.  This finding is odd because 
cytoplasmic proteins are not expected to be identified in the supernatant with secreted 
proteins.  HA-MRSA USA200, however, produces 14.45 times more anti-sigma factor B 
antagonist protein, also known as anti-anti sigma factor B, than USA400.  The high 
presence of anti-sigma factor B antagonist in HA-MRSA USA100 would lead to higher 
SigmaB activity in this strain.  Because SigmaB has been shown to have a repressive 
effect on agr activity [15] it is of no surprise CA-MRSA strain USA400, due to its 
hyperactive agr would produce SigmaB at significantly reduced levels.  SigmaB, being a 
cytoplasmic protein, is not expected to be identified in the supernatant.     
Identified Proteins Accession Number P-Value USA200 USA400 
Elastin-binding protein ebpS Q6GGT1|EBPS_STAAR 0.00040 1 14.76076 
Anti-sigma-B factor antagonist  Q6GF07|RSBV_STAAR 0.026 1 0.069202 
Uncharacterized protein SAR1965  Q6GFI2|Y1965_STAAR 0.042 1 5.188532 
Table 19. Secreted proteins of USA400 demonstrating significant changes in expression compared to 
USA200 during stationary phase of growth 
Changes in expression of major secreted proteins of HA-MRSA strains from post-
exponential phase to stationary phase.  In the transition from post-exponential phase to 
stationary phase, it is apparent HA-MRSA USA100 upregulates the production of 
penicillin binding protein 2’ (2.4-fold), putative surface protein SA2285 (9.2-fold), 
immunodominant antigen A (5.7-fold), and enterotoxin type C-3 (1.4-fold).  On the other 
hand, proteins downregulated in USA100 from post-exponential phase include foldase 
(0.26-fold), lipase 1 (0.14-fold) and 2 (0.12-fold), alpha-hemolysin (0.03-fold), SA0841 
protein (0.24-fold), and SA2006 protein (0.07-fold). 
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Identified Proteins Accession Number P-Value USA100 5hr USA100 15hr 
Penicillin binding protein 2' Q7A8C6|Q7A8C6_STAAN 0.0000014 1 2.427176057 
Putative surface protein SA2285 P61598|PLS_STAAN 0.000055 1 9.192129976 
Foldase protein prsA P60748|PRSA_STAAN 0.0048 1 0.264551095 
SA0841 protein  Q7A6G0|Q7A6G0_STAAN 0.016 1 0.238025085 
Lipase 1  P65289|LIP1_STAAN 0.021 1 0.140118214 
Alpha-Hemolysin Q7A632|Q7A632_STAAN 0.02 1 0.028642902 
Probable transglycosylase isaA  P99160|ISAA_STAAN 0.033 1 5.734707283 
Lipase 2  Q7A7P2|LIP2_STAAN 0.0011 1 0.12382117 
Enterotoxin type C-3  P0A0L4|ENTC3_STAAN 0.0012 1 1.40410766 
SA2006 protein  Q7A483|Q7A483_STAAN 0.015 1 0.070417081 
Table 20. Secreted proteins of USA100 demonstrating significant changes in expression from post-
exponential to stationary phase 
When switching from post-exponential phase to stationary phase, HA-MRSA USA200 
clearly upregulates the production of penicillin binding protein 2’ (11-fold).  Lipase 1 and 
a putative exported protein (Q6GIA6), on the other hand, are downregulated in the 
stationary phase 0.4-fold and 0.6-fold, respectively.  Putative exported protein Q6GIA6 is 
predicted to have a signal peptide sequence, and contains a MAP conserved domain 
putatively involved in cell adherence.  Downregulation of this putative exporter protein 
can perhaps be associated with the fact that S. aureus cells transition from adhesion in the 
earlier phases of growth to toxin production in the stationary phase. 
Identified Proteins Accession Number P-Value USA200 5hr USA200 15hr  
Penicillin-binding protein 2' Q6GKQ7|Q6GKQ7_STAAR 0.01135 
 
1 10.90122846 
 
Putative exported protein  Q6GIA6|Q6GIA6_STAAR 0.025 1 0.588479043 
Lipase 1  Q6GDD3|LIP1_STAAR 0.042 1 0.399557859 
Table 21. Secreted proteins of USA200 demonstrating significant changes in expression from post-
exponential to stationary phase 
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Changes in expression of major secreted proteins of CA-MRSA strains from post-
exponential phase to stationary phase.  Numerous proteins have been found to be 
significantly changed in CA-MRSA USA300 during the transition from post-exponential 
phase to stationary phase.  A few proteins including, 50S ribosomal protein L11 (1.8-
fold), penicillin binding protein 2’ (29.6-fold), immunodominant antigen A (9.5-fold), 
antibacterial protein Q2FHR3 (2.1-fold), and a putative cell wall surface anchor family 
protein (1.6-fold), were prevalent during stationary growth of USA300.  Proteins that 
were significantly downregulated in stationary phase include: adenylate kinase (0.09-
fold), alpha hemolysin (0.2-fold), antibacterial protein Q2FHR4 (0.5-fold), fructose 
bisphosphate aldolase (0.04-fold), Panton-Valentine leukocidin LukS (0.05-fold), 
peptidoglycan hydrolase (0.04-fold), phenol soluble modulin PSMα1 (0.02-fold), putative 
lipoprotein (0.05-fold), putative uncharacterized protein SAUSA300_pUSA010004 (0.2-
fold), putative uncharacterized protein SAUSA300_1759 (0.03-fold), putative 
uncharacterized protein SAUSA300_2164 (0.2-fold), serine protease SplB (0.4-fold), and 
triacylglycerol lipase (0.3-fold).  There was no significant change in thermonuclease 
production between the two phases.  The presence of 50S ribosomal protein L11, 
adenylate kinase, and fructose bisphosphate is unexpected because these are cytoplasmic 
proteins and should not be identified in the supernatant as secreted proteins.   
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Identified Proteins Accession Number P-Value USA300 
5hr 
 USA300 
15hr 
50S ribosomal protein L11  Q2FJA3|RL11_STAA3 0.026 1 1.797912631 
Adenylate kinase  Q2FER0|Q2FER0_STAA3 0.0138 1 0.086472995 
Alpha-hemolysin  Q2FHS2|Q2FHS2_STAA3 1.07517E-05 1 0.154783038 
Antibacterial protein Q2FHR4|Q2FHR4_STAA3 0.009 1 0.543067428 
Antibacterial protein  Q2FHR3|Q2FHR3_STAA3 0.033 1 2.0973797 
Fructose bisphosphate aldolase  Q2FF03|Q2FF03_STAA3 0.01485 1 0.039119603 
Panton-Valentine leukocidin, LukS Q2FGU9|Q2FGU9_STAA3 0.024 1 0.049059483 
Penicillin-binding protein 2'  Q2FKM6|Q2FKM6_STAA3 1.4E-10 1 29.55802797 
Peptidoglycan hydrolase Q2FJZ4|Q2FJZ4_STAA3 0.039 1 0.039707336 
Phenol-soluble modulin alpha 1 
peptide  
P0C7Y0|PSMA1_STAA3 0.014 1 0.018357338 
Probable transglycosylase isaA Q2FDT8|ISAA_STAA3 0.016 1 9.526965248 
Putative cell wall surface anchor 
family protein  
Q2FE08|Q2FE08_STAA3 1.1E-14 1 1.56173773 
Putative lipoprotein  Q2FIT2|Q2FIT2_STAA3 0.015 1 0.048020221 
Putative uncharacterized protein 
SAUSA300_1759 
Q2FFS8|Q2FFS8_STAA3 0.019 1 0.026126756 
Putative uncharacterized protein 
SAUSA300_2164 
Q2FES8|Q2FES8_STAA3 0.031 1 0.209015255 
Putative uncharacterized protein 
SAUSA300_pUSA010004 
Q2FDE2|Q2FDE2_STAA3 0.0048 1 0.115393064 
Serine protease splB  Q2FFT0|SPLB_STAA3 0.00435 1 0.413303495 
Thermonuclease Q2FIK2|Q2FIK2_STAA3 0.000636 1 0.848936408 
Triacylglycerol lipase Q2FDJ1|Q2FDJ1_STAA3 0.0046 1 0.334270278 
Table 22. Secreted proteins of USA300 demonstrating significant changes in expression from post-
exponential to stationary phase 
When switching from post-exponential growth to stationary growth, CA-MRSA USA400 
upregulates the production of surface protein MW2416 (1.6-fold) which is putatively 
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involved in cleaving human IgA and in adhesion, enterotoxin type C (5.8-fold), and 
penicillin binding protein 2’(49.5-fold).  Proteins downregulated by USA400 during the 
stationary phase include: lipase 1 (0.5-fold) and 2 (0.2-fold), MW1056 protein (0.1-fold), 
MW0863 protein (0.5-fold), MW2130 protein (0.4-fold), and alpha hemolysin (0.002-
fold). MW0863 and MW2130 proteins contain conserved MAP domains and are 
homologous to cell adherence proteins.   
Identified Proteins Accession Number P-Value USA400 5hr USA400 15hr 
Lipase 2 Q8NYC2|LIP2_STAAW 0.00044 1 0.230035026 
Lipase 1  Q8NUI5|LIP1_STAAW 0.0043 1 0.453603588 
ENTEROTOXIN TYPE C  Q8NXJ6|Q8NXJ6_STAAW 0.020833 1 5.7943177 
MW1056 protein  Q8NX40|Q8NX40_STAAW 0.017 1 0.132835969 
MW0863 protein Q8NXE3|Q8NXE3_STAAW 0.019 1 0.518113878 
MW2130 protein  Q7A090|Q7A090_STAAW 0.024 1 0.368062689 
Putative surface protein MW2416  Q8NUV0|PLS_STAAW 0.032 1 1.554528324 
Penicillin binding protein 2' Q7A209|Q7A209_STAAW 0.019 1 49.50848166 
Alpha-Hemolysin Q8NX49|Q8NX49_STAAW 0.00089 1 0.001530173 
Table 23. Secreted proteins of USA400 demonstrating significant changes in expression from post-
exponential to stationary phase 
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Discussion 
 
Proteomics, the identification of entire protein sets present in biological samples, is a 
useful complementary experimental approach to genomics and transcriptomics.  
Proteomics has become an extremely useful tool for the study of differential protein 
expression, gaining significance due to highly dynamic protein expression profiles.  
Understanding changes in a given proteome from a particular organism can provide much 
insight into its behavior, physiology and interaction with its environment.  Most of the 
proteomic studies published thus far involve 2D gel electrophoresis with very little 
emphasis on proteomic analysis of complex protein mixtures.  For a proteomic study, it is 
necessary to maximize protein concentration in order to facilitate the identification of 
proteins after mass spectrometric analysis.  It is also necessary to devise a method that 
can be easily employed and provide reproducible results.  Several published proteomic 
studies of S. aureus involved methods that have not been optimized to provide 
comprehensive coverage of the proteome.  Previous studies have been fraught with 
problems, including the use of a urea concentration that is too low for the solubilization 
of insoluble proteins; a lack of filter sterilization for supernatants to remove bacterial 
cells and ensure purity of secreted proteins; and secreted proteins centrifuged during 
precipitation at a speed too low to ensure maximal protein recovery [176, 206, 208]. 
Appropriate method refinement is therefore important for obtaining reproducible data 
across several biological replicates of a sample.  For the extraction of cytoplasmic 
proteins, we chose to compare various cell lysis techniques and solubilization buffers.  
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We also focused on concentration, precipitation, and washing of secreted proteins for a 
high yield of protein and subsequent mass spectrometric analysis.  In addition, apart from 
traditional 1D or 2D gel electrophoresis, we performed in-solution trypsin digestion of 
extracted proteins followed by mass spectrometry.   
After our refinement of the methods for extracting cytoplasmic and secreted proteins, we 
used these newly developed tools to catalogue the intracellular proteome and secretome 
of a commonly used and well studied lab strain of S. aureus known as SH1000 [86].  We 
focused on proteome coverage at two different phases of growth: post-exponential phase 
and stationary phase.  We did this in order to provide an insight into the physiology of S. 
aureus and how it adapts to its changing environment over time by utilizing differential 
protein synthesis.  From our study we found that there is a clear prevalence of ribosomal 
proteins, involved in protein synthesis, during post-exponential growth when compared to 
SH1000 during stationary phase; likely due to the scarcity of nutrients in the later growth 
phase, resulting in a reduction of translation occurring within the cell.  In a study by 
Becher et al., several subproteomic fractions of a S. aureus strain known as COL were 
analyzed by mass spectrometry [10].  When studying the change of cytoplasmic proteins 
of COL in the transition from post-exponential to stationary phase, Becher et al. also 
found ribosomal proteins were no longer being synthesized, and were potentially 
degraded in stationary phase [10].   
Moreover, in our study, the glycolytic enzymes glyceraldehyde 3-phosphate, fructose 
bisphosphate aldolase, phosphoglycerate kinase, phosphoglycerate mutase, and enolase 
are generally found to be downregulated in stationary phase when compared to post-
exponential phase.  This would perhaps be expected as the availability of carbon sources 
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becomes limited during stationary growth, and as such, enzymes involved in the 
catabolism of glucose would no longer be required in the absence of primary carbon 
sources.  On the other hand, proteins involved in the tricarboxylic acid (TCA) cycle, such 
as aconitate dehydrogenase, isocitrate dehydrogenase, components of the 2-oxoglutarate 
dehydrogenase complex, components of succinate dehydrogenase, fumarate hydratase, 
and malate dehydrogenase are upregulated during stationary phase growth of S. aureus.  
This could result from the catabolism of any remaining pyruvate molecules generated by 
glycolysis during post-exponential phase.  Also, phosphoenolpyruvate carboxykinase 
(PckA), a protein involved in gluconeogenesis, is upregulated in the stationary phase of 
SH1000 and was not detected in post-exponential growth phases.  This observation 
concurs with the 2009 study by Becher et al., where it was suggested that the presence of 
PckA could be indicative of carbon source starvation, as expected in stationary phase, 
when nutrients become scarce [10].  
In addition to proteins involved in carbon utilization, the production of Clp protease 
subunits is also higher in stationary phase than in the post-exponential phase.  These 
proteases, which respond to heat, osmotic, and oxidative stresses, enable S. aureus to 
survive in these situations and they tend to accumulate in stationary phase [26, 27,62].  
Furthermore, according to our data, anti-sigma factor B antagonist protein is upregulated 
in the stationary phase whilst the anti-sigma factor of Sigma B known as RsbW is 
downregulated in the stationary phase. This correlates with reports that Sigma B activity 
is upregulated in stationary phase [62, 112].  Specifically, the anti-sigma factor B 
antagonist, also known as anti-anti-sigma factor RsbV, functions to liberate Sigma B 
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from its anti-sigma factor, RsbW [134], to regulate the transcription of certain genes in 
stationary phase [111].      
When analyzing the secretome of SH1000 in the transition from post-exponential to 
stationary phase, there is a clear upregulation of toxins and secreted proteases in the later 
phase of growth.  These proteins include alpha hemolysin [146], gamma hemolysin [49], 
staphopain A and B [25, 99, 203], delta hemolysin [146], serine proteases SplB and SplC 
[161], PSMα1, PSMβ1, and PSMβ2 [159].  Interestingly, some of these secreted proteins 
are not detected at all during the post-exponential phase of growth.  Upregulation of these 
secreted proteins is expected in stationary phase of growth due to increased agr activity 
as a direct result of higher cell density [139, 152].   
Agr is a quorum sensing, two-component regulator that is expressed in the post-
exponential phase of S. aureus growth.  During the post-exponential phase, agr represses 
surface and attachment proteins and induces the transcription of secreted toxins and 
proteases [202].  As the population density of S. aureus increases, it secretes an auto-
inducing peptide that accumulates in the extracellular environment.  When S. aureus 
senses the concentration of the AIP has reached a threshold level it induces the 
transcription of virulence determinants, by the use of an effector molecule, as a response 
to stress such as nutrient limitation and high population density during stationary growth 
[139,152].  The agr effector molecule is a small regulatory RNA, known as RNAIII, 
which acts as a regulator of target genes [91, 145] by binding to target mRNA molecules 
and either stabilizing them or targeting them for destruction [135, 113, 186].  RNAIII 
facilitates the upregulation of secreted virulence factors [18, 66], and negatively regulates 
the synthesis of surface proteins, such as protein A and the fibronectin-binding proteins, 
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which are used for adhesion [91, 143, 171].  Therefore, the upregulation in production of 
secreted toxins and proteases such as alpha hemolysin, delta hemolysin, gamma 
hemolysin, staphopains A and B, delta hemolysin, serine proteases SplB and SplC, the 
phenol-soluble modulins (PSMα1, PSMβ1, and PSMβ2) is indicative of agr activity, 
which is expected in stationary phase.  We also observed accumulation of lipase 1 and 2 
with the onset of stationary growth. Though it is not clear if the transcription of these 
enzymes is regulated by agr, they are found to be downregulated in agr mutants of S. 
aureus [95].  From this observation, it is possible to speculate the potentially positive 
effect of agr activity on the production of lipases 1 and 2.   
Though the production of agr-regulated proteins is increased in stationary phase; overall 
agr activity would ultimately be expected to be reduced in the strain SH1000.  SH1000 is 
a strain that descended from another S. aureus strain known as 8325-4, whose Sigma B 
activity is diminished by a natural deletion in one of its positive effectors (rsbU).  
SH1000 was derived from 8325-4 via a full restoration of this deletion, and thus Sigma B 
activity [86].  Because Sigma B is an antagonist of agr, agr-regulated secreted toxins are 
downregulated in SH1000 as opposed to 8325-4 and other strains of S. aureus [15, 68, 
86].  In accordance with this observation, production of the agr-regulated protein V8 
protease appears to be diminished in SH1000.  In our findings, this protein was not 
detected in the post-exponential phase and was only detected at very low levels in 
stationary growth, when agr activity is at its highest.  Furthermore, staphyloxanthin, an 
orange carotenoid pigment of S. aureus [111], is highly pronounced in strain SH1000 
[86] due to Sigma B activity [111].  Our data indicate that staphyloxanthin biosynthesis 
protein is greatly upregulated from post-exponential phase to stationary phase.  This 
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finding concurs with the observation that cultures of SH1000, and therefore the resulting 
cell pellets, acquire a darker orange color later in growth when Sigma B activity is 
upregulated [86].       
Having determined the reproducibility of our protein extraction protocols, we next set out 
to characterize the secretomes of clinically relevant strains of S. aureus. Specifically, two 
HA-MRSA (USA100 and USA200) and two CA-MRSA (USA300 and USA400) strains 
were analyzed via quantitative methods at post-exponential and stationary phases of 
growth.  We focused on these growth phases in particular because toxins are produced 
beginning in the post-exponential phase and accumulate throughout stationary phase.  We 
undertook a complete proteomic analysis of differential protein production in the 
secretomes of these clinically significant strains using the popular quantification 
technique iTRAQ [47].  After extraction of the secretomes, proteins were digested with 
the protease trypsin to produce peptides.  The resulting peptides were isobarically labeled 
using iTRAQ reagents for mass spectrometric analysis of three biological replicates for 
subsequent identification and relative quantification of the proteins secreted by these four 
strains.  With this approach we sought to identify and also quantify the production of 
secreted proteins that enable this pathogen to swiftly infect and cause disease in patients.   
When comparing HA-MRSA USA100 to CA-MRSA USA300 during post-exponential 
phase of growth, it is evident USA100 produces more surface-associated proteins than 
USA300.  Putative surface protein SA2285, serine-aspartate repeat-containing protein D, 
and immunodominant antigen A, are both significantly upregulated in the HA-MRSA 
strain USA100.  Immunodominant antigen A, involved in peptidoglycan hydrolysis [48], 
has been identified as a secreted and cell wall associated protein [170].  A study by 
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Dubrac et al. in 2007 found that transcription of the isaA gene, encoding the 
immunodominant antigen A protein, is directly activated by the essential two-component 
system known as WalKR (also known as YycFG) [48].  Interestingly, the activity of 
WalKR, is upregulated during colonization of human nares in carriers of S. aureus.  
Seemingly, colonizing S. aureus preferentially expresses proteins involved in adherence 
to tissues, while at the same time downregulating the production of secreted toxins [21, 
22].  Interestingly, agr does not appear to be active during nasal colonization, therefore S. 
aureus would be expected to increase production of surface proteins and decrease 
production of secreted toxins and proteases that are regulated by agr, concurring with the 
observation of increased WalKR activity during nasal colonization.  Therefore, it is 
unsurprising to find a surface protein such as immunodominant antigen A to be 
significantly upregulated in a HA-MRSA strain such as USA100 where agr is not as 
active as it is in a CA-MRSA strain such as USA300.   
On another note, many surface proteins covalently linked to the cell wall require a 
peptide sorting signal, containing an LPXTG motif located at the C-terminus of the 
protein [175].  Proteins containing the LPXTG motif are often attached to the cell wall by 
a protease known as sortase [126, 140].  Instead of the traditional LPXTG motif 
contained by many surface proteins of S. aureus, putative surface protein SA2285 and 
serine-aspartate repeating protein D, known as SdrD, both contain YSIRK signal peptides 
[38].  YSIRK is a variation of the peptide sequence that marks a protein destined for the 
cell wall to be secreted in a ring-like manner near the site of cell division [38].  Proteins 
containing the YSIRK motif have been associated with adhesion to bones during 
infection [187].  A study by Trad et al. found a correlation between the prevalence of the 
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sdrD gene and strains of S. aureus that commonly cause bone infections [187].  In fact, a 
study by Sabat et al. found that a mutation in sdrD and sdrE, a gene tandemly encoded 
with sdrD in the sdr locus, resulted in significantly decreased potential for S. aureus to 
cause bone infections such as osteomyelitis [169].  Interestingly, HA-MRSA strains are 
known to commonly cause chronic infections such as osteomyelitis [108, 119] whereas 
CA-MRSA strains are known to cause acute infections such as skin and soft tissue 
diseases [24, 94, 103].  It is no surprise then that a HA-MRSA strain such as USA100 
upregulates the production of surface associated proteins such as immunodominant A, 
SdrD, and protein SA2285 that could enable the pathogen to infect the host and lead to a 
chronic disease.  Though it is not known whether these surface associated proteins are 
agr-regulated, this observation concurs with the fact that CA-MRSA strains such as 
USA300, having higher agr activity, would therefore express less surface associated 
proteins than HA-MRSA strains such as USA100 [116, 119].           
When comparing HA-MRSA USA100 to CA-MRSA USA400 in the post-exponential 
phase of growth we observed that USA100 produced 25 times more putative surface 
protein SA2285 than USA400.  As stated earlier, because agr activity is expected to be 
decreased in HA-MRSA than in CA-MRSA, the expression of surface-associated 
proteins would be upregulated in HA-MRSA as agr is a negative effector of surface 
proteins during the later stages of bacterial growth [116, 119].  On the same note, agr is a 
positive effector on the presence of proteases such as staphopain A [117], which is 
produced in elevated quantities in CA-MRSA USA400 compared to HA-MRSA USA100 
in our study.  In a 2007 study by Vincents et al., the extracellular proteases staphopain A 
and staphopain B were found to have a role in the downregulation of human cystatin 
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activity [191].  Cystatins are a family of cysteine protease inhibitors that potentially 
protect against proteases secreted by invading pathogenic microorganisms.  Though body 
fluids may have high concentrations of these protease inhibitors, they are still vulnerable 
to attack by other proteases [188].  These proteases, such as staphopain A, may have a 
role in evasion of the host immune system allowing S. aureus to survive and cause 
disease in the individual.  Additionally, it was shown by Imamura et al. in a 2005 study 
that staphopain A can instigate vascular leakage consequently leading to septic shock in 
affected individuals [88].  Because CA-MRSA strains are not only known for causing 
cutaneous infections but also sepsis [63, 110, 177], our observation of elevated 
Staphopain A production in these strains appears to fit with previous studies on this 
enzyme.        
All strains of S. aureus, regardless of antibiotic resistance, have penicillin binding 
proteins known as PBP1, PBP2, and PBP3.  These penicillin binding proteins, having 
high affinity for β-lactam antibiotics, are bound by these antimicrobial agents, in turn 
compromising the integrity of the cell wall by preventing cross-linking across the layers 
of peptidoglycan [122].  PBP2A, encoded by the mecA gene, has a low affinity for β-
lactams, therefore it is not targeted by these antibiotics; consequently preventing 
weakening of the cell wall.  Resistance to β-lactam antibiotics in CA-MRSA, however, is 
conferred by PBP4 [131], a β-lactamase [141].  On the other hand, loss of PBP2A, also 
known as penicillin binding protein 2’, in HA-MRSA reduces antibiotic resistance 
whereas loss of PBP4 in HA-MRSA strains has little effect on antibiotic resistance [101].  
Therefore, it would be expected to detect penicillin binding protein 2’ in much higher 
quantities in HA-MRSA strains of S. aureus than in CA-MRSA.  Our data suggests that 
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this is true as there is a clear upregulation of penicillin binding protein 2’ in HA-MRSA 
USA100 compared to CA-MRSA strains USA300 and USA400.   
Overall, toxin production in S. aureus is dramatically upregulated during stationary phase 
[18, 66].  When compared side by side, the production of gamma hemolysin component 
C and alpha hemolysin are drastically upregulated in CA-MRSA USA300 as opposed to 
HA-MRSA USA100.  As stated earlier, agr activity in CA-MRSA strains is expected to 
be higher than in HA-MRSA strains.  This increase in agr activity leads to elevated 
expression of major secreted virulence factors, such as gamma and alpha hemolysins [18, 
66, 75, 133].  In a 2010 study by Pang et al., agr activity of a USA300 strain was 
measured by RT-PCR after it had been phagocytosed by polymorphonuclear neutrophils 
(PMN).  PMNs are white blood cells used by the host immune system to ingest and 
degrade invading pathogenic microorganisms.  A USA300 strain containing an agr 
mutation lost significant viability within the PMN as opposed to the USA300 wild type 
strain containing an intact and fully functional agr [147].  It was found that once inside 
the PMN, agr activity by USA300 increased significantly, leading to an increased 
production of α-hemolysin.  This upregulation of α-hemolysin by USA300 in part was 
responsible for the lysis of PMNs, allowing for evasion of the host immune system, as 
opposed to a USA300 agr mutant strain [147].  Our data concurs with the findings by 
Pang et al. at the proteomic level, by showing CA-MRSA USA300 upregulates the 
production of alpha-hemolysin and other toxins due to a higher agr activity compared to 
a HA-MRSA strain such as USA100, where agr activity is diminished, and therefore the 
production of alpha hemolysin and other secreted virulence factors is reduced.     
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S. aureus produces superantigens such as enterotoxins, which are known to result in 
gastroenteritis caused by food poisoning [7, 115].  As reported by Baba et al., 
staphylococcal enterotoxin C is encoded on a pathogenicity island [6], and is not typically 
found to be expressed in HA-MRSA strains [58].  Unsurprisingly, as shown by our data, 
CA-MRSA USA400 produced 21.88 times more enterotoxin C than HA-MRSA 
USA100.  In a case report from 2002, an outbreak of gastroenteritis occurred within a 
family that was caused by a CA-MRSA strain producing enterotoxin C.  This report 
became the first case of CA-MRSA as the sole culprit of a gastroenteritis outbreak [96].  
In addition, CA-MRSA USA400 has been found to express the collagen adhesion gene 
(cna), which is associated with increased binding of S. aureus to host membrane proteins 
for the pathogenesis of necrotizing pneumonia [6, 43, 83].  Interestingly, when compared 
to HA-MRSA USA100, the production of surface proteins such as elastin binding 
protein, SA2006 protein, and SA0841 involved in adhesion is dramatically upregulated in 
USA400.  Elastin binding protein is also drastically upregulated in USA400 when 
compared to HA-MRSA USA200, as shown by our data.  Not surprisingly, USA400 is 
known to be a strong former of biofilms [97].  It is possible to speculate that these 
adhesion proteins may have a strong role in biofilm formation, and perhaps explain the 
elevated levels of this aggregation phenotype in USA400 strains [95].   
Additionally, when compared to USA100 during stationary phase, USA400 also 
significantly upregulates lipase 1 and lipase 2.  In a recent study [95] both lipase 1 and 
lipase 2, which facilitate tissue invasion [167], were found in low quantities in an agr 
mutant of S. aureus [95].  Likewise, a study of HA-MRSA and CA-MRSA strains from 
Brazil showed that toxins such as enterotoxin C and PVL were rarely detected in HA-
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MRSA isolates [181].  According to our study, the production of lipase 1 and lipase 2 is 
remarkably higher in CA-MRSA strains than HA-MRSA strains. Further to this, in a 
study by Abdelnour et al., an agr mutation in S. aureus led to a marked reduction of toxin 
and enzyme production, including the production of lipases [4].  In a mouse model of 
septic arthritis infection, an agr mutant of S. aureus was significantly less virulent than 
the wild-type counterpart [4].  Also, lipase was found to be important in preventing the 
phagocytic killing of S. aureus after engulfment by granulocytes, also known as 
polymorphonuclear neutrophils [165].  This observation indicates that lipases can be 
considered virulence factors, which may be responsible for the pathogenesis of S. aureus. 
As mentioned earlier, having higher agr activity, CA-MRSA strains express agr-
regulated proteins such as lipases 1 and 2 significantly more than HA-MRSA, potentially 
contributing to its hypervirulence.         
Conversely, the high presence of anti-sigma factor B antagonist, also known as anti-anti-
sigma factor B, in HA-MRSA USA100 would lead to higher SigmaB activity in this 
strain.  Because SigmaB has been shown to have a repressive effect on agr activity [15], 
it is of no surprise CA-MRSA strain USA400, due to its hyperactive agr would produce 
SigmaB at reduced levels.  Though the presence of an intracellular protein such as anti-
sigma factor B antagonist in the secretome of S.aureus may be puzzling, the resulting 
quantitation of this protein is exactly what is expected when comparing HA-MRSA and 
CA-MRSA strains.  As indicated by our data, there is an astonishing 14.5 increase of 
anti-sigma factor B antagonist production in the HA-MRSA USA200 compared to CA-
MRSA USA400.  Anti-sigma factor B antagonist is a positive effector of Sigma B 
activity.  The positive effect of Sigma B on surface proteins contributes to adhesion of the 
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cell to host tissue, whilst at the same time negatively impacting the production of secreted 
virulence factors when S. aureus enters stationary phase [206, 208].  As expected, Sigma 
B activity is reduced in CA-MRSA, as these strains of S. aureus are known for the 
increased secretion of virulence factors, such as toxins and proteases.             
The secretion of the zinc metalloprotease aureolysin was significantly upregulated in the 
CA-MRSA strain USA400 when compared to the HA-MRSA strain USA100.  Because 
this protease is positively regulated by agr [30, 49, 183], it is expected to be highly 
expressed in strains with a hyperactive agr regulon, such as a CA-MRSA isolates.  
Indeed, we have conducted assays in our laboratory to determine the presence of secreted 
proteases such as aureolysin in HA-MRSA and CA-MRSA strains.  A total of 24 
USA100 strains and 158 USA300 strains were studied, and it was determined that the 
CA-MRSA USA300 isolates produced far more secreted proteases than HA-MRSA 
USA100 isolates (Rivera and Shaw, unpublished observation).  This observation 
correlates with the fact that CA-MRSA strains of S. aureus, having higher agr activity, 
secrete significantly more proteases than HA-MRSA strains.                   
Because most of the scientific studies involving HA-MRSA and CA-MRSA strains are at 
the genomic and transcriptomic level, our study aimed to compare clinically significant 
strains of S. aureus currently afflicting individuals in healthcare facilities and in the 
community at the proteomic level.  The reproducibility of protein extraction and iTRAQ-
labeling followed by mass spectrometric analysis can be used to corroborate present 
literature and to speculate and answer relevant biological questions.  With our study, we 
found many differences in protein secretion amongst the four clinical strains that support 
studies of these proteins at the genomic and transcriptomic levels.  Overall, we identified 
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many secreted toxins and proteases that were upregulated in hypervirulent CA-MRSA 
strains such as USA300 and USA400, typical of increased agr activity.  On the same 
token, we found surface-associated proteins to be upregulated in HA-MRSA such as 
USA100 and USA200, concurring with the finding that agr activity in these particular 
strains is diminished in comparison to CA-MRSA strains.      
Consideration of the presence of cytoplasmic proteins in secreted fractions.  Even 
after having refined methods for the extraction of secreted proteins from supernatants of 
S. aureus cultures, contamination by cytoplasmic proteins is a common problem.  From 
our study in particular, we have identified several classes of cytoplasmic proteins in the 
supernatants of S. aureus, such as those involved in central carbon metabolism and 
protein synthesis.  Though the identification of cytoplasmic proteins in the extracellular 
milieu of S. aureus would be unexpected, a few cytoplasmic proteins have been 
discovered existing as secreted proteins by “non-classical” protein secretion methods.  In 
a study by Pasztor et al., a wild-type strain of S. aureus known as strain 22 secreted 
cytoplasmic proteins into the supernatant, whereas secretion of cytoplasmic proteins in an 
atl (coding for major autolysin) mutant was attenuated [151].  In addition, the presence of 
cytoplasmic proteins, clearly missing a signal peptide sequence for secretion, has been 
observed in the culture supernatants of Bacillus subtilis and S. aureus [179, 184, 206].  
Because the most abundant cytoplasmic proteins are not necessarily seen in supernatants, 
it is possible the cell secretes these proteins by as yet unknown mechanisms, instead of 
their being present in supernatants as a result of cell lysis.  The study by Pasztor et al., 
found the protein major autolysin to be responsible for the secretion of a common 
cytoplasmic protein, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [1451].  As 
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another example, enolase was found to have a role in S. aureus adhesion by binding to 
human laminin and plasminogen [73].  It is thus possible for cytoplasmic proteins, 
consistently identified as secreted proteins, to have extracellular functions.  Because 
surface-associated proteins mediate host-bacterial interactions, these newly discovered 
“secreted proteins” could serve as novel antigens, and lead to development of new 
antimicrobial treatment that could perhaps alleviate the rampant spread of the extremely 
adaptive and pathogenic S. aureus.   
82 
 
 
 
 
 
Future Directions 
 
With our currently refined method for the extraction of secreted proteins, it is possible we 
are excluding certain proteins with low molecular weight.  The Centricon columns used 
for the concentration of secreted proteins have a cutoff of 5 kDa.  Any protein with a 
molecular weight less than 5.0 kDa may not be retained by the concentration column, and 
could thus be omitted from subsequent mass spectrometric analysis.  The molecular 
weights of phenol soluble modulins produced by S. aureus, for example, range from 2.17 
kDa to 4.5 kDa.  Phenol soluble modulins, being important virulence factors of S. aureus, 
which are highly expressed in clinical strains, could potentially be omitted from a 
proteomic study if Centricon columns are used for the concentration of secreted proteins.  
The method could be further refined by excluding the concentration step altogether and 
precipitating secreted proteins from the supernatant with TCA immediately after filter 
sterilization.  Though, with this revision, it is possible to sacrifice overall protein 
concentration, it could provide full coverage of all the proteins secreted by S. aureus at a 
particular growth phase, including proteins with low molecular weights. 
Another important modification of the refined method for extraction of secreted proteins 
involves fractionation of the sample prior to MS analysis.  Our first MudPIT analysis of 
SH1000 cytoplasmic proteins produced the highest yield of identified proteins.  This first 
MudPIT analysis involved the fractionation of the complex sample using the HPLC.  Due 
to the inconsistent results from HPLC fractionation, we resorted to gas fractionation of 
the samples.  Gas fractionation, however, yielded low protein identifications compared to 
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HPLC fractionation.  Ideally, we would like to fractionate samples using a new HPLC for 
future proteomic studies.   
The next step, after having analyzed the secretomes of HA-MRSA and CA-MRSA 
strains, would be comparing and analyzing the surface-associated proteomes, known as 
the “surfome”, as well as the membrane-associated proteins, of these same clinical 
strains.  To date, proteomic studies of surface-exposed proteins have been completed 
using only CA-MRSA strains of S. aureus.  A proteomic analysis of surface-associated 
proteins produced by CA-MRSA compared to HA-MRSA could lead to a better 
understanding of any difference in the pathogenesis amongst these strains.  Apart from 
adhesion to the host tissue, surface-associated proteins can also mediate evasion of the 
host immune system and invasion of host cells [60, 142].  Though surface-associated 
proteins have consistently been identified in the secretome, a proteomic method targeted 
to the surface of the cell could lead to the identification of even more surface-associated 
proteins that could potentially be specific to a given lineage.  Understanding any 
differences in surface proteins associated with adhesion of the cell to tissue or in-
dwelling devices amongst clinical strains could lead to a better understanding of the host-
pathogen physiology, and potentially provide novel vaccine candidates. 
Also, many conserved hypothetical proteins were found upregulated in the HA-MRSA 
and CA-MRSA strains.  These proteins, not known to be controlled by the central global 
regulator agr, are currently uncharacterized.  I would suggest studying and characterizing 
these proteins in an attempt to determine if they are unique to any particular clinical 
strain that could result in differential pathogeneses of these strains. 
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Appendix 1.  Cytoplasmic proteins identified from overnight cultures of S. aureus 
SH1000 separated by 1D SDS-PAGE 
 
Identified Proteins (380) Accession Number Spectral Counts 
bifunctional autolysin (atl)  SACOL1062 67 
ATP-dependent Clp protease, putative  SACOL2563 56 
sdrD protein (sdrD) SACOL0609 43 
N-acetylmuramoyl-L-alanine amidase domain protein  SACOL2666 36 
DNA-directed RNA polymerase, beta' subunit (rpoC)  SACOL0589 35 
translation elongation factor G (fusA)  SACOL0593 34 
chaperonin, 60 kDa (groEL)  SACOL2016 32 
ATP synthase F1, beta subunit (atpD)   SACOL2095 32 
dnaK protein (dnaK)   SACOL1637 31 
transketolase (tkt)   SACOL1377 30 
DNA-directed RNA polymerase, beta subunit (rpoB)   SACOL0588 29 
lipase (geh)   SACOL2694 28 
enolase (eno)   SACOL0842 25 
ribosomal protein S1   SACOL1516 24 
fructose-bisphosphate aldolase, class I (fdaB)   SACOL2622 23 
Aerolysin-Leukocidin family protein  SACOL2006 23 
glutamyl-tRNA(Gln) amidotransferase, B subunit (gatB)   SACOL1960 23 
phosphoenolpyruvate-protein phosphotransferase (ptsI)  SACOL1092 23 
FeS assembly ATPase SufC   SACOL0914 22 
pyruvate kinase (pyk) [2.7.1.40]   SACOL1745 22 
cell wall surface anchor family protein (sasG)   SACOL2505 22 
translation elongation factor Tu (tuf)   SACOL0594 21 
glyceraldehyde 3-phosphate dehydrogenase (gapA1)   SACOL0838 19 
lipoprotein, putative   SACOL0444 19 
FeS assembly protein SufD (sufD)   SACOL0915 19 
sdrC protein (sdrC)  SACOL0608 19 
polyribonucleotide nucleotidyltransferase (pnp)   SACOL1293 19 
succinyl-CoA synthase, beta subunit (sucC)  SACOL1262 18 
alkyl hydroperoxide reductase, subunit F (ahpF)   SACOL0451 18 
aldehyde dehydrogenase   SACOL2114 18 
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sulfatase family protein   SACOL0778 18 
pyruvate dehydrogenase complex E2 component, dihydrolipoamide acetyltransferase (pdhC)   SACOL1104 17 
clumping factor A (clfA)   SACOL0856 17 
cell division protein FtsZ (ftsZ)   SACOL1199 17 
pyruvate dehydrogenase complex E1 component, beta subunit (pdhB)   SACOL1103 16 
fumarylacetoacetate hydrolase family protein   SACOL0973 16 
acetolactate synthase, catabolic (budB)   SACOL2199 16 
fibronectin-binding protein A (fnbA)   SACOL2511 16 
cell division protein FtsA (ftsA)   SACOL1198 15 
protein export protein PrsA, putative   SACOL1897 15 
peptide chain release factor 1 (prfA)   SACOL2110 15 
conserved hypothetical protein   SACOL1767 15 
amino acid ABC transporter, amino acid-binding protein   SACOL2412 14 
DNA polymerase III, beta subunit (dnaN)   SACOL0002 14 
phosphoglucosamine mutase GlmM (glmM)   SACOL2151 14 
pyruvate dehydrogenase complex E3 component, lipoamide dehydrogenase (pdhD)   SACOL1105 13 
cysteine synthase (cysK)  SACOL0557 13 
trigger factor (tig)  SACOL1722 13 
seryl-tRNA synthetase (serS)   SACOL0009 13 
map protein, programmed frameshift (map)   SACOL2002 13 
conserved hypothetical protein TIGR00092   SACOL0435 13 
alkaline shock protein 23   SACOL2173 12 
triosephosphate isomerase (tpiA)   SACOL0840 12 
DNA-directed RNA polymerase, alpha subunit (rpoA)   SACOL2213 12 
phosphate acetyltransferase (pta)   SACOL0634 12 
ATP synthase F1, alpha subunit (atpA)   SACOL2097 12 
pyruvate carboxylase (pyc)   SACOL1123 12 
phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent (pgm)   SACOL0841 12 
fibronectin binding protein B (fnbB)   SACOL2509 12 
clumping factor B (clfB)   SACOL2652 12 
3-oxoacyl-(acyl-carrier-protein) synthase II (fabF)  SACOL0988 11 
pyridoxine biosynthesis protein   SACOL0564 11 
hydroxymethylglutaryl-CoA synthase   SACOL2561 11 
glucosamine-6-phosphate isomerase, putative  SACOL1912 11 
penicillin-binding protein 2 (pbp2)   SACOL1490 11 
formate acetyltransferase (pflB)   SACOL0204 10 
3-oxoacyl-(acyl-carrier-protein) reductase (fabG1)   SACOL1245 10 
rod shape-determining protein MreC (mreC)  SACOL1704 10 
conserved hypothetical protein   SACOL2136 10 
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lipoprotein, putative   SACOL1101 10 
GMP synthase (guaA)   SACOL0461 10 
LPXTG cell wall surface anchor family protein (sasF)   SACOL2668 10 
phosphoribosylformylglycinamidine synthase II (purL)   SACOL1078 10 
phenylalanyl-tRNA synthetase, beta subunit (pheT)   SACOL1149 10 
alkyl hydroperoxide reductase, C subunit (ahpC)   SACOL0452 9 
staphyloxanthin biosynthesis protein   SACOL2291 9 
glucosamine--fructose-6-phosphate aminotransferase (isomerizing) (glmS)   SACOL2145 9 
pyruvate dehydrogenase complex E1 component, alpha subunit (pdhA)  SACOL1102 9 
ribosomal protein L4 (rplD)  SACOL2238 9 
phosphoglycerate kinase (pgk)   SACOL0839 9 
oxidoreductase, short chain dehydrogenase-reductase family   SACOL2321 9 
2-oxoglutarate dehydrogenase, E2 component, dihydroipoamide succinyltransferase (sucB)   SACOL1448 9 
manganese-dependent inorganic pyrophosphatase (ppaC)   SACOL1982 9 
branched-chain amino acid aminotransferase (ilvE)   SACOL0600 9 
D-alanine aminotransferase (dat)   SACOL1800 9 
LysM domain protein   SACOL0507 9 
hypoxanthine phosphoribosyltransferase (hpt)   SACOL0554 9 
N utilization substance protein A, putative  SACOL1285 9 
conserved hypothetical protein   SACOL1792 9 
S-adenosylmethionine synthetase (metK)   SACOL1837 9 
translation elongation factor Ts (tsf)   SACOL1276 8 
aconitate hydratase (acnA)   SACOL1385 8 
transaldolase (tal)  SACOL1831 8 
ferritins family protein   SACOL1952 8 
conserved hypothetical protein   SACOL0597 8 
L-lactate dehydrogenase (ldh1)   SACOL0222 8 
acid phosphatase5'-nucleotidase, lipoprotein e(P4) family   SACOL0303 8 
aerobic glycerol-3-phosphate dehydrogenase (glpD)   SACOL1321 8 
glutamyl-tRNA(Gln) amidotransferase, A subunit (gatA)   SACOL1961 8 
dihydroorotase (pyrC)   SACOL1213 8 
surface protein, putative   SACOL0479 8 
leukocidin subunit precursor, putative   SACOL2004 8 
catalase (kataA)   SACOL1368 7 
glucose-6-phosphate isomerase (pgi)   SACOL0966 7 
conserved hypothetical protein   SACOL1902 7 
universal stress protein family   SACOL1759 7 
acyl carrier protein (acpP)   SACOL1247 7 
ribosomal protein L10 (rplJ)   SACOL0585 7 
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ribosomal Protein L25 (rplY)  SACOL0545 7 
ribosomal protein L1 (rplA)   SACOL0584 7 
aminotransferase, class II   SACOL0596 7 
conserved hypothetical protein   SACOL1985 7 
malonyl CoA-acyl carrier protein transacylase (fabD)  SACOL1244 7 
ATP synthase F1, gamma subunit (atpG)   SACOL2096 7 
DAK2 domain protein   SACOL1240 7 
acetyl-CoA acetyltransferase   SACOL0426 7 
conserved hypothetical protein   SACOL0455 7 
alpha-hemolysin precursor (hlY)   SACOL1173 7 
DNA-binding protein HU (hup)  SACOL1513 6 
immunodominant antigen A (isaA)   SACOL2584 6 
inosine-5'-monophosphate dehydrogenase (guaB)   SACOL0460 6 
fructose-bisphosphate aldolase, class II (fbaA)   SACOL2117 6 
ribosomal protein L21 (rplU)   SACOL1702 6 
FeS assembly protein SufB (sufB)   SACOL0918 6 
threonyl-tRNA synthetase (thrS)   SACOL1729 6 
ribosomal protein L6 (rplF)   SACOL2224 6 
ribosomal protein S3 (rpsC)  SACOL2233 6 
ribosomal protein S4 (rpsD)   SACOL1769 6 
ribosomal protein L3 (rplC)   SACOL2239 6 
deoxyribose-phosphate aldolase (deoC2)   SACOL2129 6 
3-oxoacyl-(acyl-carrier-protein) synthase III (fabH)   SACOL0987 6 
6-phosphofructokinase (pfkA)  SACOL1746 6 
conserved hypothetical protein   SACOL0669 6 
conserved hypothetical protein   SACOL1447 6 
sasB protein (sasB)   SACOL2150 6 
conserved hypothetical protein   SACOL0912 5 
ornithine aminotransferase (rocD2)   SACOL0960 5 
ribosomal protein L2 (rplB)   SACOL2236 5 
glycyl-tRNA synthetase (glyS)   SACOL1622 5 
malate:quinone oxidoreductase (mqo2)  SACOL2623 5 
formate dehydrogenase, alpha subunit, putative   SACOL2301 5 
ribosomal protein L20 (rplT)   SACOL1725 5 
NADP-dependent malic enzyme, putative   SACOL1749 5 
conserved hypothetical protein TIGR01033   SACOL0727 5 
L-lactate dehydrogenase (ldh2)    SACOL2618 5 
anti-sigma B factor (rsbW)   SACOL2055 5 
immunodominant antigen B (isaB)   SACOL2660 5 
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acetoin reductase   SACOL0111 5 
serine hydroxymethyltransferase (glyA)   SACOL2105 5 
glutamyl aminopeptidase, putative   SACOL1402 5 
DNA-directed RNA polymerase, delta subunit (rpoE)   SACOL2120 5 
NAD(P)H dehydrogenase (quinone), putative  SACOL0190 5 
oxidoreductase, short-chain dehydrogenase-reductase family   SACOL2488 5 
Staphylococcus aureus sex pheromone (camS)   SACOL1964 5 
dephospho-CoA kinase (coaE)   SACOL1735 5 
lipoprotein, putative   SACOL0449 5 
IgG-binding protein SBI   SACOL2418 5 
cysteine protease precursor SspB (sspB2)   SACOL1970 5 
ribosomal protein L15 (rplO)   SACOL2220 4 
hydrolase, alpha-beta hydrolase fold family   SACOL2597 4 
succinyl-CoA synthase, alpha subunit (sucD)   SACOL1263 4 
valyl-tRNA synthetase (valS)   SACOL1710 4 
superoxide dismutase (sodA2)   SACOL1610 4 
peptidase, M20-M25-M40 family   SACOL1801 4 
conserved hypothetical protein   SACOL1020 4 
conserved hypothetical protein   SACOL1789 4 
pyrimidine-nucleoside phosphorylase (pdp)   SACOL2128 4 
conserved hypothetical protein   SACOL1788 4 
naphthoate synthase (menB)   SACOL1054 4 
arginyl-tRNA synthetase (argS)   SACOL0663 4 
iron compound ABC transporter, iron compound-binding protein   SACOL2277 4 
translation elongation factor P (efp)   SACOL1587 4 
staphylococcus tandem lipoprotein   SACOL0486 4 
2-oxoisovalerate dehydrogenase, E1 component, beta subunit  SACOL1561 4 
single-stranded DNA-binding protein (ssb2)   SACOL0438 4 
hydrolase, haloacid dehalogenase-like family   SACOL0602 4 
transcriptional regulator, putative   SACOL1065 4 
penicillin-binding protein 3 (pbp3)   SACOL1609 4 
antibacterial protein (phenol soluble modulin)   SACOL1186 3 
ThiJ-PfpI family protein   SACOL1933 3 
antibacterial protein (phenol soluble modulin)   SACOL1187 3 
hexulose-6-phosphate synthase, putative   SACOL0617 3 
2-oxoglutarate dehydrogenase, E1 component (sucA)  SACOL1449 3 
purine nucleoside phosphorylase (deoD2)   SACOL2130 3 
NADH dehydrogenase, putative   SACOL0944 3 
ribosomal protein S2 (rpsB)   SACOL1274 3 
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acetate kinase (ackA)   SACOL1760 3 
adenylosuccinate synthetase (purA)   SACOL0018 3 
ribosomal protein S7 (rpsG)   SACOL0592 3 
glucose-6-phosphate 1-dehydrogenase (zwf)  SACOL1549 3 
ribosomal protein S5 (rpsE)   SACOL2222 3 
lysyl-tRNA synthetase (lysS)   SACOL0562 3 
uracil phosphoribosyltransferase (upp)  SACOL2104 3 
ribosomal protein L5 (rplE)  SACOL2227 3 
peptidyl-prolyl cis-trans isomerase, cyclophilin-type  SACOL0957 3 
cytochrome aa3 quinol oxidase, subunit II (qoxA)   SACOL1070 3 
CTP synthase (pyrG)   SACOL2119 3 
4-diphosphocytidyl-2C-methyl-D-erythritol synthase, putative  SACOL0240 3 
ribosomal protein L17 (rplQ)  SACOL2212 3 
NAD(P)H-flavin oxidoreductase (frp)  SACOL2534 3 
cysteine desulfurase, SufS subfamily  SACOL0916 3 
ribosomal protein L13 (rplM)  SACOL2207 3 
ribosomal protein S12 (rpsL)  SACOL0591 3 
elastin binding protein, putative  SACOL1522 3 
carbamoyl-phosphate synthase, large subunit (carB)   SACOL1215 3 
ribosomal protein L22 (rplV)  SACOL2234 3 
D-alanine-activating enzyme-D-alanine-D-alanyl carrier protein ligase (dltA)   SACOL0935 3 
phosphomethylpyrimidine kinase (thiD1)  SACOL0626 3 
methionine aminopeptidase, type I   SACOL1946 3 
ATP-dependent Clp protease, ATP-binding subunit ClpX (clpX)  SACOL1721 3 
hydrolase, haloacid dehalogenase-like family  SACOL0931 3 
UTP-glucose-1-phosphate uridylyltransferase family protein  SACOL2161 3 
1-phosphofructokinase (fruK)   SACOL0758 3 
LysM domain protein  SACOL0723 3 
ATP-dependent Clp protease, proteolytic subunit ClpP (clpP)   SACOL0833 3 
xanthine phosphoribosyltransferase (xpt)    SACOL0458 3 
peptide ABC transporter, peptide-binding protein  SACOL2476 3 
conserved hypothetical protein  SACOL1464 3 
penicillin-binding protein 1 (pbp1)  SACOL1194 3 
phage infection protein, putative  SACOL2665 3 
protein phosphatase 2C domain protein  SACOL1231 3 
secretory extracellular matrix and plasma binding protein (empbp)  SACOL0858 3 
thymidylate kinase (tmk)   SACOL0524 3 
phospholipase C (hlb)   SACOL2003 3 
6,7-dimethyl-8-ribityllumazine synthase (ribH)   SACOL1817 2 
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6-phosphogluconate dehydrogenase, decarboxylating (gnd)   SACOL1554 2 
delta-1-pyrroline-5-carboxylate dehydrogenase, putative  SACOL2569 2 
D-isomer specific 2-hydroxyacid dehydrogenase family protein  SACOL2296 2 
alcohol dehydrogenase, zinc-containing   SACOL0660 2 
adenylosuccinate lyase (purB)   SACOL1969 2 
cold shock protein, CSD family  SACOL1437 2 
ribosomal subunit interface protein  SACOL0815 2 
phosphocarrier protein HPr (ptsH)  SACOL1091 2 
asparaginyl-tRNA synthetase (asnS)   SACOL1494 2 
conserved hypothetical protein  SACOL1992 2 
fumarate hydratase, class II (fumC)    SACOL1908 2 
mannitol-1-phosphate 5-dehydrogenase (mtlD)   SACOL2149 2 
immunoglobulin G binding protein A precursor (spa)  SACOL0095 2 
conserved hypothetical protein  SACOL2379 2 
adenylate kinase (adk)   SACOL2218 2 
aspartyl-tRNA synthetase (aspS)   SACOL1685 2 
DNA gyrase, A subunit (gyrA)   SACOL0006 2 
oxidoreductase, aldo-keto reductase family  SACOL0763 2 
lipoprotein, putative  SACOL2365 2 
ribosomal protein L11 (rplK)  SACOL0583 2 
isocitrate dehydrogenase, NADP-dependent (icd)   SACOL1741 2 
cell division protein FtsH, putative  SACOL0555 2 
translation initiation factor IF-3 (infC)  SACOL1727 2 
molybdenum ABC transporter, molybdenum-binding protein ModA (modA)  SACOL2272 2 
tyrosyl-tRNA synthetase (tyrS)   SACOL1778 2 
ribose-phosphate pyrophosphokinase (prsA)   SACOL0544 2 
DNA repair exonuclease family protein  SACOL1900 2 
epimerase-dehydratase, putative  SACOL2446 2 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 (murAB)   SACOL2116 2 
DHH subfamily 1 protein  SACOL1751 2 
copper ion binding protein  SACOL2573 2 
pyrroline-5-carboxylate reductase (proC)    SACOL1546 2 
ferrochelatase (hemH)   SACOL1888 2 
conserved hypothetical protein  SACOL1426 2 
thiamine-phosphate pyrophosphorylase (thiE)  SACOL2083 2 
cell-division initiation protein, putative  SACOL1205 2 
phenylalanyl-tRNA synthetase, alpha subunit (pheS)   SACOL1148 2 
decarboxylase family protein  SACOL0740 2 
hydrolase, haloacid dehalogenase-like family  SACOL0606 2 
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conserved hypothetical protein  SACOL2020 2 
hydrolase, haloacid dehalogenase-like family  SACOL1365 2 
ABC transporter, substrate-binding protein  SACOL0217 2 
transcriptional regulator, putative  SACOL1398 2 
acetyl-CoA carboxylase, biotin carboxyl carrier protein (accB)  SACOL1572 2 
chaperonin, 33 kDa  SACOL0556 2 
ferredoxin (fer)  SACOL1525 2 
lipoprotein, putative  SACOL1589 2 
serine protease SplB (splB)  SACOL1868 2 
formate--tetrahydrofolate ligase (fhs)  SACOL1782 1 
conserved hypothetical protein  SACOL2163 1 
PTS system, IIA component  SACOL1457 1 
thiol peroxidase, putative  SACOL1762 1 
thioredoxin (trxA)  SACOL1155 1 
translation initiation factor IF-2 (infB)  SACOL1288 1 
Dps family protein  SACOL2131 1 
ABC transporter, substrate-binding protein  SACOL0688 1 
ribosomal protein L16 (rplP)  SACOL2232 1 
catabolite control protein A (ccpA)  SACOL1786 1 
conserved hypothetical protein  SACOL1630 1 
N-acetylglucosamine-6-phosphate deacetylase (nagA)   SACOL0761 1 
ATP-dependent Clp protease, ATP-binding subunit ClpB (clpB)  SACOL0979 1 
ribosomal protein S11 (rpsK)  SACOL2214 1 
pyruvate oxidase   SACOL2553 1 
phosphoribosylamine--glycine ligase (purD)   SACOL1083 1 
acetyltransferase, GNAT family  SACOL1189 1 
quinol oxidase, subunit I (qoxA)   SACOL1069 1 
conserved hypothetical protein  SACOL1802 1 
oxidoreductase, aldo-keto reductase family  SACOL1835 1 
thioredoxin, putative  SACOL0875 1 
glutamate-1-semialdehyde-2,1-aminomutase (hemL1)   SACOL1714 1 
hydroxyethylthiazole kinase (thiM)  SACOL2084 1 
prolyl-tRNA synthetase (proS)   SACOL1282 1 
alanyl-tRNA synthetase (alaS)   SACOL1673 1 
imidazolonepropionase (hutI)   SACOL2323 1 
ribonucleoside-diphosphate reductase, alpha subunit    SACOL0792 1 
ribosomal protein L23 (rplW)  SACOL2237 1 
heat shock protein GrpE (grpE)  SACOL1638 1 
conserved hypothetical protein  SACOL1670 1 
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4-oxalocrotonate tautomerase (dmpI)   SACOL1399 1 
ABC transporter, ATP-binding protein  SACOL1427 1 
heat shock protein HslVU, ATPase subunit HslU (hslU)  SACOL1271 1 
DNA polymerase I (polA)   SACOL1737 1 
conserved hypothetical protein  SACOL2143 1 
serine protease HtrA, putative  SACOL1777 1 
aminotransferase, putative  SACOL2000 1 
D-alanine--D-alanine ligase   SACOL2074 1 
chaperonin, 10 kDa (groES)  SACOL2017 1 
glucokinase (glk)   SACOL1604 1 
polypeptide deformylase (def1)   SACOL1100 1 
glutamate-1-semialdehyde-2,1-aminomutase (hemL2)   SACOL1922 1 
ribosome-binding factor A (rbfA)  SACOL1289 1 
pyridine nucleotide-disulfide oxidoreductase  SACOL1520 1 
ribonucleoside-diphosphate reductase 2, beta subunit (nrdF)   SACOL0793 1 
enoyl-(acyl-carrier-protein) reductase (fabI)   SACOL1016 1 
phosphoribosylformylglycinamidine synthase I (purQ)   SACOL1077 1 
fatty acid-phospholipid synthesis protein PlsX (plsX)  SACOL1243 1 
ATP synthase F0, B subunit (atpF)   SACOL2099 1 
signal peptidase IB (spsB)   SACOL0969 1 
RNA methyltransferase, TrmH family  SACOL0578 1 
NifU domain protein  SACOL0917 1 
3,4-dihydroxy-2-butanone-4-phosphate synthase-GTP cyclohydrolase II (ribBA)  SACOL1818 1 
phosphoribosylformylglycinamidine cyclo-ligase (purM)  SACOL1080 1 
glyoxalase family protein  SACOL2533 1 
DNA-binding response regulator SrrA (srrA)  SACOL1535 1 
phosphoribosylglycinamide formyltransferase (purN)   SACOL1081 1 
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)   SACOL2073 1 
tellurite resistance protein, putative  SACOL1441 1 
degV family protein  SACOL1460 1 
conserved hypothetical protein  SACOL0742 1 
deoxyribose-phosphate aldolase (deoC1)   SACOL0123 1 
femB protein  SACOL1411 1 
glycerol-3-phosphate dehydrogenase, NAD-dependent (gpsA)   SACOL1514 1 
GTP-binding protein, GTP1-OBG family  SACOL1699 1 
urease accessory protein UreG (ureG)  SACOL2285 1 
DAK2 domain protein  SACOL0708 1 
HAM1 protein  SACOL1162 1 
conserved hypothetical protein  SACOL1558 1 
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FtsK-SpoIIIE family protein  SACOL1791 1 
conserved hypothetical protein  SACOL2605 1 
peptide chain release factor 2, programmed frameshift (prfB)  SACOL0818 1 
cytidylate kinase (cmk)   SACOL1518 1 
Gid protein (gid)  SACOL1268 1 
conserved hypothetical protein  SACOL1120 1 
general stress protein 13  SACOL0552 1 
conserved domain protein  SACOL2557 1 
hypothetical protein  SACOL0272 1 
conserved hypothetical protein  SACOL1885 1 
uroporphyrinogen decarboxylase (hemE)   SACOL1889 1 
transcriptional regulator, putative  SACOL2302 1 
YlmF protein (ylmF)  SACOL1202 1 
dnaJ protein (dnaJ)  SACOL1636 1 
degV family protein  SACOL0812 1 
PTS system, mannitol-specific IIBC components  SACOL2146 1 
orotidine 5'-phosphate decarboxylase (pyrF)   SACOL1216 1 
lipoprotein, putative  SACOL0851 1 
cobyric acid synthase, putative  SACOL1950 1 
glycerophosphoryl diester phosphodiesterase GlpQ, putative  SACOL0962 1 
thioredoxin, putative  SACOL0881 1 
5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase (metE)  SACOL0428 1 
response regulator-related protein  SACOL2360 1 
hydrolase, haloacid dehalogenase-like family  SACOL0619 1 
conserved hypothetical protein  SACOL0579 1 
staphyloxanthin biosynthesis protein, putative  SACOL2295 1 
LPXTG cell wall surface anchor protein (sasE)  SACOL1140 1 
16S rRNA processing protein RimM (rimM)  SACOL1255 1 
conserved hypothetical protein  SACOL1373 1 
conserved hypothetical protein  SACOL1375 1 
oxygen-independent coproporphyrinogen III oxidase, putative  SACOL1640 1 
iron compound ABC transporter, iron compound-binding protein  SACOL2010 1 
acetolactate synthase, large subunit, biosynthetic type (ilvB)  SACOL2043 1 
monooxygenase family protein  SACOL2297 1 
staphylococcus tandem lipoprotein  SACOL2497 1 
membrane protein, putative  SACOL2554 1 
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SH1000 from MudPit analysis 
 
Identified Proteins (747) Accession 
Number 
Spectral 
Counts 
alkaline shock protein 23  SACOL2173 1129 
enolase (eno)  SACOL0842 886 
translation elongation factor Tu (tuf)  SACOL0594 873 
glyceraldehyde 3-phosphate dehydrogenase (gapA1)  SACOL0838 873 
formate acetyltransferase (pflB)  SACOL0204 577 
aldehyde dehydrogenase (aldA1)  SACOL0154 372 
ATP-dependent Clp protease, putative  SACOL2563 371 
DNA-binding protein HU (hup)  SACOL1513 356 
pyruvate dehydrogenase complex E3 component, lipoamide dehydrogenase 
(pdhD)  
SACOL1105 341 
dnaK protein (dnaK)  SACOL1637 298 
translation elongation factor Ts (tsf)  SACOL1276 294 
antibacterial protein (phenol soluble modulin)  SACOL1186 283 
translation elongation factor G (fusA)  SACOL0593 281 
fructose-bisphosphate aldolase, class I (fdaB)  SACOL2622 281 
alkyl hydroperoxide reductase, C subunit (ahpC)  SACOL0452 265 
ThiJ-PfpI family protein  SACOL1933 251 
conserved hypothetical protein  SACOL0912 240 
phosphoglycerate mutase (gpm)  SACOL2415 219 
formate--tetrahydrofolate ligase (fhs)  SACOL1782 208 
conserved hypothetical protein  SACOL2163 196 
pyruvate dehydrogenase complex E2 component, dihydrolipoamide 
acetyltransferase (pdhC)  
SACOL1104 192 
cysteine synthase (cysK)  SACOL0557 192 
catalase (kataA)   SACOL1368 187 
ornithine aminotransferase (rocD2)  SACOL0960 182 
DNA-directed RNA polymerase, beta' subunit (rpoC)  SACOL0589 175 
DNA-directed RNA polymerase, beta subunit (rpoB)  SACOL0588 172 
acyl-CoA dehydrogenase family protein  SACOL0213 171 
ribosomal protein S1 (rpsA)  SACOL1516 169 
ribosomal protein L2 (rplB)  SACOL2236 166 
phosphoenolpyruvate carboxykinase (ATP) (pckA)  SACOL1838 162 
pyruvate dehydrogenase complex E1 component, beta subunit (pdhB)  SACOL1103 156 
chaperonin, 60 kDa (groEL)  SACOL2016 155 
glucosamine--fructose-6-phosphate aminotransferase (isomerizing) (glmS)  SACOL2145 153 
transketolase (tkt)  SACOL1377 146 
thioredoxin-disulfide reductase (trxB)  SACOL0829 146 
pyruvate kinase (pyk)  SACOL1745 143 
antibacterial protein (phenol soluble modulin)  SACOL1187 143 
6,7-dimethyl-8-ribityllumazine synthase (ribH)  SACOL1817 143 
succinyl-CoA synthase, beta subunit (sucC)  SACOL1262 139 
glucose-6-phosphate isomerase (pgi)   SACOL0966 138 
glycyl-tRNA synthetase (glyS)  SACOL1622 130 
6-phosphogluconate dehydrogenase, decarboxylating (gnd)  SACOL1554 130 
hydrolase, alpha-beta hydrolase fold family  SACOL2597 128 
aconitate hydratase (acnA)  SACOL1385 124 
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inosine-5'-monophosphate dehydrogenase (guaB)  SACOL0460 124 
succinyl-CoA synthase, alpha subunit (sucD)  SACOL1263 124 
transaldolase (tal)  SACOL1831 123 
hexulose-6-phosphate synthase, putative  SACOL0617 123 
ribosomal protein L15 (rplO)  SACOL2220 120 
cell division protein FtsZ (ftsZ)  SACOL1199 116 
ATP synthase F1, beta subunit (atpD)  SACOL2095 115 
pyruvate dehydrogenase complex E1 component, alpha subunit (pdhA)  SACOL1102 114 
thioredoxin (trxA)  SACOL1155 111 
ribosomal protein S8 (rpsH)  SACOL2225 111 
glutamine synthetase FemC (femC)  SACOL1329 111 
triosephosphate isomerase (tpiA)  SACOL0840 110 
delta-1-pyrroline-5-carboxylate dehydrogenase, putative  SACOL2569 107 
phosphate acetyltransferase (pta) SACOL0634 104 
ribosomal protein S6 (rpsF)  SACOL0437 103 
malate:quinone oxidoreductase (mqo2)  SACOL2623 101 
seryl-tRNA synthetase (serS)   SACOL0009 97 
formate dehydrogenase, alpha subunit, putative  SACOL2301 97 
PTS system, IIA component  SACOL1457 95 
3-oxoacyl-(acyl-carrier-protein) reductase (fabG1)  SACOL1245 94 
conserved hypothetical protein  SACOL0597 92 
alkyl hydroperoxide reductase, subunit F (ahpF)  SACOL0451 91 
phosphoglycerate kinase (pgk)  SACOL0839 89 
ferritins family protein  SACOL1952 87 
alcohol dehydrogenase, zinc-containing  SACOL0660 84 
D-isomer specific 2-hydroxyacid dehydrogenase family protein  SACOL2296 84 
3-hydroxyacyl-CoA dehydrogenase protein  SACOL0212 84 
ornithine carbamoyltransferase (arcB2)  SACOL2656 84 
thiol peroxidase, putative  SACOL1762 83 
universal stress protein family  SACOL1759 81 
staphylococcal accessory regulator A (sarA)  SACOL0672 81 
aldehyde dehydrogenase  SACOL2114 80 
conserved hypothetical protein  SACOL1484 80 
trigger factor (tig)  SACOL1722 79 
3-oxoacyl-(acyl-carrier-protein) synthase II (fabF)  SACOL0988 78 
2-oxoglutarate dehydrogenase, E1 component (sucA)  SACOL1449 77 
NADH dehydrogenase, putative  SACOL0944 77 
peptidase, M20-M25-M40 family  SACOL1801 75 
fructose-bisphosphate aldolase, class II (fbaA)   SACOL2117 74 
glutamate dehydrogenase, NAD-specific (gluD)  SACOL0961 74 
bifunctional autolysin (atl)  SACOL1062 71 
hydroxymethylglutaryl-CoA synthase  SACOL2561 70 
L-lactate dehydrogenase (ldh1)  SACOL0222 70 
purine nucleoside phosphorylase (deoD2)  SACOL2130 69 
NADP-dependent malic enzyme, putative  SACOL1749 69 
glycine cleavage system H protein (gcvH)  SACOL0877 67 
isoleucyl-tRNA synthetase (ileS)   SACOL1206 66 
methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate 
cyclohydrolase (folD)  
SACOL1072 65 
ATP synthase F1, alpha subunit (atpA)  SACOL2097 64 
adenylosuccinate lyase (purB)  SACOL1969 64 
ribosomal protein L1 (rplA)  SACOL0584 63 
pyrimidine-nucleoside phosphorylase (pdp)  SACOL2128 63 
conserved hypothetical protein  SACOL1902 62 
pyruvate carboxylase (pyc)  SACOL1123 62 
fumarylacetoacetate hydrolase family protein  SACOL0973 61 
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pyridoxine biosynthesis protein  SACOL0564 61 
ribosomal protein L7-L12 (rplL)  SACOL0586 61 
conserved hypothetical protein  SACOL1680 61 
superoxide dismutase (sodA2)  SACOL1610 60 
translation initiation factor IF-2 (infB)  SACOL1288 59 
arginine deiminase (arcA)  SACOL2657 59 
DNA-directed RNA polymerase, alpha subunit (rpoA)  SACOL2213 58 
ribosomal protein S2 (rpsB)  SACOL1274 58 
aminotransferase, class II  SACOL0596 58 
aerobic glycerol-3-phosphate dehydrogenase (glpD)  SACOL1321 58 
Dps family protein  SACOL2131 58 
alkylhydroperoxidase, AhpD family  SACOL2484 58 
lipoprotein, putative  SACOL0444 57 
glutamyl-tRNA(Gln) amidotransferase, B subunit (gatB)  SACOL1960 57 
2-oxoglutarate dehydrogenase, E2 component, dihydroipoamide 
succinyltransferase (sucB)  
SACOL1448 57 
ribosomal subunit interface protein  SACOL0815 56 
glutamyl-tRNA synthetase (gltX)  SACOL0574 56 
ribosomal protein S13-S18 (rpsM)  SACOL2215 56 
ribosomal protein L20 (rplT)  SACOL1725 55 
adenylosuccinate synthetase (purA)  SACOL0018 55 
oligoendopeptidase F (pepF) SACOL1005 54 
flavohemoprotein, putative  SACOL0220 54 
urocanate hydratase (hutU)  SACOL2324 54 
FeS assembly protein SufB (sufB)  SACOL0918 53 
spoVG protein (spoVG)  SACOL0541 52 
phosphoenolpyruvate-protein phosphotransferase (ptsI)  SACOL1092 51 
ribosomal protein L21 (rplU)  SACOL1702 51 
acetate kinase (ackA)  SACOL1760 51 
glucosamine-6-phosphate isomerase, putative  SACOL1912 50 
conserved hypothetical protein  SACOL1789 50 
conserved hypothetical protein  SACOL1020 50 
valyl-tRNA synthetase (valS)  SACOL1710 50 
metallo-beta-lactamase family protein  SACOL1098 50 
conserved hypothetical protein  SACOL0457 49 
ribosomal Protein L25 (rplY)  SACOL0545 48 
threonyl-tRNA synthetase (thrS)  SACOL1729 48 
succinate dehydrogenase, flavoprotein subunit (sdhA)  SACOL1159 48 
conserved hypothetical protein  SACOL2136 47 
conserved hypothetical protein  SACOL1992 47 
glucose-6-phosphate 1-dehydrogenase (zwf)   SACOL1549 46 
fumarate hydratase, class II (fumC) SACOL1908 46 
glutamyl-tRNA(Gln) amidotransferase, A subunit (gatA)  SACOL1961 45 
uracil phosphoribosyltransferase (upp)  SACOL2104 45 
aldehyde dehydrogenase (aldA2)  SACOL1984 45 
D-isomer specific 2-hydroxyacid dehydrogenase family protein  SACOL2535 44 
conserved hypothetical protein  SACOL2711 44 
alcohol dehydrogenase, zinc-containing  SACOL2178 44 
acyl carrier protein (acpP)  SACOL1247 43 
ribosomal protein L16 (rplP)  SACOL2232 43 
mannitol-1-phosphate 5-dehydrogenase (mtlD)  SACOL2149 43 
ribosomal protein S19 (rpsS)  SACOL2235 43 
methionyl-tRNA synthetase (metS)  SACOL0533 43 
ribosomal protein S5 (rpsE)  SACOL2222 42 
ABC transporter, substrate-binding protein  SACOL0688 42 
L-lactate dehydrogenase (ldh2)  SACOL2618 42 
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asparaginyl-tRNA synthetase (asnS) SACOL1494 42 
conserved hypothetical protein  SACOL0633 42 
FeS assembly protein SufD (sufD)  SACOL0915 41 
phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent (pgm)  SACOL0841 41 
proline dipeptidase  SACOL1588 41 
cell division protein FtsA (ftsA)  SACOL1198 40 
deoxyribose-phosphate aldolase (deoC1) SACOL0123 40 
catabolite control protein A (ccpA)  SACOL1786 40 
conserved hypothetical protein  SACOL1630 40 
PTS system, mannitol-specific IIA component  SACOL2148 40 
ribosomal protein L4 (rplD)  SACOL2238 39 
polyribonucleotide nucleotidyltransferase (pnp)  SACOL1293 39 
manganese-dependent inorganic pyrophosphatase (ppaC)  SACOL1982 39 
conserved hypothetical protein  SACOL1985 39 
lysyl-tRNA synthetase (lysS)  SACOL0562 39 
phosphocarrier protein HPr (ptsH)  SACOL1091 39 
N-acetylglucosamine-6-phosphate deacetylase (nagA)  SACOL0761 39 
deoxyribose-phosphate aldolase (deoC2)  SACOL2129 38 
branched-chain amino acid aminotransferase (ilvE)  SACOL0600 38 
glycine cleavage system P protein, subunit 2   SACOL1593 38 
glycine cleavage system P protein, subunit 1  SACOL1594 38 
D-alanine aminotransferase (dat)  SACOL1800 37 
ribosomal protein S7 (rpsG)  SACOL0592 37 
conserved hypothetical protein  SACOL1788 37 
serine hydroxymethyltransferase (glyA)  SACOL2105 37 
adenylate kinase (adk)  SACOL2218 37 
naphthoate synthase (menB)  SACOL1054 36 
peptidyl-prolyl cis-trans isomerase, cyclophilin-type  SACOL0957 36 
FeS assembly ATPase SufC  SACOL0914 35 
ribosomal protein L10 (rplJ)  SACOL0585 35 
protein export protein PrsA, putative  SACOL1897 35 
ribosomal protein S4 (rpsD)  SACOL1769 35 
ribosomal protein L5 (rplE)  SACOL2227 35 
oxidoreductase, aldo-keto reductase family  SACOL1835 35 
fructose-1,6-bisphosphatase, putative  SACOL2527 35 
oxidoreductase, short chain dehydrogenase-reductase family  SACOL2321 34 
ribosomal protein L17 (rplQ)  SACOL2212 34 
acetyl-CoA synthetase (acs)  SACOL1783 34 
conserved hypothetical protein  SACOL2175 34 
alanine dehydrogenase (ald2)  SACOL1758 34 
acetolactate synthase, catabolic (budB)  SACOL2199 33 
ribosomal protein L22 (rplV)  SACOL2234 33 
CTP synthase (pyrG) SACOL2119 33 
acetyltransferase, GNAT family  SACOL1189 33 
phosphoribosylaminoimidazolecarboxamide formyltransferase-IMP 
cyclohydrolase (purH)  
SACOL1082 33 
glutamyl aminopeptidase, putative  SACOL1402 32 
cytochrome aa3 quinol oxidase, subunit II (qoxA)  SACOL1070 32 
pyruvate oxidase  SACOL2553 32 
thioredoxin, putative  SACOL0875 32 
coenzyme A disulfide reductase  SACOL0975 32 
phosphoribosylamine--glycine ligase (purD)  SACOL1083 31 
acetyl-CoA synthetase, putative  SACOL2624 31 
universal stress protein family  SACOL1753 31 
phosphoglucosamine mutase GlmM (glmM)  SACOL2151 30 
conserved hypothetical protein TIGR01033  SACOL0727 30 
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anti-sigma B factor (rsbW)  SACOL2055 30 
3-oxoacyl-(acyl-carrier-protein) synthase III (fabH)  SACOL0987 30 
acetoin reductase  SACOL0111 30 
arginyl-tRNA synthetase (argS)  SACOL0663 30 
transcriptional regulator CodY (codY)  SACOL1272 30 
argininosuccinate synthase (argG) SACOL0964 30 
clumping factor A (clfA)  SACOL0856 29 
DNA polymerase III, beta subunit (dnaN)  SACOL0002 29 
NAD(P)H-flavin oxidoreductase (frp)   SACOL2534 29 
conserved hypothetical protein  SACOL1802 29 
indole-3-pyruvate decarboxylase (ipdC)  SACOL0173 29 
ribosomal protein S11 (rpsK)  SACOL2214 28 
6-phosphofructokinase (pfkA)   SACOL1746 28 
ribosomal protein L11 (rplK)  SACOL0583 28 
ATP-dependent Clp protease, ATP-binding subunit ClpB (clpB)  SACOL0979 28 
metallo-beta-lactamase family protein  SACOL1294 28 
GMP synthase (guaA)  SACOL0461 27 
ribosomal protein S3 (rpsC)  SACOL2233 27 
immunoglobulin G binding protein A precursor (spa)  SACOL0095 27 
conserved hypothetical protein  SACOL2379 27 
aminopeptidase PepS (pepS)  SACOL1937 27 
cysteine desulfurase, SufS subfamily  SACOL0916 26 
4-diphosphocytidyl-2C-methyl-D-erythritol synthase, putative  SACOL0240 26 
glutamate-1-semialdehyde-2,1-aminomutase (hemL1)  SACOL1714 26 
hydroxyethylthiazole kinase (thiM)  SACOL2084 26 
bacterioferritin comigratory protein (bcp)  SACOL1921 26 
conserved hypothetical protein  SACOL2596 26 
long-chain-fatty-acid--CoA ligase, putative  SACOL0214 26 
conserved hypothetical protein  SACOL1975 26 
ribosome recycling factor (frr)  SACOL1278 26 
RNAIII-activating protein TRAP  SACOL1891 25 
phosphopentomutase (deoB)  SACOL0124 25 
acetyl-CoA acetyltransferase  SACOL0211 25 
ribosomal protein L6 (rplF)  SACOL2224 24 
N utilization substance protein A, putative  SACOL1285 24 
leucyl-tRNA synthetase (leuS)  SACOL1808 24 
anti-anti-sigma factor RsbV (rsbV)  SACOL2056 24 
glutamyl aminopeptidase (pepA1)  SACOL1795 24 
ribosomal protein L27 (rpmA)  SACOL1700 24 
ribosomal protein S16 (rpsP)  SACOL1254 24 
conserved hypothetical protein  SACOL1115 23 
thioredoxin, putative  SACOL1794 23 
HPr kinase-phosphatase (hprK)  SACOL0825 23 
phenylalanyl-tRNA synthetase, beta subunit (pheT)  SACOL1149 22 
oxidoreductase, aldo-keto reductase family  SACOL0763 22 
DNA gyrase, A subunit (gyrA)  SACOL0006 22 
imidazolonepropionase (hutI)  SACOL2323 22 
conserved hypothetical protein TIGR00103  SACOL0521 22 
molybdopterin biosynthesis MoeA protein, putative  SACOL2266 22 
glutamyl-aminopeptidase (pepA2)  SACOL2463 22 
ribosomal protein S20 (rpsT)  SACOL1642 22 
3-methyl-2-oxobutanoate hydroxymethyltransferase (panB)  SACOL2615 22 
autoinducer-2 production protein LuxS (luxS)  SACOL2126 22 
preprotein translocase, SecA subunit (secA)  SACOL0816 22 
arsenate reductase, putative  SACOL0876 22 
lipase (geh)  SACOL2694 21 
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conserved hypothetical protein  SACOL1792 21 
phosphoribosylformylglycinamidine synthase II (purL)  SACOL1078 21 
DNA-directed RNA polymerase, delta subunit (rpoE)  SACOL2120 21 
heat shock protein GrpE (grpE)  SACOL1638 21 
delta-aminolevulinic acid dehydratase (hemB)   SACOL1715 21 
phosphoribosylformylglycinamidine synthase, PurS protein (purS)  SACOL1076 21 
ornithine carbamoyltransferase (arcB1)  SACOL1181 21 
cold shock protein, CSD family  SACOL1437 20 
hypoxanthine phosphoribosyltransferase (hpt)  SACOL0554 20 
translation elongation factor P (efp)  SACOL1587 20 
carbamate kinase (arcC2)  SACOL2654 20 
NAD-NADP octopine-nopaline dehydrogenase family protein  SACOL2293 20 
formiminoglutamase (hutG)  SACOL2327 20 
ribosomal protein L29 (rpmC)  SACOL2231 20 
ribosomal protein L3 (rplC)  SACOL2239 19 
ribosomal protein L13 (rplM)  SACOL2207 19 
acetyl-CoA acetyltransferase  SACOL0426 19 
aspartyl-tRNA synthetase (aspS)  SACOL1685 19 
ribosomal protein S18 (rpsR)  SACOL0439 19 
ribosomal protein S9 (rpsI)  SACOL2206 19 
peptidase, M20-M25-M40 family  SACOL0085 19 
conserved hypothetical protein  SACOL2609 19 
N-acetylmuramoyl-L-alanine amidase domain protein  SACOL2666 18 
acid phosphatase5'-nucleotidase, lipoprotein e(P4) family  SACOL0303 18 
DAK2 domain protein  SACOL1240 18 
dihydroorotase (pyrC) SACOL1213 18 
oxidoreductase, short-chain dehydrogenase-reductase family  SACOL2488 18 
tyrosyl-tRNA synthetase (tyrS)  SACOL1778 18 
prolyl-tRNA synthetase (proS)  SACOL1282 18 
alanyl-tRNA synthetase (alaS)   SACOL1673 18 
ribosomal protein L30p-L7e (rpmD)  SACOL2221 18 
cysteinyl-tRNA synthetase (cysS)  SACOL0576 18 
proline dipeptidase (pepQ)  SACOL1756 18 
ribosomal protein L31 (rpmE)  SACOL2112 18 
HIT family protein  SACOL1894 18 
cytosol aminopeptidase  SACOL0945 18 
isocitrate dehydrogenase, NADP-dependent (icd)  SACOL1741 17 
glyoxalase family protein  SACOL2533 17 
NH(3)-dependent NAD+ synthetase (nadE)  SACOL1974 17 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1 (murAA)  SACOL2092 17 
phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)  SACOL1075 17 
phosphoribosylaminoimidazole carboxylase, catalytic subunit (purE)  SACOL1073 17 
conserved hypothetical protein  SACOL1987 17 
elastin binding protein, putative  SACOL1522 16 
methionine aminopeptidase, type I  SACOL1946 16 
D-alanine-activating enzyme-D-alanine-D-alanyl carrier protein ligase (dltA)  SACOL0935 16 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2 (murAB)  SACOL2116 16 
glutamate-1-semialdehyde-2,1-aminomutase (hemL2)  SACOL1922 16 
ribosomal protein L18 (rplR)  SACOL2223 16 
conserved hypothetical protein  SACOL0738 16 
sigma factor B regulator protein (rsbU)  SACOL2057 16 
conserved hypothetical protein  SACOL1350 16 
translation initiation factor IF-3 (infC)  SACOL1727 15 
quinol oxidase, subunit I (qoxA)  SACOL1069 15 
polypeptide deformylase (def1)  SACOL1100 15 
transcriptional regulator, MarR family (norR)  SACOL0746 15 
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oligoendopeptidase F, putative  SACOL1419 15 
betaine aldehyde dehydrogenase (betB)  SACOL2628 15 
nucleoside diphosphate kinase  SACOL1509 15 
DNA-binding response regulator YycF (yycF)  SACOL0019 15 
conserved hypothetical protein  SACOL1306 15 
heat shock protein HslVU, ATPase subunit HslV (hslV)  SACOL1270 15 
glyceraldehyde 3-phosphate dehydrogenase (gapA2)  SACOL1734 15 
ribosomal protein S12 (rpsL)  SACOL0591 14 
phosphomethylpyrimidine kinase (thiD1) SACOL0626 14 
ribonucleoside-diphosphate reductase, alpha subunit  SACOL0792 14 
conserved hypothetical protein  SACOL1670 14 
DNA polymerase I (polA)  SACOL1737 14 
peptidase, M20-M25-M40 family  SACOL1555 14 
recA protein  SACOL1304 14 
conserved hypothetical protein  SACOL2174 14 
GTP-binding protein TypA (typA)  SACOL1118 14 
oxidoreductase, putative  SACOL0399 14 
succinate dehydrogenase, iron-sulfur protein (sdhB)  SACOL1160 14 
alanine dehydrogenase (ald1) SACOL1478 14 
PTS system, IIABC components  SACOL0175 14 
ScdA protein (scdA)  SACOL0244 14 
amino acid ABC transporter, amino acid-binding protein  SACOL2412 13 
conserved hypothetical protein TIGR00092  SACOL0435 13 
malonyl CoA-acyl carrier protein transacylase (fabD)  SACOL1244 13 
conserved hypothetical protein  SACOL1447 13 
lipoprotein, putative  SACOL2365 13 
carbamoyl-phosphate synthase, large subunit (carB)  SACOL1215 13 
RNA polymerase sigma factor RpoD (rpoD)  SACOL1618 13 
ABC transporter, ATP-binding protein  SACOL1427 13 
conserved hypothetical protein  SACOL2143 13 
glycosyl transferase, group 2 family protein  SACOL0243 13 
ribosomal protein L36 (rpmJ)  SACOL2216 13 
NADH-dependent flavin oxidoreductase, Oye family  SACOL0959 13 
ribosomal protein L35 (rpmI)  SACOL1726 13 
conserved hypothetical protein  SACOL1672 13 
pyrroline-5-carboxylate reductase (proC) SACOL1546 12 
ribosomal protein L23 (rplW)  SACOL2237 12 
cell division protein FtsH, putative  SACOL0555 12 
epimerase-dehydratase, putative  SACOL2446 12 
fatty acid-phospholipid synthesis protein PlsX (plsX)  SACOL1243 12 
aminotransferase, putative  SACOL2000 12 
enoyl-(acyl-carrier-protein) reductase (fabI)  SACOL1016 12 
transcription elongation factor GreA (greA)  SACOL1665 12 
threonine dehydratase, catabolic (ilvA1)  SACOL1477 12 
transcriptional regulator, TenA family  SACOL2086 12 
alcohol dehydrogenase, zinc-containing  SACOL0241 12 
glycerol kinase (glpK)  SACOL1320 12 
dihydroxyacetone kinase family protein  SACOL0707 12 
conserved hypothetical protein  SACOL0455 11 
molybdenum ABC transporter, molybdenum-binding protein ModA (modA)  SACOL2272 11 
serine protease HtrA, putative  SACOL1777 11 
glucokinase (glk)  SACOL1604 11 
glutathione peroxidase (gpxA1)  SACOL1325 11 
excinuclease ABC, A subunit (uvrA)  SACOL0824 11 
DNA-directed RNA polymerase, omega subunit (rpoZ)  SACOL1222 11 
OsmC-Ohr family protein  SACOL0872 11 
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SIS domain protein  SACOL0618 11 
conserved hypothetical protein  SACOL2456 11 
conserved hypothetical protein  SACOL2300 11 
conserved hypothetical protein  SACOL1767 10 
NAD(P)H dehydrogenase (quinone), putative  SACOL0190 10 
hydrolase, haloacid dehalogenase-like family  SACOL0931 10 
staphylococcus tandem lipoprotein  SACOL0486 10 
ribose-phosphate pyrophosphokinase (prsA)  SACOL0544 10 
DNA repair exonuclease family protein  SACOL1900 10 
heat shock protein HslVU, ATPase subunit HslU (hslU)  SACOL1271 10 
D-alanine--D-alanine ligase  SACOL2074 10 
ribonucleoside-diphosphate reductase 2, beta subunit (nrdF)  SACOL0793 10 
phosphoribosylformylglycinamidine synthase I (purQ)  SACOL1077 10 
femX protein (femX)  SACOL2253 10 
malate:quinone oxidoreductase (mqo1)  SACOL2362 10 
peptidase T (pepT)  SACOL0806 10 
para-nitrobenzyl esterase (pnbA) SACOL2459 10 
transcription antitermination protein NusG (nusG)  SACOL0582 10 
conserved hypothetical protein TIGR00294  SACOL0613 10 
superoxide dismutase (sodA1)  SACOL0118 10 
adenine phosphoribosyltransferase (apt)  SACOL1690 10 
ribosomal protein L24 (rplX)  SACOL2228 10 
sdrD protein (sdrD)  SACOL0609 9 
penicillin-binding protein 2 (pbp2)  SACOL1490 9 
conserved hypothetical protein  SACOL0669 9 
ATP-dependent Clp protease, proteolytic subunit ClpP (clpP)  SACOL0833 9 
ATP synthase F0, B subunit (atpF)  SACOL2099 9 
chaperonin, 10 kDa (groES)  SACOL2017 9 
pyridine nucleotide-disulfide oxidoreductase  SACOL1520 9 
3,4-dihydroxy-2-butanone-4-phosphate synthase-GTP cyclohydrolase II (ribBA)  SACOL1818 9 
phosphoribosylformylglycinamidine cyclo-ligase (purM)  SACOL1080 9 
exoribonuclease, VacB-RNase II family  SACOL0846 9 
chorismate mutase-phospho-2-dehydro-3-deoxyheptonate aldolase  SACOL1787 9 
glycine cleavage system T protein (gcvT)  SACOL1595 9 
conserved hypothetical protein  SACOL1099 9 
dihydrofolate reductase (folA)  SACOL1461 9 
ribosomal protein S10 (rpsJ)  SACOL2240 9 
accessory gene regulator protein A (agrA)  SACOL2026 9 
phosphoribosylaminoimidazole carboxylase, ATPase subunit (purK)  SACOL1074 9 
alanine racemase (alr)  SACOL2060 9 
D-alanyl carrier protein (dltC)  SACOL0937 9 
conserved hypothetical protein  SACOL2288 9 
staphylococcal accessory regulator S (sarS)  SACOL0096 9 
ATP-dependent RNA helicase, DEAD-DEAH box family  SACOL2072 9 
acetyltransferase, GNAT family  SACOL2532 9 
urease accessory protein UreE (ureE)  SACOL2283 9 
lipoate-protein ligase A family protein  SACOL1591 9 
map protein, programmed frameshift (map)  SACOL2002 8 
ATP-dependent Clp protease, ATP-binding subunit ClpX (clpX)  SACOL1721 8 
1-phosphofructokinase (fruK)  SACOL0758 8 
single-stranded DNA-binding protein (ssb2)  SACOL0438 8 
UTP-glucose-1-phosphate uridylyltransferase family protein  SACOL2161 8 
cell-division initiation protein, putative  SACOL1205 8 
RNA methyltransferase, TrmH family  SACOL0578 8 
NifU domain protein  SACOL0917 8 
amidophosphoribosyltransferase (purF)  SACOL1079 8 
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DNA gyrase, B subunit (gyrB)   SACOL0005 8 
epidermin immunity protein F (epiF)  SACOL1873 8 
cell division protein FtsY, putative  SACOL1251 8 
arginase (rocF)  SACOL2154 8 
GTP-binding protein, Era-TrmE family  SACOL1515 8 
thymidylate synthase (thyA)  SACOL1462 8 
repressor of toxins (rot)  SACOL1812 8 
ATP-binding protein, Mrp-Nbp35 family  SACOL2156 8 
ATP synthase F1, delta subunit (atpH)  SACOL2098 8 
ABC transporter, ATP-binding protein  SACOL1994 8 
UDP-N-acetylmuramoylalanine--D-glutamate ligase (murD)  SACOL1196 8 
beta-hydroxyacyl-(acyl-carrier-protein) dehydratase FabZ (fabZ) SACOL2091 8 
GMP reductase (guaC)  SACOL1371 8 
phosphoglucomutase-phosphomannomutase family protein  SACOL2501 8 
drP35 protein (drp35)  SACOL2712 8 
conserved hypothetical protein  SACOL0525 8 
conserved hypothetical protein TIGR00253  SACOL1651 8 
ribosomal protein L32 (rpmF)  SACOL1137 8 
azoreductase  SACOL0607 8 
DNA-binding response regulator VraR (vraR)  SACOL1942 8 
peptide chain release factor 1 (prfA)  SACOL2110 7 
S-adenosylmethionine synthetase (metK)   SACOL1837 7 
4-oxalocrotonate tautomerase (dmpI)  SACOL1399 7 
2-oxoisovalerate dehydrogenase, E1 component, beta subunit  SACOL1561 7 
DHH subfamily 1 protein  SACOL1751 7 
DNA-binding response regulator SrrA (srrA)  SACOL1535 7 
degV family protein  SACOL1460 7 
conserved hypothetical protein  SACOL0742 7 
HAM1 protein  SACOL1162 7 
conserved hypothetical protein  SACOL1558 7 
UDP-N-acetylglucosamine pyrophosphorylase (glmU)  SACOL0543 7 
conserved hypothetical protein  SACOL1483 7 
tRNA pseudouridine 55 synthase (truB)  SACOL1290 7 
alcohol dehydrogenase, zinc-containing  SACOL2177 7 
staphylococcal accessory regulator R (sarR)  SACOL2287 7 
conserved hypothetical protein  SACOL0467 7 
conserved hypothetical protein  SACOL0409 7 
conserved hypothetical protein  SACOL0565 7 
glyoxalase family protein  SACOL1553 7 
riboflavin biosynthesis protein RibD (ribD)  SACOL1820 7 
conserved hypothetical protein  SACOL1836 7 
uridylate kinase (pyrH)  SACOL1277 7 
femA protein (femA)  SACOL1410 7 
5'-methylthioadenosine-S-adenosylhomocysteine nucleosidase (mtn)  SACOL1655 7 
molybdenum cofactor biosynthesis protein B (moaB)  SACOL2268 7 
delta-hemolysin (hld)  SACOL2022 7 
UDP-N-acetylmuramate--alanine ligase (murC)  SACOL1790 7 
conserved hypothetical protein  SACOL1310 7 
conserved hypothetical protein  SACOL1895 7 
esterase, putative  SACOL2549 7 
staphyloxanthin biosynthesis protein  SACOL2291 6 
ATP synthase F1, gamma subunit (atpG)  SACOL2096 6 
dephospho-CoA kinase (coaE)  SACOL1735 6 
copper ion binding protein  SACOL2573 6 
thiamine-phosphate pyrophosphorylase (thiE)  SACOL2083 6 
ferrochelatase (hemH)  SACOL1888 6 
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phenylalanyl-tRNA synthetase, alpha subunit (pheS)  SACOL1148 6 
femB protein  SACOL1411 6 
general stress protein 13  SACOL0552 6 
urease accessory protein UreG (ureG)  SACOL2285 6 
DAK2 domain protein  SACOL0708 6 
ribosomal protein L19 (rplS)  SACOL1257 6 
translation initiation factor IF-1 (infA)  SACOL2217 6 
NifU domain protein  SACOL0939 6 
glucose inhibited division protein A (gidA)  SACOL2737 6 
conserved hypothetical protein TIGR01777  SACOL0834 6 
phosphomethylpyrimidine kinase (thiD2)  SACOL2085 6 
sucrose-6-phosphate hydrolase (cscA)  SACOL2029 6 
cmp-binding-factor 1 (cbf1)  SACOL1898 6 
conserved hypothetical protein  SACOL0157 6 
teichoic acid biosynthesis protein, putative  SACOL0242 6 
D-isomer specific 2-hydroxyacid dehydrogenase family protein  SACOL0932 6 
isochorismatase family protein  SACOL2667 6 
iron compound ABC transporter, iron compound-binding protein  SACOL2167 6 
histidine ammonia-lyase (hutH) SACOL0008 6 
lipoate-protein ligase A family protein  SACOL1034 6 
queuine tRNA-ribosyltransferase (tgt)  SACOL1694 6 
conserved hypothetical protein  SACOL1980 6 
phytoene dehydrogenase  SACOL2579 6 
FMN reductase-related protein  SACOL0410 6 
Rrf2 family protein  SACOL1681 6 
glutamyl-tRNA(Gln) amidotransferase, C subunit (gatC)  SACOL1962 6 
conserved hypothetical protein  SACOL1387 6 
phosphosugar-binding transcriptional regulator, RpiR family  SACOL2308 6 
alpha-acetolactate decarboxylase (budA1)  SACOL2198 6 
DNA topoisomerase I (topA)  SACOL1267 6 
proline dehydrogenase (putA)  SACOL1816 6 
conserved hypothetical protein  SACOL1090 6 
conserved hypothetical protein TIGR00043  SACOL1627 6 
Aerolysin-Leukocidin family protein  SACOL2006 5 
ribosome-binding factor A (rbfA)  SACOL1289 5 
conserved hypothetical protein  SACOL1426 5 
hydrolase, haloacid dehalogenase-like family  SACOL0606 5 
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (murF)  SACOL2073 5 
tellurite resistance protein, putative  SACOL1441 5 
GTP-binding protein, GTP1-OBG family  SACOL1699 5 
conserved hypothetical protein  SACOL2605 5 
peptide chain release factor 2, programmed frameshift (prfB)  SACOL0818 5 
conserved hypothetical protein  SACOL1120 5 
2-oxoisovalerate dehydrogenase, E1 component, alpha subunit   SACOL1562 5 
conserved hypothetical protein  SACOL1940 5 
S1 RNA binding domain protein  SACOL2053 5 
tryptophanyl-tRNA synthetase (trpS)  SACOL1001 5 
HD-HDIG-KH domain protein  SACOL1305 5 
histidyl-tRNA synthetase (hisS)  SACOL1686 5 
conserved hypothetical protein  SACOL1620 5 
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylic acid synthase-2-
oxoglutarate decarboxylase (menD)   
SACOL1052 5 
conserved hypothetical protein  SACOL2381 5 
ribosomal protein L14 (rplN)  SACOL2229 5 
citrate synthase (gltA)  SACOL1742 5 
excinuclease ABC, B subunit (uvrB)  SACOL0823 5 
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NAD(P)H-flavin oxidoreductase, putative  SACOL0453 5 
peptide methionine sulfoxide reductase (msrA)  SACOL1397 5 
alpha-glucosidase (malA)  SACOL1551 5 
conserved hypothetical protein  SACOL2035 5 
signal recognition particle protein (ffh)  SACOL1253 5 
tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase (trmU)  SACOL1676 5 
GTP-binding protein Era (era)  SACOL1624 5 
2-oxoisovalerate dehydrogenase, E2 component, dihydrolipoamide 
acetyltransferase  
SACOL1560 5 
conserved hypothetical protein  SACOL2132 5 
conserved hypothetical protein  SACOL1358 5 
MutT-nudix family protein  SACOL1542 5 
YihY family protein (yihY)  SACOL1941 5 
aspartate carbamoyltransferase (pyrB) SACOL1212 5 
conserved hypothetical protein  SACOL0152 5 
MutT-nudix family protein  SACOL1724 5 
conserved hypothetical protein  SACOL1002 5 
arginine repressor (argR)  SACOL1565 5 
lipoprotein, putative  SACOL1101 4 
iron compound ABC transporter, iron compound-binding protein  SACOL2277 4 
hydrolase, haloacid dehalogenase-like family  SACOL0602 4 
conserved hypothetical protein  SACOL1464 4 
phosphoribosylglycinamide formyltransferase (purN)  SACOL1081 4 
xanthine phosphoribosyltransferase (xpt) SACOL0458 4 
hydrolase, haloacid dehalogenase-like family  SACOL1365 4 
acetyl-CoA carboxylase, biotin carboxyl carrier protein (accB)  SACOL1572 4 
dnaJ protein (dnaJ)  SACOL1636 4 
DltD protein (dltD)  SACOL0938 4 
GTP pyrophosphokinase (relA2)   SACOL1689 4 
primosomal protein N` (priA)  SACOL1224 4 
dihydroorotate dehydrogenase (pyrD)  SACOL2606 4 
porphobilinogen deaminase (hemC)  SACOL1717 4 
exonuclease RexA (rexA)  SACOL0971 4 
glycerophosphoryl diester phosphodiesterase, putative  SACOL1130 4 
DNA topoisomerase IV, A subunit (parC)  SACOL1390 4 
sulfite reductase (NADPH) flavoprotein alpha-component (cysJ)  SACOL2639 4 
argininosuccinate lyase (argH)  SACOL0963 4 
dehydrosqualene desaturase (crtN)  SACOL2576 4 
heat shock protein, Hsp20 family  SACOL2385 4 
oxidoreductase, aldo-keto reductase family  SACOL1543 4 
glycosyl transferase, group 1 family protein  SACOL1043 4 
DNA-dependent DNA polymerase family X  SACOL1153 4 
serine acetyltransferase (cysE)  SACOL0575 4 
S-adenosyl-methyltransferase MraW  SACOL1192 4 
N-acetyltransferase family protein  SACOL2722 4 
phosphotyrosine protein phosphatase  SACOL1939 4 
exodeoxyribonuclease VII, large subunit (xseA)  SACOL1568 4 
deoxyribonuclease, TatD family  SACOL0534 4 
pur operon repressor (purR)  SACOL0539 4 
glycerate kinase family protein  SACOL0805 4 
carbamoyl-phosphate synthase, small subunit (carA)  SACOL1214 4 
GTP-binding protein LepA (lepA)  SACOL1641 4 
oxidoreductase, aldo-keto reductase family  SACOL2192 4 
conserved hypothetical protein  SACOL2318 4 
conserved hypothetical protein TIGR00282  SACOL1307 4 
conserved hypothetical protein  SACOL0271 4 
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conserved hypothetical protein  SACOL1284 4 
conserved hypothetical protein  SACOL1899 4 
conserved hypothetical protein  SACOL0615 4 
inositol monophosphatase family protein  SACOL1116 4 
conserved hypothetical protein TIGR00147  SACOL1958 4 
trans-sulfuration enzyme family protein  SACOL0503 4 
GTP pyrophosphokinase (relA1)  SACOL1010 4 
UTP-glucose-1-phosphate uridylyltransferase (galU) SACOL2508 4 
transcriptional regulator, Fur family  SACOL1541 4 
sulfatase family protein  SACOL0778 3 
immunodominant antigen B (isaB)  SACOL2660 3 
FtsK-SpoIIIE family protein  SACOL1791 3 
cytidylate kinase (cmk)  SACOL1518 3 
Gid protein (gid)  SACOL1268 3 
conserved hypothetical protein  SACOL1885 3 
uroporphyrinogen decarboxylase (hemE)  SACOL1889 3 
transcriptional regulator, putative  SACOL2302 3 
YlmF protein (ylmF)  SACOL1202 3 
orotidine 5'-phosphate decarboxylase (pyrF)  SACOL1216 3 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-
undecaprenol N-acetylglucosamine transferase (murG)  
SACOL1453 3 
mevalonate kinase (mvk)  SACOL0636 3 
pyrimidine operon regulatory protein (pyrR)  SACOL1210 3 
lipoate synthase (lipA)  SACOL0927 3 
rhodanese-like domain protein  SACOL1807 3 
DNA ligase, NAD-dependent (ligA)  SACOL1965 3 
transferrin receptor  SACOL0799 3 
pyridine nucleotide-disulfide oxidoreductase  SACOL0640 3 
conserved hypothetical protein  SACOL0614 3 
peptide chain release factor 3 (prfC)  SACOL1025 3 
conserved hypothetical protein  SACOL2436 3 
DNA topoisomerase IV, B subunit (parE)  SACOL1389 3 
N utilization substance protein B (nusB)  SACOL1569 3 
rhodanese-like domain protein  SACOL1592 3 
ribosomal protein S21 (rpsU)  SACOL1632 3 
DNA-3-methyladenine glycosylase   SACOL1711 3 
conserved hypothetical protein  SACOL0198 3 
conserved hypothetical protein  SACOL1297 3 
phosphomevalonate kinase   SACOL0638 3 
conserved hypothetical protein  SACOL1286 3 
capsular polysaccharide biosynthesis protein Cap5O (cap5O)  SACOL0150 3 
RNA polymerase sigma-37 factor (rpoF)  SACOL2054 3 
glycosyl transferase, group 1 family protein  SACOL0612 3 
conserved hypothetical protein TIGR01741  SACOL0282 3 
dihydrodipicolinate reductase (dapB)  SACOL1431 3 
conserved hypothetical protein  SACOL0599 3 
formate dehydrogenase, NAD-dependent  SACOL0162 3 
PTS system, IIBC components  SACOL0516 3 
conserved hypothetical protein  SACOL0401 3 
phosphopantothenoylcysteine decarboxylase-phosphopantothenate--cysteine 
ligase (coaBC)  
SACOL1223 3 
mevalonate diphosphate decarboxylase (mvaD)  SACOL0637 3 
conserved hypothetical protein  SACOL0804 3 
HD domain protein  SACOL0821 3 
conserved hypothetical protein  SACOL1011 3 
hypothetical protein  SACOL1042 3 
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aminotransferase, class V  SACOL1677 3 
protein-export membrane protein SecDF  SACOL1692 3 
amino acid ABC transporter, ATP-binding protein  SACOL2453 3 
glutamate racemase (murI)  SACOL1161 3 
HD domain protein  SACOL0658 3 
staphylococcal accessory protein X (sarX)  SACOL0726 3 
6-pyruvoyl tetrahydrobiopterin synthase, putative  SACOL0771 3 
diaminopimelate decarboxylase (lysA)  SACOL1435 3 
PhoH family protein  SACOL1628 3 
hypothetical protein  SACOL0156 3 
conserved hypothetical protein  SACOL1239 3 
DNA repair protein RecN (recN)  SACOL1564 3 
acetyl-CoA carboxylase, carboxyl transferase, beta subunit (accD)  SACOL1748 3 
sdrC protein (sdrC)  SACOL0608 2 
Staphylococcus aureus sex pheromone (camS)  SACOL1964 2 
signal peptidase IB (spsB)  SACOL0969 2 
conserved hypothetical protein  SACOL2020 2 
decarboxylase family protein  SACOL0740 2 
ferredoxin (fer)  SACOL1525 2 
ABC transporter, substrate-binding protein  SACOL2403 2 
conserved domain protein  SACOL1466 2 
type I restriction-modification system, M subunit (hsdM1) SACOL0476 
(+1) 
2 
exonuclease RexB (rexB)  SACOL0970 2 
adenosylmethionine--8-amino-7-oxononanoate aminotransferase (bioA)   SACOL2427 2 
oxidoreductase, Gfo-Idh-MocA family  SACOL0196 2 
conserved hypothetical protein  SACOL2489 2 
riboflavin biosynthesis protein RibF (ribF)  SACOL1291 2 
UDP-N-acetylglucosamine 2-epimerase Cap5G (cap5G)  SACOL0142 2 
conserved domain protein  SACOL0445 2 
conserved hypothetical protein  SACOL0830 2 
transcriptional regulator, Fur family  SACOL1611 2 
protoporphyrinogen oxidase (hemG)  SACOL1887 2 
hydrolase, haloacid dehalogenase-like family  SACOL0976 2 
hypothetical protein  SACOL0182 2 
iron-dependent repressor (sirR)  SACOL0691 2 
alkaline phosphatase synthesis transcriptional regulatory protein PhoP (phoP)  SACOL1740 2 
peptidase, M16 family  SACOL1298 2 
UDP-N-acetylmuramoylalanyl-D-glutamate--2,6-diaminopimelate ligase (murE)  SACOL1023 2 
hydrolase, alpha-beta hydrolase fold family  SACOL0668 2 
thymidine kinase (tdk)  SACOL2111 2 
transcriptional regulator, putative  SACOL2650 2 
conserved hypothetical protein  SACOL0058 2 
PTS system, IIBC components  SACOL0178 2 
phosphoglycerate mutase family protein  SACOL0447 2 
conserved hypothetical protein  SACOL0753 2 
conserved hypothetical protein  SACOL1112 2 
fibronectin-fibrinogen binding-related protein  SACOL1220 2 
ribosomal protein L28 (rpmB)  SACOL1238 2 
conserved hypothetical protein  SACOL1376 2 
transcriptional antiterminator LicT, putative  SACOL1393 2 
aspartate-semialdehyde dehydrogenase (asd)  SACOL1429 2 
dihydrodipicolinate synthase (dapA)   SACOL1430 2 
conserved hypothetical protein TIGR00256  SACOL1688 2 
cytosolic long-chain acyl-CoA thioester hydrolase family protein  SACOL1936 2 
conserved hypothetical protein  SACOL1993 2 
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isopentenyl diphosphate isomerase (fni) SACOL2341 2 
staphylococcal accessory protein Z (sarZ)  SACOL2384 2 
ABC transporter, ATP-binding protein  SACOL2462 2 
gluconokinase (gntK)  SACOL2515 2 
galactoside O-acetyltransferase SACOL2570 2 
hydrolase, CocE-NonD family  SACOL2612 2 
tributyrin esterase EstA, putative  SACOL2651 2 
rod shape-determining protein MreC (mreC)  SACOL1704 1 
LysM domain protein  SACOL0507 1 
LPXTG cell wall surface anchor family protein (sasF)  SACOL2668 1 
lipoprotein, putative  SACOL0449 1 
penicillin-binding protein 1 (pbp1)  SACOL1194 1 
protein phosphatase 2C domain protein  SACOL1231 1 
secretory extracellular matrix and plasma binding protein (empbp)  SACOL0858 1 
chaperonin, 33 kDa  SACOL0556 1 
immunodominant antigen A (isaA)  SACOL2584 0 
cell wall surface anchor family protein (sasG)  SACOL2505 0 
fibronectin binding protein B (fnbB)  SACOL2509 0 
fibronectin-binding protein A (fnbA)  SACOL2511 0 
clumping factor B (clfB)  SACOL2652 0 
LysM domain protein  SACOL0723 0 
leukocidin subunit precursor, putative  SACOL2004 0 
alpha-hemolysin precursor (hlY)  SACOL1173 0 
surface protein, putative  SACOL0479 0 
IgG-binding protein SBI  SACOL2418 0 
cysteine protease precursor SspB (sspB2)  SACOL1970 0 
sasB protein (sasB)  SACOL2150 0 
transcriptional regulator, putative  SACOL1065 0 
phage infection protein, putative  SACOL2665 0 
transcriptional regulator, putative  SACOL1398 0 
penicillin-binding protein 3 (pbp3)  SACOL1609 0 
phospholipase C (hlb)  SACOL2003 0 
lipoprotein, putative  SACOL1589 0 
peptide ABC transporter, peptide-binding protein  SACOL2476 0 
ABC transporter, substrate-binding protein  SACOL0217 0 
thymidylate kinase (tmk)  SACOL0524 0 
glucose inhibited division protein A (gidA)  SACOL2737-R 0 
fibronectin binding protein B (fnbB)  SACOL2509-R 0 
serine protease SplB (splB)  SACOL1868 0 
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Appendix 3.  Cytoplasmic proteins identified after MudPit analysis of SH1000 
during post-exponential phase from 2 biological replicates 
 
Identified Proteins (346) Accession Number Sample 1 Sample 2 
Elongation factor Tu   Q5HIC7|EFTU 239 119 
Probable transglycosylase isaA   Q5HCY1|ISAA 81 111 
Elongation factor G   Q5HIC8|EFG 89 65 
Enolase   Q5HHP1|ENO 64 39 
Pyruvate kinase   Q5HF76|KPYK 54 27 
Dihydrolipoyl dehydrogenase  Q5HGY8|DLDH 39 36 
Pyruvate dehydrogenase E1 component subunit beta   Q5HGZ0|ODPB 35 38 
Bifunctional autolysin   Q5HH31|ATL 45 24 
50S ribosomal protein L30   Q5HDX6|RL30 28 25 
50S ribosomal protein L15   Q5HDX7|RL15 15 45 
Pyruvate dehydrogenase E1 component subunit alpha   Q5HGZ1|ODPA 34 25 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex   
Q5HGY9|ODP2 30 23 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase   Q5HDD9|GPMA 34 13 
Phosphate acetyltransferase   Q5HI88|PTA 29 21 
Alkyl hydroperoxide reductase subunit C   Q5HIR5|AHPC 27 16 
Transketolase   Q5HG77|TKT 26 21 
30S ribosomal protein S8   Q5HDX2|RS8 15 17 
50S ribosomal protein L13   Q5HDZ0|RL13 25 14 
Glycyl-tRNA synthetase   Q5HFJ5|SYG 29 11 
50S ribosomal protein L1   Q5HID7|RL1 22 15 
Alkaline shock protein 23   Q5HE23|ASP23 24 11 
ATP synthase subunit beta   Q5HE97|ATPB 26 16 
Pyridoxal biosynthesis lyase pdxS  Q5HIF5|PDXS 21 16 
Staphylococcal secretory antigen ssaA2   Q5HDQ9|SSAA2 22 17 
L-lactate dehydrogenase 1    Q5HJD7|LDH1 26 13 
50S ribosomal protein L27   Q5HFB8|RL27 23 13 
ATP synthase subunit alpha    Q5HE95|ATPA 25 14 
Cell division protein ftsZ    Q5HGP5|FTSZ 14 18 
3-oxoacyl-[acyl-carrier-protein] reductase    Q5HGK2|FABG 18 17 
Probable malate:quinone oxidoreductase 2    Q5HCU5|MQO2 18 9 
Succinyl-CoA ligase [ADP-forming] subunit beta    Q5HGI7|SUCC 20 14 
GMP synthase [glutamine-hydrolyzing]   Q5HIQ6|GUAA 20 10 
50S ribosomal protein L6    Q5HDX3|RL6 19 11 
Glutamine synthetase    Q5HGC3|GLNA 21 7 
Uracil phosphoribosyltransferase    Q5HE88|UPP 17 13 
Glyceraldehyde-3-phosphate dehydrogenase 1    Q5HHP5|G3P1 23 7 
DNA-binding protein HU    Q5HFV0|DBH 20 11 
Antibacterial protein (Phenol soluble modulin)    Q5HGQ7|Q5HGQ7 18 6 
30S ribosomal protein S6   Q5HIS9|RS6 22 10 
60 kDa chaperonin   Q5HEH2|CH60 16 9 
UPF0365 protein  Q5HFI7|Y1630 19 11 
DNA-directed RNA polymerase subunit omega    Q5HGM2|RPOZ 13 12 
DNA-directed RNA polymerase subunit beta'  Q5HID2|RPOC 20 8 
Fructose-bisphosphate aldolase class 1    Q5HCU6|ALF1 16 10 
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DNA-directed RNA polymerase subunit beta   Q5HID3|RPOB 17 9 
Glucosamine-6-phosphate isomerase, putative    Q5HES0|Q5HES0 17 12 
6-phosphogluconate dehydrogenase, decarboxylating    Q5HFR2|6PGD 17 9 
50S ribosomal protein L5    Q5HDX0|RL5 22 8 
Putative universal stress protein  Q5HF64|Y1759 15 12 
ATP-dependent Clp protease ATP-binding subunit clpL    Q5HD02|CLPL 16 7 
Antibacterial protein (Phenol soluble modulin)    Q5HGQ8|Q5HGQ8 16 5 
Acetate kinase   Q5HF63|ACKA 16 7 
50S ribosomal protein L11    Q5HID8|RL11 11 9 
Ribosome-recycling factor    Q5HGH2|RRF 11 13 
30S ribosomal protein S19    Q5HDW2|RS19 14 11 
Succinyl-CoA ligase [ADP-forming] subunit alpha    Q5HGI6|SUCD 10 9 
Putative uncharacterized protein    Q5HIT1|Q5HIT1 10 13 
Bifunctional purine biosynthesis protein purH  Q5HH11|PUR9 18 6 
Carbamoyl-phosphate synthase large chain    Q5HGM9|CARB 12 12 
Probable thiol peroxidase   Q5HF61|TPX 14 7 
Chaperone protein hchA  Q5HIC4|HCHA 15 11 
Conserved domain protein    Q5HH57|Q5HH57 15 9 
Fructose-bisphosphate aldolase    Q5HE75|ALF2 12 6 
Pyruvate carboxylase    Q5HGX0 11 5 
Ornithine aminotransferase 2   Q5HHC8|OAT2 12 6 
Ribose-phosphate pyrophosphokinase   Q5HIH5|KPRS 15 8 
Chaperone protein dnaK    Q5HFI0|DNAK 13 8 
Elongation factor Ts    Q5HGH4|EFTS 16 5 
UPF0342 protein  Q5HET0|Y1902 13 10 
Putative 2-hydroxyacid dehydrogenase  Q5HDQ4|Y2296 11 10 
Oxidoreductase, putative  Q5HIW6|Q5HIW6 10 4 
Formate acetyltransferase    Q5HJF4|PFLB 14 1 
N utilization substance protein A, putative   Q5HGG5|Q5HGG5 13 6 
30S ribosomal protein S11    Q5HDY3|RS11 14 4 
50S ribosomal protein L32    Q5HGV6|RL32 12 6 
Naphthoate synthase    Q5HH38|MENB 14 6 
D-alanine--D-alanine ligase    Q5HEB7|DDL 14 8 
Cell cycle protein gpsB    Q5HFX8|GPSB 13 7 
Uncharacterized protein  Q5HGK7|Y1240 10 3 
30S ribosomal protein S5    Q5HDX5|RS5 10 9 
ATP-dependent Clp protease ATP-binding subunit clpC    P0C281|CLPC 12 6 
50S ribosomal protein L10    Q5HID6|RL10 12 4 
Alcohol dehydrogenase   Q5HI63|ADH 13 4 
Bifunctional protein folD  Q5HH21|FOLD 12 2 
Universal stress protein family    Q5HF68|Q5HF68 9 6 
Phosphoenolpyruvate-protein phosphotransferase   Q5HH01|PT1 10 6 
30S ribosomal protein S2   Q5HGH6|RS2 10 4 
NADH dehydrogenase-like protein  Q5HHE4|Y944 11 7 
Ribonucleoside-diphosphate reductase  Q5HHU0|Q5HHU0 11 7 
Hydroxymethylglutaryl-CoA synthase   Q5HD04|Q5HD04 9 7 
Arginyl-tRNA synthetase    Q5HI60|SYR 9 7 
Dihydrolipoyllysine-residue succinyltransferase component of 2-
oxoglutarate dehydrogenase complex    
Q5HG07|ODO2 9 4 
30S ribosomal protein S7   Q5HIC9|RS7 11 4 
30S ribosomal protein S16   Q5HGJ4|RS16 12 4 
Thioredoxin   Q5HGT9|THIO 11 5 
Phosphoribosylformylglycinamidine synthase, PurS protein    Q5HH17|Q5HH17 10 5 
30S ribosomal protein S1    Q5HFU7|RS1 11 5 
UPF0051 protein  Q5HHG8|Y918 10 3 
50S ribosomal protein L2    Q5HDW1|RL2 7 5 
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NADP-dependent malic enzyme, putative    Q5HF72|Q5HF72 7 7 
Translation initiation factor IF-2    Q5HGG2|IF2 7 2 
Putative uncharacterized protein    Q5HJK1|Q5HJK1 7 5 
3-oxoacyl-[acyl-carrier-protein] synthase 2    Q5HHA1|FABF 6 5 
Cell division protein FtsH, putative    Q5HIG4|Q5HIG4 9 5 
Asparaginyl-tRNA synthetase    Q5HFW9|SYN 9 4 
50S ribosomal protein L21    Q5HFB6|RL21 8 6 
Phenol-soluble modulin alpha 1 peptide    P0C7Y4|PSMA1 7 3 
30S ribosomal protein S10    Q5HDV7|RS10 7 7 
N-acetylmuramoyl-L-alanine amidase domain protein    Q5HCQ3|Q5HCQ3 6 5 
Uncharacterized protein  Q5HHB6|Y973 8 5 
Putative uncharacterized protein    Q5HHZ0|Q5HHZ0 7 5 
Prolyl-tRNA synthetase    Q5HGG8|SYP 7 0 
50S ribosomal protein L17    Q5HDY5|RL17 11 1 
Imidazolonepropionase    Q5HDM7|HUTI 8 5 
50S ribosomal protein L7/L12    Q5HID5|RL7 6 5 
Glutamyl-tRNA(Gln) amidotransferase subunit A    Q5HEM2|GATA 6 3 
Queuine tRNA-ribosyltransferase    Q5HFC4|TGT 7 5 
DNA polymerase III subunit beta    Q5HJZ4|DPO3B 8 2 
ATP-dependent protease ATPase subunit HslU    Q5HGH8|HSLU 8 2 
1-pyrroline-5-carboxylate dehydrogenase    Q5HCZ6|ROCA 8 2 
UvrABC system protein A    UVRA 3 1 
Serine hydroxymethyltransferase    Q5HE87|GLYA 9 4 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B    Q5HEM3|GATB 5 3 
Uncharacterized protein  Q5HEP9|Y1933 6 4 
Threonyl-tRNA synthetase    Q5HF90|SYT 8 2 
Thioredoxin, putative    Q5HF30|Q5HF30 6 4 
50S ribosomal protein L18    Q5HDX4|RL18 7 3 
GTP-sensing transcriptional pleiotropic repressor codY    Q5HGH7|CODY 6 4 
Protein grpE    Q5HFH9|GRPE 7 4 
Seryl-tRNA synthetase    Q5HJY7|SYS 6 2 
Oxidoreductase, short chain dehydrogenase/reductase family    Q5HDM9|Q5HDM
9 
7 5 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1    Q5HEA0|MURA1 6 3 
Ferritin    Q5HEN0|FTN 7 4 
50S ribosomal protein L29    Q5HDW6|RL29 5 3 
Probable catabolite control protein A    Q5HF38|CCPA 7 5 
50S ribosomal protein L33 1    Q5HFK9|RL331 
(+1) 
7 4 
50S ribosomal protein L36    Q5HDY1|RL36 3 2 
Thioredoxin reductase    Q5HHQ4|TRXB 10 0 
Phosphoglucosamine mutase    Q5HE43|GLMM 6 2 
Transaldolase    Q5HEZ4|Q5HEZ4 8 3 
6-phosphofructokinase    Q5HF75|K6PF 5 4 
50S ribosomal protein L23    Q5HDW0|RL23 4 4 
UPF0082 protein  Q5HHZ9|Y727 7 3 
Formate--tetrahydrofolate ligase    Q5HF42|FTHS 8 1 
ABC transporter, ATP-binding protein    Q5HG28|Q5HG28 9 2 
NifU domain protein    Q5HHG9|Q5HHG9 7 3 
Valyl-tRNA synthetase    Q5HFA8|SYV 5 3 
GTP-binding protein engA    Q5HFU8|ENGA 5 3 
Deoxyribose-phosphate aldolase 1    Q5HJN0|DEOC1 5 2 
Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase    Q5HF37|Q5HF37 5 4 
Putative aldehyde dehydrogenase AldA    Q5HJK3|ALDA 7 3 
HTH-type transcriptional regulator sarR    Q5HDR3|SARR 5 3 
Orotidine 5'-phosphate decarboxylase    Q5HGM8|PYRF 6 4 
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UPF0355 protein  Q5HIR0|UP355 4 4 
Adenylosuccinate synthetase    Q5HJX8|PURA 6 2 
Proline dipeptidase    Q5HFM9|Q5HFM9 7 1 
Putative uncharacterized protein    Q5HET6 5 2 
Probable manganese-dependent inorganic pyrophosphatase    Q5HEK1|PPAC 7 3 
UPF0435 protein  Q5HEP4|Y1938 6 4 
Putative NAD(P)H nitroreductase  Q5HD30|Y2534 3 5 
Probable acetyl-CoA acyltransferase    Q5HIU0|THLA 6 1 
Isoleucyl-tRNA synthetase    Q5HGN8|SYI 5 2 
Alcohol dehydrogenase, zinc-containing    Q5HE18|Q5HE18 3 3 
Hydroxymethylglutaryl-CoA reductase, degradative    Q5HD05|Q5HD05 3 2 
Putative dipeptidase  Q5HF23|PEPVL 4 3 
3-hexulose-6-phosphate synthase    Q5HIA5|HPS 5 1 
Dephospho-CoA kinase    Q5HF85|COAE 5 1 
Aminoacyltransferase femA    Q5HG45|FEMA 4 3 
FeS assembly ATPase SufC    Q5HHH2|Q5HHH2 7 1 
NifU domain protein    Q5HHE8|Q5HHE8 4 4 
Delta-hemolysin    Q5HEG6|HLD 5 4 
Hypoxanthine-guanine phosphoribosyltransferase    Q5HIG5|HPRT 3 4 
Inositol monophosphatase family protein    Q5HGX7|Q5HGX7 5 3 
Phosphoglycerate kinase    Q5HHP4|PGK 5 3 
30S ribosomal protein S4    Q5HF54|RS4 6 0 
Protein translocase subunit secA 1    Q5HHR7|SECA1 4 0 
CTP synthase    Q5HE73|PYRG 3 2 
Serine-protein kinase rsbW    Q5HED6|RSBW 3 2 
Anti-sigma-B factor antagonist    P60071|RSBV 5 2 
50S ribosomal protein L14    RL14 3 1 
S1 RNA binding domain protein    Q5HED8|Q5HED8 2 4 
3-oxoacyl-[acyl-carrier-protein] synthase 3    Q5HHA2|FABH 5 1 
tRNA uridine 5-carboxymethylaminomethyl modification enzyme 
mnmG    
Q5HCI4|MNMG 2 2 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta    Q5HF73|ACCD 4 2 
Polyribonucleotide nucleotidyltransferase    Q5HGF7|PNP 2 1 
N-acetylmuramoyl-L-alanine amidase sle1    Q5HIL2|SLE1 3 2 
D-alanine aminotransferase    Q5HF24|DAAA 3 2 
ATP synthase subunit delta    Q5HE94|ATPD 6 1 
2-oxoglutarate dehydrogenase E1 component    Q5HG06|ODO1 4 3 
30S ribosomal protein S20    Q5HFH5|RS20 4 0 
Succinate dehydrogenase, iron-sulfur protein    Q5HGT4|Q5HGT4 4 3 
Rrf2 family protein    Q5HFD6|Q5HFD6 3 2 
Probable DEAD-box ATP-dependent RNA helicase  Q5HEB9|Y2072 3 3 
Putative uncharacterized protein    Q5HEF7|Q5HEF7 3 3 
Phosphoribosylglycinamide formyltransferase    Q5HH12|PUR3 2 3 
50S ribosomal protein L25    Q5HIH4|RL25 3 2 
Tyrosyl-tRNA synthetase    Q5HF45|SYY 2 2 
Deoxyribonuclease, TatD family    Q5HII5|Q5HII5 2 1 
Aconitate hydratase    Q5HG69|ACON 3 1 
Low molecular weight protein-tyrosine-phosphatase ptpA    Q5HEP3|PTPA 1 4 
Peptide chain release factor 1    Q5HE82|RF1 2 3 
Peroxide-responsive repressor perR    Q5HER3|PERR 1 2 
Mannitol-specific phosphotransferase enzyme IIA component    PTMA 3 1 
PhoH family protein    Q5HFI9|Q5HFI9 1 2 
Mannitol-1-phosphate 5-dehydrogenase    MTLD 4 0 
Lysyl-tRNA synthetase    Q5HIF7|SYK 3 1 
UPF0297 protein  Q5HFE5|Y1672 6 1 
6,7-dimethyl-8-ribityllumazine synthase    Q5HF08|RISB 4 2 
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Putative uncharacterized protein    Q5HEL5|Q5HEL5 4 2 
Probable transglycosylase sceD    Q5HEA4|SCED 2 2 
Guanylate kinase    Q5HGM3|KGUA 4 2 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2    Q5HJC1|ISPD2 3 3 
Oxidoreductase, aldo/keto reductase family    Q5HHW7|Q5HHW
7 
3 0 
50S ribosomal protein L9    Q5HJY1|RL9 4 0 
Ribonuclease J 1    Q5HGZ5|RNJ1 5 0 
33 kDa chaperonin    Q5HIG3|HSLO 5 0 
Putative uncharacterized protein    Q5HGE0|Q5HGE0 3 3 
Phosphoribosylamine--glycine ligase    Q5HH10|PUR2 3 1 
ATP synthase gamma chain    Q5HE96|ATPG 2 1 
Trigger factor    Q5HF97|TIG 3 0 
Nitrite reductase [NAD(P)H], large subunit    Q5HDF6|Q5HDF6 2 2 
Penicillin-binding protein 2    Q5HFX3|Q5HFX3 4 0 
Riboflavin biosynthesis protein RibF    Q5HGF9|Q5HGF9 2 0 
UPF0122 protein  Q5HGJ6|Y1252 3 0 
Uridylate kinase    Q5HGH3|PYRH 3 2 
Phosphoribosylformylglycinamidine synthase 2    Q5HH15|PURL 1 1 
Catalase    Q5HG86|CATA 3 1 
Phosphate acyltransferase    Q5HGK4|PLSX 3 2 
Phosphoribosylformylglycinamidine synthase 1    Q5HH16|PURQ 4 2 
Probable cysteine desulfurase    Q5HHH0|CSD 5 1 
30S ribosomal protein S18    Q5HIS7|RS18 3 1 
Molybdopterin molybdenumtransferase    Q5HDT4|MOEA 3 2 
MutT/nudix family protein    Q5HF95|Q5HF95 3 0 
5-methyltetrahydropteroyltriglutamate--homocysteine 
methyltransferase    
Q5HIT8|METE 2 0 
Putative uncharacterized protein    Q5HIN0|Q5HIN0 3 0 
Malonyl CoA-acyl carrier protein transacylase    Q5HGK3|FABD 6 0 
Uncharacterized protein  Q5HG10|Y1445 2 1 
Alcohol dehydrogenase, zinc-containing    Q5HJC0|Q5HJC0 1 3 
50S ribosomal protein L3    Q5HDV8|RL3 2 1 
ComE operon protein 2    Q5HFH2|RANDO
M_Q5HFH2-R 
1 1 
Xanthine phosphoribosyltransferase    Q5HIQ9|XPT 2 1 
Chaperone protein clpB    Q5HHB0|CLPB 4 1 
Fumarate hydratase class II    Q5HES4|FUMC 3 1 
Copper chaperone copZ    Q5HCZ2|COPZ 1 2 
Probable glycine dehydrogenase [decarboxylating] subunit 1    Q5HFM3|GCSPA 3 2 
Glucose-specific phosphotransferase enzyme IIA component    Q5HFZ9|PTGA 4 1 
UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol N-acetylglucosamine transferase    
Q5HG02|MURG 3 1 
Methionyl-tRNA formyltransferase    Q5HGL6|FMT 4 1 
Putative trmH family tRNA/rRNA methyltransferase    Q5HIE3|TRMHL 3 1 
Translation initiation factor IF-3    Q5HF92|IF3 2 2 
30S ribosomal protein S3    Q5HDW4|RS3 2 1 
Alcohol dehydrogenase, zinc-containing    Q5HDI5|Q5HDI5 2 2 
Histidyl-tRNA synthetase    Q5HFD2|SYH 2 2 
Aspartate carbamoyltransferase    Q5HGN2|PYRB 2 2 
Glutamate-1-semialdehyde 2,1-aminomutase 1    Q5HFA5|GSA1 2 2 
Putative uncharacterized protein    Q5HGK8 2 2 
Pyrimidine-nucleoside phosphorylase    Q5HE64|PDP 2 0 
PTS system, IIBC components    Q5HJD5|Q5HJD5 1 0 
50S ribosomal protein L4    RANDOM_RL4-R 1 0 
Elastin-binding protein ebpS    Q5HFU2|EBPS 2 0 
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Extracellular matrix-binding protein ebh    Q5HFY8|EBH 1 0 
Septation ring formation regulator ezrA    Q5HF56|EZRA 4 0 
Phosphopentomutase    Q5HJM9|DEOB 5 0 
Phosphoribosylaminoimidazole carboxylase ATPase subunit    Q5HH19|PURK 3 0 
Aspartate-semialdehyde dehydrogenase    Q5HG26|Q5HG26 2 0 
Bacterioferritin comigratory protein    Q5HER1|Q5HER1 1 0 
50S ribosomal protein L24    Q5HDW9|RL24 2 0 
Dps family protein    Q5HE61|Q5HE61 3 0 
Uroporphyrinogen decarboxylase    Q5HEU2|DCUP 4 0 
DNA polymerase I    Q5HF83|Q5HF83 4 0 
UPF0133 protein  Q5HIJ8|Y521 2 1 
Putative hemin transport system permease protein hrtB    RANDOM_HRTB-
R 
1 0 
Glutamate-1-semialdehyde 2,1-aminomutase 2    Q5HER0|GSA2 2 2 
Phosphoribosylformylglycinamidine cyclo-ligase    Q5HH13|PUR5 3 1 
30S ribosomal protein S12    Q5HID0|RS12 2 1 
Putative septation protein spoVG    Q5HIH8|SP5G 3 1 
Inosine-5'-monophosphate dehydrogenase    Q5HIQ7|IMDH 1 3 
Putative uncharacterized protein    Q5HFG6|Q5HFG6 2 2 
Pyruvate carboxylase    Q5HGX0|Q5HGX0 12 5 
Putative uncharacterized protein    Q5HFX9|Q5HFX9 1 1 
S-adenosylmethionine synthase    Q5HEY9|METK 2 1 
Peptidase, M20/M25/M40 family    Q5HJR7|Q5HJR7 2 1 
Iron compound ABC transporter, iron compound-binding protein    Q5HDS3|Q5HDS3 2 1 
S-ribosylhomocysteine lyase    Q5HE66|LUXS 1 1 
Putative uncharacterized protein    Q5HI16|Q5HI16 1 0 
DNA topoisomerase 4 subunit B    Q5HG65|PARE 2 0 
30S ribosomal protein S21    Q5HFI5|RS21 0 1 
Peptide deformylase    Q5HGZ3|DEF 0 2 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha    Q5HF74|ACCA 3 0 
UDP-N-acetylmuramoylalanine--D-glutamate ligase    Q5HGP8|MURD 1 0 
Trans-sulfuration enzyme family protein    Q5HIL6|Q5HIL6 2 0 
Dehydrosqualene synthase    Q5HCY8|CRTM 1 0 
Serine-aspartate repeat-containing protein C    Q5HIB4|SDRC 4 0 
Transcription antitermination protein nusG    Q5HID9|NUSG 3 0 
Bifunctional protein glmU    Q5HIH6|GLMU 3 0 
GTP-binding protein TypA    Q5HGX5|Q5HGX5 3 0 
Sun protein    Q5HGL5 2 0 
Aspartyl-tRNA synthetase    Q5HFD3|SYD 2 0 
Lipoate-protein ligase A family protein    Q5HH58|Q5HH58 1 0 
Coenzyme A disulfide reductase    Q5HHB4|CDR 3 0 
Cysteine synthase    Q5HIG2|CYSK 0 3 
Acetyl-CoA carboxylase, biotin carboxylase    Q5HFP5|Q5HFP5 2 0 
N-acetylglucosamine-6-phosphate deacetylase    Q5HHW9|Q5HHW
9 
4 0 
Probable branched-chain-amino-acid aminotransferase    Q5HIC1|ILVE 2 0 
Probable malate:quinone oxidoreductase 1    Q5HDJ0|MQO1 1 2 
LexA repressor    Q9L4P1|LEXA 2 1 
FtsK/SpoIIIE family protein    Q5HF33|Q5HF33 1 1 
Menaquinone biosynthesis methyltransferase ubiE    Q5HFV2|UBIE 1 1 
Adenylate kinase    Q5HDX9|KAD 1 0 
UPF0403 protein  Q5HFZ5|Y1464 1 0 
Conserved virulence factor B    Q5HG29|CVFB 1 0 
UTP--glucose-1-phosphate uridylyltransferase    Q5HD54|GTAB 2 0 
Urease accessory protein ureE    Q5HDR7|UREE 2 0 
UDP-N-acetylenolpyruvoylglucosamine reductase    Q5HHT2|MURB 1 0 
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Ribonuclease J 2    Q5HGF6|RNJ2 1 0 
Aerobic glycerol-3-phosphate dehydrogenase    Q5HGD1|GLPD 1 0 
Glutamate synthase, small subunit    Q5HIK4|Q5HIK4 1 0 
Alanyl-tRNA synthetase    Q5HFE4|SYA 3 0 
Aminotransferase, putative    Q5HEI3|Q5HEI3 3 0 
Putative uncharacterized protein    Q5HEU6|Q5HEU6 3 0 
Hydrolase, haloacid dehalogenase-like family    Q5HHB3|Q5HHB3 3 0 
Acid phosphatase5'-nucleotidase, lipoprotein e(P4) family    Q5HJ61|Q5HJ61 3 0 
DNA ligase    Q5HEL8|DNLJ 2 0 
Amino acid ABC transporter, ATP-binding protein    Q5HDA5|Q5HDA5 1 0 
Ribonucleoside-diphosphate reductase 2, beta subunit    Q5HHT9|Q5HHT9 2 0 
Probable ctpA-like serine protease    Q5HG01|CTPAL 1 0 
Capsular polysaccharide biosynthesis protein Cap5F    Q5HJL6|Q5HJL6 2 0 
Aminomethyltransferase    Q5HFM2|GCST 1 0 
Lipase 1    Q5HCM7|LIP1 2 0 
Methionine aminopeptidase    Q5HEN6|AMPM 2 0 
Thymidylate synthase    Q5HFZ6|TYSY 2 0 
Serine protease HtrA, putative    Q5HF46|Q5HF46 2 0 
Putative uncharacterized protein    Q5HIE4|Q5HIE4 2 0 
Putative uncharacterized protein    Q5HI54|Q5HI54 1 0 
Peptidase, M20/M25/M40 family    Q5HFR1|Q5HFR1 1 0 
Leucyl-tRNA synthetase    Q5HF16|SYL 1 0 
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase    Q5HEB8|Q5HEB8 1 0 
Putative uncharacterized protein    Q5HE21|Q5HE21 0 1 
Glutamyl-tRNA synthetase    Q5HIE7|SYE 0 1 
Cobyric acid synthase, putative    Q5HEN2|Q5HEN2 0 1 
Putative phosphotransferase  Q5HFJ7|Y1620 1 0 
ATP-dependent protease subunit HslV    Q5HGH9|HSLV 1 0 
Glycerol kinase    Q5HGD2|GLPK 1 0 
77 kDa membrane protein    Q5HEI2|RANDOM
_OMP7-R 
1 0 
Protein esaA    Q5HJ90|RANDOM
_ESAA-R 
1 0 
ATP-dependent Clp protease proteolytic subunit    Q5HHQ0|CLPP 1 0 
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Appendix 4.  Cytoplasmic proteins identified after MudPit analysis of SH1000 
during stationary phase from 2 biological replicates 
 
Identified Proteins (366) Accession Number Sample 1 Sample 2 
Elongation factor Tu  Q5HIC7|EFTU 246 521 
Antibacterial protein (Phenol soluble modulin)  Q5HGQ7|Q5HGQ7 115 215 
Probable transglycosylase isaA  Q5HCY1|ISAA 140 124 
Pyruvate kinase  Q5HF76|KPYK 115 58 
Uracil phosphoribosyltransferase  Q5HE88|UPP 66 66 
Elongation factor G  Q5HIC8|EFG 81 67 
Dihydrolipoyl dehydrogenase  Q5HGY8|DLDH 78 48 
Bifunctional autolysin  Q5HH31|ATL 92 31 
Cell division protein ftsZ  Q5HGP5|FTSZ 68 43 
Delta-hemolysin  Q5HEG6|HLD 98 18 
Pyruvate dehydrogenase E1 component subunit beta  Q5HGZ0|ODPB 36 59 
Antibacterial protein (Phenol soluble modulin)  Q5HGQ8|Q5HGQ8 40 31 
50S ribosomal protein L1  Q5HID7|RL1 59 30 
50S ribosomal protein L30  Q5HDX6|RL30 45 31 
Cysteine synthase  Q5HIG2|CYSK 43 39 
Inosine-5'-monophosphate dehydrogenase  Q5HIQ7|IMDH 47 28 
Pyruvate dehydrogenase E1 component subunit alpha  Q5HGZ1|ODPA 44 26 
50S ribosomal protein L6  Q5HDX3|RL6 42 24 
Pyridoxal biosynthesis lyase pdxS  Q5HIF5|PDXS 36 31 
60 kDa chaperonin  Q5HEH2|CH60 46 15 
DNA-binding protein HU  Q5HFV0|DBH 37 17 
Bifunctional purine biosynthesis protein purH  Q5HH11|PUR9 35 21 
Staphylococcal secretory antigen ssaA2  Q5HDQ9|SSAA2 32 26 
30S ribosomal protein S5  Q5HDX5|RS5 32 23 
Bifunctional protein folD  Q5HH21|FOLD 40 9 
Enolase  Q5HHP1|ENO 36 15 
Ornithine aminotransferase 2  Q5HHC8|OAT2 25 26 
Phenol-soluble modulin alpha 1 peptide  P0C7Y4|PSMA1 22 11 
Putative universal stress protein  Q5HF64|Y1759 17 24 
50S ribosomal protein L27  Q5HFB8|RL27 27 12 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex  
Q5HGY9|ODP2 19 22 
Chaperone protein hchA  Q5HIC4|HCHA 25 18 
Alkaline shock protein 23  Q5HE23|ASP23 29 12 
Alkyl hydroperoxide reductase subunit C  Q5HIR5|AHPC 23 18 
30S ribosomal protein S1  Q5HFU7|RS1 34 9 
50S ribosomal protein L5  Q5HDX0|RL5 25 17 
Carbamoyl-phosphate synthase large chain  Q5HGM9|CARB 19 21 
30S ribosomal protein S8  Q5HDX2|RS8 7 17 
Phosphoribosylformylglycinamidine synthase 2  Q5HH15|PURL 24 14 
Phosphate acetyltransferase  Q5HI88|PTA 20 20 
Fructose-bisphosphate aldolase class 1  Q5HCU6|ALF1 23 9 
Ribose-phosphate pyrophosphokinase  Q5HIH5|KPRS 20 16 
Probable malate:quinone oxidoreductase 2  Q5HCU5|MQO2 20 18 
UPF0365 protein  Q5HFI7|Y1630 17 13 
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N-acetylmuramoyl-L-alanine amidase domain protein  Q5HCQ3|Q5HCQ3 14 18 
3-oxoacyl-[acyl-carrier-protein] reductase  Q5HGK2|FABG 23 14 
50S ribosomal protein L13  Q5HDZ0|RL13 20 16 
50S ribosomal protein L21  Q5HFB6|RL21 23 7 
Glycyl-tRNA synthetase  Q5HFJ5|SYG 19 11 
D-alanine--D-alanine ligase  Q5HEB7|DDL 20 10 
Chaperone protein dnaK  Q5HFI0|DNAK 23 6 
ATP-dependent Clp protease ATP-binding subunit clpL  Q5HD02|CLPL 15 12 
Acetate kinase  Q5HF63|ACKA 17 13 
sp|Q5HG77|TKT_STAAC Q5HG77|TKT 20 11 
Oxidoreductase, short chain dehydrogenase/reductase family  Q5HDM9|Q5HDM9 14 15 
Translation initiation factor IF-2  Q5HGG2|IF2 17 11 
Ribonucleoside-diphosphate reductase  Q5HHU0|Q5HHU0 17 8 
ATP synthase subunit beta  Q5HE97|ATPB 13 11 
DNA-directed RNA polymerase subunit beta  Q5HID3|RPOB 12 13 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1  Q5HEA0|MURA1 18 7 
Succinyl-CoA ligase [ADP-forming] subunit beta  Q5HGI7|SUCC 9 15 
ATP synthase subunit alpha  Q5HE95|ATPA 12 17 
Dihydrolipoyllysine-residue succinyltransferase component of 2-
oxoglutarate dehydrogenase complex  
Q5HG07|ODO2 14 14 
Oxidoreductase, putative  Q5HIW6|Q5HIW6 18 8 
DNA-directed RNA polymerase subunit beta'  Q5HID2|RPOC 13 7 
1-pyrroline-5-carboxylate dehydrogenase  Q5HCZ6|ROCA 8 14 
Imidazolonepropionase  Q5HDM7|HUTI 14 8 
Cell cycle protein gpsB  Q5HFX8|GPSB 19 6 
N utilization substance protein A, putative  Q5HGG5|Q5HGG5 13 10 
UvrABC system protein A  UVRA 5 2 
Putative 2-hydroxyacid dehydrogenase  Q5HDQ4|Y2296 16 8 
Uncharacterized protein  Q5HHB6|Y973 13 11 
GMP synthase [glutamine-hydrolyzing]  GUAA 14 2 
Succinyl-CoA ligase [ADP-forming] subunit alpha  Q5HGI6|SUCD 14 7 
NADH dehydrogenase-like protein  Q5HHE4|Y944 15 9 
Uncharacterized protein  Q5HGK7|Y1240 13 10 
Pyruvate carboxylase  Q5HGX0 9 2 
Pyrimidine-nucleoside phosphorylase  Q5HE64|PDP 9 9 
Uncharacterized protein  Q5HEP9|Y1933 10 7 
Probable catabolite control protein A  Q5HF38|CCPA 14 8 
GTPase obg  Q5HFB9|OBG 8 6 
Putative uncharacterized protein  Q5HIT1|Q5HIT1 10 11 
ATP-dependent Clp protease ATP-binding subunit clpC  P0C281|CLPC 8 12 
3-oxoacyl-[acyl-carrier-protein] synthase 2  Q5HHA1|FABF 13 8 
Alanine dehydrogenase 2  Q5HF65|DHA2 14 4 
Bifunctional protein glmU  Q5HIH6|GLMU 15 4 
30S ribosomal protein S10  Q5HDV7|RS10 8 13 
50S ribosomal protein L15  Q5HDX7|RL15 5 12 
Elongation factor Ts  Q5HGH4|EFTS 12 7 
30S ribosomal protein S11  Q5HDY3|RS11 12 4 
Glucosamine-6-phosphate isomerase, putative  Q5HES0|Q5HES0 12 5 
Catalase  Q5HG86|CATA 13 6 
FeS assembly ATPase SufC  Q5HHH2|Q5HHH2 9 10 
30S ribosomal protein S2  Q5HGH6|RS2 9 8 
NADP-dependent malic enzyme, putative  Q5HF72|Q5HF72 7 10 
DNA-directed RNA polymerase subunit omega  Q5HGM2|RPOZ 7 10 
Naphthoate synthase  Q5HH38|MENB 7 8 
Phosphoglucosamine mutase  Q5HE43|GLMM 10 5 
Aspartate-semialdehyde dehydrogenase  Q5HG26|Q5HG26 9 4 
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Ribosome-recycling factor  Q5HGH2|RRF 6 10 
6-phosphogluconate dehydrogenase, decarboxylating  Q5HFR2|6PGD 11 2 
UPF0342 protein  Q5HET0|Y1902 13 5 
Dephospho-CoA kinase  Q5HF85|COAE 8 5 
L-lactate dehydrogenase 1  Q5HJD7|LDH1 5 8 
Probable manganese-dependent inorganic pyrophosphatase  Q5HEK1|PPAC 7 5 
30S ribosomal protein S7  Q5HIC9|RS7 4 9 
30S ribosomal protein S19  Q5HDW2|RS19 10 6 
ATP-dependent protease ATPase subunit HslU  Q5HGH8|HSLU 6 9 
30S ribosomal protein S4  Q5HF54|RS4 10 4 
Glutamyl-tRNA(Gln) amidotransferase subunit A  Q5HEM2|GATA 7 5 
Protein recA  Q5HGE6|RECA 10 3 
Conserved domain protein  Q5HH57|Q5HH57 9 5 
Fructose-bisphosphate aldolase  Q5HE75|ALF2 12 2 
Transcriptional regulator sarA  Q5HI51|SARA 10 5 
Putative uncharacterized protein  Q5HG68|RANDOM
_Q5HG68-R 
2 0 
Urocanate hydratase  Q5HDM6|HUTU 8 3 
Hydroxymethylglutaryl-CoA reductase, degradative  Q5HD05|Q5HD05 6 5 
Aconitate hydratase  Q5HG69|ACON 8 3 
Probable thiol peroxidase  Q5HF61|TPX 5 7 
S-adenosylmethionine synthase  Q5HEY9|METK 7 5 
Phenol-soluble modulin alpha 4 peptide  P0C821|PSMA4 8 5 
Universal stress protein family  Q5HF68|Q5HF68 6 2 
50S ribosomal protein L14  Q5HDW8|RL14 4 4 
Transaldolase  Q5HEZ4|Q5HEZ4 6 3 
Valyl-tRNA synthetase  Q5HFA8|SYV 10 3 
GTP-binding protein engA  Q5HFU8|ENGA 6 4 
Prolyl-tRNA synthetase  Q5HGG8|SYP 6 3 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2  Q5HJC1|ISPD2 7 4 
DNA polymerase III subunit beta  Q5HJZ4|DPO3B 5 7 
50S ribosomal protein L16  Q5HDW5|RL16 9 3 
50S ribosomal protein L33 2  Q5HG85|RL332 
(+1) 
8 3 
PTS system, IIBC components  Q5HJD5|Q5HJD5 1 0 
Alcohol dehydrogenase, zinc-containing  Q5HE18|Q5HE18 8 3 
Asparaginyl-tRNA synthetase  Q5HFW9|SYN 4 2 
6-phosphofructokinase  Q5HF75|K6PF 5 5 
Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B  Q5HEM3|GATB 7 4 
Putative aldehyde dehydrogenase  Q5HE78|ALD1 4 4 
Acid phosphatase5'-nucleotidase, lipoprotein e(P4) family  Q5HJ61|Q5HJ61 7 2 
UPF0082 protein  Q5HHZ9|Y727 7 2 
Aminotransferase, putative  Q5HEI3|Q5HEI3 7 3 
Glutamine synthetase  Q5HGC3|GLNA 6 0 
Capsular polysaccharide biosynthesis protein Cap5B  Q5HJM0|Q5HJM0 6 6 
HTH-type transcriptional regulator sarR  Q5HDR3|SARR 9 1 
Glutamate-1-semialdehyde 2,1-aminomutase 2  Q5HER0|GSA2 3 6 
Polyribonucleotide nucleotidyltransferase  Q5HGF7|PNP 8 3 
Inositol monophosphatase family protein  Q5HGX7|Q5HGX7 8 4 
sp|Q5HGP8|MURD_STAAC Q5HGP8|MURD 3 2 
UPF0051 protein  Q5HHG8|Y918 3 5 
HTH-type transcriptional regulator mgrA  Q5HHY2|MGRA 6 5 
50S ribosomal protein L10  Q5HID6|RL10 2 6 
Putative aldehyde dehydrogenase AldA  Q5HJK3|ALDA 5 2 
50S ribosomal protein L2  Q5HDW1|RL2 6 3 
Queuine tRNA-ribosyltransferase  Q5HFC4|TGT 4 6 
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Putative uncharacterized protein  Q5HEL5|Q5HEL5 7 3 
S1 RNA binding domain protein  Q5HED8|Q5HED8 4 5 
Putative dipeptidase  Q5HF23|PEPVL 6 4 
Putative uncharacterized protein  Q5HI16|Q5HI16 6 4 
Hypoxanthine-guanine phosphoribosyltransferase  Q5HIG5|HPRT 3 5 
Penicillin-binding protein 2'  Q5HJW3|RANDO
M_Q5HJW3-R 
2 0 
Deoxyribose-phosphate aldolase 2  DEOC2 0 1 
Putative uncharacterized protein  Q5HF32|Q5HF32 8 0 
Threonyl-tRNA synthetase  Q5HF90|SYT 8 2 
ABC transporter, ATP-binding protein  Q5HG28|Q5HG28 4 5 
30S ribosomal protein S12  RS12 4 2 
50S ribosomal protein L3  Q5HDV8|RL3 4 2 
Succinate dehydrogenase, iron-sulfur protein  Q5HGT4|Q5HGT4 2 6 
Extracellular matrix-binding protein ebh  Q5HFY8|RANDO
M_EBH-R 
1 0 
Serine hydroxymethyltransferase  Q5HE87|GLYA 4 3 
Glyceraldehyde-3-phosphate dehydrogenase 1  Q5HHP5|G3P1 4 3 
FtsK/SpoIIIE family protein  Q5HF33|Q5HF33 5 3 
Rrf2 family protein  Q5HFD6|Q5HFD6 4 5 
Putative uncharacterized protein  Q5HHZ0|Q5HHZ0 4 6 
Pyruvate oxidase  Q5HD12|Q5HD12 5 2 
Uncharacterized protein  Q5HG10|Y1445 2 4 
50S ribosomal protein L23  Q5HDW0|RL23 4 5 
50S ribosomal protein L17  Q5HDY5|RL17 5 4 
Formate acetyltransferase  Q5HJF4|PFLB 3 7 
Phosphoribosylformylglycinamidine synthase, PurS protein  Q5HH17|Q5HH17 4 6 
Molybdopterin molybdenumtransferase  Q5HDT4|MOEA 5 3 
Isocitrate dehydrogenase [NADP]  Q5HF79|IDH 1 7 
ATP synthase subunit delta  Q5HE94|ATPD 3 4 
Formate--tetrahydrofolate ligase  Q5HF42|FTHS 5 1 
Xanthine phosphoribosyltransferase  Q5HIQ9|XPT 8 1 
50S ribosomal protein L18  Q5HDX4|RL18 4 2 
Hydroxymethylglutaryl-CoA synthase  Q5HD04|Q5HD04 4 0 
ATP-dependent Clp protease ATP-binding subunit clpX  Q5HF98|CLPX 2 5 
50S ribosomal protein L4  Q5HDV9|RL4 2 2 
Iron compound ABC transporter, iron compound-binding protein  Q5HE28|Q5HE28 3 3 
30S ribosomal protein S16  Q5HGJ4|RS16 3 3 
Cell division protein FtsH, putative  Q5HIG4|Q5HIG4 6 3 
ABC transporter, ATP-binding/permease protein  Q5HI25 1 0 
Teichoic acids export ATP-binding protein TagH  TAGH 0 2 
Tetrapyrrole methylase family protein  Q5HII8|Q5HII8 2 2 
Putative uncharacterized protein  Q5HGX3|Q5HGX3 7 1 
Elastin-binding protein ebpS  Q5HFU2|EBPS 6 1 
Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase 
trmFO  
Q5HGI1|TRMFO 3 4 
50S ribosomal protein L9  Q5HJY1|RL9 6 2 
Alcohol dehydrogenase, zinc-containing  Q5HJC4|Q5HJC4 2 5 
sp|Q5HHP4|PGK_STAAC Q5HHP4|PGK 5 2 
Transcription termination factor Rho  Q5HE79|Q5HE79 2 4 
Uridylate kinase  Q5HGH3|PYRH 4 4 
CTP synthase  Q5HE73|PYRG 3 2 
Aerobic glycerol-3-phosphate dehydrogenase  Q5HGD1|GLPD 3 2 
Dihydroorotate dehydrogenase  Q5HCW1|Q5HCW1 4 3 
50S ribosomal protein L32  Q5HGV6|RL32 3 4 
Putative pyridoxine kinase  Q5HI96|PDXK 4 3 
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Serine protease HtrA, putative  Q5HF46|Q5HF46 3 4 
2-oxoglutarate dehydrogenase E1 component  Q5HG06|ODO1 4 2 
Probable DEAD-box ATP-dependent RNA helicase  Q5HEB9|Y2072 1 5 
Extracellular matrix-binding protein ebh  Q5HFY8|EBH 0 1 
N-acetylglucosamine-6-phosphate deacetylase  Q5HHW9|Q5HHW
9 
3 1 
Seryl-tRNA synthetase  Q5HJY7|SYS 5 2 
Mannitol-1-phosphate 5-dehydrogenase  MTLD 3 0 
30S ribosomal protein S13  Q5HDY2|RS13 5 1 
Putative NAD(P)H nitroreductase  Q5HD30|Y2534 4 3 
Low molecular weight protein-tyrosine-phosphatase ptpA  Q5HEP3|PTPA 5 2 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta  Q5HF73|ACCD 4 4 
GTP-sensing transcriptional pleiotropic repressor codY  Q5HGH7|CODY 5 2 
Phosphoribosylaminoimidazole-succinocarboxamide synthase  Q5HH18|PUR7 3 2 
Probable endonuclease 4  Q5HFK3|END4 5 0 
GTP-binding protein TypA  Q5HGX5|Q5HGX5 6 0 
Lysyl-tRNA synthetase  Q5HIF7|SYK 6 0 
Chaperone protein clpB  Q5HHB0|CLPB 1 4 
Orotidine 5'-phosphate decarboxylase  Q5HGM8|PYRF 4 3 
Alcohol dehydrogenase, iron-containing  Q5HJM2|Q5HJM2 0 1 
Putative uncharacterized protein  Q5HJK1|Q5HJK1 4 1 
UDP-N-acetylenolpyruvoylglucosamine reductase  Q5HHT2|MURB 4 2 
Succinate dehydrogenase, flavoprotein subunit  Q5HGT5|Q5HGT5 4 1 
Putative uncharacterized protein  Q5HET6 1 3 
Phosphopantothenoylcysteine decarboxylase/phosphopantothenate-
-cysteine ligase  
Q5HGM1|Q5HGM1 0 2 
Primosomal protein DnaI  Q5HF89 3 0 
UPF0297 protein  Q5HFE5|Y1672 6 1 
Alcohol dehydrogenase  Q5HI63|ADH 4 3 
Lipoate-protein ligase A family protein  Q5HH58|Q5HH58 3 3 
Membrane protein, putative  Q5HDB3|RANDO
M_Q5HDB3-R 
1 1 
Phosphoribosylaminoimidazole carboxylase ATPase subunit  Q5HH19|PURK 5 0 
Dihydropteroate synthase  Q5HIG1|DHPS 3 0 
Probable transglycosylase sceD  Q5HEA4|SCED 3 0 
3-hydroxyacyl-CoA dehydrogenase protein  Q5HJE6|Q5HJE6 3 0 
sp|Q5HGG0|TRUB_STAAC Q5HGG0|TRUB 5 0 
Adenylosuccinate synthetase  Q5HJX8|PURA 5 0 
Guanylate kinase  Q5HGM3|KGUA 7 0 
Putative septation protein spoVG  Q5HIH8|SP5G 6 0 
Pseudouridine synthase  Q5HGN5|Q5HGN5 2 2 
Translation initiation factor IF-3  Q5HF92|IF3 3 3 
Protein nagD homolog  Q5HHF6|NAGD 3 3 
Ferritin  Q5HEN0|FTN 2 3 
Signal recognition particle protein  Q5HGJ5|Q5HGJ5 2 2 
Acetyltransferase, GNAT family  Q5HD32|Q5HD32 2 2 
Phosphoribosylglycinamide formyltransferase  Q5HH12|PUR3 0 4 
Aspartyl-tRNA synthetase  Q5HFD3|SYD 2 1 
UPF0355 protein  Q5HIR0|UP355 4 2 
Putative uncharacterized protein  Q5HE56|Q5HE56 2 1 
Uroporphyrinogen decarboxylase  Q5HEU2|DCUP 3 3 
Probable cysteine desulfurase  Q5HHH0|CSD 2 4 
N-acetylmuramoyl-L-alanine amidase sle1  Q5HIL2|SLE1 3 2 
NifU domain protein  Q5HHG9|Q5HHG9 3 3 
Transferrin receptor  Q5HHT4|Q5HHT 2 2 
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Acetyl-CoA carboxylase, biotin carboxylase  Q5HFP5|Q5HFP5 4 0 
Spermidine/putrescine import ATP-binding protein PotA  Q5HGY5|RANDO
M_POTA-R 
0 1 
NH(3)-dependent NAD(+) synthetase  Q5HEK9|NADE 5 0 
Ribonuclease J 1  Q5HGZ5|RNJ1 5 0 
33 kDa chaperonin  Q5HIG3|HSLO 2 0 
tRNA uridine 5-carboxymethylaminomethyl modification enzyme 
mnmG  
Q5HCI4|MNMG 5 0 
D-alanine aminotransferase  Q5HF24|DAAA 0 4 
Penicillin-binding protein 2  Q5HFX3|Q5HFX3 3 0 
Thioredoxin reductase  Q5HHQ4|TRXB 4 0 
Fumarate hydratase class II  Q5HES4|FUMC 3 1 
UvrABC system protein A  Q5HHQ9|UVRA 4 2 
Phosphoenolpyruvate-protein phosphotransferase  Q5HH01|PT1 2 1 
Putative uncharacterized protein  Q5HFY2|Q5HFY2 1 1 
Probable branched-chain-amino-acid aminotransferase  Q5HIC1|ILVE 3 1 
Pyruvate carboxylase  Q5HGX0|Q5HGX0 9 3 
Peptide deformylase  Q5HGZ3|DEF 1 1 
50S ribosomal protein L29  Q5HDW6|RL29 2 3 
Serine protease htrA-like  Q5HH63|HTRAL 3 1 
Arginyl-tRNA synthetase  Q5HI60|SYR 4 1 
NADH-dependent flavin oxidoreductase, Oye family  Q5HHC9|Q5HHC9 4 1 
Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]  Q5HE49|GLMS 3 1 
Putative uncharacterized protein  Q5HET6|Q5HET6 2 3 
Phosphoribosylamine--glycine ligase  Q5HH10|PUR2 2 1 
Acetyl-CoA synthetase, putative  Q5HCU4|Q5HCU4 2 1 
Putative uncharacterized protein  Q5HGK8 2 2 
Phosphoglycerate mutase family protein  Q5HIS0|Q5HIS0 2 0 
50S ribosomal protein L36  Q5HDY1|RL36 0 2 
10 kDa chaperonin  Q5HEH1|CH10 4 0 
Glucokinase  Q5HFL3|Q5HFL3 2 0 
Prophage L54a, major capsid protein, putative  Q5HIZ5|RANDOM
_Q5HIZ5-R 
1 0 
UPF0637 protein  Q5HGX8|Y1115 2 0 
FeS assembly protein SufD  Q5HHH1|Q5HHH1 3 0 
Uncharacterized oxidoreductase  Q5HD73|Y2488 0 4 
Triosephosphate isomerase  Q5HHP3|TPIS 2 0 
NAD-specific glutamate dehydrogenase  Q5HHC7|DHE2 3 0 
Acetoin(diacetyl) reductase  Q5HJP2|BUTA 5 0 
Enoyl-(Acyl-carrier-protein) reductase  Q5HH75|Q5HH75 1 2 
Isoleucyl-tRNA synthetase  Q5HGN8|SYI 2 1 
Putative uncharacterized protein  Q5HIN0|Q5HIN0 2 1 
Putative phosphotransferase  Q5HFJ7|Y1620 3 1 
Protein translocase subunit secA 1  Q5HHR7|SECA1 2 1 
Putative uncharacterized protein  Q5HE21|Q5HE21 2 1 
Putative uncharacterized protein  Q5HGR9|Q5HGR9 1 3 
50S ribosomal protein L25  Q5HIH4|RL25 1 1 
Probable tautomerase  Q5HG56|Y1399 2 1 
Protoporphyrinogen oxidase  Q5HEU4|Q5HEU4 1 2 
Thioredoxin, putative  Q5HHL0|Q5HHL0 1 2 
UPF0403 protein  Q5HFZ5|Y1464 2 0 
Phage infection protein, putative  Q5HCQ4|Q5HCQ4 2 0 
tr|Q5HEB8|Q5HEB8_STAAC Q5HEB8|Q5HEB8 2 0 
sp|Q5HFM2|GCST_STAAC Q5HFM2|GCST 0 2 
ATP-dependent DNA helicase RecQ  Q5HFU1|Q5HFU1 2 0 
DNA translocase ftsK  Q5HGF5|FTSK 2 0 
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Threonine dehydratase catabolic  Q5HFY5|THD2 1 0 
Transcription-repair-coupling factor  Q5HIH2|RANDOM
_MFD-R 
1 0 
Ribonuclease J 2  Q5HGF6|RNJ2 2 0 
DNA ligase  Q5HEL8|DNLJ 2 0 
Glycerol phosphate lipoteichoic acid synthase  Q5HHV4|LTAS 4 0 
Proline dipeptidase  Q5HFM9|Q5HFM9 3 0 
UDP-N-acetylmuramate--L-alanine ligase  Q5HF34|MURC 4 0 
Amino acid ABC transporter, ATP-binding protein  Q5HDA5|Q5HDA5 0 4 
NAD/NADP octopine/nopaline dehydrogenase family protein  Q5HDQ7|Q5HDQ7 4 0 
50S ribosomal protein L19  Q5HGJ1|RL19 1 1 
30S ribosomal protein S3  Q5HDW4|RS3 1 1 
Uncharacterized hydrolase  Q5HCW9|Y2597 1 1 
S1 RNA binding domain protein  Q5HED8|RANDO
M_Q5HED8-R 
1 1 
Signal peptidase IB  Q5HHB9|LEP 1 1 
Dehydrosqualene desaturase  Q5HCY9|CRTN 0 1 
Sortase  Q5HD25|Q5HD25 1 0 
Glucose-specific phosphotransferase enzyme IIA component  Q5HFZ9|PTGA 2 0 
Cobyric acid synthase, putative  Q5HEN2|Q5HEN2 0 2 
6,7-dimethyl-8-ribityllumazine synthase  Q5HF08|RISB 2 0 
Putative uncharacterized protein  Q5HIQ0|Q5HIQ0 1 0 
Exodeoxyribonuclease 7 large subunit  Q5HFP8|RANDOM
_EX7L-R 
0 1 
Anti-sigma-B factor antagonist  P60071|RSBV 3 0 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase  Q5HDD9|GPMA 3 0 
Delta-aminolevulinic acid dehydratase  Q5HFA4|HEM2 2 0 
Uncharacterized protein  Q5HG67|Y1387 2 0 
Dihydroorotase  Q5HGN1|PYRC 3 0 
Thioredoxin  Q5HGT9|THIO 3 0 
Transcription antitermination protein nusG  Q5HID9|NUSG 3 0 
2-dehydropantoate 2-reductase  Q5HCV2|Q5HCV2 3 0 
Acetolactate synthase, catabolic  Q5HDZ7|Q5HDZ7 0 2 
Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase  Q5HF37|Q5HF37 0 3 
OsmC/Ohr family protein  Q5HF52|Q5HF52 2 0 
Phosphomevalonate kinase  Q5HI84|Q5HI84 1 0 
Lipoate-protein ligase A family protein  Q5HFM6|Q5HFM6 2 0 
L-serine dehydratase, iron-sulfur-dependent, beta subunit  Q5HD20|Q5HD20 0 1 
Putative uncharacterized protein  Q5HIY4|RANDOM
_Q5HIY4-R 
0 1 
Acyl-CoA dehydrogenase family protein  Q5HJE5|Q5HJE5 1 0 
Dehydrosqualene synthase  Q5HCY8|CRTM 2 0 
Elongation factor P  Q5HFN0|EFP 2 0 
50S ribosomal protein L11  Q5HID8|RL11 2 0 
Oxidoreductase, aldo/keto reductase family  Q5HFS2|Q5HFS2 1 0 
PhoH family protein  Q5HFI9|Q5HFI9 1 0 
2-oxoisovalerate dehydrogenase, E2 component, dihydrolipoamide 
acetyltransferase  
Q5HFQ6|Q5HFQ6 1 0 
Transcriptional regulator, DeoR family  Q5HHX1|Q5HHX1 0 1 
Protein-export membrane protein SecDF  Q5HFC6|Q5HFC6 1 0 
IS1272, transposase  Q5HJW0|RANDO
M_Q5HJW0-R 
1 0 
ABC transporter, substrate-binding protein  Q5HJE1|Q5HJE1 0 1 
Formate dehydrogenase, NAD-dependent  Q5HJJ6|Q5HJJ6 1 0 
Lysostaphin resistance protein A  Q5HDM2|LYRA 1 0 
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Peptidase, M20/M25/M40 family  Q5HFR1|Q5HFR1 1 0 
Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate 
coenzyme A ligase  
Q5HIC5|BIKB 0 1 
Aminoacyltransferase femA  FEMA 0 1 
ABC transporter, ATP-binding protein  Q5HI35|Q5HI35 1 0 
Pur operon repressor  Q5HII0|Q5HII0 1 0 
Ornithine cyclodeaminase, putative  Q5HJQ2|Q5HJQ2 1 0 
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Appendix 5.  Secreted proteins identified after MudPit analysis of SH1000 during 
post-exponential phase from 2 biological replicates 
 
Identified Proteins (38) Accession Number Sample 1 Sample 2 
Probable transglycosylase isaA  Q5HCY1|ISAA 234 186 
Bifunctional autolysin  Q5HH31|ATL 42 31 
Staphylococcal secretory antigen ssaA2  Q5HDQ9|SSAA2 46 39 
Staphopain A  Q5HEL3|SSPP 10 6 
Enolase  Q5HHP1|ENO 8 7 
Surface protein, putative  Q5HDZ9|Q5HDZ9 8 2 
Probable transglycosylase sceD  Q5HEA4|SCED 5 3 
Glycerol phosphate lipoteichoic acid synthase  Q5HHV4|LTAS 5 6 
Glyceraldehyde-3-phosphate dehydrogenase 1  Q5HHP5|G3P1 7 5 
Lipase 1  Q5HCM7|LIP1 5 0 
N-acetylmuramoyl-L-alanine amidase domain protein  Q5HCQ3|Q5HCQ3 4 2 
Lipase 2  Q5HJ48|LIP2 4 4 
50S ribosomal protein L17  Q5HDY5|RL17 3 2 
Hyaluronate lyase  Q5HE02|Q5HE02 0 2 
Putative uncharacterized protein  Q5HI54|Q5HI54 3 0 
30S ribosomal protein S18  Q5HIS7|RS18 3 4 
50S ribosomal protein L28  Q5HGK9|RL28 5 5 
SdrH protein, putative  Q5HEG9|RANDO
M_Q5HEG9-R 
0 1 
6-phosphogluconate dehydrogenase, decarboxylating  Q5HFR2|6PGD 3 2 
Penicillin-binding protein 3  Q5HFK8|Q5HFK8 5 3 
Elastin-binding protein ebpS  Q5HFU2|EBPS 0 1 
UvrABC system protein A  Q5HHQ9|RANDO
M_UVRA-R 
1 0 
Gamma-hemolysin component B  Q5HDD3|HLGB 1 0 
50S ribosomal protein L22  Q5HDW3|RL22 3 3 
Helicase, putative  Q5HD63|RANDO
M_Q5HD63-R 
1 0 
Penicillin-binding protein 1  Q5HGQ0|RANDO
M_Q5HGQ0-R 
0 1 
tRNA modification GTPase mnmE  Q5HCI3|RANDOM
_MNME-R 
0 1 
Type-1 restriction enzyme R protein  Q5HJH8|RANDOM
_HSDR-R 
1 0 
Pyruvate dehydrogenase E1 component subunit beta  Q5HGZ0|ODPB 2 0 
N-acetylmuramoyl-L-alanine amidase sle1  Q5HIL2|SLE1 2 1 
Putative uncharacterized protein  Q5HI78|Q5HI78 0 1 
Leukotoxin LukE  Q5HEU9|RANDO
M_Q5HEU9-R 
1 0 
Siderophore biosynthesis protein, IucC family  Q5HJQ1|RANDOM
_Q5HJQ1-R 
0 2 
Phosphonate ABC transporter, phosphonate-binding protein  Q5HJM5|RANDO
M_Q5HJM5-R 
0 1 
Cell division protein sepF  Q5HGP2|SEPF 1 1 
Bifunctional protein folD  Q5HH21|FOLD 2 0 
Staphyloxanthin biosynthesis protein, putative  Q5HDQ5|Q5HDQ5 0 1 
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Appendix 6.  Secreted proteins identified after MudPit analysis of SH1000 during 
stationary phase from 2 biological replicates 
 
Identified Proteins (346) Accession Number Sample 1 Sample 2 
Lipase 1  Q5HCM7|LIP1 608 361 
Bifunctional autolysin  Q5HH31|ATL 269 229 
Probable transglycosylase isaA  Q5HCY1|ISAA 527 143 
Surface protein, putative  Q5HDZ9|Q5HDZ9 148 114 
Putative uncharacterized protein  Q5HI54|Q5HI54 174 119 
Enolase  Q5HHP1|ENO 70 99 
Alpha-hemolysin  Q5HGS1|Q5HGS1 85 82 
Lipase 2  Q5HJ48|LIP2 105 85 
Glyceraldehyde-3-phosphate dehydrogenase 1  Q5HHP5|G3P1 93 72 
Glycerol phosphate lipoteichoic acid synthase  Q5HHV4|LTAS 74 46 
Glutamine synthetase  Q5HGC3|GLNA 12 58 
LysM domain protein  Q5HI03|Q5HI03 56 41 
N-acetylmuramoyl-L-alanine amidase domain protein  Q5HCQ3|Q5HCQ3 36 40 
Inosine-5'-monophosphate dehydrogenase  Q5HIQ7|IMDH 33 35 
Dihydrolipoyl dehydrogenase  Q5HGY8|DLDH 30 25 
Phospholipase C  Q5HEI1|PHLC 7 29 
Formate--tetrahydrofolate ligase  Q5HF42|FTHS 28 23 
Staphopain A  Q5HEL3|SSPP 42 15 
N-acetylmuramoyl-L-alanine amidase sle1  Q5HIL2|SLE1 23 31 
Gamma-hemolysin component B  Q5HDD3|HLGB 33 10 
Fructose-bisphosphate aldolase  Q5HE75|ALF2 16 18 
Alkyl hydroperoxide reductase subunit C  Q5HIR5|AHPC 15 26 
Staphylococcal secretory antigen ssaA2  Q5HDQ9|SSAA2 47 12 
Phosphate acetyltransferase  Q5HI88|PTA 16 32 
6-phosphogluconate dehydrogenase, decarboxylating  Q5HFR2|6PGD 32 16 
Probable transglycosylase sceD  Q5HEA4|SCED 19 31 
Staphopain B  Q5HH36|SSPB 27 12 
Catalase  Q5HG86|CATA 30 15 
Clumping factor A  Q5HHM8|CLFA 33 8 
Glutamyl-tRNA synthetase  Q5HIE7|SYE 19 16 
Delta-hemolysin  Q5HEG6|HLD 6 24 
Succinyl-CoA ligase [ADP-forming] subunit alpha  Q5HGI6|SUCD 4 26 
Transcriptional regulator, putative  Q5HH28|Q5HH28 5 4 
Penicillin-binding protein 3  Q5HFK8|Q5HFK8 30 4 
Alkaline shock protein 23  Q5HE23|ASP23 13 30 
Succinyl-CoA ligase [ADP-forming] subunit beta  Q5HGI7|SUCC 1 12 
DNA-binding protein HU  Q5HFV0|DBH 4 25 
ABC transporter, substrate-binding protein  Q5HI37|Q5HI37 3 24 
2,3-bisphosphoglycerate-independent phosphoglycerate mutase  Q5HHP2|GPMI 28 10 
Pyruvate carboxylase  Q5HGX0 1 23 
3-oxoacyl-[acyl-carrier-protein] synthase 2  Q5HHA1|FABF 24 13 
50S ribosomal protein L9  Q5HJY1|RL9 2 5 
ATP synthase subunit beta  Q5HE97|ATPB 3 29 
GTP-sensing transcriptional pleiotropic repressor codY  Q5HGH7|CODY 9 15 
Foldase protein prsA  Q5HET4|PRSA 0 20 
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ATP synthase subunit alpha  Q5HE95|ATPA 8 17 
Seryl-tRNA synthetase  Q5HJY7|SYS 11 14 
Antibacterial protein (Phenol soluble modulin)  Q5HGQ7|Q5HGQ7 7 10 
1-pyrroline-5-carboxylate dehydrogenase  Q5HCZ6|ROCA 1 29 
Elastin-binding protein ebpS  Q5HFU2|EBPS 12 3 
Pyruvate kinase  Q5HF76|KPYK 2 19 
Staphyloxanthin biosynthesis protein, putative  Q5HDQ5|Q5HDQ5 15 15 
Phosphoenolpyruvate-protein phosphotransferase  Q5HH01|PT1 13 10 
Glycerophosphoryl diester phosphodiesterase GlpQ, putative  Q5HHC6|Q5HHC6 3 16 
3-oxoacyl-[acyl-carrier-protein] reductase  Q5HGK2|FABG 13 6 
DNA-directed RNA polymerase subunit beta  Q5HID3|RPOB 3 7 
Glycyl-glycine endopeptidase lytM  Q5HJ99|LYTM 12 12 
Putative uncharacterized protein  Q5HIS3|Q5HIS3 7 15 
Serine-aspartate repeat-containing protein C  Q5HIB4|SDRC 14 8 
Elongation factor Ts  Q5HGH4|EFTS 4 11 
GMP synthase [glutamine-hydrolyzing]  GUAA 9 9 
Putative uncharacterized protein  Q5HHW2|Q5HHW
2 
5 2 
Transketolase  Q5HG77|TKT 4 14 
Purine nucleoside phosphorylase  Q5HE62|Q5HE62 10 2 
Primosomal protein N`  Q5HGM0|RANDO
M_Q5HGM0-R 
2 0 
Chaperone protein dnaK  Q5HFI0|DNAK 2 11 
Triosephosphate isomerase  Q5HHP3|TPIS 8 5 
2,3-bisphosphoglycerate-dependent phosphoglycerate mutase  Q5HDD9|GPMA 1 10 
Gamma-hemolysin component C  Q5HDD4|HLGC 2 8 
50S ribosomal protein L7/L12  Q5HID5|RL7 0 1 
Cell wall surface anchor family protein  Q5HJN4|Q5HJN4 9 13 
SdrH protein, putative  Q5HEG9|Q5HEG9 19 0 
Glucose-6-phosphate isomerase  Q5HHC2|G6PI 8 13 
L-lactate dehydrogenase 1  Q5HJD7|LDH1 6 11 
Phosphoribosylaminoimidazole carboxylase, catalytic subunit  Q5HH20|Q5HH20 12 6 
Surface protein, putative  Q5HHA4|Q5HHA4 8 5 
Elongation factor Tu  Q5HIC7|EFTU 6 11 
Chaperone protein hchA  Q5HIC4|HCHA 10 10 
Urocanate hydratase  Q5HDM6|HUTU 16 0 
Phosphoglycerate kinase  Q5HHP4|PGK 0 20 
Gamma-hemolysin component A  Q5HDD6|HLGA 8 8 
Thioredoxin reductase  Q5HHQ4|TRXB 4 9 
Hydroxymethylglutaryl-CoA synthase  Q5HD04|Q5HD04 6 3 
Transaldolase  Q5HEZ4|Q5HEZ4 3 9 
DNA-directed RNA polymerase subunit beta'  Q5HID2|RPOC 5 11 
30S ribosomal protein S12  RS12 14 2 
Fructose-bisphosphate aldolase class 1  Q5HCU6|ALF1 6 10 
Uncharacterized lipoprotein  Q5HDI7|Y2365 3 9 
50S ribosomal protein L27  Q5HFB8|RL27 7 5 
Trigger factor  Q5HF97|TIG 5 0 
Deoxyribose-phosphate aldolase 2  DEOC2 0 3 
50S ribosomal protein L11  Q5HID8|RL11 5 2 
Acetoin(diacetyl) reductase  Q5HJP2|BUTA 5 6 
6-phosphofructokinase  Q5HF75|K6PF 3 8 
30S ribosomal protein S16  Q5HGJ4|RS16 1 9 
50S ribosomal protein L21  Q5HFB6|RL21 10 8 
Leucyl-tRNA synthetase  Q5HF16|SYL 4 4 
3-oxoacyl-[acyl-carrier-protein] synthase 3  Q5HHA2|FABH 1 6 
3-hydroxyacyl-CoA dehydrogenase protein  Q5HJE6|Q5HJE6 3 1 
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Putative aldehyde dehydrogenase AldA  Q5HJK3|ALDA 1 8 
Acetate kinase  Q5HF63|ACKA 2 14 
NA polymerase III subunit beta  Q5HJZ4|DPO3B 13 1 
Phenylalanyl-tRNA synthetase beta chain  Q5HGU5|SYFB 4 4 
50S ribosomal protein L30  Q5HDX6|RL30 1 8 
50S ribosomal protein L3  Q5HDV8|RL3 0 7 
LPXTG cell wall surface anchor family protein  Q5HCQ1|Q5HCQ1 2 9 
Dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex  
Q5HGY9|ODP2 0 9 
Methionyl-tRNA synthetase  Q5HII6|SYM 0 9 
Elongation factor G  Q5HIC8|EFG 2 5 
Arginase  P60086|ARGI 14 0 
33 kDa chaperonin  Q5HIG3|HSLO 7 1 
Amino acid ABC transporter, amino acid-binding protein  Q5HDE2|Q5HDE2 13 2 
Serine hydroxymethyltransferase  Q5HE87|GLYA 1 10 
Phosphate acyltransferase  Q5HGK4|PLSX 9 2 
Phosphoenolpyruvate carboxykinase [ATP]  Q5HEY8|PCKA 0 14 
50S ribosomal protein L17  Q5HDY5|RL17 3 2 
Antibacterial protein (Phenol soluble modulin)  Q5HGQ8|Q5HGQ8 2 7 
50S ribosomal protein L14  RL14 7 0 
Uncharacterized hydrolase  Q5HCW9|Y2597 8 6 
Putative uncharacterized protein  Q5HIY1 3 0 
50S ribosomal protein L22  Q5HDW3|RL22 5 3 
Phenol-soluble modulin alpha 1 peptide  P0C7Y4|PSMA1 3 7 
S-adenosylmethionine synthase  Q5HEY9|METK 9 0 
Pyruvate dehydrogenase E1 component subunit alpha  Q5HGZ1|ODPA 0 13 
Cell wall surface anchor family protein  Q5HD57|Q5HD57 10 5 
NAD-specific glutamate dehydrogenase  Q5HHC7|DHE2 3 8 
Superoxide dismutase [Mn/Fe] 1  Q5HFK7|SODM1 4 10 
Alanine dehydrogenase 2  Q5HF65|DHA2 1 9 
Alcohol dehydrogenase  Q5HI63|ADH 1 7 
50S ribosomal protein L25  Q5HIH4|RL25 1 3 
Glucose-specific phosphotransferase enzyme IIA component  Q5HFZ9|PTGA 6 8 
30S ribosomal protein S2  Q5HGH6|RS2 4 4 
Mannitol-1-phosphate 5-dehydrogenase  MTLD 0 2 
Probable thiol peroxidase  Q5HF61|TPX 3 8 
Putative septation protein spoVG  Q5HIH8|SP5G 1 6 
Uncharacterized protein  Q5HEP9|Y1933 6 3 
Glutamyl endopeptidase  Q5HH35|SSPA 0 8 
Succinate dehydrogenase, iron-sulfur protein  Q5HGT4|Q5HGT4 6 6 
Diaminopimelate decarboxylase  Q5HG20|Q5HG20 1 0 
Isoleucyl-tRNA synthetase  Q5HGN8|SYI 0 4 
Immunoglobulin G binding protein A  Q5HJQ8|Q5HJQ8 1 10 
Fumarate hydratase class II  Q5HES4|FUMC 4 1 
Adenylate kinase  Q5HDX9|KAD 3 6 
Naphthoate synthase  Q5HH38|MENB 4 2 
50S ribosomal protein L15  Q5HDX7|RL15 2 7 
30S ribosomal protein S8  Q5HDX2|RS8 3 4 
Glucosamine-6-phosphate isomerase, putative  Q5HES0|Q5HES0 1 2 
N-acetylglucosamine-6-phosphate deacetylase  Q5HHW9|Q5HHW
9 
5 2 
60 kDa chaperonin  Q5HEH2|CH60 0 7 
Polyribonucleotide nucleotidyltransferase  Q5HGF7|PNP 0 10 
Putative 2-hydroxyacid dehydrogenase  Q5HDQ4|Y2296 2 3 
2-oxoglutarate dehydrogenase E1 component  Q5HG06|ODO1 2 2 
Formate acetyltransferase  Q5HJF4|PFLB 3 2 
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Putative uncharacterized protein  Q5HEP7 1 0 
Putative uncharacterized protein  Q5HF32|Q5HF32 2 1 
Chitinase-related protein  Q5HH22|Q5HH22 3 1 
AcrB/AcrD/AcrF family protein  Q5HDU7|RANDO
M_Q5HDU7-R 
2 0 
Dihydroorotase  Q5HGN1|PYRC 7 4 
Putative uncharacterized protein  Q5HIA8|Q5HIA8 0 3 
Uncharacterized leukocidin-like protein 1  P21224|LUKL1 3 2 
50S ribosomal protein L6  Q5HDX3|RL6 2 5 
Bifunctional protein folD  Q5HH21|FOLD 2 5 
CTP synthase  Q5HE73|PYRG 0 4 
Glutathione peroxidase homolog BsaA  Q5HGC7|BSAA 0 7 
Alkyl hydroperoxide reductase subunit F  Q5HIR6|AHPF 3 4 
Universal stress protein family  Q5HF68|Q5HF68 3 3 
50S ribosomal protein L13  Q5HDZ0|RL13 7 1 
UPF0312 protein  Q5HCL0|Y2711 5 5 
Cell division protein ftsZ  Q5HGP5|FTSZ 7 1 
Pyruvate dehydrogenase E1 component subunit beta  Q5HGZ0|ODPB 0 7 
Threonyl-tRNA synthetase  Q5HF90|SYT 0 8 
Staphylococcus aureus sex pheromone  Q5HEL9|Q5HEL9 1 3 
Ribonuclease J 1  Q5HGZ5|RNJ1 1 6 
Valyl-tRNA synthetase  Q5HFA8|SYV 3 5 
Adenylosuccinate synthetase  Q5HJX8|PURA 1 4 
Immunodominant staphylococcal antigen B  ISAB 0 1 
Iron compound ABC transporter, iron compound-binding protein  Q5HDS3|Q5HDS3 3 3 
Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase  Q5HF37|Q5HF37 1 4 
Phosphopentomutase  Q5HJM9|DEOB 0 6 
Fibrinogen-binding protein  Q5HGS6|FIB 5 0 
Serine-protein kinase rsbW  Q5HED6|RSBW 2 7 
FtsK/SpoIIIE family protein  Q5HF33|Q5HF33 0 1 
Penicillin-binding protein 1  Q5HGQ0|Q5HGQ0 0 3 
Putative uncharacterized protein  Q5HFP6|Q5HFP6 2 3 
Rod shape-determining protein MreC  Q5HFB4|Q5HFB4 5 3 
Putative uncharacterized protein  Q5HG81|Q5HG81 2 3 
Probable acetyl-CoA acyltransferase  Q5HIU0|THLA 0 1 
Cysteine synthase  Q5HIG2|CYSK 2 5 
S-ribosylhomocysteine lyase  Q5HE66|LUXS 2 2 
Competence protein ComEC/Rec2, putative  Q5HFH3|Q5HFH3 1 0 
Phosphoribosylformylglycinamidine cyclo-ligase  Q5HH13|PUR5 0 5 
Putative uncharacterized protein  Q5HGE4|Q5HGE4 5 0 
10 kDa chaperonin  Q5HEH1|CH10 3 1 
Putative dipeptidase  Q5HF23|PEPVL 1 4 
Ornithine aminotransferase 2  Q5HHC8|OAT2 0 6 
Putative uncharacterized protein  Q5HET6 0 3 
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase 2  Q5HJC1|ISPD2 5 2 
Thioredoxin, putative  Q5HHK5|Q5HHK5 0 4 
UPF0133 protein  Y521 0 2 
Putative uncharacterized protein  Q5HDH4|Q5HDH4 0 5 
Elongation factor P  Q5HFN0|EFP 2 7 
Probable branched-chain-amino-acid aminotransferase  Q5HIC1|ILVE 5 2 
HIT family protein  Q5HET7|Q5HET7 1 1 
Aminopeptidase PepS  Q5HEP5|Q5HEP5 0 5 
Respiratory nitrate reductase, alpha subunit  Q5HDF9|Q5HDF9 1 0 
Adenylosuccinate lyase  Q5HEL4|PUR8 0 5 
Uracil phosphoribosyltransferase  Q5HE88|UPP 0 5 
Alcohol dehydrogenase, zinc-containing  Q5HE18|Q5HE18 2 2 
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Ribosomal large subunit pseudouridine synthase, RluD subfamily  Q5HES5|Q5HES5 0 1 
Cell division protein FtsY, putative  Q5HGJ7|Q5HGJ7 0 3 
30S ribosomal protein S1  Q5HFU7|RS1 0 4 
Putative uncharacterized protein  Q5HCV8|Q5HCV8 1 5 
Ribosome-recycling factor  Q5HGH2|RRF 3 2 
Phosphoglucomutase  Q5HD61|PGCA 4 1 
ATP-dependent Clp protease ATP-binding subunit clpL  Q5HD02|CLPL 0 1 
Putative acetyl-CoA C-acetyltransferase vraB  Q5HIA0|VRAB 1 0 
Thioredoxin, putative  Q5HHL0|Q5HHL0 0 6 
Protein essC  Q5HJ86|ESSC 0 1 
Uncharacterized protein  Q5HHB6|Y973 2 3 
30S ribosomal protein S9  Q5HDZ1|RS9 1 2 
Putative uncharacterized protein  Q5HFN8|RANDO
M_Q5HFN8-R 
0 1 
Xanthine permease  Q5HIQ8 0 1 
5' nucleotidase family protein  RANDOM_Q5HH6
1-R 
0 1 
Phage infection protein, putative  Q5HCQ4|Q5HCQ4 1 3 
50S ribosomal protein L24  Q5HDW9|RL24 2 4 
Putative uncharacterized protein  Q5HGA4|Q5HGA4 1 1 
Transcriptional regulator, putative  Q5HDP8|Q5HDP8 0 2 
1-phosphatidylinositol phosphodiesterase  Q5HJS4|Q5HJS4 0 4 
Iron-regulated surface determinant protein A  Q5HGV4|ISDA 0 1 
Flavohemoprotein, putative  Q5HJD8|Q5HJD8 0 5 
Coenzyme A disulfide reductase  Q5HHB4|CDR 1 1 
Putative uncharacterized protein  Q5HGZ2|Q5HGZ2 2 0 
Glutamyl aminopeptidase, putative  Q5HG53|Q5HG53 0 2 
5'-nucleotidase family protein  Q5HJX2|Q5HJX2 0 2 
50S ribosomal protein L23  Q5HDW0|RL23 1 1 
50S ribosomal protein L18  Q5HDX4|RL18 1 4 
Serine protease splB  Q5HEW1|SPLB 2 1 
Indole-3-pyruvate decarboxylase  Q5HJI5|Q5HJI5 4 1 
Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]  Q5HE49|GLMS 4 1 
50S ribosomal protein L35  Q5HF93|RL35 1 3 
Sensor protein srrB  Q5HFT1|SRRB 1 0 
Delta-aminolevulinic acid dehydratase  Q5HFA4|HEM2 0 5 
Iron compound ABC transporter, iron compound-binding protein  Q5HE28|Q5HE28 0 1 
Arginyl-tRNA synthetase  Q5HI60|SYR 0 4 
ATP-dependent Clp protease ATP-binding subunit clpC  P0C281|CLPC 0 2 
50S ribosomal protein L14  Q5HDW8|RL14 9 0 
Putative peptidyl-prolyl cis-trans isomerase  Q5HHD1|PPI1 0 4 
30S ribosomal protein S7  Q5HIC9|RS7 0 2 
Inosine-uridine preferring nucleoside hydrolase  Q5HJD4|RANDOM
_Q5HJD4-R 
1 0 
Formimidoylglutamase  Q5HDM3|HUTG 0 1 
3-methyl-2-oxobutanoate hydroxymethyltransferase  Q5HCV3|PANB 0 4 
50S ribosomal protein L19  Q5HGJ1|RANDOM
_RL19-R 
2 0 
Glucose-6-phosphate 1-dehydrogenase  Q5HFR7|Q5HFR7 0 4 
3-phosphoshikimate 1-carboxyvinyltransferase  Q5HFV9|AROA 1 0 
Uncharacterized protein  Q5HHR8|Y815 0 4 
2-oxoisovalerate dehydrogenase, E1 component, alpha subunit  Q5HFQ4|Q5HFQ4 2 0 
Uncharacterized N-acetyltransferase  Q5HGQ5|Y1189 0 4 
Probable manganese-dependent inorganic pyrophosphatase  Q5HEK1|PPAC 1 1 
Serine-aspartate repeat-containing protein D  Q5HIB3|SDRD 0 1 
Probable ctpA-like serine protease  Q5HG01|CTPAL 0 1 
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Pathogenicity island protein, integrase  Q5HHK1|Q5HHK1 0 1 
Aminoacyltransferase femA  FEMA 0 1 
Serine protease splC  Q5HEW2|SPLC 2 2 
D-lactate dehydrogenase  Q5HD29|LDHD 1 2 
ATP-dependent Clp protease proteolytic subunit  Q5HHQ0|CLPP 1 2 
Single-stranded-DNA-specific exonuclease RecJ  Q5HFC7|RANDO
M_Q5HFC7-R 
1 0 
Putative uncharacterized protein  Q5HE42|Q5HE42 0 2 
Ribose-phosphate pyrophosphokinase  Q5HIH5|KPRS 1 0 
ABC transporter, ATP-binding protein, putative  Q5HEQ3|RANDO
M_Q5HEQ3-R 
1 0 
Histidine ammonia-lyase  Q5HJY8|HUTH 0 2 
Probable DNA-directed RNA polymerase subunit delta  Q5HE72|RPOE 0 1 
Putative uncharacterized protein isdD  Q5HGV2|Q5HGV2 0 1 
DNA-dependent DNA polymerase family X  Q5HGU1|Q5HGU1 1 0 
Porphobilinogen deaminase  Q5HFA2|HEM3 0 2 
Signal transduction protein TRAP  Q5HEU0|TRAP 0 3 
Putative NAD(P)H nitroreductase  Q5HD30|Y2534 0 2 
Putative uncharacterized protein  Q5HF22|Q5HF22 0 3 
Pseudouridine synthase  Q5HFS9|Q5HFS9 0 3 
sp|Q5HEL0|Y1973_STAAC Q5HEL0|Y1973 1 0 
sp|Q5HE32|Y2163_STAAC Q5HE32|Y2163 0 2 
Oligoendopeptidase F  Q5HH84|Q5HH84 0 1 
Lipoprotein, putative  RANDOM_Q5HHT
0-R 
0 2 
DNA-directed RNA polymerase subunit omega  Q5HGM2|RPOZ 0 4 
Dihydrolipoyllysine-residue succinyltransferase component of 2-
oxoglutarate dehydrogenase complex  
Q5HG07|ODO2 0 3 
UPF0477 protein  Q5HH71|Y1020 0 1 
Putative uncharacterized protein  Q5HE56|Q5HE56 0 3 
Putative uncharacterized protein  Q5HIR8 0 1 
sp|Q5HHF6|NAGD_STAAC Q5HHF6|NAGD 1 2 
Malonyl CoA-acyl carrier protein transacylase  Q5HGK3|FABD 1 2 
Deoxyribose-phosphate aldolase 1  Q5HJN0|DEOC1 0 3 
Anthranilate synthase component I  Q5HG52|RANDO
M_Q5HG52-R 
0 1 
Oxidoreductase, short chain dehydrogenase/reductase family  Q5HDM9|Q5HDM
9 
0 2 
50S ribosomal protein L33 2  Q5HG85|RL332 0 1 
Metallo-beta-lactamase family protein  Q5HJT8|Q5HJT8 0 1 
Peptide chain release factor 1  Q5HE82|RF1 0 1 
Glutamyl aminopeptidase  Q5HF29|Q5HF29 0 1 
High-affinity nickel-transport protein  Q5HCK0|RANDO
M_Q5HCK0-R 
0 2 
Hypoxanthine-guanine phosphoribosyltransferase  Q5HIG5|HPRT 1 0 
Methionine import ATP-binding protein MetN 2  Q5HHK4|METN2 0 1 
D-alanine--poly(phosphoribitol) ligase subunit 1  Q5HHF2|DLTA 2 0 
Glycerol-3-phosphate acyltransferase  Q5HG66|RANDO
M_PLSY-R 
1 0 
Extracellular matrix protein-binding protein emp  Q5HHM6|EMP 0 4 
Pyruvate carboxylase  Q5HGX0|Q5HGX0 0 24 
Urease subunit alpha  Q5HDR8|URE1 0 3 
Uncharacterized lipoprotein  Q5HIN1|Y486 0 3 
Probable malate:quinone oxidoreductase 1  Q5HDJ0|MQO1 2 0 
Putative uncharacterized protein  Q5HF36|RANDOM
_Q5HF36-R 
1 0 
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5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase  Q5HFG2|MTNN 0 4 
Dps family protein  Q5HE61|Q5HE61 0 3 
NADP-dependent malic enzyme, putative  Q5HF72|Q5HF72 0 4 
tr|Q5HH17|Q5HH17_STAAC Q5HH17|Q5HH17 0 3 
Ribonucleoside-diphosphate reductase 2, beta subunit  Q5HHT9|Q5HHT9 0 3 
Putative formate dehydrogenase  Q5HDP9|FDHL 0 1 
Putative uncharacterized protein  Q5HFT3|RANDOM
_Q5HFT3-R 
0 1 
Putative uncharacterized protein  Q5HJ95|RANDOM
_Q5HJ95-R 
0 1 
Leukotoxin LukD  Q5HEV0|Q5HEV0 22 0 
tr|Q5HDI9|Q5HDI9_STAAC Q5HDI9|Q5HDI9 1 1 
3-hexulose-6-phosphate synthase  Q5HIA5|HPS 0 1 
Putative uncharacterized protein  Q5HF36|Q5HF36 0 1 
sp|Q5HIE5|SYC_STAAC Q5HIE5|SYC 0 2 
Organic hydroperoxide resistance protein-like  Q5HHL3|OHRL 1 0 
Transcription-repair-coupling factor  Q5HIH2|MFD 0 1 
GMP synthase [glutamine-hydrolyzing]  Q5HIQ6|GUAA 9 9 
Glycerol phosphate lipoteichoic acid synthase  Q5HHV4|RANDO
M_LTAS-R 
0 1 
Dihydrolipoyl dehydrogenase  Q5HFQ3|Q5HFQ3 0 2 
Peptidase, M20/M25/M40 family  Q5HFR1|Q5HFR1 0 3 
Putative uncharacterized protein  Q5HJT9|RANDOM
_Q5HJT9-R 
1 0 
Clumping factor B  Q5HCR7|CLFB 0 2 
Probable glycine dehydrogenase [decarboxylating] subunit 1  Q5HFM3|GCSPA 0 1 
Arsenate reductase, putative  Q5HHK9|Q5HHK9 0 2 
6,7-dimethyl-8-ribityllumazine synthase  Q5HF08|RISB 0 1 
Chaperone protein dnaJ  Q5HFI1|DNAJ 0 2 
Amidophosphoribosyltransferase  Q5HH14|PUR1 0 2 
Copper-exporting P-type ATPase A  Q5HCZ3|COPA 0 1 
UvrABC system protein A  Q5HHQ9|UVRA 1 0 
Mannitol-specific phosphotransferase enzyme IIA component  Q5HE46|PTMA 0 2 
Pyrroline-5-carboxylate reductase  Q5HFR9|P5CR 0 1 
Pyridoxal biosynthesis lyase pdxS  Q5HIF5|PDXS 0 2 
Thioredoxin  Q5HGT9|THIO 0 1 
NADH-dependent flavin oxidoreductase, Oye family  Q5HHC9|Q5HHC9 0 2 
sp|Q5HDW6|RL29_STAAC Q5HDW6|RL29 0 1 
Transcription-repair-coupling factor  Q5HIH2|RANDOM
_MFD-R 
0 1 
Mevalonate kinase  Q5HI86|RANDOM
_Q5HI86-R 
0 1 
Putative 8-amino-7-oxononanoate synthase/2-amino-3-ketobutyrate 
coenzyme A ligase  
Q5HIC5|BIKB 0 1 
Phosphate import ATP-binding protein pstB  P69881|RANDOM_
PSTB-R 
1 0 
Putative uncharacterized protein  Q5HGB8|RANDO
M_Q5HGB8-R 
0 1 
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Appendix 7.  Changes in secreted proteins of HA-MRSA USA200 compared to HA-
MRSA USA100 during post-exponential phase from 3 biological replicates 
 
Identified Proteins 
(109) 
Accession 
Number 
USA100 
#1 
USA100 
#2 
USA100 
#3 
USA200 
#1 
USA200 
#2 
USA200 
#3 
Lipase 1  P65289|LIP1 Ref -2.8 -2.6 1.6 -2.6 0.1 
Putative surface 
protein SA2285  P61598|PLS Ref 3.9 -0.4 -4 -0.5 -4.3 
Bifunctional 
autolysin  Q99V41|ATL Ref -0.5 -1.6 0.6 -0.3 -1 
Lipase 2  Q7A7P2|LIP2 Ref 0.6 0.8 1.3 1.8 3 
SA0841 protein  
Q7A6G0|Q7A
6G0 Ref -2.3 -1 2.5 -0.3 1.5 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 Ref -0.9 -3.5 3 1.2 -0.4 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTA
S Ref 1.2 -0.2 1 1.3 1.4 
Staphopain B  Q7A6A7|SSPB Ref -5 -2.5 2.3 -4.8 0.4 
Thermonuclease  Q7A6P2|NUC Ref 3.8 2.7 1.6 4.7 4.6 
Alpha-Hemolysin  
Q7A632|Q7A6
32 Ref -2.5 2.5 1.5 -2 3.5 
Probable 
transglycosylase isaA  P99160|ISAA Ref 2.7 -1 -0.6 2.2 -1 
SA2437 protein  
Q7A371|Q7A3
71 Ref 1.2 0.7 3 2 3.3 
SA0620 protein  
Q7A6Y9|Q7A
6Y9 Ref -2.8 -3.1 1.3 -1.1 -2.6 
Glutamyl 
endopeptidase  Q7A6A6|SSPA Ref -4.5 -3 3 -1.8 0.8 
Probable beta-
lactamase  
Q7A4X8|Q7A
4X8 Ref 
No 
Values -6.9 
Reference 
Missing 
Reference 
Missing -2.8 
Immunoglobulin G-
binding protein A  P99134|SPA Ref 5.9 4.9 -2.6 3 1.9 
Enterotoxin type C-3  
P0A0L4|ENTC
3 Ref 0.5 -0.8 0.1 0.3 -0.9 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7
J8 Ref 2.3 -2.1 0.9 2.2 -1.6 
SA2006 protein  
Q7A483|Q7A4
83 Ref -2.5 -1.3 1.4 -2 -0.4 
Staphopain A  P65826|SSPP Ref 1.9 1.9 -0.8 2.8 1.9 
Alkyl hydroperoxide 
reductase subunit C  P99074|AHPC Ref -2 -4.3 -0.5 -2.8 -4.9 
Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A7
35 Ref 9.8 4.3 0.6 10.9 5.4 
Elongation factor Tu  P99152|EFTU Ref 1.7 0.6 -0.5 2.1 2.3 
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Glycyl-glycine 
endopeptidase lytM  
Q7A7T0|LYT
M Ref 5.4 1.7 0.7 6.6 3.7 
Immunoglobulin-
binding protein sbi  Q99RL2|SBI Ref 2.4 -0.3 0.1 1.4 0.1 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 Ref 
No 
Values 3.2 
Reference 
Missing No Values 7.2 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUK
L1 Ref 4.6 1.4 0.5 4.6 2.6 
Enolase  P99088|ENO Ref 1.5 0.2 -0.6 1.6 -0.3 
Fructose-
bisphosphate aldolase  P99075|ALF2 Ref 4.2 1.6 -2.4 4 1 
Probable 
transglycosylase sceD  Q7A4F2|SCED Ref 3.9 -1.6 1.7 6.3 -1.3 
Serine-aspartate 
repeat-containing 
protein D  
Q7A780|SDR
D Ref -0.8 -3.1 -4.4 -5 -3.8 
SA0587 protein  
Q7A719|Q7A7
19 Ref 0 0 No Values -0.3 0.1 
SA0914 protein  
Q99V35|Q99V
35 Ref 5 3.6 0.1 4.8 4.5 
60 kDa chaperonin  P99083|CH60 Ref -4 -0.2 -0.5 -3.2 0.8 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1 Ref 
No 
Values 2.1 -0.6 No Values 2.6 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A3
78 Ref 0 0 No Values 1.6 2.4 
Virulence factor esxA  
Q7A7S4|ESX
A Ref 0 0 No Values -0.5 0.6 
Serine protease splB  Q7A4Y1|SPLB Ref 0.1 -1.3 No Values 0.1 -0.8 
Foldase protein prsA  P60748|PRSA Ref -1.3 -2.4 1.4 0.9 -0.6 
50S ribosomal protein 
L7/L12  P99154|RL7 Ref 
No 
Values 4 -0.7 No Values 2.8 
Iron-regulated surface 
determinant protein A  Q7A655|ISDA Ref 0.8 -0.3 0.9 1.1 0 
DNA-binding protein 
HU  Q7A5J1|DBH Ref 8.2 3.5 -1.4 9.6 5.3 
Staphylokinase  Q99SU7|SAK Ref 1.2 -0.4 -2.3 2.7 -0.5 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  
Q820A6|ODP
A Ref 0 0 No Values -2.6 -0.4 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A
6V1 Ref -3.1 2.7 -0.6 -2.8 3.3 
Chaperone protein 
dnaK  P99110|DNAK Ref 
No 
Values 0.3 2.4 No Values -0.2 
Adenylate kinase  P99062|KAD Ref 6.5 1.2 -1.1 5.6 1 
Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A
6A3 Ref -0.3 -1.2 0.8 -1.7 -1 
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50S ribosomal protein 
L30  P0A0G0|RL30 Ref 0 0 No Values 1.2 -1.1 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUK
L2 Ref -3.8 1.8 1.3 -4.1 2.7 
Dihydrolipoyl 
dehydrogenase  P99084|DLDH Ref 
No 
Values 3.8 -0.3 No Values 5.2 
Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSM
A1 Ref 1.3 2.2 0.2 3.2 3.3 
Serine protease splF  Q7A4Y4|SPLF Ref 0 
No 
Values No Values 1 No Values 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  P99063|ODPB Ref 7.3 8.3 -2.5 7.8 10.6 
50S ribosomal protein 
L17  Q7A469|RL17 Ref 2.7 0.2 -1.2 3.3 2.2 
Glutamine synthetase  P99095|GLNA Ref 
No 
Values 0.4 -0.7 No Values 0.5 
N-acetylmuramoyl-L-
alanine amidase sle1  Q7A7E0|SLE1 Ref 
No 
Values 4.5 0.5 No Values 4.6 
Alkaline shock 
protein 23  P99157|ASP23 Ref 1.7 0.4 -0.5 1.3 0.3 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  P65636|ODP2 Ref -1.8 -2.5 1.6 -1.7 
Value 
Missing 
SA2097 protein  
Q7A418|Q7A4
18 Ref 0 0 No Values 1.4 0.9 
Ribosome-recycling 
factor  P99130|RRF Ref 
No 
Values 0.7 -0.4 No Values -0.3 
Elongation factor G  P68789|EFG Ref 
No 
Values 0.7 -0.6 No Values 0.8 
Serine protease splC  Q7A4Y2|SPLC Ref 0 
No 
Values No Values 0.2 No Values 
50S ribosomal protein 
L11  P0A0F2|RL11 Ref 2.6 0.5 -2 2.9 -0.4 
Thioredoxin  P99122|THIO Ref 
No 
Values 
No 
Values -1.7 No Values No Values 
Trigger factor  P99080|TIG Ref 
No 
Values 2.4 -0.6 No Values 1 
30S ribosomal protein 
S9  P66646|RS9 Ref 
No 
Values -1 -2.2 No Values 0.2 
50S ribosomal protein 
L13  Q7A473|RL13 Ref 
No 
Values 1.8 -0.4 No Values 1 
Phosphate 
acetyltransferase  P99092|PTA Ref 3.4 1.4 -1.7 2.8 1.2 
Acyl carrier protein  P0A002|ACP Ref 
No 
Values 2.7 -1.9 No Values 1.5 
Serine-aspartate 
repeat-containing 
protein E  
Q99W46|SDR
E Ref 
No 
Values 2 -0.5 No Values 2.9 
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Beta-lactamase  
Q9AC80|Q9A
C80 Ref 1.1 1.2 0 1.6 1.2 
Cell division protein  
Q7A620|Q7A6
20 Ref 
No 
Values 2.3 -1.7 No Values 0.8 
Fructose-
bisphosphate aldolase 
class 1  P99117|ALF1 Ref 
No 
Values 0 No Values No Values 0.3 
50S ribosomal protein 
L14  Q7A463|RL14 Ref 
No 
Values 0.1 2.9 No Values 0 
Phenol-soluble 
modulin alpha 4 
peptide  
P0C824|PSMA
4 Ref 0 0 No Values 0.9 0.7 
Staphylococcal 
secretory antigen 
ssaA2  
Q7A423|SSAA
2 Ref 
No 
Values 2.4 0.8 No Values 2.7 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A
6H7 Ref 0 0 No Values -1 1.7 
SA2202 protein  
Q99RL6|Q99R
L6 Ref 0 0 No Values 0.2 -1 
50S ribosomal protein 
L22  Q7A460|RL22 Ref 3.6 
No 
Values -1 2.7 No Values 
Elastin-binding 
protein ebpS  Q7A5I6|EBPS Ref 0 0 No Values 0.6 0.4 
Triosephosphate 
isomerase  P99133|TPIS Ref 
No 
Values 0.3 -0.6 No Values 2.5 
P99156|GREA_STA
AN P99156|GREA Ref 
No 
Values 3.4 -1.3 No Values 4.9 
Cysteine synthase  P63871|CYSK Ref 
No 
Values -0.1 2.7 No Values 
Reference 
Missing 
Elongation factor Ts  P99171|EFTS Ref 
No 
Values 
No 
Values -1.2 
Reference 
Missing No Values 
30S ribosomal protein 
S6  P99142|RS6 Ref 
No 
Values 
No 
Values -2 No Values No Values 
Leukotoxin, LukD  
Q99T54|Q99T
54 Ref 0 
No 
Values No Values -0.5 No Values 
Inosine-5'-
monophosphate 
dehydrogenase  P99106|IMDH Ref 1.8 -1.2 -1.1 1.5 -0.9 
Protein grpE  P99086|GRPE Ref 
No 
Values 0.3 -1 No Values 0.3 
50S ribosomal protein 
L24  P60735|RL24 Ref 
No 
Values 0 No Values No Values -1.1 
L-lactate 
dehydrogenase 1  P65256|LDH1 Ref 1.4 
No 
Values -3 1.1 No Values 
Superoxide dismutase 
[Mn/Fe] 1  
P99098|SODM
1 Ref 
No 
Values 
No 
Values 2.2 No Values No Values 
Transketolase  P99161|TKT Ref 
No 
Values 0 No Values No Values -0.4 
30S ribosomal protein 
S16  P66440|RS16 Ref 1.8 
No 
Values -0.4 2.5 No Values 
10 kDa chaperonin  P99104|CH10 Ref 
No 
Values 2.9 -1.9 No Values 5.5 
SA0295 protein  
Q7A7Q2|Q7A
7Q2 Ref 
No 
Values 
No 
Values 0.4 No Values No Values 
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Glucose-6-phosphate 
isomerase  P99078|G6PI Ref 
No 
Values 
No 
Values -0.4 No Values No Values 
Protein esaA  
Q7A7S3|ESA
A Ref 0.1 
No 
Values 0.4 0.3 No Values 
Methicillin resistance 
mecR1 protein  
P0A0B0|RAN
DOM_MECR-
R Ref 
No 
Values 0 1.2 No Values 1.5 
Uncharacterized 
protein SA1692  
P0A0K1|Y169
2 Ref 
No 
Values 0 No Values No Values 1.2 
Chaperone protein 
hchA  P64313|HCHA Ref 
No 
Values 
No 
Values 0.5 No Values No Values 
Clumping factor A  Q99VJ4|CLFA Ref 
No 
Values 0 No Values No Values 1.2 
50S ribosomal protein 
L10  P99155|RL10 Ref 
No 
Values 2.7 0.7 No Values 3 
50S ribosomal protein 
L18  Q7A467|RL18 Ref 
No 
Values 
No 
Values -2.5 No Values No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  Q7A6I1|PPI1 Ref 
No 
Values 
No 
Values -1.2 No Values No Values 
Fibrinogen-binding 
protein  P68800|FIB Ref 
No 
Values 
No 
Values -0.1 No Values No Values 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A8
88 Ref 0 
No 
Values No Values 1 No Values 
Virulence factor esxA  ESXA Ref 
No 
Values 
No 
Values No Values No Values No Values 
50S ribosomal protein 
L15  P0A0F6|RL15 Ref 
No 
Values 
No 
Values 0.6 No Values No Values 
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Appendix 8.  Changes in secreted proteins of CA-MRSA USA300 compared to HA-
MRSA USA100 during post-exponential phase 3 biological replicates 
 
Identified Proteins 
(109) 
Accession 
Number 
USA100 
#1 
USA100 
#2 
USA100 
#3 
USA300 
#1 
USA300 
#2 
USA300 
#3 
Lipase 1  P65289|LIP1 Ref -2.8 -2.6 2.8 -1.4 -1.3 
Putative surface 
protein SA2285  
P61598|PLS Ref 3.9 -0.4 -3.7 -2.3 -4.6 
Bifunctional 
autolysin  
Q99V41|ATL Ref -0.5 -1.6 0.2 -2.1 -2.8 
Lipase 2  Q7A7P2|LIP2 Ref 0.6 0.8 2 2.2 1.5 
SA0841 protein  Q7A6G0|Q7A6
G0 
Ref -2.3 -1 1.6 -1.4 -0.7 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 
Ref -0.9 -3.5 0.8 -1.5 -3.3 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS Ref 1.2 -0.2 0.2 0.3 -2 
Staphopain B  Q7A6A7|SSPB Ref -5 -2.5 1.2 -3.4 -2.3 
Thermonuclease  Q7A6P2|NUC Ref 3.8 2.7 1.8 4.3 2.5 
Alpha-Hemolysin  Q7A632|Q7A6
32 
Ref -2.5 2.5 2.8 -0.8 3.2 
Probable 
transglycosylase 
isaA  
P99160|ISAA Ref 2.7 -1 -1.6 -2.1 -4.6 
SA2437 protein  Q7A371|Q7A3
71 
Ref 1.2 0.7 1.7 -0.5 1 
SA0620 protein  Q7A6Y9|Q7A6
Y9 
Ref -2.8 -3.1 0.4 -4.4 -2.8 
Glutamyl 
endopeptidase  
Q7A6A6|SSPA Ref -4.5 -3 0.9 -2.9 -2 
Probable beta-
lactamase  
Q7A4X8|Q7A4
X8 
Ref No 
Values 
-6.9 Reference 
Missing 
Reference 
Missing 
-6.6 
Immunoglobulin G-
binding protein A  
P99134|SPA Ref 5.9 4.9 -2.7 1 2.3 
Enterotoxin type C-3  P0A0L4|ENTC
3 
Ref 0.5 -0.8 0.1 -2.5 -1.4 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7J
8 
Ref 2.3 -2.1 0 3.4 -3.2 
SA2006 protein  Q7A483|Q7A4
83 
Ref -2.5 -1.3 2.8 -1.4 -1.1 
Staphopain A  P65826|SSPP Ref 1.9 1.9 0.8 3.1 0.7 
Alkyl hydroperoxide 
reductase subunit C  
P99074|AHPC Ref -2 -4.3 -1.5 -5.3 -6.5 
Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A7
35 
Ref 9.8 4.3 1.2 10.4 3 
Elongation factor Tu  P99152|EFTU Ref 1.7 0.6 0.2 0.2 -0.6 
Glycyl-glycine 
endopeptidase lytM  
Q7A7T0|LYT
M 
Ref 5.4 1.7 -1.2 4.4 0.7 
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Immunoglobulin-
binding protein sbi  
Q99RL2|SBI Ref 2.4 -0.3 0.3 2.3 -1.1 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 
Ref No 
Values 
3.2 Reference 
Missing 
No Values 3.3 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUKL
1 
Ref 4.6 1.4 2.3 3.3 2.4 
Enolase  P99088|ENO Ref 1.5 0.2 -0.6 -0.7 -1.2 
Fructose-
bisphosphate 
aldolase  
P99075|ALF2 Ref 4.2 1.6 -2.5 5.8 -0.1 
Probable 
transglycosylase 
sceD  
Q7A4F2|SCED Ref 3.9 -1.6 0.4 3.4 -3.2 
Serine-aspartate 
repeat-containing 
protein D  
Q7A780|SDRD Ref -0.8 -3.1 -3.7 -4.8 -6.5 
SA0587 protein  Q7A719|Q7A7
19 
Ref 0 0 No Values -1.7 -2 
SA0914 protein  Q99V35|Q99V
35 
Ref 5 3.6 -0.2 5.4 2.6 
60 kDa chaperonin  P99083|CH60 Ref -4 -0.2 -0.2 -5 -1.1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  
P99136|G3P1 Ref No 
Values 
2.1 -1.5 Reference 
Missing 
1.8 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A3
78 
Ref 0 0 No Values 1.6 1 
Virulence factor 
esxA  
Q7A7S4|ESXA Ref 0 0 No Values -0.1 -0.1 
Serine protease splB  Q7A4Y1|SPLB Ref 0.1 -1.3 Reference 
Missing 
1.6 -0.3 
Foldase protein prsA  P60748|PRSA Ref -1.3 -2.4 -0.2 -4.2 -3.3 
50S ribosomal 
protein L7/L12  
P99154|RL7 Ref No 
Values 
4 -1.9 No Values 1.4 
Iron-regulated 
surface determinant 
protein A  
Q7A655|ISDA Ref 0.8 -0.3 -0.3 -0.9 -1.2 
DNA-binding 
protein HU  
Q7A5J1|DBH Ref 8.2 3.5 -2.2 7.1 1.1 
Staphylokinase  Q99SU7|SAK Ref 1.2 -0.4 1.2 2.9 -1.2 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  
Q820A6|ODPA Ref 0 0 No Values -2.4 -3 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A6
V1 
Ref -3.1 2.7 1 -1.4 2.2 
Chaperone protein 
dnaK  
P99110|DNAK Ref No 
Values 
0.3 2.7 Reference 
Missing 
-1.9 
Adenylate kinase  P99062|KAD Ref 6.5 1.2 -2.2 4.6 -1.3 
Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A6
A3 
Ref -0.3 -1.2 1.7 -2.5 -2.3 
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50S ribosomal 
protein L30  
P0A0G0|RL30 Ref 0 0 No Values -3.7 -2.2 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUKL
2 
Ref -3.8 1.8 1.4 -2.2 -0.2 
Dihydrolipoyl 
dehydrogenase  
P99084|DLDH Ref No 
Values 
3.8 -2.4 Reference 
Missing 
3.9 
Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSMA
1 
Ref 1.3 2.2 2.8 2.9 4.7 
Serine protease splF  Q7A4Y4|SPLF Ref 0 No 
Values 
No Values 1.3 No Values 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  
P99063|ODPB Ref 7.3 8.3 -1.9 7 9.4 
50S ribosomal 
protein L17  
Q7A469|RL17 Ref 2.7 0.2 -1 2.9 -1.4 
Glutamine 
synthetase  
P99095|GLNA Ref No 
Values 
0.4 -1.5 Reference 
Missing 
-2.5 
N-acetylmuramoyl-
L-alanine amidase 
sle1  
Q7A7E0|SLE1 Ref No 
Values 
4.5 0.8 Reference 
Missing 
Value 
Missing 
Alkaline shock 
protein 23  
P99157|ASP23 Ref 1.7 0.4 -0.9 2.8 Value 
Missing 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  
P65636|ODP2 Ref -1.8 -2.5 2.8 -4.3 -2.3 
SA2097 protein  Q7A418|Q7A4
18 
Ref 0 0 No Values -0.5 -0.8 
Ribosome-recycling 
factor  
P99130|RRF Ref No 
Values 
0.7 -1.2 No Values -2 
Elongation factor G  P68789|EFG Ref No 
Values 
0.7 1 No Values -1.6 
Serine protease splC  Q7A4Y2|SPLC Ref 0 No 
Values 
No Values 1.6 No Values 
50S ribosomal 
protein L11  
P0A0F2|RL11 Ref 2.6 0.5 -2 -1.1 -2.9 
Thioredoxin  P99122|THIO Ref No 
Values 
No 
Values 
0.2 No Values No Values 
Trigger factor  P99080|TIG Ref No 
Values 
2.4 -1.5 No Values -1.9 
30S ribosomal 
protein S9  
P66646|RS9 Ref No 
Values 
-1 -1.6 No Values -2 
50S ribosomal 
protein L13  
Q7A473|RL13 Ref No 
Values 
1.8 -0.4 No Values -0.3 
Phosphate 
acetyltransferase  
P99092|PTA Ref 3.4 1.4 -2.9 3.2 0.2 
Acyl carrier protein  P0A002|ACP Ref No 
Values 
2.7 -2.3 No Values 0.2 
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Serine-aspartate 
repeat-containing 
protein E  
Q99W46|SDRE Ref No 
Values 
2 -1.7 No Values 1.4 
Beta-lactamase  Q9AC80|Q9AC
80 
Ref 1.1 1.2 -0.3 1.4 1.3 
Cell division protein  Q7A620|Q7A6
20 
Ref No 
Values 
2.3 -1.3 No Values -0.5 
Fructose-
bisphosphate 
aldolase class 1  
P99117|ALF1 Ref No 
Values 
0 No Values No Values -0.6 
50S ribosomal 
protein L14  
Q7A463|RL14 Ref No 
Values 
0.1 1.1 No Values -0.3 
Phenol-soluble 
modulin alpha 4 
peptide  
P0C824|PSMA
4 
Ref 0 0 No Values 1.3 2.2 
Staphylococcal 
secretory antigen 
ssaA2  
Q7A423|SSAA
2 
Ref No 
Values 
2.4 0.3 No Values 1 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A6
H7 
Ref 0 0 No Values 0.7 -0.5 
SA2202 protein  Q99RL6|Q99R
L6 
Ref 0 0 No Values -1.6 -1.4 
50S ribosomal 
protein L22  
Q7A460|RL22 Ref 3.6 No 
Values 
-1.7 2.6 No Values 
Elastin-binding 
protein ebpS  
Q7A5I6|EBPS Ref 0 0 No Values -2 -1.2 
Triosephosphate 
isomerase  
P99133|TPIS Ref No 
Values 
0.3 2.8 No Values 0.3 
P99156|GREA_STA
AN 
P99156|GREA Ref No 
Values 
3.4 -2.4 No Values 3.2 
Cysteine synthase  P63871|CYSK Ref No 
Values 
-0.1 2.8 No Values 3.2 
Elongation factor Ts  P99171|EFTS Ref No 
Values 
No 
Values 
-2.9 Reference 
Missing 
No Values 
30S ribosomal 
protein S6  
P99142|RS6 Ref No 
Values 
No 
Values 
-0.3 No Values No Values 
Leukotoxin, LukD  Q99T54|Q99T5
4 
Ref 0 No 
Values 
No Values 1.7 No Values 
Inosine-5'-
monophosphate 
dehydrogenase  
P99106|IMDH Ref 1.8 -1.2 -1.4 -0.2 -3.3 
Protein grpE  P99086|GRPE Ref No 
Values 
0.3 -2 No Values -1 
50S ribosomal 
protein L24  
P60735|RL24 Ref No 
Values 
0 No Values No Values -1.6 
L-lactate 
dehydrogenase 1  
P65256|LDH1 Ref 1.4 No 
Values 
-1.2 0.6 No Values 
Superoxide 
dismutase [Mn/Fe] 1  
P99098|SODM
1 
Ref No 
Values 
No 
Values 
0.9 No Values No Values 
Transketolase  P99161|TKT Ref No 
Values 
0 No Values No Values -2.7 
30S ribosomal 
protein S16  
P66440|RS16 Ref 1.8 No 
Values 
-1.3 0.2 No Values 
10 kDa chaperonin  P99104|CH10 Ref No 
Values 
2.9 0.5 No Values 3 
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SA0295 protein  Q7A7Q2|Q7A7
Q2 
Ref No 
Values 
No 
Values 
0.1 No Values No Values 
Glucose-6-phosphate 
isomerase  
P99078|G6PI Ref No 
Values 
No 
Values 
-1.5 No Values No Values 
Protein esaA  Q7A7S3|ESAA Ref 0.1 No 
Values 
0.2 -1.6 No Values 
Methicillin 
resistance mecR1 
protein  
P0A0B0|RAND
OM_MECR-R 
Ref No 
Values 
0 2.3 No Values 0.4 
Uncharacterized 
protein SA1692  
P0A0K1|Y1692 Ref No 
Values 
0 No Values No Values 0 
Chaperone protein 
hchA  
P64313|HCHA Ref No 
Values 
No 
Values 
-0.1 No Values No Values 
Clumping factor A  Q99VJ4|CLFA Ref No 
Values 
0 No Values No Values -0.4 
50S ribosomal 
protein L10  
P99155|RL10 Ref No 
Values 
2.7 -0.7 No Values 1.8 
50S ribosomal 
protein L18  
Q7A467|RL18 Ref No 
Values 
No 
Values 
-2.2 No Values No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  
Q7A6I1|PPI1 Ref No 
Values 
No 
Values 
-1.8 No Values No Values 
Fibrinogen-binding 
protein  
P68800|FIB Ref No 
Values 
No 
Values 
0.4 No Values No Values 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A8
88 
Ref 0 No 
Values 
No Values -1.7 No Values 
Virulence factor 
esxA  
ESXA Ref No 
Values 
No 
Values 
No Values No Values No Values 
50S ribosomal 
protein L15  
P0A0F6|RL15 Ref No 
Values 
No 
Values 
-0.9 No Values No Values 
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Appendix 9.  Changes in secreted proteins of CA-MRSA USA400 compared to HA-
MRSA USA100 during post-exponential phase from 3 biological replicates 
 
Identified Proteins 
(109) 
Accession 
Number 
USA100
#1 
USA100
#2 
USA100
#3 
USA400 
#1 
USA400 
#2 
USA400 
#3 
Lipase 1  P65289|LIP1 Ref -2.8 -2.6 -0.2 0.1 0.5 
Putative surface 
protein SA2285  P61598|PLS Ref 3.9 -0.4 -2.9 -1.1 -3.9 
Bifunctional 
autolysin  Q99V41|ATL Ref -0.5 -1.6 0.8 -1 -1.2 
Lipase 2  Q7A7P2|LIP2 Ref 0.6 0.8 2 1.4 2.7 
SA0841 protein  
Q7A6G0|Q7A6
G0 Ref -2.3 -1 1.2 0 1.2 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 Ref -0.9 -3.5 0.5 0.3 -2.9 
Glycerol phosphate 
lipoteichoic acid 
synthase  Q7A6U1|LTAS Ref 1.2 -0.2 0.3 2.5 0.4 
Staphopain B  Q7A6A7|SSPB Ref -5 -2.5 1.6 -4.8 -0.6 
Thermonuclease  Q7A6P2|NUC Ref 3.8 2.7 0.8 4.2 3.5 
Alpha-Hemolysin  
Q7A632|Q7A63
2 Ref -2.5 2.5 0.8 -2.9 3.2 
Probable 
transglycosylase 
isaA  P99160|ISAA Ref 2.7 -1 -0.8 2.8 -1.3 
SA2437 protein  
Q7A371|Q7A37
1 Ref 1.2 0.7 1.7 2.9 2.8 
SA0620 protein  
Q7A6Y9|Q7A6
Y9 Ref -2.8 -3.1 0.8 -2.6 -1.9 
Glutamyl 
endopeptidase  Q7A6A6|SSPA Ref -4.5 -3 1.7 -3.2 0.1 
Probable beta-
lactamase  
Q7A4X8|Q7A4
X8 Ref 
No 
Values -6.9 
Reference 
Missing 
Reference 
Missing -6 
Immunoglobulin G-
binding protein A  P99134|SPA Ref 5.9 4.9 -3.2 1.3 4.6 
Enterotoxin type C-3  
P0A0L4|ENTC
3 Ref 0.5 -0.8 1.1 3.1 1.2 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7J
8 Ref 2.3 -2.1 1 3.9 -0.7 
SA2006 protein  
Q7A483|Q7A48
3 Ref -2.5 -1.3 1.1 -2 0.7 
Staphopain A  P65826|SSPP Ref 1.9 1.9 1.4 3.9 4.1 
Alkyl hydroperoxide 
reductase subunit C  P99074|AHPC Ref -2 -4.3 -0.6 -4 -4.5 
Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A73
5 Ref 9.8 4.3 2.7 12 5.5 
Elongation factor Tu  P99152|EFTU Ref 1.7 0.6 1.4 1.7 1.7 
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Glycyl-glycine 
endopeptidase lytM  Q7A7T0|LYTM Ref 5.4 1.7 0.2 4.9 2.2 
Immunoglobulin-
binding protein sbi  Q99RL2|SBI Ref 2.4 -0.3 0.7 3.5 0.6 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 Ref 
No 
Values 3.2 
Reference 
Missing No Values 3.5 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUKL
1 Ref 4.6 1.4 2.3 1 2.8 
Enolase  P99088|ENO Ref 1.5 0.2 0.3 -0.3 -0.1 
Fructose-
bisphosphate 
aldolase  P99075|ALF2 Ref 4.2 1.6 -1.1 1.2 1 
Probable 
transglycosylase 
sceD  Q7A4F2|SCED Ref 3.9 -1.6 0.1 2.2 -1.7 
Serine-aspartate 
repeat-containing 
protein D  Q7A780|SDRD Ref -0.8 -3.1 -2.4 -3.5 -5.5 
SA0587 protein  
Q7A719|Q7A71
9 Ref 0 0 No Values -0.1 0.2 
SA0914 protein  
Q99V35|Q99V3
5 Ref 5 3.6 0.2 6 4.1 
60 kDa chaperonin  P99083|CH60 Ref -4 -0.2 0.8 -3.7 1 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1 Ref 
No 
Values 2.1 -0.4 No Values 1.9 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A37
8 Ref 0 0 No Values 1.6 1 
Virulence factor 
esxA  Q7A7S4|ESXA Ref 0 0 No Values 0.4 -0.1 
Serine protease splB  Q7A4Y1|SPLB Ref 0.1 -1.3 
Reference 
Missing 0.3 0.7 
Foldase protein prsA  P60748|PRSA Ref -1.3 -2.4 -0.4 -1.9 -1.8 
50S ribosomal 
protein L7/L12  P99154|RL7 Ref 
No 
Values 4 -0.6 No Values 3.7 
Iron-regulated 
surface determinant 
protein A  Q7A655|ISDA Ref 0.8 -0.3 0.4 0.4 0.1 
DNA-binding 
protein HU  Q7A5J1|DBH Ref 8.2 3.5 -0.5 9.4 2.6 
Staphylokinase  Q99SU7|SAK Ref 1.2 -0.4 0.1 2.9 0.4 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  Q820A6|ODPA Ref 0 0 No Values -2.2 -0.1 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A6
V1 Ref -3.1 2.7 -0.2 -3 3.5 
Chaperone protein 
dnaK  P99110|DNAK Ref 
No 
Values 0.3 1.3 
Reference 
Missing 0.5 
Adenylate kinase  P99062|KAD Ref 6.5 1.2 0.2 5.1 0.8 
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Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A6
A3 Ref -0.3 -1.2 1.1 -0.7 -1.2 
50S ribosomal 
protein L30  P0A0G0|RL30 Ref 0 0 No Values -2.2 -0.5 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUKL
2 Ref -3.8 1.8 1.7 -2.3 1.9 
Dihydrolipoyl 
dehydrogenase  P99084|DLDH Ref 
No 
Values 3.8 -0.7 No Values 4 
Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSMA
1 Ref 1.3 2.2 0.8 2.3 3.7 
Serine protease splF  Q7A4Y4|SPLF Ref 0 
No 
Values No Values 0 No Values 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  P99063|ODPB Ref 7.3 8.3 0.1 7.4 12 
50S ribosomal 
protein L17  Q7A469|RL17 Ref 2.7 0.2 -0.1 2.9 1.6 
Glutamine 
synthetase  P99095|GLNA Ref 
No 
Values 0.4 -1.1 No Values 0.5 
N-acetylmuramoyl-
L-alanine amidase 
sle1  Q7A7E0|SLE1 Ref 
No 
Values 4.5 0.3 No Values 5.9 
Alkaline shock 
protein 23  P99157|ASP23 Ref 1.7 0.4 0.3 2.1 2.6 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  P65636|ODP2 Ref -1.8 -2.5 
Value 
Missing -1.6 -1.7 
SA2097 protein  
Q7A418|Q7A41
8 Ref 0 0 No Values 0.1 0.1 
Ribosome-recycling 
factor  P99130|RRF Ref 
No 
Values 0.7 -0.7 No Values -0.4 
Elongation factor G  P68789|EFG Ref 
No 
Values 0.7 0.4 No Values 1.7 
Serine protease splC  Q7A4Y2|SPLC Ref 0 
No 
Values No Values 1 No Values 
50S ribosomal 
protein L11  P0A0F2|RL11 Ref 2.6 0.5 -1 -0.3 -0.1 
Thioredoxin  P99122|THIO Ref 
No 
Values 
No 
Values -0.3 No Values No Values 
Trigger factor  P99080|TIG Ref 
No 
Values 2.4 -1.2 No Values 1.4 
30S ribosomal 
protein S9  P66646|RS9 Ref 
No 
Values -1 0.5 No Values -0.5 
50S ribosomal 
protein L13  Q7A473|RL13 Ref 
No 
Values 1.8 0.9 No Values 2.7 
Phosphate 
acetyltransferase  P99092|PTA Ref 3.4 1.4 -1 1.8 1 
Acyl carrier protein  P0A002|ACP Ref 
No 
Values 2.7 -1.3 No Values 1.5 
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Serine-aspartate 
repeat-containing 
protein E  Q99W46|SDRE Ref 
No 
Values 2 -0.9 No Values 2.6 
Beta-lactamase  
Q9AC80|Q9AC
80 Ref 1.1 1.2 1.2 1 1.7 
Cell division protein  
Q7A620|Q7A62
0 Ref 
No 
Values 2.3 -1.3 No Values 2.7 
Fructose-
bisphosphate 
aldolase class 1  P99117|ALF1 Ref 
No 
Values 0 No Values No Values 0.4 
50S ribosomal 
protein L14  Q7A463|RL14 Ref 
No 
Values 0.1 1.1 No Values 0.6 
Phenol-soluble 
modulin alpha 4 
peptide  
P0C824|PSMA
4 Ref 0 0 No Values 3.2 3 
Staphylococcal 
secretory antigen 
ssaA2  
Q7A423|SSAA
2 Ref 
No 
Values 2.4 0.7 No Values 2.3 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A6
H7 Ref 0 0 No Values 2.3 -0.3 
SA2202 protein  
Q99RL6|Q99R
L6 Ref 0 0 No Values -0.1 0 
50S ribosomal 
protein L22  Q7A460|RL22 Ref 3.6 
No 
Values 0.4 2.5 No Values 
Elastin-binding 
protein ebpS  Q7A5I6|EBPS Ref 0 0 No Values -0.5 -0.6 
Triosephosphate 
isomerase  P99133|TPIS Ref 
No 
Values 0.3 1.1 No Values 0.5 
P99156|GREA_STA
AN P99156|GREA Ref 
No 
Values 3.4 -0.3 No Values 3.9 
Cysteine synthase  P63871|CYSK Ref 
No 
Values -0.1 0.1 No Values 3.1 
Elongation factor Ts  P99171|EFTS Ref 
No 
Values 
No 
Values -1.5 
Reference 
Missing No Values 
30S ribosomal 
protein S6  P99142|RS6 Ref 
No 
Values 
No 
Values -0.9 No Values No Values 
Leukotoxin, LukD  
Q99T54|Q99T5
4 Ref 0 
No 
Values No Values -0.5 No Values 
Inosine-5'-
monophosphate 
dehydrogenase  P99106|IMDH Ref 1.8 -1.2 -1.4 0.6 -1.2 
Protein grpE  P99086|GRPE Ref 
No 
Values 0.3 -1.4 No Values 0.2 
50S ribosomal 
protein L24  P60735|RL24 Ref 
No 
Values 0 No Values No Values -0.3 
L-lactate 
dehydrogenase 1  P65256|LDH1 Ref 1.4 
No 
Values -0.4 0.9 No Values 
Superoxide 
dismutase [Mn/Fe] 1  
P99098|SODM
1 Ref 
No 
Values 
No 
Values 1.3 No Values No Values 
Transketolase  P99161|TKT Ref 
No 
Values 0 No Values No Values -0.8 
30S ribosomal 
protein S16  P66440|RS16 Ref 1.8 
No 
Values -0.1 1.9 No Values 
10 kDa chaperonin  P99104|CH10 Ref 
No 
Values 2.9 -1.5 No Values 3.1 
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SA0295 protein  
Q7A7Q2|Q7A7
Q2 Ref 
No 
Values 
No 
Values 2.2 No Values No Values 
Glucose-6-phosphate 
isomerase  P99078|G6PI Ref 
No 
Values 
No 
Values -0.6 No Values No Values 
Protein esaA  Q7A7S3|ESAA Ref 0.1 
No 
Values 0.1 
Value 
Missing No Values 
Methicillin 
resistance mecR1 
protein  
P0A0B0|RAND
OM_MECR-R Ref 
No 
Values 0 0.8 No Values 1.4 
Uncharacterized 
protein SA1692  P0A0K1|Y1692 Ref 
No 
Values 0 No Values No Values 3.1 
Chaperone protein 
hchA  P64313|HCHA Ref 
No 
Values 
No 
Values 1 No Values No Values 
Clumping factor A  Q99VJ4|CLFA Ref 
No 
Values 0 No Values No Values -0.2 
50S ribosomal 
protein L10  P99155|RL10 Ref 
No 
Values 2.7 0.4 No Values 3.4 
50S ribosomal 
protein L18  Q7A467|RL18 Ref 
No 
Values 
No 
Values -0.1 No Values No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  Q7A6I1|PPI1 Ref 
No 
Values 
No 
Values -0.5 No Values No Values 
Fibrinogen-binding 
protein  P68800|FIB Ref 
No 
Values 
No 
Values 0.6 No Values No Values 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A88
8 Ref 0 
No 
Values No Values -0.1 No Values 
Virulence factor 
esxA  ESXA Ref 
No 
Values 
No 
Values No Values 
Reference 
Missing No Values 
50S ribosomal 
protein L15  P0A0F6|RL15 Ref 
No 
Values 
No 
Values -0.6 No Values No Values 
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Appendix 10.  Changes in secreted proteins of HA-MRSA USA200 compared to HA-
MRSA USA100 during stationary phase from 3 biological replicates 
 
Identified Proteins 
(246) 
Accession 
Number 
USA10
0#1 
USA100 
#2 
USA100 
#3 
USA200 
#1 
USA200 
#2 
USA200 
#3 
Lipase 2  Q7A7P2|LIP2 Ref -0.4 1.6 -0.2 0.7 3.8 
Lipase 1  P65289|LIP1 Ref -1 -0.8 0.4 2.6 1.5 
Alpha-Hemolysin  Q7A632|Q7A63
2 
Ref 0.6 0.2 -0.2 1 2.7 
Elongation factor Tu  P99152|EFTU Ref -1.8 -6.7 -0.1 -2.6 -6.7 
Enolase  P99088|ENO Ref -0.6 -6.6 -0.4 -0.9 -6.6 
Putative surface 
protein SA2285  
P61598|PLS Ref -4.6 -9 -4.4 -9.8 -9 
Bifunctional 
autolysin  
Q99V41|ATL Ref 0.1 -3.1 -1.3 2.6 -3.1 
SA0841 protein  Q7A6G0|Q7A6
G0 
Ref -1.4 -3 2.4 2.1 -1 
Chaperone protein 
dnaK  
P99110|DNAK Ref -3.6 -7 -0.3 -3.9 -7 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  
P99136|G3P1 Ref -2.5 -5.6 -0.5 -1.5 -5.6 
DNA-binding 
protein HU  
Q7A5J1|DBH Ref -1.7 -5.1 -0.3 -6 -5.1 
Alkyl hydroperoxide 
reductase subunit C  
P99074|AHPC Ref -4.7 -7 -0.9 -6.4 -7 
Inosine-5'-
monophosphate 
dehydrogenase  
P99106|IMDH Ref 0.2 -5.8 -0.4 0.7 -5.8 
Immunoglobulin G-
binding protein A  
SPA Ref No 
Values 
0 No Values No Values 1.1 
Formate--
tetrahydrofolate 
ligase  
Q7A535|FTHS Ref -1.6 -7.6 -0.8 -3.2 -7.6 
Dihydrolipoyl 
dehydrogenase  
P99084|DLDH Ref -0.7 -7.2 -0.3 0.3 -7.2 
50S ribosomal 
protein L7/L12  
P99154|RL7 Ref -0.2 -7.4 -1.6 0.1 -7.4 
Pyruvate kinase  Q7A559|KPYK Ref -4.6 -3.7 -1.3 -4.5 -3.7 
SA0587 protein  Q7A719|Q7A71
9 
Ref -1.3 -5 -0.1 -2.1 -5 
Phosphate 
acetyltransferase  
P99092|PTA Ref -2 -6.2 -0.6 -1.2 -6.2 
Elongation factor G  P68789|EFG Ref -1.5 -6.2 0.1 -2.1 -6.2 
Glutamine 
synthetase  
P99095|GLNA Ref -2.4 -6.7 -0.3 -2.6 -6.7 
SA2006 protein  Q7A483|Q7A48
3 
Ref 0.3 0.8 -0.6 2.9 2.4 
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Fructose-
bisphosphate 
aldolase  
P99075|ALF2 Ref -3.8 -7.4 Value 
Missing 
-3.5 -7.4 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS Ref -1 -0.5 -0.4 0.3 -0.5 
Alkaline shock 
protein 23  
P99157|ASP23 Ref 2.4 -3.9 -0.9 2.5 -3.9 
Triosephosphate 
isomerase  
P99133|TPIS Ref -2 -4 -1.2 -0.8 -4 
Enterotoxin type C-3  P0A0L4|ENTC
3 
Ref -5.3 -5.4 -0.3 -4.7 -2.6 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  
P65636|ODP2 Ref -0.6 -5.7 -0.7 -2.5 -5.7 
Cysteine synthase  P63871|CYSK Ref -0.6 -5.1 0.3 -1.2 -5.1 
Elongation factor Ts  P99171|EFTS Ref 2.5 -5 -0.5 3.4 -5 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  
Q820A6|ODPA Ref -5.5 -9.6 -0.6 -6.8 -9.6 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A6
V1 
Ref 0.1 -0.2 -0.3 2.6 Value 
Missing 
Ornithine 
aminotransferase 2  
P60298|OAT2 Ref -3.2 -9.4 -0.7 -5 -9.4 
Staphopain B  Q7A6A7|SSPB Ref -5.1 -3.5 -0.4 -3.1 -2.8 
Succinyl-CoA ligase 
[ADP-forming] 
subunit beta  
P99071|SUCC Ref -1.6 -6.2 -0.9 -4.1 -6.2 
Phosphocarrier 
protein HPr  
P99143|PTHP Ref 1.1 -5.6 -0.3 2.5 -5.6 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7J
8 
Ref -5.8 -6.1 Value 
Missing 
-3.4 -6.1 
Thermonuclease  Q7A6P2|NUC Ref 1.6 -0.9 -0.5 4.4 0.2 
Trigger factor  P99080|TIG Ref -1.3 -4.9 -0.7 -0.6 -4.9 
Aconitate hydratase  P99148|ACON Ref -0.1 -4.9 -0.1 0.7 -4.9 
Adenylate kinase  P99062|KAD Ref -3.1 -4.8 -0.4 -2.6 -4.8 
Fructose-
bisphosphate 
aldolase class 1  
P99117|ALF1 Ref -2.3 -6.6 -1.1 -2.5 -6.6 
50S ribosomal 
protein L17  
Q7A469|RL17 Ref 1.2 -3.6 -0.1 2.4 -3.6 
Glutamyl 
endopeptidase  
Q7A6A6|SSPA Ref -1.7 -3.3 -0.6 1.5 -1.3 
SA0620 protein  Q7A6Y9|Q7A6
Y9 
Ref -0.1 -2.2 1.7 2 3.1 
60 kDa chaperonin  P99083|CH60 Ref -1.3 -5.4 -0.7 -0.3 -5.4 
Probable beta-
lactamase  
Q7A4X8|Q7A4
X8 
Ref 0.8 No 
Values 
4.4 4.4 No Values 
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Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A73
5 
Ref 0.1 -3.9 Value 
Missing 
2.6 -3.9 
Alcohol 
dehydrogenase  
Q7A742|ADH Ref -0.4 -4.8 0.5 -1.3 -4.8 
Catalase  Q7A5T2|CATA Ref -3.8 -6.9 0.1 -5.3 -6.9 
SA2097 protein  Q7A418|Q7A41
8 
Ref -1.4 -2.7 0.8 1.7 -1.4 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 
Ref -4.4 -6.8 0.2 -1.1 -6.1 
Putative 
uncharacterized 
protein SAP003  
Q9AC87|Q9AC
87 
Ref 3.5 -6.8 -0.9 5.5 -6.8 
Probable thiol 
peroxidase  
P99146|TPX Ref 0.7 -6 Reference 
Missing 
-0.3 -6 
30S ribosomal 
protein S1  
Q7A5J0|RS1 Ref -0.9 -5.3 Value 
Missing 
-2.3 -5.3 
L-lactate 
dehydrogenase 1  
P65256|LDH1 Ref 2.2 -1.1 -0.5 4 -0.8 
Phosphoglycerate 
kinase  
P99135|PGK Ref -1.6 -5.4 -0.3 -1.2 -5.4 
Glucose-6-phosphate 
isomerase  
P99078|G6PI Ref -1.5 -5.4 0 -1.3 -5.4 
Transketolase  P99161|TKT Ref -1.9 -5.5 -3.1 -0.7 -5.5 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  
P99063|ODPB Ref No 
Values 
-8.1 -1.4 Reference 
Missing 
-8.1 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A6
H7 
Ref -2.9 -4.4 Value 
Missing 
-1 Value 
Missing 
Delta-hemolysin  P0A0M2|HLD Ref -2.5 No 
Values 
0.4 1.1 No Values 
Phenol-soluble 
modulin alpha 4 
peptide  
P0C824|PSMA4 Ref -2.3 0.1 -0.3 -1.3 3.2 
Foldase protein prsA  P60748|PRSA Ref -3.3 -5.7 0.3 -1.2 -5.1 
Glycyl-glycine 
endopeptidase lytM  
Q7A7T0|LYTM Ref -0.3 -0.9 2.3 3.3 5.2 
Thioredoxin  P99122|THIO Ref 0.2 -4.6 0.2 -0.7 -4.6 
SA2437 protein  Q7A371|Q7A37
1 
Ref -10 -8.7 Reference 
Missing 
-9.1 Value 
Missing 
UPF0477 protein 
SA0873  
Q7A6D4|Y873 Ref -4.7 -5.9 -1.1 -6.9 Value 
Missing 
Citrate synthase II  Q7A561|Q7A56
1 
Ref 5.5 -5.8 -0.7 7.9 -5.8 
6-phosphogluconate 
dehydrogenase, 
decarboxylating  
P63334|6PGD Ref -0.9 -4.1 0 -0.1 Value 
Missing 
Superoxide 
dismutase [Mn/Fe] 1  
P99098|SODM1 Ref -4.7 -7.7 1.3 -3.3 -7.7 
Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSMA
1 
Ref -5.3 -4.2 -0.2 -3.8 -0.8 
 
 
171 
 
Appendix 10. (Continued) 
Phosphoenolpyruvat
e carboxykinase 
[ATP]  
P99128|PCKA Ref -0.6 -8.4 Value 
Missing 
-2.3 -8.4 
Probable 
transglycosylase 
isaA  
P99160|ISAA Ref -2.4 -4.1 -0.4 -2.1 -4.1 
Glycyl-tRNA 
synthetase  
P99129|SYG Ref -0.3 -1.7 Value 
Missing 
-1.4 -1.7 
DNA-directed RNA 
polymerase subunit 
beta'  
P60285|RPOC Ref -2.4 -3.7 1.8 -2.4 Value 
Missing 
Glycine cleavage 
system H protein  
P64214|GCSH Ref 0.9 -6.8 0 2.7 Value 
Missing 
50S ribosomal 
protein L30  
P0A0G0|RL30 Ref 0.8 0.7 -2.1 -0.7 0.7 
Cold shock protein 
cspA  
Q7A5P3|CSPA Ref No 
Values 
-3.9 No Values No Values -3.9 
Serine protease splB  Q7A4Y1|SPLB Ref -0.2 -4.1 -0.4 -0.2 -2.5 
DNA-directed RNA 
polymerase subunit 
beta  
P60278|RPOB Ref No 
Values 
-6.1 -0.1 No Values -6.1 
2,3-
bisphosphoglycerate-
dependent 
phosphoglycerate 
mutase  
P99153|GPMA Ref No 
Values 
-3.4 0.3 Reference 
Missing 
-3.4 
Dihydrolipoyllysine-
residue 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase 
complex  
Q7A5N4|ODO2 Ref -5.2 -4.6 1.2 -8.3 Value 
Missing 
Seryl-tRNA 
synthetase  
P99178|SYS Ref -6.1 -9.3 -0.6 -8.5 -9.3 
NAD-specific 
glutamate 
dehydrogenase  
Q7A6H8|DHE2 Ref -2.1 -3 -0.5 -3.6 -2.8 
Succinyl-CoA ligase 
[ADP-forming] 
subunit alpha  
P99070|SUCD Ref -16.8 -25.2 No Values -17.8 -25.2 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUKL
1 
Ref 1.8 1.4 -0.4 1.8 1.9 
Acyl carrier protein  P0A002|ACP Ref -2.5 -2.9 -0.3 -3.8 Value 
Missing 
50S ribosomal 
protein L21  
Q7A583|RL21 Ref 1.8 -5.2 Reference 
Missing 
2.9 Value 
Missing 
UPF0337 protein 
SA0772  
Q7A6L9|Y772 Ref -2.6 -3.3 No Values -4.2 -3.3 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 2  
Q7A6F8|FABF Ref -2.6 -3.1 No Values -1.8 -3.1 
50S ribosomal 
protein L9  
P66318|RL9 Ref -3.2 -6.4 Value 
Missing 
-3.8 -6.4 
Beta-lactamase  Q9AC80|Q9AC
80 
Ref 0.3 -1.8 -1.6 0.2 -1.8 
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Thioredoxin 
reductase  
P99101|TRXB Ref No 
Values 
-7.7 Value 
Missing 
No Values -7.7 
Putative dipeptidase 
SA1572  
Q7A522|PEPV
L 
Ref -5.8 -9.3 Reference 
Missing 
-6 -9.3 
SA0916 protein  Q7A696|Q7A69
6 
Ref -3.9 -4.7 No Values -6.9 Value 
Missing 
Phosphoenolpyruvat
e-protein 
phosphotransferase  
Q99V14|PT1 Ref 0 -5.4 Value 
Missing 
1 -5.2 
30S ribosomal 
protein S9  
P66646|RS9 Ref 2.5 -6.4 -1 6.1 Value 
Missing 
Uncharacterized 
protein SA1692  
P0A0K1|Y1692 Ref -0.3 -1.9 -0.4 -0.9 -1.7 
50S ribosomal 
protein L11  
P0A0F2|RL11 Ref -0.6 -5.9 -0.7 -2.6 Value 
Missing 
Putative universal 
stress protein 
SA1532  
Q7A551|Y1532 Ref 0.6 -2 -0.5 0.6 Value 
Missing 
1-pyrroline-5-
carboxylate 
dehydrogenase  
P99076|ROCA Ref -1 -4.6 1 -5.2 -4.6 
Gamma-hemolysin 
component C  
Q7A3S2|HLGC Ref -5.4 -5.2 -1.1 -5.3 Value 
Missing 
Serine-aspartate 
repeat-containing 
protein D  
Q7A780|SDRD Ref 0 0 No Values -2.7 0 
Glutamyl-tRNA 
synthetase  
P99170|SYE Ref -2.6 -7.5 -0.9 -2.9 -7.5 
2,3-
bisphosphoglycerate-
independent 
phosphoglycerate 
mutase  
P64270|GPMI Ref 1.2 -4.5 -0.8 4.8 Value 
Missing 
D-lactate 
dehydrogenase  
P99116|LDHD Ref No 
Values 
0 No Values No Values 0 
50S ribosomal 
protein L10  
P99155|RL10 Ref 2.6 -5 -0.7 3.6 -5.1 
SA2202 protein  Q99RL6|Q99R
L6 
Ref -0.1 -2.5 -0.4 0.2 -2.4 
Gamma-hemolysin 
component A  
P0A072|HLGA Ref 2.2 No 
Values 
-0.8 3.7 No Values 
10 kDa chaperonin  P99104|CH10 Ref -2.1 -5.9 -0.4 -2 -5.9 
Dihydroorotase  P65906|PYRC Ref -1.6 -3.8 0.1 -0.7 -3.8 
UPF0457 protein 
SA1975.1  
Q99S93|Y197A Ref -1.5 -5.6 No Values -4.8 Value 
Missing 
Ribosome-recycling 
factor  
P99130|RRF Ref -2.6 -4.7 Reference 
Missing 
-2.2 -3.9 
Elongation factor P  P99066|EFP Ref -1 -5.3 -0.3 -2 -5.3 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUKL
2 
Ref 0.6 No 
Values 
-1.7 0.6 No Values 
UPF0355 protein 
SA0372  
Q7A7I6|UP355 Ref -1.6 -4.6 Value 
Missing 
-1.3 -4.6 
Acetate kinase  Q99TF2|ACKA Ref 2.6 -2.1 -1.5 4.2 -1.6 
Elastin-binding 
protein ebpS  
Q7A5I6|EBPS Ref -2.6 -5 -0.2 -3.3 -5 
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30S ribosomal 
protein S6  
P99142|RS6 Ref No 
Values 
-2.2 -0.8 No Values Value 
Missing 
General stress 
protein 20U  
Q7A4C8|Q7A4
C8 
Ref -0.9 -1.4 Value 
Missing 
-0.6 Value 
Missing 
50S ribosomal 
protein L24  
P60735|RL24 Ref -2.7 -7.6 No Values -3.8 Value 
Missing 
Bifunctional protein 
folD  
Q7A697|FOLD Ref No 
Values 
-0.3 0.1 No Values Value 
Missing 
50S ribosomal 
protein L22  
Q7A460|RL22 Ref -2 -4.7 0.4 0.7 -3.1 
Putative 
uncharacterized 
protein SAS040  
Q7A5U6|Q7A5
U6 
Ref -2.5 -8 -0.8 -1.8 -8 
Gamma-hemolysin 
component B  
P0A075|HLGB Ref 1 No 
Values 
-0.2 2.1 No Values 
Putative 
uncharacterized 
protein SA0395  
Q99WG7|Q99
WG7 
Ref No 
Values 
No 
Values 
0.7 Reference 
Missing 
No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  
Q7A6I1|PPI1 Ref 2.4 0.1 -2.2 6 4.4 
50S ribosomal 
protein L1  
Q99W68|RL1 Ref No 
Values 
-2.8 0.1 Reference 
Missing 
-2.8 
Virulence factor 
esxA  
ESXA (+1) Ref -0.5 No 
Values 
-0.8 0.8 No Values 
ATP-dependent Clp 
protease ATP-
binding subunit clpC  
Q7A797|CLPC Ref 1.9 -4.7 2.2 4.8 -4.7 
SA0914 protein  Q99V35|Q99V3
5 
Ref 2.4 -3.6 0.2 4.8 -3.3 
30S ribosomal 
protein S16  
P66440|RS16 Ref -1.5 -8.5 No Values -1.2 -8.5 
Translation initiation 
factor IF-1  
P65119|IF1 Ref -5.8 -9.1 Reference 
Missing 
-9.3 -9 
DNA-directed RNA 
polymerase subunit 
alpha  
P66706|RPOA Ref -1.1 -5.9 -0.1 -2 -5.9 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 
Ref -19.6 No 
Values 
No Values -16 No Values 
Deoxyribose-
phosphate aldolase 1  
P99102|DEOC1 
(+1) 
Ref -3 -4.4 -0.1 -3.1 -4.4 
Pyruvate carboxylase  Q7A666|Q7A66
6 
Ref 0 0 No Values -1.5 0 
Uncharacterized 
protein SA0829  
Q7A6H3|Y829 Ref -6.5 No 
Values 
No Values -6.8 No Values 
Probable acetyl-CoA 
acyltransferase  
Q7A7L2|THLA Ref -2.7 No 
Values 
Value 
Missing 
-4.1 No Values 
Protein grpE  P99086|GRPE Ref -3.6 -4.6 -0.4 -4.4 Value 
Missing 
50S ribosomal 
protein L3  
P60449|RL3 Ref No 
Values 
No 
Values 
0 No Values No Values 
ATP synthase 
subunit beta  
P99112|ATPB Ref -1.6 -5.5 -0.5 0 -5.5 
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Uncharacterized 
protein SA0707  
Q7A6R6|Y707 Ref -2.5 -5.2 -0.3 -3.9 -5.2 
Glucose-specific 
phosphotransferase 
enzyme IIA 
component  
P60857|PTGA Ref No 
Values 
0 No Values Reference 
Missing 
0 
Transcription 
elongation factor 
greA  
P99156|GREA Ref -2.1 -3.6 -0.7 -2.6 Value 
Missing 
SA0758 protein  Q7A6M7 Ref -0.3 -3.9 -2.9 -0.5 -3.9 
Chaperone protein 
hchA  
P64313|HCHA Ref 3 No 
Values 
0 5.5 No Values 
50S ribosomal 
protein L5  
Q7A465|RL5 Ref -0.6 No 
Values 
1.8 2.4 No Values 
Serine 
hydroxymethyltransf
erase  
P99091|GLYA Ref -4 -8 -0.9 -3.3 -8 
Methionine 
aminopeptidase  
AMPM Ref -5.7 -9.4 -0.3 -5.9 -9.4 
50S ribosomal 
protein L15  
P0A0F6|RL15 Ref 0.9 -4.1 0.4 3.6 -4.1 
ATP-dependent Clp 
protease ATP-
binding subunit clpL  
Q7A3F4|CLPL Ref -0.4 -7.4 Value 
Missing 
1.8 -6.8 
UPF0342 protein 
SA1663  
Q7A4V3|Y1663 Ref -2.4 -3.6 -1.1 -0.2 Value 
Missing 
SA0759 protein  Q7A6M6|Q7A6
M6 
Ref 1.8 -3.2 No Values 3.4 Value 
Missing 
Staphylokinase  Q99SU7|SAK Ref 0.8 -1.5 Value 
Missing 
-0.3 Value 
Missing 
Iron-regulated 
surface determinant 
protein A  
Q7A655|ISDA Ref No 
Values 
-4.7 Value 
Missing 
No Values -4.2 
Serine-aspartate 
repeat-containing 
protein E  
Q99W46|SDRE Ref 0 0 No Values 1.8 1.8 
Leukotoxin, LukD  Q99T54|Q99T5
4 
Ref No 
Values 
No 
Values 
No Values No Values No Values 
Amidophosphoribos
yltransferase  
P99164|PUR1 Ref No 
Values 
No 
Values 
-0.3 No Values No Values 
SA0859 protein  Q7A6E5|Q7A6
E5 
Ref No 
Values 
-6.3 No Values No Values Value 
Missing 
Phosphoribosylform
ylglycinamidine 
synthase 1  
P99166|PURQ Ref No 
Values 
No 
Values 
No Values No Values No Values 
Staphylococcal 
complement 
inhibitor  
Q99SU9|SCIN Ref No 
Values 
-1.8 No Values No Values -1 
Uncharacterized N-
acetyltransferase 
SA1019  
Q99UT4|Y1019 Ref -2.5 -4.4 0 -4 -4.4 
50S ribosomal 
protein L27  
P66133|RL27 Ref No 
Values 
-6.7 0 No Values Value 
Missing 
Adenylosuccinate 
lyase  
Q7A4Q3|PUR8 Ref 0 0 No Values 1 Value 
Missing 
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Naphthoate synthase  Q7A6A9|MEN
B 
Ref -8.8 No 
Values 
No Values -9.8 No Values 
Putative 
uncharacterized 
protein SA0771  
Q7A6M0|Q7A6
M0 
Ref -1.3 -2.8 Value 
Missing 
-1.6 -2.8 
Xaa-Pro dipeptidase  Q99TW4|Q99T
W4 
Ref -5.1 -8 No Values -3.7 -8 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A88
8 
Ref 0.7 No 
Values 
Value 
Missing 
2.5 No Values 
Probable glycine 
dehydrogenase 
[decarboxylating] 
subunit 1  
P64218|GCSPA Ref No 
Values 
0 No Values No Values 0 
Putative aldehyde 
dehydrogenase AldA  
Q7A825|ALDA Ref No 
Values 
0 No Values No Values 0 
L-lactate 
dehydrogenase 2  
P99119|LDH2 Ref 1.4 -4 Value 
Missing 
3.1 -3.8 
Formate 
acetyltransferase  
Q7A7X6|PFLB Ref -1.2 -4.1 1.3 -1.8 -3.3 
Signal transduction 
protein TRAP  
Q7A4W3|TRAP Ref -0.6 0 -0.2 -0.5 0.6 
Purine nucleoside 
phosphorylase  
Q7A4C9|Q7A4
C9 
Ref No 
Values 
No 
Values 
-1.1 No Values No Values 
Arginyl-tRNA 
synthetase  
Q99W05|SYR Ref No 
Values 
-7.3 -0.8 No Values -7.3 
50S ribosomal 
protein L13  
Q7A473|RL13 Ref -1.3 No 
Values 
1 0 No Values 
Probable 
transglycosylase 
sceD  
Q7A4F2|SCED Ref 0 No 
Values 
No Values 2 No Values 
Organic 
hydroperoxide 
resistance protein-
like  
Q7A6M9|OHR
L 
Ref -1.8 No 
Values 
No Values -0.2 No Values 
Serine protease splD  Q7A4Y3|SPLD Ref No 
Values 
No 
Values 
Value 
Missing 
No Values No Values 
Putative 
uncharacterized 
protein SA1986  
Q7A493|Q7A49
3 
Ref No 
Values 
No 
Values 
0.3 No Values No Values 
D-alanine--
poly(phosphoribitol) 
ligase subunit 2  
P0A019|DLTC Ref -2.5 -5.9 Value 
Missing 
-1.5 Value 
Missing 
Immunoglobulin-
binding protein sbi  
Q99RL2|SBI Ref -3.3 -6.8 Value 
Missing 
-4.9 Value 
Missing 
Putative 
uncharacterized 
protein SA1528  
Q7A553|Q7A55
3 
Ref 1.7 No 
Values 
-0.2 1.9 No Values 
GMP synthase 
[glutamine-
hydrolyzing]  
P99105|GUAA Ref No 
Values 
-5.9 Value 
Missing 
No Values Value 
Missing 
SA1524 protein  Q7A556|Q7A55
6 
Ref 1.6 -3.1 Value 
Missing 
3.1 -3.1 
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30S ribosomal 
protein S11  
P66357|RS11 Ref -2.3 -7.6 No Values -3.3 Value 
Missing 
Putative 
uncharacterized 
protein SA0919  
Q7A694|Q7A69
4 
Ref No 
Values 
-4.8 -0.2 No Values -3.2 
Phenol-soluble 
modulin alpha 3 
peptide  
P0C811|PSMA3 Ref -0.6 No 
Values 
0.4 0.3 No Values 
Ferritin  Q7A4R2|FTN Ref No 
Values 
0 No Values No Values Value 
Missing 
Alkyl hydroperoxide 
reductase subunit F  
P99118|AHPF Ref No 
Values 
-6.2 Value 
Missing 
No Values -6.2 
Anti-sigma-B factor 
antagonist  
P66838|RSBV Ref No 
Values 
-3.2 -0.6 No Values -2.3 
Nucleoside 
diphosphate kinase  
NDK (+1) Ref -3.7 -9.6 Value 
Missing 
-6.2 -9.6 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A37
8 
Ref No 
Values 
-2.5 Reference 
Missing 
Reference 
Missing 
1.7 
UPF0173 metal-
dependent hydrolase 
SA1529  
P99149|Y1529 Ref -14 -19.1 No Values -13.9 Value 
Missing 
Pyridoxal 
biosynthesis lyase 
pdxS  
P60798|PDXS Ref No 
Values 
-6.5 0 No Values -5.9 
Alanine 
dehydrogenase 2  
Q99TF4|DHA2 Ref No 
Values 
-5.4 -0.6 No Values Value 
Missing 
Urocanate hydratase  P67417|HUTU Ref No 
Values 
0 No Values No Values Value 
Missing 
Putative 
uncharacterized 
protein SA2309  
Q7A3I0|Q7A3I
0 
Ref 4.7 -3.5 Value 
Missing 
Reference 
Missing 
Value 
Missing 
CTP synthase  P99072|PYRG Ref 0.6 -5.5 Value 
Missing 
1.2 Value 
Missing 
Putative 8-amino-7-
oxononanoate 
synthase/2-amino-3-
ketobutyrate 
coenzyme A ligase  
P60120|BIKB Ref No 
Values 
-23 No Values No Values Value 
Missing 
Threonyl-tRNA 
synthetase  
P67585|SYT Ref No 
Values 
No 
Values 
-0.6 No Values No Values 
Probable 
malate:quinone 
oxidoreductase 2  
P99115|MQO2 Ref 0 0 No Values -2.8 0 
Probable branched-
chain-amino-acid 
aminotransferase  
P99138|ILVE Ref 0 0 No Values 0.1 0.4 
Methionyl-tRNA 
synthetase  
P67579|SYM Ref No 
Values 
0 No Values No Values Value 
Missing 
Tryptophanyl-tRNA 
synthetase  
P67593|SYW Ref 0 No 
Values 
No Values -3 No Values 
Mannitol-1-
phosphate 5-
dehydrogenase  
P99140|MTLD Ref 0 No 
Values 
No Values 1.8 No Values 
SA1343 protein  Q7A5G2|Q7A5
G2 
Ref No 
Values 
0 No Values No Values Value 
Missing 
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Staphopain A  P65826|SSPP Ref No 
Values 
No 
Values 
No Values No Values No Values 
UPF0082 protein 
SA0624  
P67182|Y624 Ref -2.2 -5.3 Value 
Missing 
-1.9 Value 
Missing 
Cell division protein 
ftsZ  
P99108|FTSZ Ref 2.5 -3.1 -0.3 2.3 Value 
Missing 
Adenylosuccinate 
synthetase  
P99099|PURA Ref No 
Values 
-5.1 -0.5 No Values -4.8 
Histidine ammonia-
lyase  
P64416|HUTH Ref No 
Values 
-9.6 No Values No Values Value 
Missing 
Imidazolonepropiona
se  
P64418|HUTI Ref No 
Values 
0 No Values No Values Value 
Missing 
6-
phosphofructokinase  
P99165|K6PF Ref -3.2 No 
Values 
No Values -1.7 No Values 
Lysyl-tRNA 
synthetase  
P67610|SYK Ref No 
Values 
-1.3 -0.9 No Values 0.8 
SA1599 protein  Q7A501|Q7A50
1 
Ref No 
Values 
0 No Values No Values 0.8 
SA0231 protein  Q7A7W3|Q7A7
W3 
Ref No 
Values 
-3.4 Value 
Missing 
No Values -3.3 
Phenylalanyl-tRNA 
synthetase beta chain  
P67041|SYFB Ref No 
Values 
0 No Values No Values Value 
Missing 
P60855|Y370_STAA
N 
P60855|Y370 Ref No 
Values 
0 No Values No Values 0 
50S ribosomal 
protein L23  
Q7A459|RL23 Ref No 
Values 
No 
Values 
2.3 No Values No Values 
Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A6
A3 
Ref 3 -2.3 -0.2 5.1 Value 
Missing 
SA1475 protein  Q7A581|Q7A58
1 
Ref 0 0 No Values 2.3 0.4 
Leucyl-tRNA 
synthetase  
P67513|SYL Ref No 
Values 
-6 Value 
Missing 
No Values -5.8 
Clumping factor A  Q99VJ4|CLFA Ref 0 0 No Values 0.9 Value 
Missing 
Acetate-CoA ligase  Q7A3A2|Q7A3
A2 
Ref 0 No 
Values 
No Values 3.6 No Values 
Lactonase drp35  RANDOM_DR
P35-R 
Ref 0 No 
Values 
No Values -0.3 No Values 
50S ribosomal 
protein L2  
P60432|RL2 Ref No 
Values 
0 No Values No Values 0 
Glucosamine--
fructose-6-phosphate 
aminotransferase 
[isomerizing]  
GLMS Ref No 
Values 
No 
Values 
No Values No Values No Values 
Putative 
uncharacterized 
protein SA1743  
Q7A4N7|Q7A4
N7 
Ref No 
Values 
0 No Values No Values 0 
Cell division protein  Q7A620|Q7A62
0 
Ref No 
Values 
0 No Values No Values 0 
50S ribosomal 
protein L18  
Q7A467|RL18 Ref No 
Values 
-18.9 No Values No Values -18.8 
3-hexulose-6-
phosphate synthase  
Q7A774|HPS Ref No 
Values 
No 
Values 
Reference 
Missing 
No Values No Values 
Acetoin(diacetyl) 
reductase  
P99120|BUTA Ref No 
Values 
0 No Values No Values 1.3 
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SA0022 protein  Q99XE9|Q99X
E9 
Ref 0 No 
Values 
No Values 1.9 No Values 
3-hydroxy-3-
methylglutaryl CoA 
synthase  
Q7A3F6|Q7A3
F6 
Ref No 
Values 
No 
Values 
Value 
Missing 
No Values No Values 
30S ribosomal 
protein S7  
P66616|RS7 Ref -1.5 No 
Values 
-1.5 0.1 No Values 
Uncharacterized 
lipoprotein SA2158  
Q7A3W5|Y215
8 
Ref No 
Values 
No 
Values 
No Values No Values No Values 
Ribonuclease J 1  Q7A682|RNJ1 Ref No 
Values 
No 
Values 
Value 
Missing 
Reference 
Missing 
No Values 
Trans-2-enoyl-ACP 
reductase  
Q7A6D8 Ref 0 No 
Values 
No Values 2.7 No Values 
2-C-methyl-D-
erythritol 4-
phosphate 
cytidylyltransferase 
2  
Q7A7V0|ISPD2 Ref No 
Values 
No 
Values 
-0.6 No Values No Values 
30S ribosomal 
protein S13  
P66388|RS13 Ref No 
Values 
No 
Values 
No Values No Values No Values 
30S ribosomal 
protein S2  
P66544|RS2 Ref No 
Values 
0 No Values No Values 0.2 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 3  
P99159|FABH Ref No 
Values 
No 
Values 
No Values No Values No Values 
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Appendix 11.  Changes in secreted proteins of CA-MRSA USA300 compared to HA-
MRSA USA100 during stationary phase from 3 biological replicates 
 
Identified Proteins 
(246) 
Accession 
Number 
USA10
0 
#1 
USA100 
#2 
USA100 
#3 
USA300 
#1 
USA300 
#2 
USA300 
#3 
Lipase 2  Q7A7P2|LIP2 Ref -0.4 1.6 0.6 3 4.8 
Lipase 1  P65289|LIP1 Ref -1 -0.8 0.6 1.5 2.5 
Alpha-Hemolysin  
Q7A632|Q7A63
2 Ref 0.6 0.2 0.6 4.1 4.8 
Elongation factor Tu  P99152|EFTU Ref -1.8 -6.7 0.6 -1.4 -7 
Enolase  P99088|ENO Ref -0.6 -6.6 0.6 -0.3 -6.8 
Putative surface 
protein SA2285  P61598|PLS Ref -4.6 -9 -5.1 -9.5 -11.5 
Bifunctional 
autolysin  Q99V41|ATL Ref 0.1 -3.1 -0.7 1 -2.8 
SA0841 protein  
Q7A6G0|Q7A6
G0 Ref -1.4 -3 0.6 0.5 -0.3 
Chaperone protein 
dnaK  P99110|DNAK Ref -3.6 -7 0.6 -4.1 -7.8 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1 Ref -2.5 -5.6 0.6 -1.8 -6.1 
DNA-binding 
protein HU  Q7A5J1|DBH Ref -1.7 -5.1 -0.2 -3 -4.9 
Alkyl hydroperoxide 
reductase subunit C  P99074|AHPC Ref -4.7 -7 0.6 -6.2 -6.8 
Inosine-5'-
monophosphate 
dehydrogenase  P99106|IMDH Ref 0.2 -5.8 0.6 1.7 -5.8 
Immunoglobulin G-
binding protein A  SPA Ref 
No 
Values 0 No Values No Values 1.7 
Formate--
tetrahydrofolate 
ligase  Q7A535|FTHS Ref -1.6 -7.6 0.5 -2.4 -8.9 
Dihydrolipoyl 
dehydrogenase  P99084|DLDH Ref -0.7 -7.2 0.6 0.2 -7.5 
50S ribosomal 
protein L7/L12  P99154|RL7 Ref -0.2 -7.4 0.6 -0.3 -7.4 
Pyruvate kinase  Q7A559|KPYK Ref -4.6 -3.7 -0.9 -3.8 -3.6 
SA0587 protein  
Q7A719|Q7A71
9 Ref -1.3 -5 0.6 -0.6 -4.2 
Phosphate 
acetyltransferase  P99092|PTA Ref -2 -6.2 0 -2 -7.8 
Elongation factor G  P68789|EFG Ref -1.5 -6.2 0.6 -0.4 -5.3 
Glutamine 
synthetase  P99095|GLNA Ref -2.4 -6.7 0.6 -1.9 -6.7 
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SA2006 protein  
Q7A483|Q7A48
3 Ref 0.3 0.8 0.6 3.6 2.5 
Fructose-
bisphosphate 
aldolase  P99075|ALF2 Ref -3.8 -7.4 0.6 -3.3 -10 
Glycerol phosphate 
lipoteichoic acid 
synthase  Q7A6U1|LTAS Ref -1 -0.5 0.6 -0.5 -0.3 
Alkaline shock 
protein 23  P99157|ASP23 Ref 2.4 -3.9 0.6 3.5 -2.5 
Triosephosphate 
isomerase  P99133|TPIS Ref -2 -4 0.1 -1.4 -4.4 
Enterotoxin type C-3  
P0A0L4|ENTC
3 Ref -5.3 -5.4 -2 -4.5 -4.3 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  P65636|ODP2 Ref -0.6 -5.7 0.4 -1.4 -6.1 
Cysteine synthase  P63871|CYSK Ref -0.6 -5.1 0.6 -0.4 -4.3 
Elongation factor Ts  P99171|EFTS Ref 2.5 -5 0.6 3.1 -5.2 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  Q820A6|ODPA Ref -5.5 -9.6 0.6 -6.5 -10.4 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A6
V1 Ref 0.1 -0.2 0.6 3.4 3.6 
Ornithine 
aminotransferase 2  P60298|OAT2 Ref -3.2 -9.4 0 -4.7 -10.3 
Staphopain B  Q7A6A7|SSPB Ref -5.1 -3.5 0.6 -3.6 -1.4 
Succinyl-CoA ligase 
[ADP-forming] 
subunit beta  P99071|SUCC Ref -1.6 -6.2 0.1 -1.5 -6.7 
Phosphocarrier 
protein HPr  P99143|PTHP Ref 1.1 -5.6 -1.2 1.9 -6 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7J
8 Ref -5.8 -6.1 0.6 -4.7 -5.1 
Thermonuclease  Q7A6P2|NUC Ref 1.6 -0.9 0.6 2.8 1.6 
Trigger factor  P99080|TIG Ref -1.3 -4.9 0.2 -2.1 -4.7 
Aconitate hydratase  P99148|ACON Ref -0.1 -4.9 0.5 0.5 -4.7 
Adenylate kinase  P99062|KAD Ref -3.1 -4.8 0.6 -3.7 -5.1 
Fructose-
bisphosphate 
aldolase class 1  P99117|ALF1 Ref -2.3 -6.6 0.2 -2.4 -6.8 
50S ribosomal 
protein L17  Q7A469|RL17 Ref 1.2 -3.6 0.6 1.4 -3.6 
Glutamyl 
endopeptidase  Q7A6A6|SSPA Ref -1.7 -3.3 0.6 -0.1 -1.4 
SA0620 protein  
Q7A6Y9|Q7A6
Y9 Ref -0.1 -2.2 -1.4 1 0.5 
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60 kDa chaperonin  P99083|CH60 Ref -1.3 -5.4 -0.2 -0.9 -5.6 
Probable beta-
lactamase  
Q7A4X8|Q7A4
X8 Ref 0.8 
No 
Values -3.7 0.8 No Values 
Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A73
5 Ref 0.1 -3.9 0.6 1.5 -2.9 
Alcohol 
dehydrogenase  Q7A742|ADH Ref -0.4 -4.8 0.6 0.6 -4.4 
Catalase  Q7A5T2|CATA Ref -3.8 -6.9 
Reference 
Missing -5 -7.9 
SA2097 protein  
Q7A418|Q7A41
8 Ref -1.4 -2.7 -1.1 -0.5 -2.6 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 Ref -4.4 -6.8 0.3 -4.5 -7.5 
Putative 
uncharacterized 
protein SAP003  
Q9AC87|Q9AC
87 Ref 3.5 -6.8 0.6 4.8 -7 
Probable thiol 
peroxidase  P99146|TPX Ref 0.7 -6 0.6 -0.3 -8.5 
30S ribosomal 
protein S1  Q7A5J0|RS1 Ref -0.9 -5.3 0.6 -1 -5 
L-lactate 
dehydrogenase 1  P65256|LDH1 Ref 2.2 -1.1 0.6 3.8 0.4 
Phosphoglycerate 
kinase  P99135|PGK Ref -1.6 -5.4 0.6 -0.5 -5.7 
Glucose-6-phosphate 
isomerase  P99078|G6PI Ref -1.5 -5.4 0.6 -1.4 -6 
Transketolase  P99161|TKT Ref -1.9 -5.5 -2.2 -1 -6 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  P99063|ODPB Ref 
No 
Values -8.1 -1.2 
Reference 
Missing -8.6 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A6
H7 Ref -2.9 -4.4 0.6 -3.1 -4.3 
Delta-hemolysin  P0A0M2|HLD Ref -2.5 
No 
Values 0.6 -2 No Values 
Phenol-soluble 
modulin alpha 4 
peptide  P0C824|PSMA4 Ref -2.3 0.1 0.5 0 2.3 
Foldase protein prsA  P60748|PRSA Ref -3.3 -5.7 0.1 -2.9 -5.5 
Glycyl-glycine 
endopeptidase lytM  Q7A7T0|LYTM Ref -0.3 -0.9 -1.7 0.7 0.9 
Thioredoxin  P99122|THIO Ref 0.2 -4.6 0.6 0.5 -5.1 
SA2437 protein  
Q7A371|Q7A37
1 Ref -10 -8.7 
Reference 
Missing -10 -8.3 
UPF0477 protein 
SA0873  Q7A6D4|Y873 Ref -4.7 -5.9 -0.5 -4.7 -6.8 
Citrate synthase II  
Q7A561|Q7A56
1 Ref 5.5 -5.8 0 8.5 -6.9 
6-phosphogluconate 
dehydrogenase, 
decarboxylating  P63334|6PGD Ref -0.9 -4.1 0.5 -0.5 -4.5 
Superoxide 
dismutase [Mn/Fe] 1  P99098|SODM1 Ref -4.7 -7.7 0.6 -5 -8.1 
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Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSMA
1 Ref -5.3 -4.2 -0.9 -4.1 -1.7 
Phosphoenolpyruvat
e carboxykinase 
[ATP]  P99128|PCKA Ref -0.6 -8.4 0.6 -1.4 -9.4 
Probable 
transglycosylase 
isaA  P99160|ISAA Ref -2.4 -4.1 -1 -3.1 -4.8 
Glycyl-tRNA 
synthetase  P99129|SYG Ref -0.3 -1.7 0.6 -1.3 -1 
DNA-directed RNA 
polymerase subunit 
beta'  P60285|RPOC Ref -2.4 -3.7 0.6 -1.1 -5.4 
Glycine cleavage 
system H protein  P64214|GCSH Ref 0.9 -6.8 0.6 -1.5 -5 
50S ribosomal 
protein L30  P0A0G0|RL30 Ref 0.8 0.7 -4 0 1.2 
Cold shock protein 
cspA  Q7A5P3|CSPA Ref 
No 
Values -3.9 
Reference 
Missing No Values -3.8 
Serine protease splB  Q7A4Y1|SPLB Ref -0.2 -4.1 0.5 3 -1.5 
DNA-directed RNA 
polymerase subunit 
beta  P60278|RPOB Ref 
No 
Values -6.1 -1 No Values -5.8 
2,3-
bisphosphoglycerate-
dependent 
phosphoglycerate 
mutase  P99153|GPMA Ref 
No 
Values -3.4 0.6 No Values -2.8 
Dihydrolipoyllysine-
residue 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase 
complex  Q7A5N4|ODO2 Ref -5.2 -4.6 0 -4.9 -5.9 
Seryl-tRNA 
synthetase  P99178|SYS Ref -6.1 -9.3 -0.5 -7.6 -9.7 
NAD-specific 
glutamate 
dehydrogenase  Q7A6H8|DHE2 Ref -2.1 -3 0.6 -3.2 -3.4 
Succinyl-CoA ligase 
[ADP-forming] 
subunit alpha  P99070|SUCD Ref -16.8 -25.2 No Values -17.5 -25.3 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUKL
1 Ref 1.8 1.4 0.4 4 3.5 
Acyl carrier protein  P0A002|ACP Ref -2.5 -2.9 -0.1 -4 -3.2 
50S ribosomal 
protein L21  Q7A583|RL21 Ref 1.8 -5.2 
Reference 
Missing 2.4 -5.9 
UPF0337 protein 
SA0772  Q7A6L9|Y772 Ref -2.6 -3.3 
Reference 
Missing -2.9 -3.1 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 2  Q7A6F8|FABF Ref -2.6 -3.1 
Reference 
Missing -2.2 -2.5 
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50S ribosomal 
protein L9  P66318|RL9 Ref -3.2 -6.4 0.6 -4.1 -6.5 
Beta-lactamase  
Q9AC80|Q9AC
80 Ref 0.3 -1.8 0.6 2.4 -1.2 
Thioredoxin 
reductase  P99101|TRXB Ref 
No 
Values -7.7 
Value 
Missing No Values -8.4 
Putative dipeptidase 
SA1572  
Q7A522|PEPV
L Ref -5.8 -9.3 
Reference 
Missing -5.7 -9.8 
SA0916 protein  
Q7A696|Q7A69
6 Ref -3.9 -4.7 
Reference 
Missing 
Value 
Missing 
Value 
Missing 
Phosphoenolpyruvat
e-protein 
phosphotransferase  Q99V14|PT1 Ref 0 -5.4 0.6 1.2 -4.4 
30S ribosomal 
protein S9  P66646|RS9 Ref 2.5 -6.4 0.5 
Value 
Missing -6.4 
Uncharacterized 
protein SA1692  P0A0K1|Y1692 Ref -0.3 -1.9 0.3 1 -0.1 
50S ribosomal 
protein L11  P0A0F2|RL11 Ref -0.6 -5.9 -0.7 -2.2 -5.8 
Putative universal 
stress protein 
SA1532  Q7A551|Y1532 Ref 0.6 -2 0.5 2.5 -1.6 
1-pyrroline-5-
carboxylate 
dehydrogenase  P99076|ROCA Ref -1 -4.6 -0.9 -2.2 -6 
Gamma-hemolysin 
component C  Q7A3S2|HLGC Ref -5.4 -5.2 0.6 -2 -0.6 
Serine-aspartate 
repeat-containing 
protein D  Q7A780|SDRD Ref 0 0 No Values -2.8 -1.6 
Glutamyl-tRNA 
synthetase  P99170|SYE Ref -2.6 -7.5 0.6 -2.9 -7.6 
2,3-
bisphosphoglycerate-
independent 
phosphoglycerate 
mutase  P64270|GPMI Ref 1.2 -4.5 -0.9 1.8 -4.8 
D-lactate 
dehydrogenase  P99116|LDHD Ref 
No 
Values 0 No Values No Values -2.2 
50S ribosomal 
protein L10  P99155|RL10 Ref 2.6 -5 -0.7 3.4 -4.8 
SA2202 protein  
Q99RL6|Q99R
L6 Ref -0.1 -2.5 0.4 -0.1 -1.5 
Gamma-hemolysin 
component A  P0A072|HLGA Ref 2.2 
No 
Values 0.6 4.3 No Values 
10 kDa chaperonin  P99104|CH10 Ref -2.1 -5.9 0.2 -2.6 -6.6 
Dihydroorotase  P65906|PYRC Ref -1.6 -3.8 0.2 -2.2 -2.9 
UPF0457 protein 
SA1975.1  Q99S93|Y197A Ref -1.5 -5.6 
Reference 
Missing -1.7 -5.5 
Ribosome-recycling 
factor  P99130|RRF Ref -2.6 -4.7 
Reference 
Missing -3.6 -3.9 
Elongation factor P  P99066|EFP Ref -1 -5.3 -0.4 -2.5 -5.7 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUKL
2 Ref 0.6 
No 
Values 0.5 2.6 No Values 
 
184 
 
Appendix 11. (Continued) 
UPF0355 protein 
SA0372  Q7A7I6|UP355 Ref -1.6 -4.6 0.6 -0.7 -4.1 
Acetate kinase  Q99TF2|ACKA Ref 2.6 -2.1 -0.9 4.2 -0.1 
Elastin-binding 
protein ebpS  Q7A5I6|EBPS Ref -2.6 -5 -0.4 -1.7 -4.2 
30S ribosomal 
protein S6  P99142|RS6 Ref 
No 
Values -2.2 0.6 No Values -1.9 
General stress 
protein 20U  
Q7A4C8|Q7A4
C8 Ref -0.9 -1.4 0.6 -1.2 
Value 
Missing 
50S ribosomal 
protein L24  P60735|RL24 Ref -2.7 -7.6 
Reference 
Missing -3 -7.6 
Bifunctional protein 
folD  Q7A697|FOLD Ref 
No 
Values -0.3 -0.1 No Values 1.4 
50S ribosomal 
protein L22  Q7A460|RL22 Ref -2 -4.7 0.6 1 -4.1 
Putative 
uncharacterized 
protein SAS040  
Q7A5U6|Q7A5
U6 Ref -2.5 -8 -0.2 -2 -8.5 
Gamma-hemolysin 
component B  P0A075|HLGB Ref 1 
No 
Values 0.6 2.7 No Values 
Putative 
uncharacterized 
protein SA0395  
Q99WG7|Q99
WG7 Ref 
No 
Values 
No 
Values -0.2 
Reference 
Missing No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  Q7A6I1|PPI1 Ref 2.4 0.1 0.6 
Reference 
Missing -0.2 
50S ribosomal 
protein L1  Q99W68|RL1 Ref 
No 
Values -2.8 -0.3 
Reference 
Missing -2.6 
Virulence factor 
esxA  ESXA (+1) Ref -0.5 
No 
Values 0.6 1.8 No Values 
ATP-dependent Clp 
protease ATP-
binding subunit clpC  Q7A797|CLPC Ref 1.9 -4.7 -2.4 4 -4.3 
SA0914 protein  
Q99V35|Q99V3
5 Ref 2.4 -3.6 0.6 3.3 -2.8 
30S ribosomal 
protein S16  P66440|RS16 Ref -1.5 -8.5 
Reference 
Missing -1.4 -8.9 
Translation initiation 
factor IF-1  P65119|IF1 Ref -5.8 -9.1 
Reference 
Missing -8 -8.7 
DNA-directed RNA 
polymerase subunit 
alpha  P66706|RPOA Ref -1.1 -5.9 0.6 -1.8 -5.4 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 Ref -19.6 
No 
Values No Values -19.4 No Values 
Deoxyribose-
phosphate aldolase 1  
P99102|DEOC1 
(+1) Ref -3 -4.4 -0.9 -3.6 -3.9 
Pyruvate carboxylase  
Q7A666|Q7A66
6 Ref 0 0 No Values -0.5 -0.3 
Uncharacterized 
protein SA0829  Q7A6H3|Y829 Ref -6.5 
No 
Values 
Reference 
Missing -9.7 No Values 
Probable acetyl-CoA 
acyltransferase  Q7A7L2|THLA Ref -2.7 
No 
Values 0.6 -3.2 No Values 
Protein grpE  P99086|GRPE Ref -3.6 -4.6 -1 -5 -4.6 
50S ribosomal 
protein L3  P60449|RL3 Ref 
No 
Values 
No 
Values 0.5 No Values No Values 
ATP synthase 
subunit beta  P99112|ATPB Ref -1.6 -5.5 0.6 -0.1 -4.9 
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Uncharacterized 
protein SA0707  Q7A6R6|Y707 Ref -2.5 -5.2 0.6 -1.6 -5.6 
Glucose-specific 
phosphotransferase 
enzyme IIA 
component  P60857|PTGA Ref 
No 
Values 0 No Values 
Reference 
Missing 0.4 
Transcription 
elongation factor 
greA  P99156|GREA Ref -2.1 -3.6 -0.4 -1.7 -6.2 
SA0758 protein  Q7A6M7 Ref -0.3 -3.9 -2.2 -1.2 -4 
Chaperone protein 
hchA  P64313|HCHA Ref 3 
No 
Values 0.6 5 No Values 
50S ribosomal 
protein L5  Q7A465|RL5 Ref -0.6 
No 
Values 0.3 2.5 No Values 
Serine 
hydroxymethyltransf
erase  P99091|GLYA Ref -4 -8 -0.7 -4 -8.2 
Methionine 
aminopeptidase  AMPM Ref -5.7 -9.4 -2.9 -7 -9.5 
50S ribosomal 
protein L15  P0A0F6|RL15 Ref 0.9 -4.1 0.6 0.9 -3.7 
ATP-dependent Clp 
protease ATP-
binding subunit clpL  Q7A3F4|CLPL Ref -0.4 -7.4 0.5 0.7 -6.7 
UPF0342 protein 
SA1663  Q7A4V3|Y1663 Ref -2.4 -3.6 0.6 -2.5 -4.6 
SA0759 protein  
Q7A6M6|Q7A6
M6 Ref 1.8 -3.2 
Reference 
Missing 2.5 -3 
Staphylokinase  Q99SU7|SAK Ref 0.8 -1.5 0 2.5 -0.4 
Iron-regulated 
surface determinant 
protein A  Q7A655|ISDA Ref 
No 
Values -4.7 0.2 No Values -3.7 
Serine-aspartate 
repeat-containing 
protein E  Q99W46|SDRE Ref 0 0 No Values -1.1 -2.5 
Leukotoxin, LukD  
Q99T54|Q99T5
4 Ref 
No 
Values 
No 
Values 
Reference 
Missing 
Reference 
Missing No Values 
Amidophosphoribos
yltransferase  P99164|PUR1 Ref 
No 
Values 
No 
Values 0.2 No Values No Values 
SA0859 protein  
Q7A6E5|Q7A6
E5 Ref 
No 
Values -6.3 
Reference 
Missing No Values -8.9 
Phosphoribosylform
ylglycinamidine 
synthase 1  P99166|PURQ Ref 
No 
Values 
No 
Values 
Reference 
Missing No Values No Values 
Staphylococcal 
complement 
inhibitor  Q99SU9|SCIN Ref 
No 
Values -1.8 
Reference 
Missing No Values -0.2 
Uncharacterized N-
acetyltransferase 
SA1019  Q99UT4|Y1019 Ref -2.5 -4.4 -1 -2.9 -4.1 
50S ribosomal 
protein L27  P66133|RL27 Ref 
No 
Values -6.7 0.6 No Values -6.8 
Adenylosuccinate 
lyase  Q7A4Q3|PUR8 Ref 0 0 No Values -0.2 -0.3 
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Naphthoate synthase  
Q7A6A9|MEN
B Ref -8.8 
No 
Values 
Reference 
Missing -9 No Values 
Putative 
uncharacterized 
protein SA0771  
Q7A6M0|Q7A6
M0 Ref -1.3 -2.8 0.6 -1.3 -1.8 
Xaa-Pro dipeptidase  
Q99TW4|Q99T
W4 Ref -5.1 -8 
Reference 
Missing -4.2 -8.1 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A88
8 Ref 0.7 
No 
Values 0.4 3.1 No Values 
Probable glycine 
dehydrogenase 
[decarboxylating] 
subunit 1  P64218|GCSPA Ref 
No 
Values 0 No Values No Values -0.9 
Putative aldehyde 
dehydrogenase AldA  Q7A825|ALDA Ref 
No 
Values 0 No Values No Values -0.7 
L-lactate 
dehydrogenase 2  P99119|LDH2 Ref 1.4 -4 -1.1 3.3 -2.7 
Formate 
acetyltransferase  Q7A7X6|PFLB Ref -1.2 -4.1 -0.5 -0.3 -3.7 
Signal transduction 
protein TRAP  Q7A4W3|TRAP Ref -0.6 0 -0.2 -0.5 0.9 
Purine nucleoside 
phosphorylase  
Q7A4C9|Q7A4
C9 Ref 
No 
Values 
No 
Values -0.5 No Values No Values 
Arginyl-tRNA 
synthetase  Q99W05|SYR Ref 
No 
Values -7.3 -0.8 No Values -7.7 
50S ribosomal 
protein L13  Q7A473|RL13 Ref -1.3 
No 
Values -0.2 0.3 No Values 
Probable 
transglycosylase 
sceD  Q7A4F2|SCED Ref 0 
No 
Values No Values -1.3 No Values 
Organic 
hydroperoxide 
resistance protein-
like  
Q7A6M9|OHR
L Ref -1.8 
No 
Values 
Reference 
Missing -1.6 No Values 
Serine protease splD  Q7A4Y3|SPLD Ref 
No 
Values 
No 
Values -0.6 No Values No Values 
Putative 
uncharacterized 
protein SA1986  
Q7A493|Q7A49
3 Ref 
No 
Values 
No 
Values -2.4 No Values No Values 
D-alanine--
poly(phosphoribitol) 
ligase subunit 2  P0A019|DLTC Ref -2.5 -5.9 0.2 -1.7 -5.3 
Immunoglobulin-
binding protein sbi  Q99RL2|SBI Ref -3.3 -6.8 0.6 -4.9 -7.2 
Putative 
uncharacterized 
protein SA1528  
Q7A553|Q7A55
3 Ref 1.7 
No 
Values -0.4 4.2 No Values 
GMP synthase 
[glutamine-
hydrolyzing]  P99105|GUAA Ref 
No 
Values -5.9 0.6 No Values -6.3 
SA1524 protein  
Q7A556|Q7A55
6 Ref 1.6 -3.1 -0.6 2.7 -4.5 
 
 
187 
 
Appendix 11. (Continued) 
30S ribosomal 
protein S11  P66357|RS11 Ref -2.3 -7.6 
Reference 
Missing -2.9 -8.6 
Putative 
uncharacterized 
protein SA0919  
Q7A694|Q7A69
4 Ref 
No 
Values -4.8 -0.4 No Values -4.3 
Phenol-soluble 
modulin alpha 3 
peptide  P0C811|PSMA3 Ref -0.6 
No 
Values 0.3 0 No Values 
Ferritin  Q7A4R2|FTN Ref 
No 
Values 0 No Values No Values 0.3 
Alkyl hydroperoxide 
reductase subunit F  P99118|AHPF Ref 
No 
Values -6.2 
Value 
Missing No Values -6.1 
Anti-sigma-B factor 
antagonist  P66838|RSBV Ref 
No 
Values -3.2 -0.1 No Values -2.9 
Nucleoside 
diphosphate kinase  NDK (+1) Ref -3.7 -9.6 0.2 -5.5 -9.8 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A37
8 Ref 
No 
Values -2.5 
Reference 
Missing 
Reference 
Missing -0.5 
UPF0173 metal-
dependent hydrolase 
SA1529  P99149|Y1529 Ref -14 -19.1 No Values -14.2 -19.5 
Pyridoxal 
biosynthesis lyase 
pdxS  P60798|PDXS Ref 
No 
Values -6.5 -2 No Values -5.9 
Alanine 
dehydrogenase 2  Q99TF4|DHA2 Ref 
No 
Values -5.4 -1.2 No Values -6.9 
Urocanate hydratase  P67417|HUTU Ref 
No 
Values 0 No Values No Values -0.9 
Putative 
uncharacterized 
protein SA2309  
Q7A3I0|Q7A3I
0 Ref 4.7 -3.5 0.5 
Reference 
Missing -3.4 
CTP synthase  P99072|PYRG Ref 0.6 -5.5 0.3 0.6 -5.1 
Putative 8-amino-7-
oxononanoate 
synthase/2-amino-3-
ketobutyrate 
coenzyme A ligase  P60120|BIKB Ref 
No 
Values -23 No Values No Values -24.1 
Threonyl-tRNA 
synthetase  P67585|SYT Ref 
No 
Values 
No 
Values 0.2 No Values No Values 
Probable 
malate:quinone 
oxidoreductase 2  P99115|MQO2 Ref 0 0 No Values 0.2 0.5 
Probable branched-
chain-amino-acid 
aminotransferase  P99138|ILVE Ref 0 0 No Values 0.3 -0.4 
Methionyl-tRNA 
synthetase  P67579|SYM Ref 
No 
Values 0 No Values No Values 0.1 
Tryptophanyl-tRNA 
synthetase  P67593|SYW Ref 0 
No 
Values No Values -3.1 No Values 
Mannitol-1-
phosphate 5-
dehydrogenase  P99140|MTLD Ref 0 
No 
Values No Values 0.7 No Values 
SA1343 protein  
Q7A5G2|Q7A5
G2 Ref 
No 
Values 0 No Values No Values -1.7 
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Staphopain A  P65826|SSPP Ref 
No 
Values 
No 
Values No Values No Values No Values 
UPF0082 protein 
SA0624  P67182|Y624 Ref -2.2 -5.3 0.6 -1.8 -5 
Cell division protein 
ftsZ  P99108|FTSZ Ref 2.5 -3.1 -0.5 3 -3.6 
Adenylosuccinate 
synthetase  P99099|PURA Ref 
No 
Values -5.1 -1.9 No Values -5.2 
Histidine ammonia-
lyase  P64416|HUTH Ref 
No 
Values -9.6 
Reference 
Missing No Values -9.6 
Imidazolonepropiona
se  P64418|HUTI Ref 
No 
Values 0 No Values No Values -1.4 
6-
phosphofructokinase  P99165|K6PF Ref -3.2 
No 
Values 
Reference 
Missing -0.7 No Values 
Lysyl-tRNA 
synthetase  P67610|SYK Ref 
No 
Values -1.3 -1.8 No Values 2.3 
SA1599 protein  
Q7A501|Q7A50
1 Ref 
No 
Values 0 No Values No Values 1.3 
SA0231 protein  
Q7A7W3|Q7A7
W3 Ref 
No 
Values -3.4 -0.2 No Values -3.9 
Phenylalanyl-tRNA 
synthetase beta chain  P67041|SYFB Ref 
No 
Values 0 No Values No Values -1.5 
P60855|Y370_STAA
N P60855|Y370 Ref 
No 
Values 0 No Values No Values -0.7 
50S ribosomal 
protein L23  Q7A459|RL23 Ref 
No 
Values 
No 
Values 0.5 No Values No Values 
Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A6
A3 Ref 3 -2.3 -1 3.6 -2.3 
SA1475 protein  
Q7A581|Q7A58
1 Ref 0 0 No Values 0.7 0.3 
Leucyl-tRNA 
synthetase  P67513|SYL Ref 
No 
Values -6 0.3 No Values -5.8 
Clumping factor A  Q99VJ4|CLFA Ref 0 0 No Values 0.2 
Reference 
Missing 
Acetate-CoA ligase  
Q7A3A2|Q7A3
A2 Ref 0 
No 
Values No Values 0.6 No Values 
Lactonase drp35  
RANDOM_DR
P35-R Ref 0 
No 
Values No Values -1.5 No Values 
50S ribosomal 
protein L2  P60432|RL2 Ref 
No 
Values 0 No Values No Values -0.2 
Glucosamine--
fructose-6-phosphate 
aminotransferase 
[isomerizing]  GLMS Ref 
No 
Values 
No 
Values 
Reference 
Missing No Values No Values 
Putative 
uncharacterized 
protein SA1743  
Q7A4N7|Q7A4
N7 Ref 
No 
Values 0 No Values No Values 0.6 
Cell division protein  
Q7A620|Q7A62
0 Ref 
No 
Values 0 No Values 
Reference 
Missing 0.5 
50S ribosomal 
protein L18  Q7A467|RL18 Ref 
No 
Values -18.9 No Values No Values -18.5 
3-hexulose-6-
phosphate synthase  Q7A774|HPS Ref 
No 
Values 
No 
Values No Values No Values No Values 
Acetoin(diacetyl) 
reductase  P99120|BUTA Ref 
No 
Values 0 No Values No Values -0.2 
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SA0022 protein  
Q99XE9|Q99X
E9 Ref 0 
No 
Values No Values 1.2 No Values 
3-hydroxy-3-
methylglutaryl CoA 
synthase  
Q7A3F6|Q7A3
F6 Ref 
No 
Values 
No 
Values 0.6 No Values No Values 
30S ribosomal 
protein S7  P66616|RS7 Ref -1.5 
No 
Values -0.2 -1.2 No Values 
Uncharacterized 
lipoprotein SA2158  
Q7A3W5|Y215
8 Ref 
No 
Values 
No 
Values 
Reference 
Missing No Values No Values 
Ribonuclease J 1  Q7A682|RNJ1 Ref 
No 
Values 
No 
Values -0.5 No Values No Values 
Trans-2-enoyl-ACP 
reductase  Q7A6D8 Ref 0 
No 
Values No Values 0.7 No Values 
2-C-methyl-D-
erythritol 4-
phosphate 
cytidylyltransferase 
2  Q7A7V0|ISPD2 Ref 
No 
Values 
No 
Values -1.6 No Values No Values 
30S ribosomal 
protein S13  P66388|RS13 Ref 
No 
Values 
No 
Values 
Reference 
Missing No Values No Values 
30S ribosomal 
protein S2  P66544|RS2 Ref 
No 
Values 0 No Values No Values 0.2 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 3  P99159|FABH Ref 
No 
Values 
No 
Values No Values No Values No Values 
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Appendix 12.  Changes in secreted proteins of CA-MRSA USA400 compared to HA-
MRSA USA100 during stationary phase from 3 biological replicates 
 
Identified Proteins 
(246) 
Accession 
Number 
USA10
0 
#1 
USA100 
#2 
USA100 
#3 
USA400 
#1 
USA400 
#2 
USA400 
#3 
Lipase 2  Q7A7P2|LIP2 Ref -0.4 1.6 0.7 2.9 3.7 
Lipase 1  P65289|LIP1 Ref -1 -0.8 1.1 2.5 3.7 
Alpha-Hemolysin  Q7A632|Q7A63
2 
Ref 0.6 0.2 0.5 1 2.5 
Elongation factor Tu  P99152|EFTU Ref -1.8 -6.7 0.9 -1.7 -7.3 
Enolase  P99088|ENO Ref -0.6 -6.6 0.6 -0.8 -6.9 
Putative surface 
protein SA2285  
P61598|PLS Ref -4.6 -9 -4.2 -9.2 -9.7 
Bifunctional 
autolysin  
Q99V41|ATL Ref 0.1 -3.1 -0.2 1.8 -1.8 
SA0841 protein  Q7A6G0|Q7A6
G0 
Ref -1.4 -3 1.5 1.5 1 
Chaperone protein 
dnaK  
P99110|DNAK Ref -3.6 -7 0.4 -3.6 -7.7 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  
P99136|G3P1 Ref -2.5 -5.6 0.4 -2.4 -6.3 
DNA-binding 
protein HU  
Q7A5J1|DBH Ref -1.7 -5.1 0 -2.7 -5.8 
Alkyl hydroperoxide 
reductase subunit C  
P99074|AHPC Ref -4.7 -7 1.2 -6.4 -6 
Inosine-5'-
monophosphate 
dehydrogenase  
P99106|IMDH Ref 0.2 -5.8 0.6 0.5 -6.5 
Immunoglobulin G-
binding protein A  
SPA Ref No 
Values 
0 No Values No Values Value 
Missing 
Formate--
tetrahydrofolate 
ligase  
Q7A535|FTHS Ref -1.6 -7.6 0.5 -2.8 -8.3 
Dihydrolipoyl 
dehydrogenase  
P99084|DLDH Ref -0.7 -7.2 0.8 -0.9 -7.1 
50S ribosomal 
protein L7/L12  
P99154|RL7 Ref -0.2 -7.4 0.4 0.1 -7.6 
Pyruvate kinase  Q7A559|KPYK Ref -4.6 -3.7 0.1 -4.5 -4.2 
SA0587 protein  Q7A719|Q7A71
9 
Ref -1.3 -5 0.9 -0.8 -4.8 
Phosphate 
acetyltransferase  
P99092|PTA Ref -2 -6.2 1.4 -2.1 -6.9 
Elongation factor G  P68789|EFG Ref -1.5 -6.2 1.2 -1.3 -6.2 
Glutamine 
synthetase  
P99095|GLNA Ref -2.4 -6.7 0.4 -2.4 -7.3 
SA2006 protein  Q7A483|Q7A48
3 
Ref 0.3 0.8 1.4 4.1 3.6 
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Fructose-
bisphosphate 
aldolase  
P99075|ALF2 Ref -3.8 -7.4 1.8 -3.8 -8.1 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS Ref -1 -0.5 0.9 -0.1 -1.2 
Alkaline shock 
protein 23  
P99157|ASP23 Ref 2.4 -3.9 2.2 4.1 -2.8 
Triosephosphate 
isomerase  
P99133|TPIS Ref -2 -4 0 -1.7 -4.7 
Enterotoxin type C-3  P0A0L4|ENTC
3 
Ref -5.3 -5.4 4.4 -1.2 0.5 
Dihydrolipoyllysine-
residue 
acetyltransferase 
component of 
pyruvate 
dehydrogenase 
complex  
P65636|ODP2 Ref -0.6 -5.7 -0.7 -2.3 -6.4 
Cysteine synthase  P63871|CYSK Ref -0.6 -5.1 1.1 -0.3 -5.1 
Elongation factor Ts  P99171|EFTS Ref 2.5 -5 0.7 2.7 -5.7 
Pyruvate 
dehydrogenase E1 
component subunit 
alpha  
Q820A6|ODPA Ref -5.5 -9.6 0.5 -7.2 -10.3 
Putative 
uncharacterized 
protein SA0663  
Q7A6V1|Q7A6
V1 
Ref 0.1 -0.2 0.3 4.2 3.2 
Ornithine 
aminotransferase 2  
P60298|OAT2 Ref -3.2 -9.4 0.9 -4.4 -9.7 
Staphopain B  Q7A6A7|SSPB Ref -5.1 -3.5 0 -3 -0.5 
Succinyl-CoA ligase 
[ADP-forming] 
subunit beta  
P99071|SUCC Ref -1.6 -6.2 0 -2.2 -6.6 
Phosphocarrier 
protein HPr  
P99143|PTHP Ref 1.1 -5.6 0.8 1.9 -6.3 
Putative 
uncharacterized 
protein SA0359  
Q7A7J8|Q7A7J
8 
Ref -5.8 -6.1 0.9 -2.6 -3.5 
Thermonuclease  Q7A6P2|NUC Ref 1.6 -0.9 1.2 2.4 0.7 
Trigger factor  P99080|TIG Ref -1.3 -4.9 -0.2 -1 -5 
Aconitate hydratase  P99148|ACON Ref -0.1 -4.9 0.9 0.8 -5.2 
Adenylate kinase  P99062|KAD Ref -3.1 -4.8 0.4 -3.3 -5.5 
Fructose-
bisphosphate 
aldolase class 1  
P99117|ALF1 Ref -2.3 -6.6 0.4 -2.3 -7.2 
50S ribosomal 
protein L17  
Q7A469|RL17 Ref 1.2 -3.6 1.4 1.5 -3.7 
Glutamyl 
endopeptidase  
Q7A6A6|SSPA Ref -1.7 -3.3 2.7 1.3 1 
SA0620 protein  Q7A6Y9|Q7A6
Y9 
Ref -0.1 -2.2 2.2 2.1 2.9 
60 kDa chaperonin  P99083|CH60 Ref -1.3 -5.4 0.9 -1.4 -5.8 
Probable beta-
lactamase  
Q7A4X8|Q7A4
X8 
Ref 0.8 No 
Values 
2.9 0.4 No Values 
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Putative 
uncharacterized 
protein SA0570  
Q7A735|Q7A73
5 
Ref 0.1 -3.9 0.9 2.9 -1.5 
Alcohol 
dehydrogenase  
Q7A742|ADH Ref -0.4 -4.8 0.5 -0.7 -5.1 
Catalase  Q7A5T2|CATA Ref -3.8 -6.9 Reference 
Missing 
-5.3 -7.6 
SA2097 protein  Q7A418|Q7A41
8 
Ref -1.4 -2.7 0.3 -0.1 -2.1 
Penicillin binding 
protein 2 prime  
Q7A8C6|Q7A8
C6 
Ref -4.4 -6.8 1 -3.5 -5.8 
Putative 
uncharacterized 
protein SAP003  
Q9AC87|Q9AC
87 
Ref 3.5 -6.8 -0.1 5.3 -7.5 
Probable thiol 
peroxidase  
P99146|TPX Ref 0.7 -6 3.1 -1.7 -6.7 
30S ribosomal 
protein S1  
Q7A5J0|RS1 Ref -0.9 -5.3 2 -1.2 -5.7 
L-lactate 
dehydrogenase 1  
P65256|LDH1 Ref 2.2 -1.1 1.5 3.5 0.1 
Phosphoglycerate 
kinase  
P99135|PGK Ref -1.6 -5.4 1.1 -0.5 -5.3 
Glucose-6-phosphate 
isomerase  
P99078|G6PI Ref -1.5 -5.4 0.9 -2.1 -5.8 
Transketolase  P99161|TKT Ref -1.9 -5.5 0.6 -2.3 -5.9 
Pyruvate 
dehydrogenase E1 
component subunit 
beta  
P99063|ODPB Ref No 
Values 
-8.1 0.6 Reference 
Missing 
-8.7 
Glycerophosphoryl 
diester 
phosphodiesterase  
Q7A6H7|Q7A6
H7 
Ref -2.9 -4.4 1 -2.6 -4.1 
Delta-hemolysin  P0A0M2|HLD Ref -2.5 No 
Values 
1.6 -0.3 No Values 
Phenol-soluble 
modulin alpha 4 
peptide  
P0C824|PSMA4 Ref -2.3 0.1 2.4 1.9 4 
Foldase protein prsA  P60748|PRSA Ref -3.3 -5.7 1.7 -1.9 -4.9 
Glycyl-glycine 
endopeptidase lytM  
Q7A7T0|LYTM Ref -0.3 -0.9 0.8 1.9 2.5 
Thioredoxin  P99122|THIO Ref 0.2 -4.6 -0.2 0.6 -5.4 
SA2437 protein  Q7A371|Q7A37
1 
Ref -10 -8.7 Reference 
Missing 
-8.2 -6.9 
UPF0477 protein 
SA0873  
Q7A6D4|Y873 Ref -4.7 -5.9 1.3 -5.4 -5.5 
Citrate synthase II  Q7A561|Q7A56
1 
Ref 5.5 -5.8 0.2 8.2 -6.5 
6-phosphogluconate 
dehydrogenase, 
decarboxylating  
P63334|6PGD Ref -0.9 -4.1 0.9 -0.5 -3.9 
Superoxide 
dismutase [Mn/Fe] 1  
P99098|SODM1 Ref -4.7 -7.7 0.9 -3.9 -8 
Phenol-soluble 
modulin alpha 1 
peptide  
P0C7Y7|PSMA
1 
Ref -5.3 -4.2 3.9 -1.1 0.2 
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Phosphoenolpyruvat
e carboxykinase 
[ATP]  
P99128|PCKA Ref -0.6 -8.4 1.1 -4.7 -9.1 
Probable 
transglycosylase 
isaA  
P99160|ISAA Ref -2.4 -4.1 0.9 -2.9 -4.6 
Glycyl-tRNA 
synthetase  
P99129|SYG Ref -0.3 -1.7 -0.5 -3.9 -0.8 
DNA-directed RNA 
polymerase subunit 
beta'  
P60285|RPOC Ref -2.4 -3.7 0.2 -2.4 -4.5 
Glycine cleavage 
system H protein  
P64214|GCSH Ref 0.9 -6.8 0.1 1.2 -6.8 
50S ribosomal 
protein L30  
P0A0G0|RL30 Ref 0.8 0.7 0.2 -0.1 1.4 
Cold shock protein 
cspA  
Q7A5P3|CSPA Ref No 
Values 
-3.9 No Values No Values -4.6 
Serine protease splB  Q7A4Y1|SPLB Ref -0.2 -4.1 0.6 1.5 -2.2 
DNA-directed RNA 
polymerase subunit 
beta  
P60278|RPOB Ref No 
Values 
-6.1 0.5 No Values -5.8 
2,3-
bisphosphoglycerate-
dependent 
phosphoglycerate 
mutase  
P99153|GPMA Ref No 
Values 
-3.4 1.4 No Values -3.9 
Dihydrolipoyllysine-
residue 
succinyltransferase 
component of 2-
oxoglutarate 
dehydrogenase 
complex  
Q7A5N4|ODO2 Ref -5.2 -4.6 0.3 -7.1 -4.7 
Seryl-tRNA 
synthetase  
P99178|SYS Ref -6.1 -9.3 0.6 -7.6 -9.3 
NAD-specific 
glutamate 
dehydrogenase  
Q7A6H8|DHE2 Ref -2.1 -3 0.5 -2.9 -3.4 
Succinyl-CoA ligase 
[ADP-forming] 
subunit alpha  
P99070|SUCD Ref -16.8 -25.2 No Values -17.9 -25.7 
Uncharacterized 
leukocidin-like 
protein 1  
Q7A4L0|LUKL
1 
Ref 1.8 1.4 1.9 3.9 3.3 
Acyl carrier protein  P0A002|ACP Ref -2.5 -2.9 2 -2.5 Value 
Missing 
50S ribosomal 
protein L21  
Q7A583|RL21 Ref 1.8 -5.2 Reference 
Missing 
3 -5.9 
UPF0337 protein 
SA0772  
Q7A6L9|Y772 Ref -2.6 -3.3 No Values -2.1 -3.9 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 2  
Q7A6F8|FABF Ref -2.6 -3.1 Reference 
Missing 
-2.7 -2 
50S ribosomal 
protein L9  
P66318|RL9 Ref -3.2 -6.4 0.4 -3.5 -6.8 
Beta-lactamase  Q9AC80|Q9AC
80 
Ref 0.3 -1.8 1.1 2.1 -0.6 
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Thioredoxin 
reductase  
P99101|TRXB Ref No 
Values 
-7.7 Value 
Missing 
No Values -8.5 
Putative dipeptidase 
SA1572  
Q7A522|PEPV
L 
Ref -5.8 -9.3 Reference 
Missing 
-5.1 -10 
SA0916 protein  Q7A696|Q7A69
6 
Ref -3.9 -4.7 Reference 
Missing 
Value 
Missing 
0.9 
Phosphoenolpyruvat
e-protein 
phosphotransferase  
Q99V14|PT1 Ref 0 -5.4 0.7 0.1 -4.4 
30S ribosomal 
protein S9  
P66646|RS9 Ref 2.5 -6.4 0.9 Value 
Missing 
-6.2 
Uncharacterized 
protein SA1692  
P0A0K1|Y1692 Ref -0.3 -1.9 1.7 1.9 -0.7 
50S ribosomal 
protein L11  
P0A0F2|RL11 Ref -0.6 -5.9 0.5 -2.4 -5.7 
Putative universal 
stress protein 
SA1532  
Q7A551|Y1532 Ref 0.6 -2 1.6 1.4 -1.6 
1-pyrroline-5-
carboxylate 
dehydrogenase  
P99076|ROCA Ref -1 -4.6 -0.3 -3.7 -5.1 
Gamma-hemolysin 
component C  
Q7A3S2|HLGC Ref -5.4 -5.2 -0.4 -1.7 -1.3 
Serine-aspartate 
repeat-containing 
protein D  
Q7A780|SDRD Ref 0 0 No Values -2.8 -0.4 
Glutamyl-tRNA 
synthetase  
P99170|SYE Ref -2.6 -7.5 2.3 -3.4 -7.8 
2,3-
bisphosphoglycerate-
independent 
phosphoglycerate 
mutase  
P64270|GPMI Ref 1.2 -4.5 -0.7 Reference 
Missing 
-5 
D-lactate 
dehydrogenase  
P99116|LDHD Ref No 
Values 
0 No Values No Values -0.7 
50S ribosomal 
protein L10  
P99155|RL10 Ref 2.6 -5 1 3.9 -4.4 
SA2202 protein  Q99RL6|Q99R
L6 
Ref -0.1 -2.5 -0.4 0.6 -1.7 
Gamma-hemolysin 
component A  
P0A072|HLGA Ref 2.2 No 
Values 
0.8 6.3 No Values 
10 kDa chaperonin  P99104|CH10 Ref -2.1 -5.9 0.7 -1.6 -5.9 
Dihydroorotase  P65906|PYRC Ref -1.6 -3.8 0.4 -0.7 -4.2 
UPF0457 protein 
SA1975.1  
Q99S93|Y197A Ref -1.5 -5.6 No Values -1.2 -5 
Ribosome-recycling 
factor  
P99130|RRF Ref -2.6 -4.7 Reference 
Missing 
-2.2 -3.7 
Elongation factor P  P99066|EFP Ref -1 -5.3 1.4 -1.6 -5 
Uncharacterized 
leukocidin-like 
protein 2  
Q99SN7|LUKL
2 
Ref 0.6 No 
Values 
0.7 3.1 No Values 
UPF0355 protein 
SA0372  
Q7A7I6|UP355 Ref -1.6 -4.6 Reference 
Missing 
-0.2 -4.1 
Acetate kinase  Q99TF2|ACKA Ref 2.6 -2.1 0 2.9 -0.2 
Elastin-binding 
protein ebpS  
Q7A5I6|EBPS Ref -2.6 -5 4.4 -1.3 -2.5 
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30S ribosomal 
protein S6  
P99142|RS6 Ref No 
Values 
-2.2 2 No Values Value 
Missing 
General stress 
protein 20U  
Q7A4C8|Q7A4
C8 
Ref -0.9 -1.4 Value 
Missing 
-0.6 2.4 
50S ribosomal 
protein L24  
P60735|RL24 Ref -2.7 -7.6 Reference 
Missing 
-3.6 -8 
Bifunctional protein 
folD  
Q7A697|FOLD Ref No 
Values 
-0.3 0.3 No Values Value 
Missing 
50S ribosomal 
protein L22  
Q7A460|RL22 Ref -2 -4.7 1.8 0.8 -3.7 
Putative 
uncharacterized 
protein SAS040  
Q7A5U6|Q7A5
U6 
Ref -2.5 -8 0.2 -2.3 -8.5 
Gamma-hemolysin 
component B  
P0A075|HLGB Ref 1 No 
Values 
0.4 4.5 No Values 
Putative 
uncharacterized 
protein SA0395  
Q99WG7|Q99
WG7 
Ref No 
Values 
No 
Values 
1.2 Reference 
Missing 
No Values 
Putative peptidyl-
prolyl cis-trans 
isomerase  
Q7A6I1|PPI1 Ref 2.4 0.1 -1.2 6.5 Value 
Missing 
50S ribosomal 
protein L1  
Q99W68|RL1 Ref No 
Values 
-2.8 2 Reference 
Missing 
-1.6 
Virulence factor 
esxA  
ESXA (+1) Ref -0.5 No 
Values 
-0.2 1.2 No Values 
ATP-dependent Clp 
protease ATP-
binding subunit clpC  
Q7A797|CLPC Ref 1.9 -4.7 0.1 5.5 -3.7 
SA0914 protein  Q99V35|Q99V3
5 
Ref 2.4 -3.6 1.5 4.9 -2.1 
30S ribosomal 
protein S16  
P66440|RS16 Ref -1.5 -8.5 No Values -1.2 -9.2 
Translation initiation 
factor IF-1  
P65119|IF1 Ref -5.8 -9.1 Reference 
Missing 
-8 -8.2 
DNA-directed RNA 
polymerase subunit 
alpha  
P66706|RPOA Ref -1.1 -5.9 0.2 -2.6 -4.9 
Truncated beta-
hemplysin  
Q99QR7|Q99Q
R7 
Ref -19.6 No 
Values 
No Values -19.4 No Values 
Deoxyribose-
phosphate aldolase 1  
P99102|DEOC1 
(+1) 
Ref -3 -4.4 1 -2.3 -4.1 
Pyruvate carboxylase  Q7A666|Q7A66
6 
Ref 0 0 No Values -1.5 -0.7 
Uncharacterized 
protein SA0829  
Q7A6H3|Y829 Ref -6.5 No 
Values 
Reference 
Missing 
-9 No Values 
Probable acetyl-CoA 
acyltransferase  
Q7A7L2|THLA Ref -2.7 No 
Values 
Reference 
Missing 
-2.1 No Values 
Protein grpE  P99086|GRPE Ref -3.6 -4.6 1.3 -4.6 -4.1 
50S ribosomal 
protein L3  
P60449|RL3 Ref No 
Values 
No 
Values 
Value 
Missing 
No Values No Values 
ATP synthase 
subunit beta  
P99112|ATPB Ref -1.6 -5.5 1.1 -1.5 -5.4 
Uncharacterized 
protein SA0707  
Q7A6R6|Y707 Ref -2.5 -5.2 Reference 
Missing 
-2.4 -5.9 
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Glucose-specific 
phosphotransferase 
enzyme IIA 
component  
P60857|PTGA Ref No 
Values 
0 No Values Reference 
Missing 
0.2 
Transcription 
elongation factor 
greA  
P99156|GREA Ref -2.1 -3.6 2 -1.7 -4.4 
SA0758 protein  Q7A6M7 Ref -0.3 -3.9 0.3 -2.4 -4.7 
Chaperone protein 
hchA  
P64313|HCHA Ref 3 No 
Values 
0.5 5.6 No Values 
50S ribosomal 
protein L5  
Q7A465|RL5 Ref -0.6 No 
Values 
1.2 2.7 No Values 
Serine 
hydroxymethyltransf
erase  
P99091|GLYA Ref -4 -8 -0.2 -4.1 -8.8 
Methionine 
aminopeptidase  
AMPM Ref -5.7 -9.4 -0.1 -6.5 -9.3 
50S ribosomal 
protein L15  
P0A0F6|RL15 Ref 0.9 -4.1 1.5 1.1 -2.8 
ATP-dependent Clp 
protease ATP-
binding subunit clpL  
Q7A3F4|CLPL Ref -0.4 -7.4 1.6 1.4 -5.4 
UPF0342 protein 
SA1663  
Q7A4V3|Y1663 Ref -2.4 -3.6 1.3 -1.2 -4.3 
SA0759 protein  Q7A6M6|Q7A6
M6 
Ref 1.8 -3.2 Reference 
Missing 
3.2 -2.6 
Staphylokinase  Q99SU7|SAK Ref 0.8 -1.5 -0.9 2.9 -1.2 
Iron-regulated 
surface determinant 
protein A  
Q7A655|ISDA Ref No 
Values 
-4.7 2 No Values -2.8 
Serine-aspartate 
repeat-containing 
protein E  
Q99W46|SDRE Ref 0 0 No Values 0.3 -0.7 
Leukotoxin, LukD  Q99T54|Q99T5
4 
Ref No 
Values 
No 
Values 
No Values Reference 
Missing 
No Values 
Amidophosphoribos
yltransferase  
P99164|PUR1 Ref No 
Values 
No 
Values 
0.2 No Values No Values 
SA0859 protein  Q7A6E5|Q7A6
E5 
Ref No 
Values 
-6.3 No Values No Values -7.1 
Phosphoribosylform
ylglycinamidine 
synthase 1  
P99166|PURQ Ref No 
Values 
No 
Values 
No Values No Values No Values 
Staphylococcal 
complement 
inhibitor  
Q99SU9|SCIN Ref No 
Values 
-1.8 Reference 
Missing 
No Values 0 
Uncharacterized N-
acetyltransferase 
SA1019  
Q99UT4|Y1019 Ref -2.5 -4.4 1.8 -2.5 -3.2 
50S ribosomal 
protein L27  
P66133|RL27 Ref No 
Values 
-6.7 2.7 No Values -6.5 
Adenylosuccinate 
lyase  
Q7A4Q3|PUR8 Ref 0 0 No Values 0 0.1 
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Naphthoate synthase  Q7A6A9|MEN
B 
Ref -8.8 No 
Values 
No Values -11.1 No Values 
Putative 
uncharacterized 
protein SA0771  
Q7A6M0|Q7A6
M0 
Ref -1.3 -2.8 0.9 -1.2 -1.9 
Xaa-Pro dipeptidase  Q99TW4|Q99T
W4 
Ref -5.1 -8 Reference 
Missing 
-3.2 -7 
1-
phosphatidylinositol 
phosphodiesterase 
precurosr  
Q7A888|Q7A88
8 
Ref 0.7 No 
Values 
0 2.9 No Values 
Probable glycine 
dehydrogenase 
[decarboxylating] 
subunit 1  
P64218|GCSPA Ref No 
Values 
0 No Values No Values -0.4 
Putative aldehyde 
dehydrogenase AldA  
Q7A825|ALDA Ref No 
Values 
0 No Values No Values 0.5 
L-lactate 
dehydrogenase 2  
P99119|LDH2 Ref 1.4 -4 0.6 2.5 -3.4 
Formate 
acetyltransferase  
Q7A7X6|PFLB Ref -1.2 -4.1 2.1 -1 -3.4 
Signal transduction 
protein TRAP  
Q7A4W3|TRAP Ref -0.6 0 2.1 0.3 1.3 
Purine nucleoside 
phosphorylase  
Q7A4C9|Q7A4
C9 
Ref No 
Values 
No 
Values 
-0.4 No Values No Values 
Arginyl-tRNA 
synthetase  
Q99W05|SYR Ref No 
Values 
-7.3 1.3 No Values -7.8 
50S ribosomal 
protein L13  
Q7A473|RL13 Ref -1.3 No 
Values 
2.4 -0.3 No Values 
Probable 
transglycosylase 
sceD  
Q7A4F2|SCED Ref 0 No 
Values 
No Values -0.6 No Values 
Organic 
hydroperoxide 
resistance protein-
like  
Q7A6M9|OHR
L 
Ref -1.8 No 
Values 
Reference 
Missing 
-0.5 No Values 
Serine protease splD  Q7A4Y3|SPLD Ref No 
Values 
No 
Values 
-0.2 No Values No Values 
Putative 
uncharacterized 
protein SA1986  
Q7A493|Q7A49
3 
Ref No 
Values 
No 
Values 
0.4 No Values No Values 
D-alanine--
poly(phosphoribitol) 
ligase subunit 2  
P0A019|DLTC Ref -2.5 -5.9 0.6 -1.2 -6.4 
Immunoglobulin-
binding protein sbi  
Q99RL2|SBI Ref -3.3 -6.8 0.7 -2.9 -6.7 
Putative 
uncharacterized 
protein SA1528  
Q7A553|Q7A55
3 
Ref 1.7 No 
Values 
1 2.3 No Values 
GMP synthase 
[glutamine-
hydrolyzing]  
P99105|GUAA Ref No 
Values 
-5.9 0.4 No Values Value 
Missing 
SA1524 protein  Q7A556|Q7A55
6 
Ref 1.6 -3.1 0.1 Value 
Missing 
-3.5 
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30S ribosomal 
protein S11  
P66357|RS11 Ref -2.3 -7.6 Reference 
Missing 
-3 -8.3 
Putative 
uncharacterized 
protein SA0919  
Q7A694|Q7A69
4 
Ref No 
Values 
-4.8 1.5 No Values -2.7 
Phenol-soluble 
modulin alpha 3 
peptide  
P0C811|PSMA3 Ref -0.6 No 
Values 
3.6 3 No Values 
Ferritin  Q7A4R2|FTN Ref No 
Values 
0 No Values No Values 0.2 
Alkyl hydroperoxide 
reductase subunit F  
P99118|AHPF Ref No 
Values 
-6.2 Value 
Missing 
No Values -5.6 
Anti-sigma-B factor 
antagonist  
P66838|RSBV Ref No 
Values 
-3.2 1.4 No Values -2.1 
Nucleoside 
diphosphate kinase  
NDK (+1) Ref -3.7 -9.6 1.8 -5.5 -9.4 
Zinc 
metalloproteinase 
aureolysin  
Q7A378|Q7A37
8 
Ref No 
Values 
-2.5 Reference 
Missing 
Reference 
Missing 
1 
UPF0173 metal-
dependent hydrolase 
SA1529  
P99149|Y1529 Ref -14 -19.1 No Values -13.7 Value 
Missing 
Pyridoxal 
biosynthesis lyase 
pdxS  
P60798|PDXS Ref No 
Values 
-6.5 0.8 No Values -5.2 
Alanine 
dehydrogenase 2  
Q99TF4|DHA2 Ref No 
Values 
-5.4 0.1 No Values Value 
Missing 
Urocanate hydratase  P67417|HUTU Ref No 
Values 
0 No Values No Values 0.2 
Putative 
uncharacterized 
protein SA2309  
Q7A3I0|Q7A3I
0 
Ref 4.7 -3.5 0.5 Reference 
Missing 
Value 
Missing 
CTP synthase  P99072|PYRG Ref 0.6 -5.5 0.7 0.5 -4.5 
Putative 8-amino-7-
oxononanoate 
synthase/2-amino-3-
ketobutyrate 
coenzyme A ligase  
P60120|BIKB Ref No 
Values 
-23 No Values No Values -23.5 
Threonyl-tRNA 
synthetase  
P67585|SYT Ref No 
Values 
No 
Values 
0.1 No Values No Values 
Probable 
malate:quinone 
oxidoreductase 2  
P99115|MQO2 Ref 0 0 No Values 0.1 0.7 
Probable branched-
chain-amino-acid 
aminotransferase  
P99138|ILVE Ref 0 0 No Values 0 -0.7 
Methionyl-tRNA 
synthetase  
P67579|SYM Ref No 
Values 
0 No Values No Values -0.4 
Tryptophanyl-tRNA 
synthetase  
P67593|SYW Ref 0 No 
Values 
No Values Value 
Missing 
No Values 
Mannitol-1-
phosphate 5-
dehydrogenase  
P99140|MTLD Ref 0 No 
Values 
No Values 0.8 No Values 
SA1343 protein  Q7A5G2|Q7A5
G2 
Ref No 
Values 
0 No Values No Values -0.7 
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Staphopain A  P65826|SSPP Ref No 
Values 
No 
Values 
No Values No Values No Values 
UPF0082 protein 
SA0624  
P67182|Y624 Ref -2.2 -5.3 1.3 -1.9 -5.4 
Cell division protein 
ftsZ  
P99108|FTSZ Ref 2.5 -3.1 1.9 3.8 Value 
Missing 
Adenylosuccinate 
synthetase  
P99099|PURA Ref No 
Values 
-5.1 -0.5 No Values -4.8 
Histidine ammonia-
lyase  
P64416|HUTH Ref No 
Values 
-9.6 Reference 
Missing 
No Values -9.8 
Imidazolonepropiona
se  
P64418|HUTI Ref No 
Values 
0 No Values No Values -0.7 
6-
phosphofructokinase  
P99165|K6PF Ref -3.2 No 
Values 
Reference 
Missing 
-1.2 No Values 
Lysyl-tRNA 
synthetase  
P67610|SYK Ref No 
Values 
-1.3 -0.4 No Values 3.5 
SA1599 protein  Q7A501|Q7A50
1 
Ref No 
Values 
0 No Values No Values 1.5 
SA0231 protein  Q7A7W3|Q7A7
W3 
Ref No 
Values 
-3.4 Value 
Missing 
No Values -3.8 
Phenylalanyl-tRNA 
synthetase beta chain  
P67041|SYFB Ref No 
Values 
0 No Values No Values -0.7 
P60855|Y370_STAA
N 
P60855|Y370 Ref No 
Values 
0 No Values No Values -0.7 
50S ribosomal 
protein L23  
Q7A459|RL23 Ref No 
Values 
No 
Values 
1.2 No Values No Values 
Putative 
uncharacterized 
protein SA0908  
Q7A6A3|Q7A6
A3 
Ref 3 -2.3 1.5 5 -1.1 
SA1475 protein  Q7A581|Q7A58
1 
Ref 0 0 No Values 3.1 0.7 
Leucyl-tRNA 
synthetase  
P67513|SYL Ref No 
Values 
-6 0.9 No Values -6.1 
Clumping factor A  Q99VJ4|CLFA Ref 0 0 No Values 0.7 Value 
Missing 
Acetate-CoA ligase  Q7A3A2|Q7A3
A2 
Ref 0 No 
Values 
No Values -0.2 No Values 
Lactonase drp35  RANDOM_DR
P35-R 
Ref 0 No 
Values 
No Values Value 
Missing 
No Values 
50S ribosomal 
protein L2  
P60432|RL2 Ref No 
Values 
0 No Values No Values 0.1 
Glucosamine--
fructose-6-phosphate 
aminotransferase 
[isomerizing]  
GLMS Ref No 
Values 
No 
Values 
No Values No Values No Values 
Putative 
uncharacterized 
protein SA1743  
Q7A4N7|Q7A4
N7 
Ref No 
Values 
0 No Values No Values 2 
Cell division protein  Q7A620|Q7A62
0 
Ref No 
Values 
0 No Values Reference 
Missing 
0.7 
50S ribosomal 
protein L18  
Q7A467|RL18 Ref No 
Values 
-18.9 No Values No Values -19.2 
3-hexulose-6-
phosphate synthase  
Q7A774|HPS Ref No 
Values 
No 
Values 
No Values No Values No Values 
Acetoin(diacetyl) 
reductase  
P99120|BUTA Ref No 
Values 
0 No Values No Values 0.5 
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Appendix 12. (Continued) 
SA0022 protein  Q99XE9|Q99X
E9 
Ref 0 No 
Values 
No Values 1.4 No Values 
3-hydroxy-3-
methylglutaryl CoA 
synthase  
Q7A3F6|Q7A3
F6 
Ref No 
Values 
No 
Values 
0.5 No Values No Values 
30S ribosomal 
protein S7  
P66616|RS7 Ref -1.5 No 
Values 
0.8 0.3 No Values 
Uncharacterized 
lipoprotein SA2158  
Q7A3W5|Y215
8 
Ref No 
Values 
No 
Values 
No Values No Values No Values 
Ribonuclease J 1  Q7A682|RNJ1 Ref No 
Values 
No 
Values 
-0.5 Reference 
Missing 
No Values 
Trans-2-enoyl-ACP 
reductase  
Q7A6D8 Ref 0 No 
Values 
No Values 1.2 No Values 
2-C-methyl-D-
erythritol 4-
phosphate 
cytidylyltransferase 
2  
Q7A7V0|ISPD2 Ref No 
Values 
No 
Values 
0.7 No Values No Values 
30S ribosomal 
protein S13  
P66388|RS13 Ref No 
Values 
No 
Values 
Reference 
Missing 
No Values No Values 
30S ribosomal 
protein S2  
P66544|RS2 Ref No 
Values 
0 No Values No Values 0.9 
3-oxoacyl-[acyl-
carrier-protein] 
synthase 3  
P99159|FABH Ref No 
Values 
No 
Values 
No Values No Values No Values 
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Appendix 13.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
6.97556
2 
0.483219009 6.927312411 0.2789866
2 
Bifunctional autolysin Q99V41|ATL_STAAN 5.10456
9 
0.956585247 18.73978299 0.5522847
5 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 4.94771
9 
0.572118202 11.56327181 0.3303125
9 
Lipase 1  P65289|LIP1_STAAN 5.20026
7 
0.790831535 15.20751659 0.4565868 
Lipase 2  Q7A7P2|LIP2_STAAN 6.21763
0 
0.485646794 7.810801323 0.2803883
0 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
18.7176
8 
4.147290327 22.15706589 2.3944391
8 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 1.46850
5 
0.299009925 20.36151418 0.1726334
6 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 0.15786
1 
0.043353443 27.46291637 0.0250301
2 
SA0841 protein  Q7A6G0|Q7A6G0_STA
AN 
19.0509
2 
3.570102378 18.73978299 2.0611995
6 
Thermonuclease  Q7A6P2|NUC_STAAN 5.17655
9 
0.538252457 10.39787968 0.3107602
0 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 1.42085
9 
0.164297809 11.56327181 0.0948573
8 
Relative Standard Deviation 
Average 
15.53919237 
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Appendix 14.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
1.55197
9 
0.062808912 4.047019914 0.0362627
4 
Bifunctional autolysin Q99V41|ATL_STAAN 1.07338
2 
0.273251875 25.45708615 0.1577620
4 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 0.81606
9 
0.094364312 11.56327181 0.0544812
6 
Lipase 1  P65289|LIP1_STAAN 1.26257
1 
0.098616943 7.810801323 0.0569365
1 
Lipase 2  Q7A7P2|LIP2_STAAN 1.70502
5 
0.139465418 8.179669083 0.0805203
9 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
3.49856
5 
0.40454866 11.56327181 0.2335662
7 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 0.75190
4 
0.163402663 21.73185194 0.0943405
7 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.09079
6 
0.00975663 10.74561596 0.0056329
9 
SA0841 protein  Q7A6G0|Q7A6G0_STAA
N 
3.32674
0 
0.13463385 4.047019914 0.0777308
8 
Thermonuclease  Q7A6P2|NUC_STAAN 2.16692
8 
0.377881349 17.43856716 0.2181698
9 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 1.13177
3 
0.17211471 15.20751659 0.0993704
7 
    Relative Standard 
Deviation Average 
12.52651742 
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Appendix 15.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
11.3863 1.574696933 13.82975009 0.9091516
9 
Bifunctional autolysin Q99V41|ATL_STAAN 2.31777 0.703685578 30.36035003 0.4062730
5 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 3.06652 0.58416065 19.04959703 0.3372653
0 
Lipase 1  P65289|LIP1_STAAN 6.45108 1.345409444 20.85556249 0.7767725
0 
Lipase 2  Q7A7P2|LIP2_STAAN 5.66591 0.392495798 6.927312411 0.2266075
5 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
8.42533 2.547636686 30.23782481 1.4708787
2 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 1.26059 0.051016689 4.047019914 0.0294544
9 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.09355 0.02793254 29.85727152 0.0161268
5 
SA0841 protein  Q7A6G0|Q7A6G0_STAA
N 
6.13305 1.168321299 19.04959703 0.6745306
1 
Thermonuclease  Q7A6P2|NUC_STAAN 4.42601 0.737871913 16.67126423 0.4260105
4 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 0.9137 0.074737667 8.179669083 0.0431498
1 
    Relative Standard Deviation 
Average 
    18.09683806 
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Appendix 16.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
20.6408 0.816267 3.954618 0.471272 
Bifunctional autolysin Q99V41|ATL_STAAN 3.60024 0.636098 17.66821 0.367252 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 
3.48220 0 0 0 
Lipase 1  P65289|LIP1_STAAN 12.7267 1.041007 8.179669 0.601025 
Lipase 2  Q7A7P2|LIP2_STAAN 8.29239 1.553977 18.73978 0.897189 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
5.92752 0.234411 3.954618 0.135337 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 0.89696 0.125036 13.93987 0.072189 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.21798 0.015101 6.927312 0.008718 
SA0841 protein  Q7A6G0|Q7A6G0_STAA
N 
6.13305 1.168321 19.0496 0.674531 
Thermonuclease  Q7A6P2|NUC_STAAN 10.4798 2.185624 20.85556 1.261871 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 1.10097 0.118306 10.74562 0.068304 
 
 
  Relative Standard Deviation 
Average 
 
 
  11.27408 
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Appendix 17.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
12.4560 1.338483 10.74562 0.772773 
Bifunctional autolysin Q99V41|ATL_STAAN 1.15527 0.538799 46.63829 0.311076 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 3.41005 0.278931 8.179669 0.161041 
Lipase 1  P65289|LIP1_STAAN 14.2620 0.577188 4.04702 0.33324 
Lipase 2  Q7A7P2|LIP2_STAAN 15.8009 4.717723 29.85727 2.723778 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STA
AN 
4.40974 1.812254 41.09659 1.046306 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 0.33369 0.063568 19.0496 0.036701 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 0.1252 0.008673 6.927312 0.005007 
SA0841 protein  Q7A6G0|Q7A6G0_STA
AN 
8.46258 1.44561 17.08238 0.834623 
Thermonuclease  Q7A6P2|NUC_STAAN 7.36710 1.258477 17.08238 0.726582 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 2.05105 0.160204 7.810801 0.092494 
    Relative Standard Deviation 
Average 
    18.95608 
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Appendix 18.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 
4.25341 0.924345 21.73185 0.533671 
Bifunctional autolysin 
Q99V41|ATL_STAAN 
0.47842 0.037369 7.810801 0.021575 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 
0.41789 0.11444 27.38478 0.066072 
Lipase 1  
P65289|LIP1_STAAN 
2.25452 0.672825 29.84336 0.388456 
Lipase 2  
Q7A7P2|LIP2_STAAN 
1.74389 0.120805 6.927312 0.069747 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STA
AN 
1.10097 0.118306 10.74562 0.068304 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 
0.17882 0.034065 19.0496 0.019667 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 
0.06506 0.015199 23.35989 0.008775 
SA0841 protein  
Q7A6G0|Q7A6G0_STA
AN 
1.29216 0.105695 8.179669 0.061023 
Thermonuclease  
Q7A6P2|NUC_STAAN 
0.87194 0.060402 6.927312 0.034873 
Least Abundant Protein 
Enolase  
P99088|ENO_STAAN 
0.40873 0.056527 13.82975 0.032636 
 
 
  
Relative Standard Deviation 
Average 
 
 
  
15.9809 
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Appendix 19.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
1.01446 0.20982 20.68284 0.12114 
Bifunctional autolysin Q99V41|ATL_STAAN 2.17455 0.44976 20.68284 0.259669 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 1.13374 0.193671 17.08238 0.111816 
Lipase 1  P65289|LIP1_STAAN 1.05598 0.160589 15.20752 0.092716 
Lipase 2  Q7A7P2|LIP2_STAAN 3.41005 0.278931 8.179669 0.161041 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
1.09741 0.044413 4.04702 0.025642 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 0.58809 0.0238 4.04702 0.013741 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.13222 0.022588 17.08238 0.013041 
SA0841 protein  Q7A6G0|Q7A6G0_STAA
N 
1.48431 0.121412 8.179669 0.070097 
Thermonuclease  Q7A6P2|NUC_STAAN 1.67714 0.279601 16.67126 0.161428 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 0.93762 0.116176 12.39047 0.067074 
    Relative Standard Deviation 
Average 
    13.11391 
  
208 
 
 
 
 
Appendix 20.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from post-exponential phase 
 
Ten Most Abundant 
Proteins Accession Number 
Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 1.26468 0.135898 10.74562 0.078461 
Bifunctional autolysin Q99V41|ATL_STAAN 0.85670 0.127044 14.82936 0.073349 
Glycerol phosphate 
lipoteichoic acid 
synthase  Q7A6U1|LTAS_STAAN 3.11402 0.334621 10.74562 0.193193 
Lipase 1  P65289|LIP1_STAAN 10.5729 0.732423 6.927312 0.422865 
Lipase 2  Q7A7P2|LIP2_STAAN 3.32674 0.134634 4.04702 0.077731 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 3.28699 1.428436 43.45718 0.824708 
Probable 
transglycosylase isaA  P99160|ISAA_STAAN 1.58824 0.062809 3.954618 0.036263 
Putative surface 
protein SA2285  P61598|PLS_STAAN 0.11620 0.027602 23.75351 0.015936 
SA0841 protein  
Q7A6G0|Q7A6G0_STAA
N 5.79219 0.234411 4.04702 0.135337 
Thermonuclease  Q7A6P2|NUC_STAAN 2.04051 0.481623 23.603 0.278065 
Least Abundant Protein 
Enolase  P99088|ENO_STAAN 0.56152 0.022206 3.954618 0.012821 
    
Relative Standard Deviation 
Average 
    
13.64226 
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Appendix 21.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from post-exponential phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 
3.31918 0.860895 25.93696 0.497038 
Bifunctional autolysin 
Q99V41|ATL_STAAN 
2.15409 0.266903 12.39047 0.154096 
Glycerol phosphate 
lipoteichoic acid 
synthase  
Q7A6U1|LTAS_STAAN 
2.10945 0.312818 14.82936 0.180606 
Lipase 1  
P65289|LIP1_STAAN 
11.4446 2.180165 19.0496 1.258719 
Lipase 2  
Q7A7P2|LIP2_STAAN 
5.16867 0.42278 8.179669 0.244092 
Penicillin binding 
protein 2' 
Q7A8C6|Q7A8C6_STAA
N 
2.00154 0.555139 27.7356 0.32051 
Probable 
transglycosylase isaA  
P99160|ISAA_STAAN 
1.17618 0.0476 4.04702 0.027482 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 
0.14702 0.00595 4.04702 0.003435 
SA0841 protein  
Q7A6G0|Q7A6G0_STAA
N 
4.82990 0.502207 10.39788 0.28995 
Thermonuclease  
Q7A6P2|NUC_STAAN 
2.83787 0.759821 26.77427 0.438683 
Least Abundant Protein 
Enolase  
P99088|ENO_STAAN 
1.29414 0.134563 10.39788 0.07769 
 
 
  
Relative Standard Deviation 
Average 
 
 
  
14.88961 
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Appendix 22.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from stationary phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
2.58828 0.269126 10.39788 0.15538 
DNA-binding protein 
HU  
Q7A5J1|DBH_STAAN 0.52736 0.078205 14.82936 0.045151 
Elongation factor Tu  P99152|EFTU_STAAN 1.00641 0.139185 13.82975 0.080358 
Enolase  P99088|ENO_STAAN 1.38491 0.113281 8.179669 0.065403 
Formate--
tetrahydrofolate ligase  
Q7A535|FTHS_STAAN 0.73816 0.181347 24.5674 0.104701 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  
P99136|G3P1_STAAN 2.85928 0.498617 17.43857 0.287877 
Lipase 1  P65289|LIP1_STAAN 9.46840 1.319883 13.93987 0.762035 
Lipase 2  Q7A7P2|LIP2_STAAN 3.10395 0.125618 4.04702 0.072525 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.11164 0.038674 34.64102 0.022329 
SA0841 protein Q7A6G0|Q7A6G0_STAA
N 
12.1451 0.841333 6.927312 0.485744 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 2.58010 0.102033 3.954618 0.058909 
    Relative Standard Deviation 
Average 
    13.88659 
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Appendix 23.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from stationary phase 
 
Ten Most 
Abundant Proteins Accession Number 
Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAAN 1.12305 0.044413 3.954618 0.025642 
DNA-binding 
protein HU  Q7A5J1|DBH_STAAN 1.04784 0.041438 3.954618 0.023924 
Elongation factor Tu  P99152|EFTU_STAAN 1.15053 0.079701 6.927312 0.046016 
Enolase  P99088|ENO_STAAN 1.15606 0.159881 13.82975 0.092308 
Formate--
tetrahydrofolate 
ligase  Q7A535|FTHS_STAAN 1.17999 0.126798 10.74562 0.073207 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1_STAAN 1.20366 0.0476 3.954618 0.027482 
Lipase 1  P65289|LIP1_STAAN 1.59106 0.426635 26.81436 0.246318 
Lipase 2  Q7A7P2|LIP2_STAAN 1.20563 0.098617 8.179669 0.056937 
Putative surface 
protein SA2285  P61598|PLS_STAAN 0.09647 0.021376 22.15707 0.012342 
SA0841 protein 
Q7A6G0|Q7A6G0_STAA
N 1.55701 0.16731 10.74562 0.096597 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 1.35545 0.145652 10.74562 0.084092 
    
Relative Standard Deviation 
Average 
    
11.09171 
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Appendix 24.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and HA-MRSA USA200 from stationary phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
0.60183 0.0238 3.954618 0.013741 
DNA-binding protein 
HU  
Q7A5J1|DBH_STAAN 0.16219 0.072474 44.68319 0.041843 
Elongation factor Tu  P99152|EFTU_STAAN 0.07019 0.002776 3.954618 0.001603 
Enolase  P99088|ENO_STAAN 0.08088 0.00841 10.39788 0.004856 
Formate--
tetrahydrofolate ligase  
Q7A535|FTHS_STAAN 0.25040 0.017346 6.927312 0.010015 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  
P99136|G3P1_STAAN 0.05993 0.006437 10.74562 0.003716 
Lipase 1  P65289|LIP1_STAAN 0.49038 0.05099 10.39788 0.029439 
Lipase 2  Q7A7P2|LIP2_STAAN 0.58901 0.046006 7.810801 0.026562 
Putative surface 
protein SA2285  
P61598|PLS_STAAN 0.05076 0 0 0 
SA0841 protein Q7A6G0|Q7A6G0_STAA
N 
0.33828 0.026424 7.810801 0.015256 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 0.32728 0.071125 21.73185 0.041064 
    Relative Standard Deviation 
Average 
    11.67405 
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Appendix 25.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from stationary phase 
 
Ten Most Abundant 
Proteins Accession Number 
Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 15.6923 1.631676 10.39788 0.942049 
DNA-binding protein 
HU  Q7A5J1|DBH_STAAN 0.77599 0.031404 4.04702 0.018131 
Elongation factor Tu  P99152|EFTU_STAAN 2.19483 0.088825 4.04702 0.051283 
Enolase  P99088|ENO_STAAN 1.92932 0.340877 17.66821 0.196805 
Formate--
tetrahydrofolate ligase  Q7A535|FTHS_STAAN 1.71544 0.260877 15.20752 0.150617 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1_STAAN 5.61599 1.171247 20.85556 0.67622 
Lipase 1  P65289|LIP1_STAAN 5.68343 0.657191 11.56327 0.37943 
Lipase 2  Q7A7P2|LIP2_STAAN 7.87275 1.167478 14.82936 0.674044 
Putative surface 
protein SA2285  P61598|PLS_STAAN 0.11324 0.035899 31.69967 0.020726 
SA0841 protein 
Q7A6G0|Q7A6G0_STAA
N 5.16021 0.204067 3.954618 0.117818 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 16.7655 0.663015 3.954618 0.382792 
    
Relative Standard Deviation 
Average 
    
12.56589 
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Appendix 26.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from stationary phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative 
Standard 
Deviation 
Standar
d Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
14.2620 0.577188 4.04702 0.33324 
DNA-binding protein HU  Q7A5J1|DBH_STAAN 10.0847 0.408134 4.04702 0.235636 
Elongation factor Tu  P99152|EFTU_STAAN 16.1745 2.820606 17.43857 1.628478 
Enolase  P99088|ENO_STAAN 15.0243 2.077825 13.82975 1.199633 
Formate--tetrahydrofolate 
ligase  
Q7A535|FTHS_STAAN 9.30818 3.193771 34.31142 1.843925 
Glyceraldehyde-3-phosphate 
dehydrogenase 1  
P99136|G3P1_STAAN 10.9418 2.050485 18.73978 1.183848 
Lipase 1  P65289|LIP1_STAAN 18.4655 2.135221 11.56327 1.23277 
Lipase 2  Q7A7P2|LIP2_STAAN 19.6983 0 0 0 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 0.46480 0.110408 23.75351 0.063744 
SA0841 protein Q7A6G0|Q7A6G0_STA
AN 
19.6983 0 0 0 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 11.4446 2.180165 19.0496 1.258719 
    Relative Standard Deviation 
Average 
    13.34363 
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Appendix 27.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA300 from stationary phase 
 
Ten Most Abundant 
Proteins Accession Number 
Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 7.15414 0.768757 10.74562 0.443842 
DNA-binding protein 
HU  Q7A5J1|DBH_STAAN 0.37107 0.030353 8.179669 0.017524 
Elongation factor Tu  P99152|EFTU_STAAN 0.21798 0.015101 6.927312 0.008718 
Enolase  P99088|ENO_STAAN 0.30827 0.021355 6.927312 0.01233 
Formate--
tetrahydrofolate ligase  Q7A535|FTHS_STAAN 0.23440 0.029044 12.39047 0.016769 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1_STAAN 0.17706 0.012265 6.927312 0.007081 
Lipase 1  P65289|LIP1_STAAN 4.01386 1.149492 28.63803 0.663659 
Lipase 2  Q7A7P2|LIP2_STAAN 6.71829 1.187002 17.66821 0.685316 
Putative surface 
protein SA2285  P61598|PLS_STAAN 0.06129 0.006374 10.39788 0.00368 
SA0841 protein 
Q7A6G0|Q7A6G0_STAA
N 1.95856 0.160204 8.179669 0.092494 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 1.74389 0.120805 6.927312 0.069747 
    
Relative Standard Deviation 
Average 
    
11.26443 
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Appendix 28.  Statistical analyses of the first biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from stationary phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative 
Standard 
Deviation 
Standar
d Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
1.74110
1 
0 0 0 
DNA-binding protein HU  Q7A5J1|DBH_STAAN 0.63029
9 
0.025508 4.04702 0.014727 
Elongation factor Tu  P99152|EFTU_STAAN 1.12489
7 
0.092013 8.179669 0.053124 
Enolase  P99088|ENO_STAAN 0.96134
2 
0.13401 13.93987 0.077371 
Formate--tetrahydrofolate 
ligase  
Q7A535|FTHS_STAAN 0.79542
2 
0.065063 8.179669 0.037564 
Glyceraldehyde-3-phosphate 
dehydrogenase 1  
P99136|G3P1_STAAN 1.38702
5 
0.144221 10.39788 0.083266 
Lipase 1  P65289|LIP1_STAAN 6.99713
1 
0.809097 11.56327 0.467133 
Lipase 2  Q7A7P2|LIP2_STAAN 5.66591
7 
0.392496 6.927312 0.226608 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 0.08485
9 
0.023239 27.38478 0.013417 
SA0841 protein Q7A6G0|Q7A6G0_STA
AN 
5.53058 0.218713 3.954618 0.126274 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 4.39652
9 
0.343404 7.810801 0.198264 
    Relative Standard Deviation 
Average 
    9.307717 
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Appendix 29.  Statistical analyses of the second biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from stationary phase 
 
Ten Most Abundant 
Proteins Accession Number 
Averag
e 
Standard 
Deviation 
Relative Standard 
Deviation 
Standard 
Error 
Alpha-Hemolysin  
Q7A632|Q7A632_STAA
N 1.41647 0.098124 6.927312 0.056652 
DNA-binding protein 
HU  Q7A5J1|DBH_STAAN 1.15059 0.079701 6.927312 0.046016 
Elongation factor Tu  P99152|EFTU_STAAN 1.78853 0.192189 10.74562 0.11096 
Enolase  P99088|ENO_STAAN 1.76009 0.306935 17.43857 0.177209 
Formate--
tetrahydrofolate ligase  Q7A535|FTHS_STAAN 1.49338 0.227107 15.20752 0.13112 
Glyceraldehyde-3-
phosphate 
dehydrogenase 1  P99136|G3P1_STAAN 1.66876 0.179319 10.74562 0.10353 
Lipase 1  P65289|LIP1_STAAN 2.04784 0.082877 4.04702 0.047849 
Lipase 2  Q7A7P2|LIP2_STAAN 1.82740 0.149475 8.179669 0.0863 
Putative surface 
protein SA2285  P61598|PLS_STAAN 0.14046 0.064804 46.13595 0.037415 
SA0841 protein 
Q7A6G0|Q7A6G0_STAA
N 2.58010 0.102033 3.954618 0.058909 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 1.87803 0.259728 13.82975 0.149954 
    
Relative Standard Deviation 
Average 
    
13.10354 
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Appendix 30.  Statistical analyses of the third biological replicate comparing HA-
MRSA USA100 and CA-MRSA USA400 from stationary phase 
 
Ten Most Abundant 
Proteins 
Accession Number Averag
e 
Standard 
Deviation 
Relative 
Standard 
Deviation 
Standar
d Error 
Alpha-Hemolysin  Q7A632|Q7A632_STAA
N 
0.72515 0.056641 7.810801 0.032701 
DNA-binding protein HU  Q7A5J1|DBH_STAAN 0.17286 0.067446 39.01742 0.03894 
Elongation factor Tu  P99152|EFTU_STAAN 0.08880 0.010269 11.56327 0.005929 
Enolase  P99088|ENO_STAAN 0.12221 0.004833 3.954618 0.00279 
Formate--tetrahydrofolate 
ligase  
Q7A535|FTHS_STAAN 0.23961 0.025748 10.74562 0.014866 
Glyceraldehyde-3-phosphate 
dehydrogenase 1  
P99136|G3P1_STAAN 0.07031 0.018855 26.81436 0.010886 
Lipase 1  P65289|LIP1_STAAN 2.60351 0.817272 31.39105 0.471852 
Lipase 2  Q7A7P2|LIP2_STAAN 1.70223 0.067317 3.954618 0.038865 
Putative surface protein 
SA2285  
P61598|PLS_STAAN 0.05076 0 0 0 
SA0841 protein Q7A6G0|Q7A6G0_STA
AN 
1.35107 0.054678 4.04702 0.031569 
Least Abundant Protein 
Serine protease splB Q7A4Y1|SPLB_STAAN 0.45432 0.196599 43.27277 0.113506 
    Relative Standard Deviation 
    16.59741 
 
